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ABSTRACT
Urinary tract infections (UTIs) are among the most common bacterial infections in
humans, accounting for $3.5 billion in health care expenditures yearly in the United States alone.
Yet, treatments for UTI have seen little innovation over the past decade. As demonstrated in
other body sites, such as the vagina and gastrointestinal (GI) tract, acute and infectious diseases
often have indirect microbial contributions which serve as intriguing new targets for therapies.
The recent discovery of the existence of a resident community of bacteria (i.e., microbiota) in the
bladders of both women and men, represents a novel avenue for targeting UTIs. However, before
targeted approaches aimed at modulating the urinary microbiota can be thoroughly investigated,
it is first necessary to understand the normal modulations of these bacteria in the context of the
host.
Temporal dynamics in the vaginal and GI microbiota have been well described, and often
linked to lifestyle factors or behaviors. Rigorous, longitudinal studies are required to study these
trends. To date, few studies have assessed the urinary microbiota in such a manner – none were
comprehensive, and all were in the context of lower urinary tract symptoms. This is primarily due
to the impracticality of collecting repeated transurethral catheterized urine specimens for
analysis.
I sought an extensive and in-depth analysis of the temporal dynamics of the lower urinary
tract (LUT) microbiota in individuals without confounding urinary symptoms or disorders.
xix

Moreover, I intend to determine if any observed changes have correlations to participantreported lifestyle factors. Through these analyses, I will aim to achieve three things. First, these
data will provide the first description of the normal dynamics of the LUT microbiota. Second, our
study design will serve as a framework for future research on this topic. Finally, our findings will
increase our understanding of the development, risk, and prevention of UTIs by identifying
patterns and potential causes of fluctuations within the LUT microbiota.
In this thesis, I performed a clinical survey study as well as traditional mechanistic
investigations to describe and understand the relationship between urinary microbiota dynamics
and lifestyle. In the primary clinical study, I used next-generation sequencing and bacterial
culture, as previously described and validated, to identify and taxonomically characterize the
bacteria present in mid-stream voided urine (MSU) and peri-urethral swab specimens obtained
daily from healthy, pre-menopausal women, for three months. Measures of microbiota temporal
stability as well as changes in microbiota composition and alpha-diversity were obtained. I
assessed for relationships between these values and various participant-reported lifestyle
factors. Ultimately, I found that reporting of menstruation and sexual activity had significant
impact on the microbiota of the MSU specimens in particular. The microbiota variability was
observed across participants, while specific trends were very individualized but were consistent
over time.
I then sought to determine if the lifestyle factors were directly responsible for the
observed microbiota changes. I chose to investigate sexual intercourse in particular because of
the literature-documented epidemiological association with UTI risk in women. I first
xx

investigated the biological mechanism of these changes by analyzing specimens from male and
female sexual partners. I determined that urinary Streptococcus isolates, which appear in
elevated abundance in the MSU specimens of the female following sexual intercourse, are
genomically related to isolates from the male’s oral flora. These data suggest that direct
movement of bacteria between sexual partners results in altered female LUT microbiota
following sexual intercourse. I then asked what the clinical significance of these changes were by
studying the in vitro phenotypes of isolates from the normal LUT flora (i.e., Lactobacillus) as well
as isolates from MSU specimens following sexual intercourse (i.e., Streptococcus). In relation to
UTI risk, I found that urinary Lactobacillus isolates were bacteriostatic against strains of
uropathogenic Escherichia coli (UPEC) while urinary Streptococcus isolates were not. These
findings may directly relate to sexual intercourse and UTI risk, in which the normal LUT flora are
protective against UTI, while the flora following sexual intercourse are not.
Altogether, these data show that the LUT microbiota are dynamic and directly respond to
lifestyle. Large clinical studies should be performed to further investigate the clinical significance
of these findings.

xxi
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CHAPTER I
INTRODUCTION AND LITERATURE REVIEW
The Human Microbiota
Bacteria and archaea evolved about 3 billion years ago and have since adapted to every
conceivable niche on Earth, including the human body. Much as the soil of a tropical rainforest
harbors a unique but specific community of microorganisms, so do our bodies. These
microorganisms are highly adapted to each of our organs and provide us with a range of vital
functions that have yet to be fully appreciated or understood. Considering that these
microorganisms are equal in number to our somatic cells1, the extent of their influence is
seemingly infinite.
The microorganisms that colonize our bodies are collectively known as the human
microbiota. These microbes, which include bacteria, bacteriophage, fungi, protozoa, and viruses,
when defined by their genomes, are referred to as the human microbiome. From a medical
perspective, microbes have traditionally been associated with disease and, as such, our primary
focus has been on eliminating and preventing their colonization of the human body. The Human
Microbiome Project (HMP) represents the first major shift from studying microbes in relation to
disease to exploring them in the context of health. The HMP used culture-independent methods
to characterize the populations of microorganisms that naturally colonize humans (i.e., not in the
context of disease). The project sampled a cohort of 300 individuals at five different body sites:
v
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2

the gastrointestinal (GI) tract, oral cavity, vaginal/urogenital tract, skin, and nasal cavity2. Besides
providing an in-depth comprehensive description of the microbiome at each body niche, the
project generated two important conclusions. The first was that, although the diversity and
abundance of microbes varied dramatically, each body niche sampled showed a level of
specificity that was consistent within and between subjects. This means that the microbiome of
a particular body niche is more similar amongst people than it is amongst other body niches2. The
second conclusion was that the human microbiome has a degree of plasticity; the abundance and
diversity of microorganisms within a person is not constant2. Recent research shows that this
plasticity is largely determined by our lifestyle choices and behaviors - a topic that will serve as
the main focus of this thesis.
The Role of the Human Microbiota
The human microbiota play essential roles in a variety of processes throughout the body.
These include priming the immune system to recognize “self” versus “non-self” antigens,
breaking down indigestible food using fermentation, synthesizing several key vitamins, and
inhibiting colonization of pathogenic microorganisms. In return, our bodies provide protection,
energy sources, and ideal growth conditions for the microbes. The symbiotic nature of this
relationship leads to the opportunity for disease should an imbalance arise. Therefore, the
balance of benefit versus harm depends largely on the overall state of the microbiota in terms of
its distribution, diversity, and composition3. As a result, the microbiota are also associated with
numerous diseases, including inflammatory bowel disease (IBD)4 5, cancer6, and depression7.

3
The associations with both health and disease make the human microbiota an innovative
clinical target. Modulating the microbiota for preventative or therapeutic means is a novel
approach to targeting disease. These approaches, while still in their infancy, can generally be
classified into three models: additive, subtractive, or modulatory therapies. Additive therapy
involves introducing natural or engineered strains or consortia of microorganisms to supplement
the existing microbiota. Subtractive therapy is the targeted elimination of harmful members of
the microbiota. Modulatory therapy is the addition of non-living matter, such as prebiotics, which
are used to alter the composition or activity of the microbiota8. In recent years, a massive amount
of research has gone into studying these approaches, which ultimately have the potential to
revolutionize and personalize clinical treatments. Early data show incredibly promising results;
for example, the use of fecal microbiota transplantation for treatment of Clostridium difficile
infection9.
Measuring the Microbiome
Targeting the genomes of microorganisms in a given population provides a less biased
means of classifying and characterizing the microbiota, than do approaches that first require
culturing of the microorganisms. Next Generation Sequencing (NGS) is a culture-independent
method for analyzing a population of microorganisms from a particular specimen. NGS uses
massively parallel sequencing methods to generate large numbers of relatively short sequence
reads. NGS can be performed on a clonal bacterial isolate [e.g., Whole Genome Sequencing
(WGS)] or on a patient or environmental specimen containing a complex population of microbes

4
(i.e., metagenomics). Both approaches can be used to understand the gene content of a bacterial
isolate or specimen; they can also be used to taxonomically classify microbes.
The most widely used method to taxonomically classify bacteria makes use of the 16S
rRNA gene. When transcribed, this ~1500 base gene forms an RNA molecule that serves as a key
component of the cell’s ribosomes by acting as a binding scaffold for ribosomal proteins. As such,
the 16S rRNA gene is essential to the cell and is highly conserved throughout the bacterial
domain9 10. The 16S rRNA gene contains some regions that are highly conserved and others that
are highly variable. The nine variable regions of the 16S rRNA gene (i.e., V1-V9) contain
polymorphisms that provide the means for measuring evolutionary and phylogenetic
relatedness9

. The 16S rRNA gene sequence can be determined using shotgun amplicon
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sequencing. This approach uses universal primers to amplify and thus sequence the gene from a
mixed population of bacteria (e.g., a patient specimen). However, NGS generates short sequence
reads; thus, only one to three of the variable regions can be targeted at once. The full sequence
of the 16S rRNA gene is generally necessary to obtain species-level taxonomic classifications.
Therefore, shotgun amplicon sequencing of the 16S rRNA gene usually only provides adequate
data for family and/or genus-level taxonomic classifications. However, a recently developed
probabilistic-based approach to evaluate taxonomic classifications [i.e. Bayesian LCA-based
Taxonomic Classification Method (BLCA)] can attain accurate species-level identifications for
some partial 16S rRNA gene sequences11.
Studies employing 16S rRNA gene sequencing assess differences in observed communities
of bacteria amongst samples to obtain statistically significant correlations between sample type
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and either bacterial composition or biodiversity12. These studies have provided key data
describing microbiome differences among specimens and environments, over time, between
individuals, and between health and disease states. However, these studies are also limited to
providing only bacterial identifications. Shotgun metagenomics goes beyond identification and
provides functional potential of the genomic content. In this approach, the genomes within a
patient sample are fragmented, sequenced, and aligned to reference genomes or assembled de
novo using overlapping reads. Not only does this approach offer further insight into phylogenetic
relatedness of the microbes, it also provides knowledge of the potential role of the microbial
community.
Analyzing Microbiome Data
16S rRNA amplicon sequencing relies on polymerase chain reaction (PCR) amplification to
isolate and amplify the gene, or variable region of the gene. This approach does not supply
quantitative data for several reasons, including biases in the amplification process, differential
amplification rates of sequences, and the presence of multiple copies of the 16S rRNA gene in
most bacterial strains. Therefore, data regarding the number of sequence reads obtained in a
given sample cannot be directly compared to other samples. Because of this limitation,
microbiome data are typically represented in terms of relative abundance. Relative abundance
values are the percent composition of a taxon relative to the total number of taxa in the
community. For sequencing data, this refers to the percent of sequence reads for a taxa relative
to the total number of sequence reads in that sample. When presented in this manner, relative
abundance plots show how common or rare a taxon is relative to other taxa in the sample.
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Statistical measures can be performed comparing these percentages between specimens.
Relative abundance data can also be used to make generalized groupings of samples based on
the dominant taxa present. These are referred to as enterotypes in the context of the GI
microbiome13, community state types (CSTs) in the vagina14, and urotypes in urine15. These
groupings are determined by clustering samples based on taxonomic similarities (e.g., Bray-Curtis
dissimilarity measurements).
Early studies assessing the microbiome were largely exploratory. As such, methods to
investigate differences between and among groups were also exploratory. Principal coordinate
analysis (PCoA) is a common method used to assess and emphasize similarities and differences
within a population. Data are transformed into principal components, where the first principal
component has the largest possible variance and each succeeding orthogonal component has the
next highest variance. When plotted, data points with distinct variance patterns will appear far
apart, while data points with similar variance will cluster together. Various metadata can then be
applied to determine qualitatively if trends exist. For example, PCoA of microbiome data
collected from the HMP showed distinct clusters that corresponded well to specimen type,
despite there being no individual taxa that alone could discriminate specimen types2.
The complexity of microbiome data can also be expressed through biodiversity measures.
The diversity of species within a population (i.e., alpha-diversity) is a measure of both species
richness and species evenness. Richness refers to the number of unique species, while evenness
is how the species are distributed in the population. Various alpha-diversity calculations rely on
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one or both of these measures. Mean alpha-diversity can be calculated for a group and statistical
measures can be used to determine significance between or among groups.
The microbiome can be assessed between subjects or within subjects over time. Temporal
measurements of the microbiome within a subject include assessments of both stability and
resiliency. Stability refers to the level of change over time, while resiliency refers to the
permanence of the change. These metrics can be assessed using measures of similarity, such as
Bray-Curtis Dissimilarity or Jensen-Shannon Divergence. Measuring the rate of change in these
values or variability within the means provides information regarding stability and resiliency.
These measures often serve as exploratory analyses that generate testable hypotheses.
“Urine Denial”: The Concept of Bladder Sterility
The human urinary bladder is a muscular organ that collects and stores urine from the
kidneys. The kidneys function to filter and eliminate waste from the blood and maintain overall
fluid balance. Waste, in the form of urine, exits the kidneys and passes into the bladder via the
ureters. A typical urinary bladder can hold 300 to 500 milliliters (mL) of urine before a sensation
of urge is experienced. When urine is being stored, the detrusor muscle surrounding the bladder
is relaxed, and the internal urethral sphincter remains tense preventing urine from exiting the
bladder. During urination, the detrusor muscle is voluntarily contracted, and the internal urethral
sphincter relaxes allowing urine to exit the bladder, pass through the urethra, and out of the
body16.
Urine is an aqueous solution of mostly (>95%) water, but also includes various
nitrogenous molecules, such as urea and creatinine, ions such as chloride, sodium, and
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potassium, and other metabolic waste components including proteins and hormones. The exact
proportions of the various constituents of urine vary among individuals and also with factors such
as diet and health17.
Traditionally, bladder urine has been considered sterile in the absence of clinical infection.
This concept is largely grounded by work done in the mid-twentieth century by Dr. Edward Kass,
who sought to establish a diagnostic means to determine risk of pyelonephritis (i.e., kidney
infection) in patients undergoing pelvic surgeries18. To identify a valid diagnostic, Kass assessed
urine from symptomatic and asymptomatic women and determined that bacterial levels greater
than 105 colony forming units per milliliter (CFU/mL) urine could distinguish between infection
and contamination in these patients19. Using this technique, patients who screened positive were
given antibiotic treatments prior to surgery, which ultimately improved outcomes and lowered
incidence of pyelonephritis19. Because of the dramatic clinical improvement and effectiveness of
this diagnostic measure, the medical field slowly adopted it as a means to also diagnose acute
bladder infections.
The misconceptions surrounding bladder sterility were further entrenched by the notion
that potential urinary pathogens originate from the bowel and colonize the bladder and urinary
system by ascension through the urethra20. Such a notion supports the idea that acute bladder
infections are solely the result of enteric organisms, like Escherichia coli. As such, a culturedependent method specifically designed to cultivate these organisms was used in conjunction
with Kass’s diagnostic threshold. These assumptions, together with the fact that acute bladder
infections rarely progress to pyelonephritis, and the observation that a large percentage of
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bladder infections resolve spontaneously (25-45% of women)21 22, created a situation whereby
the re-evaluation of knowledge was considered unnecessary and medically unimportant.
It remained understood that the bladder was sterile until a decade into the twenty-first
century, though earlier attempts to overturn this idea were reported. For example, Rosalind
Maskell and co-workers showed that patients with symptoms of bladder infection had slowgrowing, non-enteric organisms present at lower than acceptable thresholds23 24. Stamm et al.
collected midstream voided urine (MSU) specimens from symptomatic women (n=187) and
found that only 51% would have been diagnosed with a urinary tract infection (UTI) by standard
definitions25. They found that use of 102 CFU/mL would be a more appropriate diagnostic as this
had high sensitivity and specificity values25. Furthermore, Stark et al. collected transurethral
catheter (TUC) urine specimens from 110 symptomatic patients, 34 of which had >105 CFU/mL of
bacteria26. However, in 41 patients who had bacteria at <105 CFU/mL, 96% had subsequent urine
cultures, usually within three days of the original, that reached >105 CFU/mL26. This shows that
failure to treat at lower thresholds in symptomatic patients usually develops into higher bacterial
counts. Despite all of these data, which clearly showed that standard approaches to diagnosing
acute bladder infections were not clinically appropriate, it was not until the advent of DNA-based
evidence in the 2010s that a re-interpretation of these methods was generally accepted.
The Discovery of the Female Urinary Microbiota and Microbiome
In part, due to the circumstances described above, the HMP did not publish a description
of the microbiome of the bladder or lower urinary tract. However, Nelson et al. assessed voided
urines (i.e., non-catheterized), using 16S rRNA gene sequencing to show that diverse bacteria
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colonized the urogenital tract of the adult male28. They also showed that these bacterial
communities differed between men with and without sexually transmitted infections (STIs), and
that those with STI had predominantly anaerobic and previously uncultivated bacteria27. Another
study by the same authors demonstrated similarities between the bacterial communities of
paired voided urine specimens and urethral swabs28. These data show that previously undetected
bacteria colonize the male urogenital tract and may relate to urinary symptoms. A detailed
discussion of the findings in men is located in the section, Description of the Male Urinary
Microbiota.
In an effort to determine if the findings in men were applicable to women, Wolfe et al.
used 16S rRNA gene sequencing to assess the microbiome of voided urine specimens from
women who did not meet the clinical and microbiologic criteria for a UTI (i.e., symptomatic and
>105 CFU/mL of non-vaginal or skin flora on blood or MacConkey agar incubated in ambient
atmosphere at 35°C for 24 hours)29. Additional specimens were collected from study patients to
distinguish vulvo-vaginal contamination from true inhabitants of the bladder. Suprapubic
aspirates (SPA) (i.e., collection of urine directly through the lower abdomen using a needle) and
TUC urine samples were collected, analyzed, and compared to the voided urine, a vaginal swab,
and a skin swab from the SPA needle insertion site29. Bacterial composition and diversity were
similar between SPA and TUC urine, but different from the vaginal and skin swabs, as well as the
voided urine, which contained a mixture of urinary (i.e., SPA and TUC) and genital (i.e., vulvovaginal) flora29. Because SPA and TUC specimens sample bladder urine, Wolfe et al. concluded
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that the bladders of women contain a unique microbiome that, similarly to men27 28, contain
bacterial genera not cultivated by the standard urine culture (SUC) method29.
The findings in females by Wolfe et al. have since been verified by others30

31 32 33

.

Unsurprisingly, the data using 16S rRNA gene sequencing were in stark contrast to data obtained
from SUC-dependent methods, even from the same urine specimen. Data for Patient 18 from the
Wolfe et al. study clearly show these discrepancies (Figure 1). This figure shows the 16S rRNA

Figure 1. Bacterial Abundance, Culture, and Gram-Stain Results for Patient 18. Pie charts (left)
of the most abundant bacterial genera of TUC (A), SPA (B), sham-needle stick (C), and skin swab
(D) using 16S rRNA gene sequencing from Patient 18, a culture-positive patient. Pie chart of SUC
culture data (right) from TUC urine. Gram-stain assessment (bottom) of TUC urine showing
Gram-positive cocci (A & B) and Gram-negative rods (C) (Wolfe et al, 2012).
gene sequencing data for the various specimen types (left panels), the SUC culture results for the
TUC specimen (right), and the Gram-stain results for the TUC specimen (bottom) from a single
patient29. The left panels are an example of the difference in bacterial composition and
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abundance amongst the specimen types; similarities exist between TUC and SPA urine. However,
the data between 16S rRNA gene sequencing and bacterial culture for the TUC urine specimen
differ dramatically. The SUC method showed the presence of 105 CFU/mL of E. coli, which
accounted for 100% of detected bacteria using this approach. However, the sequencing data
showed that E. coli comprised less than 1% of the total bacteria sequences. The TUC urine had
50 times greater relative abundance of Aerococcus and 17 times more Actinobaculum (now called
Actinotignum). Furthermore, Gram-stain assessment (bottom) of the TUC urine showed that the
non-E. coli bacterial DNA is not entirely exogenous (e.g., from dead and lysed cells), as Grampositive cocci (possibly indicative of Aerococcus and Actinobaculum) are clearly visible in panels
A and B. The discrepancy between the results lies in limitations associated with the SUC method.
In a clinical laboratory, a urine specimen will undergo the SUC protocol for the detection of
urinary infections. This protocol involves plating 0.001 mL of urine spread quantitatively onto 5%
sheep blood (BAP) and MacConkey agars (BD BBL™ Prepared Plated Media, Cockeysville, MD)
and incubated aerobically at 35°C for 24 hours. The SUC protocol would not be appropriate for
growth of many of the organisms detected by 16S rRNA gene sequencing, as most are facultative
or strict, slow-growing anaerobes. To invesitgate this, Hilt et al. designed a more appropriate
protocol [i.e., the Expanded Quantitative Urine Culture (EQUC) protocol]34. EQUC uses 0.1 mL of
urine spread quantitatively onto BAP, Chocolate, and Colistin Naladixic Acid (CNA) agars (BD
BBL™ Prepared Plated Media) and incubated in 5% CO2 at 35°C for 48 hours; BAP incubated
aerobically at 35°C for 48 hours; CDC Anaerobic 5% sheep blood (Anaerobic BAP) agar (BD BBL™
Prepared Plated Media) incubated anaerobically at 35°C for 48 hours. Each distinct colony
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morphology was sub-cultured at 48 hours to obtain pure culture for microbial identification34.
Comparatively, EQUC uses 100 times more urine, allowing for detection of microbes at the lower
threshold of 10 CFU/mL urine, two times longer incubation times to allow for growth of fastidious
and slow growing organisms, non-aerobic incubation conditions for the growth of facultative and
strict anaerobes, and selective media for Gram-positives (i.e. CNA) and fastidious organisms
(Chocolate agar). Hilt et al. used EQUC to examine the microbiota of 65 TUC urine specimens and
compared the results to SUC. 80% (52/65) of the TUC urine specimens had bacterial growth
detected by EQUC; 92% (48/52) of those specimens were reported as no growth (< 103 CFU/mL
urine) by SUC34. Microbial identification was determined using a Matrix-Assisted Laser
Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDI-TOF MS, Bruker Daltonics,
Billerica, MA). Genera detected by EQUC largely matched those observed by 16S rRNA gene
sequencing.
Together, Wolfe et al. and Hilt et al. showed that both bacterial DNA and live cultivatable
bacteria exist in catheterized (i.e., TUC) urine specimens in women, effectively showing that
bladder urine is not sterile29 34.
Urine is Not Sterile: Now What?
The finding that communities of bacteria exist in an environment previously thought to
be sterile raises numerous clinical and basic science questions. These questions can be
appropriately grouped into the canonical problem-solving questions. “Who”: Which
microorganisms are present normally, and does this differ by demographic and clinical measures?
“What”: What is the role of the microbiota? Do they interact with the urothelium and immune
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system? Do they interact with each other? “When”: When is the microbiota established - at birth
or beyond? “Where”: Where do the bacteria reside? Are they associated with the uroepithelial
tissue of the bladder? Do they transit between pelvic floor sites? “Why”: Does the microbiota
contribute in previously undescribed ways to the etiologies of any lower urinary tract diseases or
disorders? is it protective against colonization of pathogenic microbes? “How”: How do the
microbiota change over time and, if so, does this relate to environment and lifestyle? At the time
of writing this thesis, some of these questions have begun to be explored. The final question (i.e.
“How”) will be addressed here. In this section, we provide an up-to-date description of data
relating to each of these questions in relation to the female urinary microbiota. For a description
of the male urinary microbiota and a comparison to female, see the section Description of the
Male Urinary Microbiota.
Since the discovery of the female urinary microbiome and microbiota in 2012, several
research groups have published descriptive studies on this topic. Because these groups employed
a variety of methods and techniques to study the bacterial communities, it is difficult to directly
compare data. In general, however, these studies detected similar populations of bacteria [e.g.,
microorganisms typically found in the vagina, such as Lactobacillus and Gardnerella, but also a
distinct set of mainly Gram-positive bacteria, including Streptococcus, Staphylococcus, and
Corynebacterium (see Figure 2)] and thus came to comparable conclusions. The techniques
varied by urine specimen type (e.g., MSU, TUC, SPA), whether culture-dependent or DNA–
dependent approaches were used, the volume of urine used for DNA extraction (ranged from
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Figure 2. Phylogenetic tree representing diversity of bacteria cultured from the female
bladder. A representation of the full bacterial diversity (n=149 isolates) that can be isolated
using the EQUC method from TUC urine specimens. Visualization was done in iTOL (ThomasWhite et al, 2018).
0.1mL to 30mL), the DNA extraction method (e.g., magnetic-bead extraction, phenol-chloroform
extraction), and which hypervariable region(s) was (were) amplified. A discussion of data
collected entirely from MSU specimens is located in the section, Longitudinal Assessment of the
Lower Urinary Tract Microbiota – What Specimen to Collect?
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Correlations with Health and Disease
A comprehensive analysis of the urinary microbiota of TUC specimens in healthy women
of varying demographics has yet to be published. However, several studies used small cohorts of
healthy women as controls for comparison to particular disease populations15 31 35 36. I compiled
EQUC and 16S rRNA gene sequencing data on TUC urine specimens from 224 healthy female
patients and compared the data across demographics and clinical variables. These patients were
recruited from various studies15 34 35 performed at Loyola University Chicago from 2013-2018. In
summation, I found that the urinary microbiota profiles are highly stratified by dominant taxa.
For these participants, I determined the urotype (classified by a genus with >50% relative
abundance; if no genus has ≤50% relative abundance, the specimen is designated as ‘mixed’) and
found that women with a Gardnerella urotype were likely to be younger, have a higher body
mass index (BMI), and a low median vaginal parity score (i.e., number of vaginal deliveries).
Women with an Escherichia urotype were likely to be older and post-menopausal, and unlikely
to engage in vaginal intercourse.
Correlations between the female urinary microbiota and various lower urinary tract
diseases and disorders have been described, including: urinary incontinence (UI)15 35 37 38 39 40 41,
interstitial cystitis/painful bladder syndrome (IC/PBS)33

, UTI and UTI symptoms43

36 42

,

44 45 46

overactive bladder (OAB)34 47 48, and neuropathic bladder30 49. These are described below.
UI is described in more detail in Appendix B, where I correlate symptom severity, as
defined by urinary distress inventory (UDI) questionnaire scores, to the urinary microbiota and
microbiome using EQUC and 16S rRNA gene sequencing. Pearce et al. collected TUC specimens
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from 182 women with urgency urinary incontinence (UUI), a form of UI combining leakage of
urine (incontinence) with feelings of urgency37. Using 16S rRNA gene sequencing of the V4
hypervariable region to analyze 1mL TUC specimen, 51% (93/182) had a detectable urinary
microbiome (i.e., “sequence-positive”)37. The sequence-positive patients tended to be
dominated by Lactobacillus or Gardnerella (i.e., urotypes)37. Thomas-White et al. also used 16S
rRNA gene sequencing of the V4 hypervariable region to assess 1 mL TUC specimens from women
with UUI (n=74)35. These data were compared to a non-UI cohort (n=60). They found that UUI
patients have higher alpha diversity levels, and similarly to Pearce et al. the majority of the
specimens were dominated by Lactobacillus and Gardnerella35. This finding contrasts with data
from Karstens et al., who also used 30 ml TUC specimens and 16S rRNA gene sequencing of the
V4 hypervariable region but recruited a smaller sample size [UUI (n=10); non-UI (n=10)]31. They
found lower diversity levels in the UUI cohort31. Brubaker et al. recruited 155 women with UUI as
part of a clinical trial to assess cystoscopic onabotulinum toxin A infection and oral placebo
medication versus cystoscopic placebo injection and active oral medication for UUI treatment50.
Using 16S rRNA gene sequencing of the V4 hypervariable region to assess 1mL TUC specimens,
39% (60/155) had a detectable urinary microbiome, with similar composition to previous
studies50. These patients (n=60) had a significantly higher mean number of UUI episodes per
day50. Finally, Komesu et al. recruited women with (n=123) and without (n=84) mixed urinary
incontinence, a form of UI encompassing symptoms of both UUI and SUI (stress urinary
incontinence)40. 16S rRNA gene sequencing of the V4-V6 hypervariable regions were performed
on 0.28 mL of urine collected from TUC specimens40. Post-hoc analyses found more Lactobacillus
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and Mixed urotypes in younger (<51 years old) women40. Collectively, these data show that
trends exist between the female urinary microbiota and UI, as well as UI subtypes (i.e., UUI and
MUI).
IC/PBS is described in detail in Appendix C and Appendix D. I saw no difference in
composition or diversity between the urinary microbiota (using EQUC) or microbiome (using 16S
rRNA gene sequencing of the V4 hypervariable region) in MSU specimens of women with IC/PBS
(n=21) and demographically similar non-IC/PBS women (n=20) in a small case-controlled study
described in Appendix C. Using EQUC on TUC specimens, however, I saw a higher frequency of
the Streptococcus urotype in women with IC/PBS (n=49) compared to women without (n=40);
this is described in more detail in Appendix D. Other groups have also sought a relationship
between the urinary microbiota and IC/PBS. Abernathy et al. collected TUC specimens from 40
women, half with IC/PBS and half without. 16S rRNA gene sequencing (hypervariable region was
not specified) showed lower richness and lower abundance of Lactobacillus (particularly
Lactobacillus acidophilus) in the IC/PBS cohort36. Using 16S rRNA gene sequencing on clean catch
voided urine, Siddiqui et al. observed the opposite trend with Lactobacillus having an overall
higher abundance in women with IC/PBS (n=8)33. The data were not compared to a control
population33. Finally, Nickel et al. analyzed initial void and MSU specimens from 213 patients with
IC/PBS42. Some patients were currently experiencing symptom flares (n=86), while others were
not (n=127)42. DNA sequencing was done on 3 mL of urine using taxa-specific primer pairs,
including a pair for fungi. No taxa other than the yeast genera Candida and Saccharomyces were
significantly different between groups; the fungal taxa were more prevalent in the flare group42.
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Altogether, these data show somewhat conflicting results for associations between the female
urinary microbiota and IC/PBS, making it difficult to reach a definitive conclusion regarding a
microbiologic etiology for IC/PBS. More research on this topic should be done.
UTI diagnosis, etiologies, and symptom presentation are further described below (see UTI
Risk and Lifestyle) and in Appendix E. Using EQUC, Price et al. showed differences in the urinary
microbiota of TUC urine specimens between women who do (n=75) and do not (n=75) self-report
UTI44. These differences included higher frequency of the Escherichia urotype and lower alpha
diversity in the self-report UTI cohort44. A more detailed explanation of this study and related
studies are found in Appendix F and Appendix G.
OAB manifests as frequent feelings of urgency. If involuntary leakage of urine also occurs,
the patient is diagnosed with UUI. OAB is conventionally considered a neurological disorder. Hilt
et al. and Thomas-White et al. found differences between both the urinary microbiota and
microbiome of TUC urine specimens from OAB (n=60) and non-OAB (n=60) patients. Patients with
OAB had higher alpha diversity values by both EQUC and 16S rRNA gene sequencing (V4
hypervariable region), as well as fewer Lactobacillus urotypes34 35. However, by EQUC, Pearce et
al. found that, within the Lactobacillus genus, the species Lactobacillus crispatus was significantly
associated with the non-OAB patients, while Lactobacillus gasseri was associated with OAB15.
Neuropathic bladder syndrome is also a neurological disorder that causes difficulty or the
full inability to pass urine without the use of a catheter. Fouts et al. and Groah et al. both found
that patients with neuropathic bladder diagnosis had lower abundances of detectable
Lactobacillus in TUC urine specimens30 49.
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Microbiota correlations to other urologic-related diseases and disorders exist. For
example, several groups have detected the presence of bacteria and bacterial communities in
kidney stones, suggesting a novel microbial etiology for stone formation51

. Using MSU

52

specimens, Kramer et al. found that higher microbial diversity was associated with higher
estimated glomerular filtration rate (eGFR) in patients with non-dialysis-dependent chronic
kidney disease (CKD)53. Assessing specimens collected by a modified MSU collection protocol, Liu
et al. and Ling et al. found lower bacterial richness and differences in various taxa, between
patients with and without type 2 diabetes mellitus (T2DM) 55 54.
Whether the urinary microbiota directly or indirectly contribute to the etiologies of the
diseases and disorders described above remain unclear. However, Thomas-White et al. provided
data showing that the bladder bacterial communities in patients with OAB could be predictive of
treatment response, suggesting a possible bacterial etiology35. In this study, patients with OAB
were given the anticholinergic drug, Solifenacin (Vesicare), which is a competitive antagonist of
the cholinergic muscarinic receptor, meaning that it prevents the binding of acetylcholine
thereby reducing muscle tone in the bladder. Thomas-White et al. found that a less diverse
urinary microbiota (i.e., a mean of three unique microorganisms detected by EQUC) correlated
with a more robust treatment response, whereas patients with a more diverse urinary microbiota
(i.e., a mean of five unique microorganisms detected by EQUC) did not respond, or required a
dosage increase35. These data provide evidence that the urinary microbiota may be directly
involved in disease etiologies.
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Some evidence exists showing a positive or beneficial role for the urinary microbiota. For
example, in patients undergoing pelvic organ prolapse and urinary incontinence (POP-UI)
surgery, Thomas-White et al. and Fok et al. found that 32% of women whose day of surgery TUC
urine specimens had bacteria detected by SUC developed a post-operative UTI. By 16S rRNA gene
sequencing, these specimens were dominated by the family Enterobacteriaceae (which includes
the species E. coli). By contrast, in those who did not have SUC-detectable bacteria on the day of
surgery, only 4% developed a post-operative UTI; by 16S rRNA gene sequencing, these latter
specimens were dominated primarily by Lactobacillus55. Furthermore, Thomas-White et al. found
that in this same patient population, UTI risk was associated with a depletion of Lactobacillus
iners specifically56. These data suggest that some populations of urinary microorganisms may predispose the bladder to infection, while others may be beneficial or protective.
Description of Urinary Bacterial Isolates
Even unique bacterial isolates of the same species may have contrasting roles; WGS
analysis of bacterial isolates obtained by EQUC show varied genotypes. These are described in
more detail in Appendix H. In 2018, Thomas-White et al. used WGS to investigate the genetic
diversity of the urinary microbiota by analyzing the genomic content of 149 bacterial strains
obtained from TUC specimens from 77 patients of varying health and disease status57.
Phylogenetic analysis (Figure 2) showed that the EQUC-measured urinary microbiota are mainly
composed of members of the Gram-positive phyla Firmicutes (47.4%) and Actinobacteria
(38.5%). Furthermore, the degree of phylogenetic variation among isolates of the same species
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varied dramatically (Figure 2), again suggesting somewhat individualized roles for the urinary
microbiota.
To better understand the association between the urinary microbiota and health and
disease, it is necessary to understand the anatomical location of the bacteria and whether they
transit among pelvic floor sites. The bladder epithelium, or uroepithelium, is a type of transitional
epithelial cell coated with uroplakin, a family of proteins that associate with each other and form
plaques58. These plaques are highly glycosylated and act to create a permeability barrier to
separate the tissue from the urine58. To prevent bacterial attachment, a negatively charged
glycosaminoglycan layer also covers the uroepithelium59 60. Some bacteria can bypass these
defenses with the use of specific virulence factors. E. coli, for example, can bind to mannose on
the uroplakin through the expression of a FimH-containing type-1 pilus61. This process allows E.
coli to successfully adhere to and colonize the uroepithelium. Whether similar mechanisms exist
for the commensal urinary microbiota are currently unclear, but possible. Using shed
uroepithelial cells from the urine of patients, as well as in vitro work using patient-derived
bacterial strains, Khasriya et al. found that members of the urinary microbiota are within or
closely associated with the shed cells32. In unpublished work, we found both uropathogens and
commensal flora associated with bladder biopsies; the bacterial communities were similar to
those identified in the corresponding patients’ TUC and SPA specimens. Together, these data
provide initial evidence to support bacterial colonization of the bladder in vivo.
Tissue-unattached microbes would potentially exist as planktonic, or free-floating cells in
the urine, and therefore could leave the bladder during urination. Transit of microbes in the
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Figure 3. Functional diversity between genomes of bacterial strains isolated from the bladder,
vagina, and intestine. Discriminant analysis of principal components using conserved protein
domains (CDD). Each color dot represents a strain from 3 different niches: blue (vagina; n = 92),
red (bladder; n = 67), and green (gut; n = 152). (Thomas-White et al, 2018).
opposite direction is more complicated. In unpublished work, we tested the in vitro motility of
representative bacterial isolates from the urinary microbiota (isolated from TUC specimens) to
determine if transit into the bladder is biologically possible. Other than some Gram-negative
uropathogens (e.g., Escherichia, Proteus and Pseudomonas), we found that the bacterial isolates
were not motile; this suggests that self-propelled transit into the bladder and thus against the
flow of urine is unlikely. However, the in vitro conditions were not set to mimic the appropriate
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in vivo environment, making the conclusions somewhat tenuous. However, a scan of the
genomes of these isolates does not reveal genes associated with the most common motility
mechanisms, flagella and type IV pili.
Regardless, it is likely that strain similarities exist between bladder organisms and
urethral, peri-urethral, vaginal, and possibly GI tract organisms. Thomas-White et al. compared
genomes of urinary bacterial isolates (see Figure 2) with 67 publicly available vaginal and 120 GI
species cultivated from unrelated women57. Using whole-genome pairwise average nucleotide
identity (ANI), 23 species were found at ANI > 95% in both the bladder and vaginal microbiota57.
This contrasts to just the one species (Bifidobacterium bifidum) that was found at ANI > 95% in
all three sites57. Together, these data suggest that transit of microbes between the vaginal and
urinary tract likely occurs. A comparison using discriminant analysis of principle components of
conserved protein domains in a subset of the analyzed genomes is seen in Figure 357. This
comparison shows clear overlapping potential protein functions within the vaginal and urinary
strains, and separation from GI strains (Figure 3). Furthermore, Thomas-White et al. used ANI to
assess the relatedness between species (i.e., Streptococcus anginosus, E. coli, L. iners, L.
crispatus) isolated from the vagina and urine of the same woman. All isolate pairs had ANI >
99%57. Altogether, these data provide strong evidence for the movement of microbiota between
the vaginal and urinary tracts. However, these data alone are not enough to provide an
explanation of directionality of movement.
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Other Urinary Microorganisms
In addition to bacteria, viruses and fungi have also been detected in the urinary bladder.
Miller-Ensminger et al. found several hundred phage-like sequences in the genomes of urinary
bacterial species isolated from females, some of which can be cultivated from the bacterial
isolate62. Some of these phage populations varied between women with and without OAB, which
suggests that they may play a role in urinary health. A description of phage populations found in
Gardnerella isolates is found in Appendix I. Fungi have also been detected in urine specimens by
several groups. Nickel et al. observed an increase in the number of patients with detectable fungi
(i.e., the genera Candida and Saccharomyces) during IC/PBS symptomatic flares42. Ackerman et
al. describe the detection of numerous fungal taxa in TUC urine specimens using NGS63.
In conclusion, the field of the female urinary microbiota is still very much in its infancy.
Much work has been done to provide descriptive analyses of the composition and diversity of
the communities of bacteria, viruses, and fungi, as well as the relationship to health and disease.
Several questions still remain: How do these communities become established? How stable are
these communities over time and does our lifestyle determine this? How do the microorganisms
interact with one another and with the immune system? And ultimately, what can we do clinically
to transform these findings into meaningful patient care?
Description of the Male Urinary Microbiota
Though the majority of the work presented in this thesis is done in females, some data
shown in Chapter VI comes from males. Considerably less research has focused on the microbial
communities of the male lower urinary tract. This may be due to the lower incidence of
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moderate-to-severe lower urinary tract symptoms (LUTS) in men (8.5%) than women (13.9%)64,
thereby prompting less of an interest to explore novel etiologies of LUTS in men. Initial work by
Nelson et al. used 16S rRNA gene sequencing of voided urine specimens (1.5mL) obtained from
a small cohort of young men (n=19), revealing high abundances of the following genera:
Lactobacillus, Corynebacterium, Streptococcus, Sneathia, Aerococcus, Anaerococcus, Prevotella,
Gemella, and Veillonella27. Several of these taxa include strict anaerobic microorganisms.
Interestingly, some of these taxa (especially Prevotella, Sneathia, Dialister, Atopobium) were
found more frequently in men who had a sexually transmitted infection (STI) (8/10)27. In men
who did not have an STI (n=9), facultative anaerobes such as Lactobacillus, Corynebacterium,
Staphylococcus, Propionibacterium and Streptococcus were commonly found27. These data
suggest that urinary microbes in men may play a role in urinary health, specifically STI risk.
Male and female lower urinary tract anatomies are considerably different; thus,
interpretation of urine specimens also differs. An in-depth discussion of the difference in urine
specimens collected from a female and what these may tell us about the urinary microbiota, are
discussed in the section Longitudinal Assessment of the Lower Urinary Tract Microbiota – What
Specimen to Collect? In males, the urethra is about eight inches long and opens at the end of the
external urethral meatus at the distal portion of the penis65. The distal male urethra (i.e., preprostatic and prostatic urethra) is lined with transitional epithelial tissue, which is similar to the
bladder uroepithelium; pseudostratified columnar epithelial tissue is found in the membranous
urethra and proximal spongy urethra; stratified squamous tissue is found in the distal spongy
urethra (i.e., penile urethra)65. In males, both urine and semen pass through the urethra. In
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females, where only urine passes, the urethra is considerably shorter (about 2 inches) and exits
between the clitoris and the vagina66. The proximal half of the female urethra is lined with
transitional epithelial tissue, while stratified squamous tissue is found in the distal half66.
Therefore, a voided urine specimen from a female may be sampling the microbial content of the
bladder, urethra, peri-urethra, and vagina; whereas in a male, a voided specimen is primarily
sampling the urethra. The latter was confirmed by Dong et al., who recruited 32 men (median 28
years of age) to collect urethral swabs (swabs inserted 1-3 centimeters into the urethra and
rotated) and voided urine (5mL)28. Using 16S rRNA gene sequencing of the V1-V3 hypervariable
regions and the Kolmogrorov-Smirnov test for similarity, they found that paired urine and swab
specimens were statistically similar for most (30/32) patients28. The contribution of the coronal
sulcus (CS) of the penis to the voided urine specimen was negligible, as assessed by Nelson et al.
in 201267. These authors recruited 18 young men and collected CS swabs and voided urine
specimens. Using 16S rRNA gene sequencing of the V1-V3 hypervariable regions, they found that
59.1% of taxa identified in the urine specimens belonged to Streptococcus, Lactobacillus,
Gardnerella, and Veillonella; only 1.3% of taxa identified in the CS specimens belonged to these
genera (the 1.3% was primarily Streptococcus)67. These data show that the microbiota of voided
urine and the CS are highly dissimilar. The microbiologic difference between a voided urine and
TUC specimen was recently assessed by Bajic et al68. They recruited 49 male participants (range
40-85 years of age) to collect MSU and TUC specimens prior to surgery. Using EQUC and 16S rRNA
gene sequencing of the V4 hypervariable region, they found that when combined, the two
methods detected bacteria in 98% (48/49) of voided urine specimens, but only 39% (19/49) of
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TUC specimens68. Patients with and without detectable microbiota did not differ with respect to
age, race, ethnicity, BMI, tobacco use, hypertension, diabetes status, or circumcision status,
suggesting that the microbiologic differences between specimen types indicate that separate
niches were sampled (i.e., voided urine does not primarily sample the male bladder)68.
Correlations with Health and Disease
Very little work has been done to determine the contribution of the male urinary
microbiota to urinary health and disease. Lewis et al. collected MSU specimens from six
asymptomatic healthy males (range 39-83 years of age) and performed 16S rRNA gene
sequencing on the V1-V3 hypervariable regions (2mL urine)69. Most of the specimens had greater
than 50% abundance of bacteria belonging to the phylum Firmicutes. An assessment of
demographics showed a slight trend with increasing alpha diversity (i.e. richness) and age69; this
was not significant, likely due to the low sample size. Bajic et al. recruited 28 male participants
with benign prostate enlargement (BPE)-related LUTS, and 21 controls without68. Analysis of TUC
specimens using EQUC and 16S rRNA gene sequencing showed a trend between detection of a
microbiota and increasing BPE/LUTS symptoms as assessed by the International Prostate
Symptom Scores68. In addition to BPE/LUTS, Shrestha et al. showed a relationship to prostate
cancer. Voided urine specimens from 129 men with benign tumors (n=63) or prostate cancer
(n=66) (as assessed by tissue biopsies) were collected and 16S rRNA gene sequencing was
performed on the V6 hypervariable region70. No significant differences in alpha diversity were
seen between cohorts, but abundance of pathogenic taxa (e.g., Ureaplasma, Gardnerella) were
higher in the prostate cancer group70. The inclusion of Gardnerella, which is associated with
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Bacterial Vaginosis (BV) in women, as a pathogenic taxa was not explained. Finally, Wu et al.
assessed the relationship to bladder cancer by recruiting 31 male patients with histologically
confirmed urothelial carcinoma and 18 patients with non-neoplastic conditions71. 16S rRNA gene
sequencing of the V4 hypervariable region was performed on voided urine specimens of various
volumes. The authors observed increased alpha diversity (richness), higher abundance of
Acinetobacter and Anaerococcus, and lower abundance of Serratia and Proteus in the cancer
cohort71. Collectively, these data suggest that the male urinary microbiota may be involved in
urinary health and/or the development or progression of certain urinary diseases, such as
BPE/LUTS and both prostate and bladder cancers; the microbiota could also serve as biomarkers
for these conditions.
When the male urinary microbiota becomes established remains unclear. However, data
from Lee et al. show that some bacterial communities exist in infants (< one year old)72. Urine
specimens were collected by urination into a sterile bag (this specimen type is described in
further detail in the section, Longitudinal Assessment of the Lower Urinary Tract Microbiota –
What Specimen to Collect?). Specimens from 66 male infants were collected: 41 with UTI
(defined as presences of a single uropathogen at >103 CFU/mL in a SPA specimen) and 25
without72. Routine SUC was performed on the urine specimens; in addition, 0.001mL of urine was
cultured anaerobically in Lactobacillus-Selective DifcoTM Rogosa agar (Becton, Dickinson and Co,
Franklin Lakes, NJ) at 37°C for 48 hours72. Lactobacillus sp. were identified in some urine
specimens, and the mean CFU/mL was higher (i.e. >103 CFU/mL) in the non-UTI cohort72. Though
other taxa were not assessed, and this method of urine specimen collection is prone to
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contamination, these data provide some evidence that a male urinary microbiota might be
established very early in life.
Correlations with Lifestyle and Preliminary Measures of Stability
In relation to lifestyle factors, the effect of sexual intercourse has been assessed by one
group. The 18 male participants in the Nelson et al. study were queried regarding prior sexual
behavior67. Interestingly, detection of BV-associated anaerobic taxa (e.g. Atopobium,
Megasphera, Mobiluncus, Prevotella, Gemella, Gardnerella) as well as non-BV taxa that are
common in the vaginal tract (e.g., Lactobacillus, Staphylococcus) did not differ between those
who reported prior vaginal intercourse and those who did not67. Though the cohort was small,
and information regarding recent behavior was not specified, these data provide evidence that
sexual intercourse does not alter the male urinary microbiota.
An assessment of microbial stability was also determined by Nelson et al. (2012). The 18
male participants collected voided urine specimens at one-month intervals for three months (i.e.,
four specimens collected)67. Using Sørensen’s similarity index, they determined that urine
specimens from the same participants were significantly more similar to one another over time
than urine specimens from other participants67. Some bacterial taxa (i.e., Propionibacterium and
Lactobacillus) had long durations of colonization, while others (i.e., Corynebacterium,
Anaerococcus, Staphylococcus, and Prevotella) were more infrequent67. Despite the use of nondaily longitudinal specimens, these data show that that the male urinary microbiota are relatively
stable over a three-month period of time. Some taxa seem to be less stable, but whether lifestyle
can explain these differences is currently unclear.
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Differences between the Male and Female Urinary Microbiota
Differences exist between the male and female urinary microbiota. Lewis et al. found that
the phylum Firmicutes dominate the urinary microbiome of MSU specimens in both men (n=6)
and women (n=10), but the phyla Actinobacteria and Bacteroidetes were significantly more
abundant in women69. Furthermore, the association between increased alpha diversity and age
was stronger in women69. Gottshick et al. compared 16S rRNA gene sequencing data on MSU
specimens from healthy men (n=31), and women with (n=43) and without (n=49) BV73. Using
PCoA, they observed significant overlap between the male and non-BV female microbiome
composition data73. However, there were some bacterial taxa that were not found in the male
specimens [e.g., Gardnerella, Atopobium, and several Lactobacillus operational taxonomic units
(OTUs)]73. These data show that, generally, the male and female urinary microbiota are similar,
but certain differences exist.
The Microbiome is Shaped by Environment
The HMP showed massive differences in the composition of the microbiome between
subjects2. However, at the time, it was unclear whether these differences were driven primarily
by “nature” or “nurture”. In other words, is the microbiome determined by our genetics or by
our environment?
The GI microbiome is believed to be established at birth. Microbes from the mother and
the environment colonize the infant’s gut74 75. The initial composition of the GI microbiome is
affected by mode of delivery and undergoes rapid and dramatic changes for the first year of life74.
After this point, the GI microbiome remains largely stable74. Initial studies investigating how this
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stable population of microbes is determined, pointed largely to genetics. It was observed that
family members and twins often had more similar microbiome characteristics than unrelated
individuals76

. Some studies identified heritable bacterial taxa79

77 78

, while others found

80

associations between certain host single nucleotide polymorphisms (SNPs) and the microbiome81
. However, the extent of the microbiome impacted by these findings, as well as the influence of

82

shared environment, were unclear from these studies.
Recently, Rothschild et al. examined the microbiome and genotypes of more than 1,000
healthy individuals with several distinct ancestral origins, but a relatively common environment83.
Blood and stool samples were collected from healthy adults. Metagenomic and 16S rRNA gene
sequencing were performed on the stool specimens. The cohort consisted of a variety of Israeli
ancestries (i.e., Ashkenazi, North African, Middle Eastern, Sephardi, Yemenite, other) that
showed clear separation based on genetics. However, the microbiome showed no significant
variation across ancestral types assessed by PCoA, alpha-diversity measures, or abundance of
specific taxa for ancestral types or shared ancestry. Furthermore, relatives with no history of
household sharing showed microbiome characteristics that were less similar than relatives with
a history of household sharing83. Other studies have shown similar impactful roles for
environment in shaping the microbiome84

, though these did not consider host genetics.
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Together, these data show that environment largely influences the GI microbiome, likely more
than genetics.
Environment, unlike genetics, can be manipulated and changed. Therefore, it is plausible
to hypothesize that our microbiota can also change, and these changes should correlate to
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particular environmental and lifestyle factors. The next sections will discuss how environment
and lifestyle influence the microbiota of the GI tract and vagina as a framework for understanding
how these factors may influence the microbiota of novel sites, such as the bladder and lower
urinary tract.
The GI Microbiota and Lifestyle
Description of GI Tract Physiology
The environment of the GI tract differs by physiology, digestive content, pH, oxygen
tension, host secretions, and immune system interface among each anatomic compartment86. As
such, the microbial content differs as well. Sampling feces from a subject provides insight into
only the distal potion of the GI tract (i.e., the large intestine). The large intestine and colon are
characterized by slow flow rates, low oxygen tension, and mildly acidic pH. It harbors the greatest
microbial content (approximately 1011 cells per gram of feces) and species diversity (between 100
and 1000 unique species) consisting of mainly obligate anaerobes, such as Prevotella2 87. By
comparison, the small intestine has rapid flow rates and high bile concentrations. However,
studying the microbiome of the small intestine requires more invasive approaches, such as an
ileostomy. Such studies have concluded that this site consists of mainly facultative anaerobes,
such as Lactobacillus, Enterococcus, and Bacteroides.
The primary function of the GI microbiota is metabolism. The majority of microbial
metabolism within the colon is fermentative88. Saccharolytic fermentation pathways result in the
large concentration of short-chain fatty acids (SCFAs) associated with the colon (especially
acetate, propionate, and butyrate)89. SCFAs support the growth of other microbial species90,
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promote down-regulation of proinflammatory cytokines91, and induction of FOXP3-expressing
regulatory T-cells92, resulting in an anti-inflammatory gut environment.
The species composition of the GI microbiota differs substantially between individuals93.
Subtle trends in composition and diversity exist among demographics, including age, nationality,
race, gender, and BMI87

93 94 9596

. However, metagenomic analysis shows that the predicted

functionality of the microbial gene content is similar among individuals, suggesting that the
differences in species composition may not be biologically meaningful2.
Correlations between the GI Microbiota and Lifestyle
The GI microbiota has a high degree of variability within an individual during the first three
years of life followed by a more stable state during adulthood94 . The initial composition of the GI
microbiota resembles the body niche of the method of child delivery (i.e., skin microbiota for
cesarean section, or vaginal microbiota for vaginal delivery)2. From adolescence to adulthood,
levels of Bacteroides tend to decrease, while levels of Proteobacteria increase97 98. This results in
a greater tendency towards a pro-inflammatory gut phenotype with age.
Besides age, lifestyle and environmental factors can dramatically impact the GI
microbiota. Generally, these changes occur rapidly and are inherently reversible. However, the
biological consequences of these changes can be long lasting and thus justify the continued
research in this area - research aimed at understanding these trends from both a therapeutic and
preventative standpoint. For example, diet has been extensively studied in relation to the GI
microbiota. Modulating one’s diet is an ideal opportunity for a low-risk intervention or
preventative measure for conditions in which the GI microbiota and its metabolic products have
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been shown to be causative of disease99. Data show that long-term diet largely impacts GI
microbiota composition13. However, extreme alterations to diet can cause dramatic shifts in the
microbiota within days100 84. This can be visualized from work done by David et al., where two
subjects sampled the GI microbiome (i.e., colon microbiome) from self-collected stool samples.
Samples were collected daily, or near daily, for 8-12 months100 . David et al. found that the time
spent living abroad rapidly altered the composition and diversity of Subject A’s microbiome, likely
attributable to a substantial change in the diet100. Other researchers have found that certain types
of diets correlate to various GI microbiota characteristics. In general, a high fat diet correlates
with higher microbial diversity84, higher relative composition of Bacteroides and Clostridiales, and
lower relative composition of Bifidobacterium13 85 101. A protein-rich diet correlates with higher
alpha-diversity84 but lower microbial richness102, higher relative composition of Bacteroides13, and
lower relative composition of Lactobacillus and Bifidobacterium102 103. In contrast, diets high in
fiber show trends opposite those of protein-rich diets13 104. These associations are summarized in
Table 1A.
Besides diet, other lifestyle factors correlate to particular GI microbiota states.
Smoking105, alcohol consumption106 107 108, and antibiotic use109 are all correlated with decreased
alpha-diversity. Correlation to particular GI microbiota states vary with antibiotic use. However,
unlike other lifestyle factors discussed, repeated use of antibiotics does not show resiliency of
the GI microbiota110. This means that over time the GI microbiota fail to return to a baseline state
following antibiotic use – a finding that does not seem to apply to any other studied lifestyle
factor in this context. Furthermore, the same antibiotic can affect certain microbes differently
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depending on the rest of the microbiota111. Other lifestyle factors that can impact the GI
microbiota include probiotic use, which generally correlates to higher alpha-diversity values and
species richness112 113 114

, and sleep deprivation and stress, which correlate to lower relative

115

composition of Bacteroidetes116 117.
Temporal Dynamics of the GI Microbiota
In general, the GI microbiota are stable throughout life, other than the first year of life,
during which there is dramatic variation and lack of microbial stability94 118 119. With age, comes a
decrease in the ratio of Bacteroides to Proteobacteria97 98.
Because lifestyle factors are, in large part, controlled by the host, day-to-day variation
exist in their usage. As a result, the short-term temporal dynamics of the GI microbiota are
affected. The GI microbiota are remarkably stable when viewed across months or years100 120 121,
but short-term variations exist is response to the lifestyle factors described in Table 1100 120 121.
Observable changes in the microbiota in response to the lifestyle factors are seen on a rapid
timescale. For example, dietary changes result in microbiota changes within a few days13 122. For
most lifestyle factors, the microbial changes are reversed almost immediately following cessation
of use123. These data show that the GI microbiota are both stable and resilient. The notable
exception is antibiotic use, where compositional changes and antibiotic resistance genes persist
for years124 125.
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Table 1A. Impact of Extrinsic Lifestyle Factors on Microbiota and Risk for BV and UTI.
Lifestyle
Factors

Diet

Smoking
Alcohol Use
Antibiotic
Use
Probiotic Use

Impact on GI Microbiota
High Fat:
↑ Diversity
↑ Bacteroides, Clostridiales
↓ Bifidobacteria
Protein-rich:
↑ Diversity, ↓ Richness
↑ Bacteroides
↓ Bifidobacteria
High Fiber:
↑ Richness
↑ Bifidobacteria, Firmicutes
Sugar-Free:
↑ Bacteroides
↓ Bifidobacteria
Gluten-Free:
↑ Richness
↑ Bifidobacteria
↓ Diversity
↑ Firmicutes
↓ Proteobacteria
↓ Diversity
↑ Proteobacteria
↓ Bacteroidetes
↓ Diversity
↓ Richness
↕ Composition1
Oral:
↑ Diversity
↑ Richness
↕ Composition2
Oral Hygiene:
No Impact3

Hygiene

Birth Control

Sex

N/A

N/A

Impact on Vaginal Microbiota and BV Risk

[13 84 85 101]

[13 101 102
103

]

[13 104]
[138 139]
[140 141]

Iron-Deficiency:
↑ BV Risk
↑ Candida
↓ Lactobacillus
Vitamin E-Deficiency:
↑ BV Risk
↑ Coccobacilli4

[126 127]

Cranberry Juice:
↓ UTI Risk9
↓ Biofilms

[127 132]

Fluid Intake:
No Effect

Calcium-Deficiency:
↑ BV Risk
↑ Coccobacilli4
High Fat:
↑ BV Risk
↑ Coccobacilli4
High Glycemic Load:
↓ BV Risk

[132]

[106 107 108]

↑ BV Risk
↑ Gardnerella, Mycoplasma
↓ Lactobacillus
↓ BV Risk
↓ Anaerobic bacteria

109 124 148

↑ BV Risk
↓ Lactobacillus restoration5

[105]

[

]

[112 113 114
115

]

[163]

UTI Risk

Oral:
↓ BV Risk
↑ Lactobacillus6
Menstrual Protection7:
No Impact
Douching:
↕ BV Risk8
↕ Lactobacillus8
Oral Contraceptives:
↓ BV Risk
↑ Lactobacillus
↓ Candida
Intrauterine Device (IUD):
↑ BV Risk
↓ Lactobacillus
↑ Candida, Mycoplasma
Vaginal Intercourse:
Condom Use:
↓ BV Risk
High Frequency:
↑ BV Risk
↓ Lactobacillus
Female Partner:
↑ BV Risk
Oral Sex:
No Impact

[132]
[142]

[143 144]
[146]
[

149

Carbonated Drinks:
↑ UTI Risk10
↑ Hematuria
Vitamin C:
↓ UTI Risk
Vegetarian Diet:
↓ UTI Risk
No Effect
↕ UTI Risk11
↕ UTI Risk12,13

]

[154 155 156 157]

[164 165 166]
[166 167 168 169]

[170 171 172]

[174 175]

[178]
[178 183 184]
[185 186]
[178 187]

Oral:
↕ UTI Risk14
Intra-vaginal:
↕ UTI Risk14
Menstrual Protection7:
↕ UTI Risk15
Douching:
No Effect
Bathing:
↕ UTI Risk15
Oral Contraceptives:
No Effect
Condom Use:
↕ UTI Risk16
Vaginal Intercourse:
↕ UTI Risk17

[128 129 130 131]

[133 134]

[135 136 137]
[136]
[131]

[145]
[131 147]
[150 151 152 153]
[158 159]
[160 161 162]
[131 136]
[131 136]
[131 136]
[136 173]

[153 176 177]

[179 180 181 182]
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Table 1B. Impact of Intrinsic Lifestyle Factors on Microbiota and Risk for BV and UTI.
Lifestyle
Factors

Impact on GI
Microbiota

Menstruation

N/A

Pregnancy

N/A

Menopause

N/A

Sex Hormones

N/A

Urine Properties &
Constituents

N/A

Impact on Vaginal Microbiota and BV Risk
No Impact on BV Risk
Compositional changes18
Full-Term:
↑ Lactobacillus
↓ Prevotella, anaerobes
Pre-Term:
↓ Lactobacillus
↑ Gardnerella, Ureaplasma
↑ BV Prevalence19
↑ BV Risk
↓ Lactobacillus
↓ Diversity
↑ Lactobacillus

N/A

UTI Risk

[188 189 190 191]
[

N/A

192 193

]
N/A

[193 194 195]

[196 197 198 199]
[203 204]

↑ UTI Risk
Oral/Vaginal Estrogen:
↓ or No Effect on UTI Risk
Glucose:
↑ UTI Risk/Presence
Bilirubin:
↑ UTI Risk/Presence20
Ketones:
No Effect
Specific Gravity:
No Effect
Blood/Hematuria:
↑ UTI Risk/Presence
pH (Alkaline):
↑ UTI Risk/Presence
Protein:
↑ UTI Risk/Presence
Urobilirubin:
No Effect
Nitrites:
↑ UTI Risk/Presence
Leukocyte esterase:
↑ UTI Risk/Presence

[158 200 201 202]
[205 206 207 208]
[209]
[210]
[211]
[211]
[211 212 213 214]
[211]
[211 212]
[210 211]
[211 212 213 214 215]
[211 212 213 214 215]

1 Varies with antibiotic, 2 Varies with species of probiotic, 3 Assessed impact of Triclosan
(toothpaste component) on GI microbiome, 4 Presence of Coccobacilli by Gram strain is highly
indicative of Gardnerella vaginalis, 5 Assessed Metronidazole treatment, 6 All used a
Lactobacillus probiotic, 7 Tampon or Pad use, 8 Data conflict, 9 Some data show no effect, 10
Some data show no effect, 11 Data conflict, 12 Antibiotics used as prophylaxis, 13 Varies with
antibiotic, 14 All used a Lactobacillus probiotic; data conflict, 15 Data conflict, 16 Data conflict,
17 Increased in pre-menopausal, 18 Compositional changes vary greatly among individuals, 19
Women with BV at the start of pregnancy are at greater risk for Pre-term birth, 20 Increased UTI
Risk in neonates
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The Vaginal Microbiota and Lifestyle
Description of Vaginal Tract Physiology
The vaginal mucosa is comprised of stratified squamous epithelium overlaid by a mucosal
layer covered by cervicovaginal fluid216. Besides providing both physical and biochemical
protection from invading microorganisms, the vaginal environment has additional layers of
defense to inhibit microbial colonization; these include acid pH, production of antimicrobial
peptides (e.g., β-defensins and mucins) and surfactant proteins216. Nevertheless, an intrinsic
population of bacteria colonize the vagina. This vaginal microbiota can generally be classified into
five groups (i.e., CSTs), though some research suggests otherwise. CSTI-IV are dominated by
species of the genus Lactobacillus (i.e. L. iners, L. crispatus, L. gasseri, and Lactobacillus jensenii),
while CST-V is dominated by a diverse group of anaerobic bacteria (e.g. Gardnerella, Prevotella,
Anaerococcus)14 217. CST may correlate to demographics, particularly race and ethnicity; typically,
African American/Blacks and Hispanics harbor CST-V, as well as displaying higher vaginal pH
regardless of clinical infection14 217.
Colonization by Lactobacillus (i.e., CSTI-IV) reportedly protects against infection via
several different mechanisms. They exclude pathogens by competing for epithelial binding sites
and inhibit pathogen proliferation by producing lactic acid, hydrogen peroxide, and/or
bacteriocins218 219 220. Lactobacilli also can modulate the host immune response by inducing proinflammatory or anti-inflammatory cytokines or by intermittently translocating across the
mucosa, inducing systemic immune events, in the gastrointestinal tract221. These mechanisms
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may relate to data showing that lactobacilli are commonly non-dominant in women with vaginal
disorders222.
The vaginal microbiota has been greatly studied in the context of BV. The putative cause
of BV is thought to be microbiologic in nature. BV presents clinically as vaginal malodor and
discharge, vulvar irritation, dysuria, and abdominal pain223. Microscopically, BV is characterized
by increased vaginal pH, presence of clue cells in the discharge (i.e., vaginal epithelial cells
covered with coccobacilli), and detection of anaerobic bacteria223. BV is characterized using
Nugent scores, which range from 0-10 – a score of 0-3 is considered normal, 4-6 is designated
intermediate, and 7-10 is considered BV224. The values are determined from a Gram stain of a
vaginal smear specimen at 1000x oil immersion. Values are based on the presence of
Lactobacillus, Gardnerella/Bacteroides morphotypes, and curved Gram-variable rods224.
Correlations between the Vaginal Microbiota, BV Risk, and Lifestyle
Numerous lifestyle factors are correlated to BV risk and subsequently vaginal microbiota
composition and diversity characteristics (Table 1). Dietary characteristics, such as iron, vitamin
E, and calcium-deficiencies, are linked to BV risk, lower Lactobacillus levels, higher microscopic
detection of coccobacilli (i.e. Gardnerella), and higher levels of Candida126 127 132 142. High glycemic
diets are correlated with lower BV risk142. Smoking143 144, antibiotic use149, use of an intrauterine
device (IUD)170
partner185

186

, high frequency of vaginal sex178

174 175

, and vaginal sex with a female

183 184

are associated with higher BV risk, lower Lactobacillus, and higher levels of

anaerobes, such as Gardnerella and Mycoplasma (Table 1). Factors associated with lower BV risk
and the corresponding microbiota characteristics include alcohol consumption146, probiotic use154

41
, use of oral contraceptives170

155 156 157

, and condom use during vaginal sex178 (Table 1).

171 172

Menstrual protection, such as tampon or pad use164 165 166, and oral sex178 187 are not associated
with BV risk or microbiota changes. Menstruation is associated with individualized compositional
changes and greater diversity, but not BV risk188 171 190 191 (Table 1B).
Temporal Dynamics of the Vaginal Microbiota
The temporal dynamics of the vaginal microbiota have also been studied primarily in the
context of BV. Early work by Brotman et al. recruited 39 women to self-collect vaginal swabs
twice weekly for 16 weeks225. Participants completed a behavioral diary consisting of yes/no
questions regarding vaginal-related factors (e.g., vaginal douching, menstrual bleeding, sexual
activity, tampon use, medications). Nugent scores were calculated from the vaginal smears to
determine BV status, and Gram-strain results were recorded. Brotman et al. found that most
women (73%) experienced spontaneous and frequent fluctuations between normal and BV
states225. Lubricant use and rectal intercourse were associated with BV onset225. The vaginal swab
specimens from the participants in this study were later used for 16S rRNA gene sequencing. As
reported by Gajer et al., the vaginal communities, in general, showed low constancy and high
levels of species turnover, but overall the dynamics varied widely among women, even those
within the same CST188. By calculating the rate of change of the log of Jensen-Shannon divergence
values between time points, Gajer et al. found that menses correlated to low levels of constancy
or stability. Sexual activity was correlated to low constancy and was independent of the
menstrual cycle188. Diversity indices did not show significant correlations to menses or sexual
activity, indicating that the low levels of stability were due to compositional changes. Despite
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these general associations, various trends were seen across participants. The vaginal
communities of some women were resilient and showed predictable changes, while others were
invariant or continuously variant. For example, when the taxonomic data were compared to
participant-reported menstruation, four unique trends were seen. One participant’s specimens
(Subject 24) normally contained high abundance of L. crispatus, except during menstruation
when Gardnerella repeatedly dominated the microbiome. This trend was reproducible over four
menses. Subject 12 had high levels of L. iners and during menstruation a disruption was also
observed, but unlike Subject 24, the pattern differed at each instance. Subject 29 was invariant,
except for one instance where the L. crispatus was replaced by L. iners, but this did not
correspond to menstruation. Finally, Subject 6 was continuously variant despite menstruation.
No recorded metadata can explain the differences in microbial response to menstruation seen in
these four participants188. Collectively, these data show that, unlike the GI microbiota, the vaginal
microbiota do not consistently show long-term stability; intrapersonal variation in temporal
dynamics exist and do not always correlate to lifestyle factors or behaviors.
A possible explanation for the participant disparities reported by Brotman and Gajer and
co-workers is that the data are not representative of long-term trends. Without more clinical
measures, it remains unclear whether the participants were sampled during an “atypical” time.
Ravel et al.’s approach to measuring the dynamics of the vaginal microbiota took this into account
by sampling participants who were currently experiencing BV symptoms (N=15), had
asymptomatic BV (N=6), or did not have BV or symptoms (N=4)226. Despite these clear clinical
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distinctions in the participants, Ravel et al. found similar findings, where community dynamics
were again highly individualized226.
An additional finding of Ravel et al. was that women with symptomatic BV who were given
antibiotic treatment experienced initial changes towards a less BV-associated microbiota (i.e.,
Lactobacillus-dominant). However, the effect was short-lived; in most individuals, the community
returned to its pretreatment state within 4 weeks226. Another group has observed similar
trends227.
Besides BV, vaginal microbiota dynamics have also been studied in the context of
pregnancy. Romero et al. recruited 22 pregnant women who delivered at term (38 to 42 weeks).
Vaginal swabs were collected every four weeks until 24 weeks of gestation, and every 2 weeks
until the last prenatal visit193. The microbial data were compared to the participant data from the
work of Brotman and Gajer and co-workers. Romero et al. calculated the Jensen-Shannon
divergence values between each timepoint and the mean community state for each participant
as a measure of overall instability193. The mean within-subject values were significantly lower for
non-pregnant women, showing that the vaginal communities are more stable during
pregnancy193.
In conclusion, the vaginal microbiota of some women are very dynamic, while others are
very stable. Menstruation and sexual activity generally result in reduced stability, while
pregnancy shows the opposite trend.
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UTI Risk and Lifestyle
Not only is it unknown if lifestyle factors and behaviors can affect the urinary microbiota,
but it is also unclear whether temporal dynamics even exist in these bacterial communities. I
hypothesize that dynamics do exist in the urinary microbiota due to evidence presented above
showing the existence of dynamics in the GI tract and vaginal microbiota. These microbiota,
especially those of the vagina, contain bacterial constituents similar to those of the urinary
microbiota. And, like the bladder, the bacterial communities of the GI tract and vagina exist in a
confined organ that is susceptible to outside influence and associated with a highly specialized
tissue. Furthermore, I hypothesize that lifestyle factors and behaviors associated with UTI risk
(Table 1) will correlate to observed temporal dynamics.
Current Understand of UTI and an Overview of Risk Factors
UTIs are described in more detail in Appendix E. In brief, UTIs are the most common
bacterial infections and amongst the most common reasons for antibiotic treatment228 229. Almost
half of women experience at least one UTI in their lifetime, and 10% have one annually230. UTIs
typically present as one or more of the following symptoms or characteristics: urine odor, painful
urination, frequent urination, nocturia (urination at night), urgency of urination, hematuria
(blood in the urine), unexplained lower back pain or pelvic pain, and feelings of urinary retention.
In healthy pre-menopausal, non-pregnant women with no prior history of urogenital
abnormalities, presence of acute cystitis and/or pyelonephritis is classified as an uncomplicated
UTI20. To provide a rapid diagnosis of bacteriuria (i.e., presence of a uropathogenic bacterial
species in the urine) and pyuria (i.e., presence of white blood cells in the urine), dipstick tests are
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commonly used. These test for leukocyte esterase, nitrates, and red blood cells. However, SUC is
the definitive test for UTI, and it can also provide appropriate antibiotic susceptibilities. Typically,
a positive SUC result is the presence of a single organism (typically E. coli) isolated at ≥ 105 CFU/mL
urine231. A positive SUC with or without pyuria, in the absence of urinary symptoms, is commonly
referred to as asymptomatic bacteriuria (ABU or ASB)231 232. The high morbidity of cystitis typically
prompts prescription of antibiotics228.
Risk factors for UTI are detailed in Table 1, and include factors related to diet, medication
use, hygiene, sexual activity, menstruation, and several others. Components of diet, including
cranberry juice (results vary among studies) and Vitamin C225

, have been shown to

227 198 199 131

decrease risk for UTI. Carbonated drinks have an increased UTI risk131

, while total fluid intake

133

has no effect129 130. Oral and intra-vaginal probiotic use158 159 160 161 162 and estrogen use203 205 206 207
208

have decreased UTI risk. Vaginal sex without condom use is correlated with increased UTI risk,

particularly within five days of intercourse131 173 176 177 179. Post-menopausal women are more at
risk for UTI than pre-menopausal women, likely due to decreased vaginal estrogen158

.

200 201 202

Alcohol consumption, antibiotic use, bathing, and menstrual protection have been shown to
impact UTI risk in some studies, but not others128

. There is no evidence that

131 135 136 137 145 147

smoking, oral contraceptives, or douching have an effect on UTI risk128 131 134 159.
Probiotics and UTI Risk
Probiotics are microorganisms that have beneficial effects, such as the restoration or
maintenance of bacterial communities in the body. They are usually taken orally, but can be given
through alternate routes, such as vaginally. It has been shown that use of probiotics (oral and
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vaginal), particularly Lactobacillus sp., can alter the vaginal microbiome and reduce BV risk (Table
1)154

155 156 157

. There are also data relating probiotics to UTI risk. Reid et al. recruited 41 post-

menopausal women with acute UTIs161. All were treated with antibiotics (norfloxacin or
trimethoprim/sulfamethoxazole) for three days, resulting in the eradication of the infection in all
women. Half of the women were given post-therapy vaginal administration of Lactobacillus
suppositories. In these patients, the recurrence rate of UTI within 6 months was 21%; this was
compared to 41% recurrence in the patients not given the post-therapy161. Further research
showed that weekly use of the suppository reduced UTI recurrence from 6 to 1.6 per year160.
Conflicting data were reported in a randomized controlled trial of 252 post-menopausal women
with recurrent UTIs. In this trial, Beerepoot et al. compared the effects of 12 months of
prophylaxis of trimethoprim/sulfamethoxazole (480mg once/day) to an oral Lactobacillus
probiotic (twice/day)158. The probiotic capsule contained 109 CFU/mL of Lactobacillus rhamnosus
GR-1 and Lactobacillus reuteri RC-14. Patients who received the antibiotic prophylaxis (n=126)
reported an average incidence of 2.9 UTIs during the 12 months, while patients who received the
probiotic (n=126) reported 3.3 UTIs, which did not significantly differ158. However, strains of E.
coli isolated from the prophylaxis cohort showed increasing resistance (20% at baseline to 80%
by one month) to trimethoprim/sulfamethoxazole, trimethoprim, and amoxicillin; this trend was
not observed in the probiotic cohort158. These data show that probiotic use may lower risk for
UTI.
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Correlations between UTI Risk and Lifestyle
Several comprehensive studies assessing UTI risk and lifestyle have been performed.
Foxman and co-workers have provided several of these studies. An in-depth assessment of UTI
risk factors in young women was published in the 1980s as a series of reports. Foxman et al.
collected MSU specimens from 225 pre-menopausal college-aged women [mean age of 21.5
(range of 16-39)] at a student health clinic and assessed for UTI using the following criteria:
>50,000 CFU/mL of a single bacterial species detected using SUC and presence of one or more
symptoms of a UTI233

. All participants completed a self-administered lifestyle questionnaire

131

prior to diagnosis. The questionnaire queried information relating to diet, urination habits,
clothing worn, sexual habits, and birth control method used in the preceding four weeks233 131. 44
participants were diagnosed with a UTI; 181 served as non-UTI controls. 100% (44/44) of the UTI
participants reported that they engaged in sexual intercourse at least once in the previous four
weeks, while only 47% (85/181) of the controls had done so233. Similarly, engaging in sexual
intercourse with more than one partner and starting a new sexual relationship were more
commonly reported in the UTI cohort233. Among the women who reported being sexually active,
the birth control method of diaphragm use was also associated with the UTI cohort233. Oral
contraceptive had no association. These findings were independent of the frequency of sexual
intercourse233. Because of the strong correlation between sexual intercourse and UTI, Foxman et
al. statistically corrected for these data in their remaining assessments of the lifestyle
questionnaire. An assessment of diet showed a positive correlation to the UTI population for
consumption of tea, soft drinks, cranberry juice, vitamin C, citrus juice, coffee, and milk within
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the past four weeks131. A vegetarian diet and consumption of garlic, ginger, chile peppers, and
alcohol beverages were negatively correlated to the UTI cohort131. In relation to hygiene, Foxman
et al. found a positive correlation between UTI and tampon use, as well as reporting of douching,
but bathing habits (e.g., frequency of showing, taking a bath) did not131. Frequency of urination
was not correlated to UTI; in sexually active women, reporting of urination before sexual
intercourse was positively correlated with UTI, while urinating afterwards was negatively
correlated131. Altogether, Foxman et al. found associations between UTI risk and diet, sexual
habits, and urination habits233 131.
In follow-up work, Foxman et al. recruited a much larger cohort of college-aged women
(n=1641) through a similar recruitment process as described in their previous work233

. The

131

population had a mean age of 21.9 years [standard deviation (SD) = 4.4] and was comprised of
women with (n=237) and without (n=1404) UTI, as defined previously233

. All participants

131 136

completed a lifestyle questionnaire regarding the preceding four weeks. In agreement with their
previous work, Foxman et al. found that women with UTI were more likely to have engaged in
sexual intercourse, but they also found a positive relationship between the frequency of sexual
intercourse and UTI136. Additionally, women with UTI were more likely to use a diaphragm than
oral contraceptives for birth control methods136. Urination habits also showed similar trends.
Urinating after intercourse was associated with increased overall fluid intake. By controlling for
this confounding variable, Foxman et al. found that always urinating after sexual intercourse was
protective (i.e., associated with the non-UTI cohort)136. The association was so strong that in
those women who report always urinating after sexual intercourse, the association between

49
diaphragm use and UTI was lower136. Toileting habits like frequency of urination, delaying or
hesitating to urinate, direction of toilet tissue wiping, and use of laxatives and stool softeners
showed no correlation to UTI136. Use of feminine hygiene products and type of product used also
showed no correlation to UTI136. Dietary factors also provided similar results as previously
described233

, except cranberry juice consumption was not associated with a protective

131

effect136. Total fluid intake and cigarette smoking showed no correlation136. Foxman et al. also
queried measures of stress including getting enough sleep, feeling alone, and a self-perceived
measure of stress level. Interestingly, women in the UTI cohort were likely to report the lowest
levels of self-perceived stress136.
Foxman also assessed UTI risk factors in post-menopausal women. Foxman et al. recruited
222 women aged 40-65, who did (n=63) and did not (n=159) have a UTI; the clinical and
microbiologic measures used to determine UTI were not described182. Consistent with previous
work, the participants completed a lifestyle questionnaire; however, the questionnaire used in
the present study queried behaviors of the preceding two weeks, rather than four182. Contrary to
data in pre-menopausal women, Foxman et al. found that UTI participants were less likely to
report sexual activity in the past two weeks, but individual types of sexual activity were not
associated with either cohort182. No other factors contradicted those reported previously in premenopausal women, but most showed no association with either cohort182; it must be considered
that the sample size of this present study was considerably smaller. Women in the UTI cohort
were more likely to report incontinence or urine loss182, but UTIs can cause urinary incontinencelike symptoms in older women234, so the significance of this finding is unclear. Foxman et al. also
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found that non-UTI women were considerably more likely to use estrogen replacement
therapies182.
The work of Foxman and co-workers provided a foundation for modern clinical
understandings of UTI risk and lifestyle. In general, subsequent work has supported the
conclusions made (Table 1). An example of an exception includes work by Fihn et al. showing that
in women with acute UTI caused by E. coli (n=604), use of spermicide-coated condoms conferred
a significantly higher risk of UTI compared to demographically matched controls (n=629)177. Also,
several studies have shown significant reduction in UTI risk, bacteriuria, and pyuria following
consumption of cranberry juice128

129 130

contrary to Foxman’s work136. Antibiotic use was not

assessed as a UTI risk factor in Foxman’s work (it was an exclusion factor), but others have, in the
context of prophylaxis. Harding et al. recruited 40 women with a history of recurrent UTI (rUTI)
(as defined as ≥3 incidences of UTI in one year) to complete three consecutive three-month long
regimens of various prophylactic antibiotics150. While taking sulfamethoxazole (500mg/day) UTI
incidence (per patient/year) was 2.5, methenamine mandelate (2g/day) with ascorbic acid
(2g/day) was 1.6, and trimethoprim (40mg/day) with sulfamethoxazole (200mg/day) was 0.1,
compared to 3.6 using no drug therapy150. Nicolle et al. found similar data when assessing UTI
incidence over five years (mean=32 months) in a small cohort of women (n=11) with a history of
rUTI using trimethoprim-sulfamethoxazole prophylaxis151. Other studies have shown that
antibiotic prophylaxis, when compared to vaginal oestrogens (n=150), oral Lactobacillus probiotic
(n=238), and D-mannose supplement (n=94), results in an average of 24% lowered risk of UTI
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recurrence in women with history of rUTI235. These data show that prophylactic antibiotic use
reduces UTI risk, at least in populations of women with rUTI.
Antibiotic use is also the only lifestyle factor, to my knowledge, that has been studied in
the context of the urinary microbiota. Gottschick et al. compared data collected from MSU and
vaginal swab specimens of primarily pre-menopausal women with (n=42) and without (n=49)
BV73. Patients with BV were treated with oral metronidazole (2g; single dose) and specimens were
collected before (day of) and after (7-28 days) treatment73. They observed significant changes in
the urinary microbiota composition following antibiotic treatment. Urotype frequencies of L.
iners and Enterobacteriaceae increased following treatment, while Gardnerella and anaerobic
taxa decreased, as well as overall alpha diversity levels73. The antibiotic treatment also lowered
the proportion of women with significant correlations between the urinary and vaginal
microbiota (9%)73. These data show that antibiotic treatment of vagina-related diseases (i.e., BV)
can alter the urinary microbiota. A caveat of these data is the length of time between the first
and second specimen collection and also lack of patient lifestyle data.
Considering that dynamics in the GI and vaginal microbiota occur rapidly (i.e., within a
few days) in response to or following certain lifestyle factors, the use of questionnaires regarding
behaviors across several weeks in Foxman’s work, represents a major limitation to the
conclusions made about UTI risk. To my knowledge, none of the lifestyle factors described above
have been assessed for UTI risk on a daily timescale, with the exception of sexual intercourse.
Nicolle et al. recruited 27 sexually active pre-menopausal women, 14 with history of UTI and 13
without (i.e., none within two years)180. MSU specimens were collected each morning over
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several months (17-95 days; mean=66 days) and Dipslide cultures were performed (these consist
of a sterile culture medium on a plastic carrier that is dipped into the urine specimen and then
incubated). Dipslide tests were kept at room temperature until being submitted to the laboratory
for incubation on a weekly basis180. UTI diagnosis was determined as ≥105 CFU/mL of a single
bacterial species. Participants maintained a calendar where they recorded the date and time of
sexual intercourse episodes, menstruation days, menstrual protection used, contraceptives used,
and urinary symptoms. The mean intercourse frequency for both cohorts was 2/week180.
Regardless of cohort, this value was significantly (p<0.02) higher in those who developed a UTI(s)
(n=13) compared to those who did not (n=14)180. 75% of all UTI episodes occurred within 24 hours
of sexual intercourse180; differences were not seen between cohorts. UTI incidence did not
correlate to any other lifestyle factor assessed. Buckley et al. found supporting data from a
microbiologic rather than symptomatic perspective. They recruited 20 pre-menopausal females
to provide urine specimens (type of specimen was not specified) before, 1 hour after, 6-10 hours
after, and 30-48 hours after sexual intercourse for assessment of bacterial counts (type of
microbiologic culture/technique was not specified)181. Of the 76 intercourse episodes assessed,
46 had colony counts that started and remained below 104 CFU/mL, 7 had counts above 105
CFU/mL before and after, and 23 had an increase of more than one log after intercourse181. None
of the 23 episodes resulted in reporting of urinary symptoms. In 7/23 episodes, counts after
intercourse were >105 CFU/mL; these were commonly identified as E. coli181. In the remaining 16
episodes, colony counts were between 104 and 105 CFU/mL after intercourse. Interestingly, these
organisms were frequently identified as non-pathogens such as Corynebacterium and non-Group
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D Streptococcus (i.e., not Enterococcus)181. The rise in bacterial counts in these 23 episodes was
transient; counts were less than 104 in 16/23 by the 30-48-hour timepoint181. In an unrelated
study from Buckley et al., half of the participants were instructed to urinate immediately
following intercourse, while the other half were told to not urinate. This did not have an impact
on the data181. Collectively, these data show that, in general, sexual intercourse results in a rapid
(i.e., with 24 hours) increase in UTI risk and urinary bacterial counts. These trends are discussed
again in Chapter V.
Correlations between UTI Risk and Urine Properties
Traditionally, it has been understood that risk factors result in UTI by altering the urinary
and urogenital environment to be more susceptible to infection. As such, various properties and
constituents of urine have also been studied in relation to UTI (Table 1B). Typically, these are
measured by urinalysis. The simplest approach is a urine dipstick test, which is a urine test strip
comprised of several chemical pads that react, via color changes, when exposed to a urine
sample. This approach is in contrast to a microscopic urinalysis where a urine specimen is
centrifuged, resuspended and added to a glass slide for microscopic analysis and enumeration of
eukaryotic cells (e.g., leukocytes and erythrocytes), urinary crystals (e.g., calcium oxalate), and
bacterial cells211.
Urine dipsticks can test for a variety of urine characteristics and properties, some of which
are correlated to UTI risk. Specific gravity is the urine osmolality and provides information
regarding the hydration of the person. These values range from 1.000 to 1.030, where values
above 1.020 indicate dehydration211. The pH of the urine ranges from 4.5 to 8.0 but is usually
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slight acidic (i.e., 6.0)211. Diets that are high in protein and acidic fruits can cause more acidic
urine, while foods high in citrate, like oranges, can lead to more alkaline urine236. Urine with an
alkaline pH is considered indicative of a UTI211 212 213 214 215. Hematuria, or blood in the urine, can
be detected visually, but microscopic hematuria is determined by detection of peroxidase activity
of the urine, which is indicative of the presence of erythrocytes. Urologic hematuria is not
typically considered indicative of UTI, but rather more serious urologic conditions211. In healthy
individuals, levels of protein in the urine (proteinuria) should be minimal to none, as these should
be reabsorbed and metabolized by the proximal tubules of the kidney. Significant proteinuria,
defined as greater than 150 mg per day, is considered indicative of renal disease. Proteinuria is
not related to UTI. Glucose in the urine (glycosuria) is found in those with diabetes mellitus, liver
disease, and several other diseases. Glycosuria is associated with higher UTI risk209 211. Ketones,
from fat metabolism, are also not normally found in urine, but are associated with higher UTI
risk209 211. Starvation and diets low in carbohydrates can lead to detection of ketones in the urine.
Bilirubin and/or urobilirubin in the urine are signs of liver disease and are considered a risk factor
for UTI in neonates210 211. Nitrates are common in urine from the breakdown of amino acids, but
nitrites will only be found if bacteria capable of reducing the nitrates are present211. Both Gramnegative and Gram-positive are capable of this conversion and it has not been assessed in the
context of the urinary microbiota. Despite this, presence of nitrites is considered indicative of a
UTI211

. Finally, leukocyte esterase is produced by neutrophils and is considered

212 213 214 215

indicative of an immune response to a UTI211 212 213 214 215. However, detection of leukocyte esterase
can occur following exercise, or with non-UTI diseases, such as viral infections and bladder
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tumors. In some cases, the dipstick-measured urine property (e.g., presence of leukocyte
esterase and nitrites) is likely a direct result of the UTI, rather than a risk factor for it. But, in other
cases, like the presence of ketones or certain pH levels, which can be altered by diet, it is unclear
what the relationship is between the risk factor and the urine property, and furthermore how
these relate to the urinary microbiota. I assess this complicated relationship in Chapter IV.
Longitudinal Assessment of the Lower Urinary Tract Microbiota
Rationale and Problems
I have cited evidence that temporal dynamics exist in the GI and vaginal microbiota and
that, in large part, these dynamics correlate to lifestyle factors, behaviors, or events.
Furthermore, I have described how lifestyle impacts UTI risk. Collectively, these data prompted
us to hypothesize that temporal dynamics exist in the female urinary microbiota and correlate to
lifestyle. To date, few studies have assessed the urinary microbiota longitudinally. Thomas-White
et al. assessed the microbiota of TUC specimens in women with OAB at three timepoints (several
weeks apart) as a measure of treatment (i.e., Solifenacin) efficacy35. Changes in the microbiota
and microbiome were observed, but conclusions cannot be made regarding dynamics because of
the influence of the drug, the disease state of the patients, the varying demographic and clinical
measures, and lack of lifestyle data. Ideally, a study assessing the temporal dynamics of the
urinary microbiota should involve a cohort of demographically similar women who provide
detailed lifestyle information and biological specimens on a daily timescale for several months.
While certainly difficult to coordinate, this is a relatively straightforward study design. The
challenge exists in the collection and interpretation of the biological specimens. Differences exist
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in the urinary microbiome between voided (i.e., non-catheterized) and catheterized urine
specimens29. These differences, and how they relate to surrounding niches (e.g., urethral, periurethral, vaginal), have yet to be studied in great detail. Furthermore, intermittent and Foley
catheterization are associated with an elevated UTI risk237 and these have yet to be studied in
relation to the urinary microbiota. Therefore, daily collection of catheterized specimens to study
the urinary microbiota is impractical and possibly harmful. A voided urine specimen must be
used, but proper interpretation of the resultant microbiologic data is complicated.
What Specimen to Collect?
Various urine collection methods exist. The gold standard for urine collection to diagnose
bladder infections is a SPA specimen. This procedure involves the use of a needle to aspirate urine
directly from the bladder through the abdomen, thus eliminating the possibility of contamination
from the skin and urethra. SPA specimens are only collected from patients that are fully hydrated,
have a palpable bladder, and no indication of intestinal obstruction or abdominal scarring238.
Collection of these specimens is considered invasive and proper collection involves the use of
ultrasound guidance. Altogether, these considerations make daily collection of SPA specimens
for longitudinal research a non-viable option.
Urethral catheterization, or TUC, specimens are the next most accurate specimen in
capturing bladder-specific urine. In the context of the female urinary microbiota, Wolfe et al.
showed similarities between TUC and SPA specimens29, suggesting that the process of
catheterization does not introduce urethral contaminants, or alter the bladder urine microbiota,
a finding confirmed by others63. However, catheterization is still an invasive procedure that
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requires some technical skill to perform. Repeated, or intermittent catheterization, is associated
with an increased risk of symptomatic urinary infections237. Indwelling, or Foley catheterization,
does not require frequent removal and insertion, but can result in high infection rates. Bacteria
can migrate along the inside and outside of the catheter to enter the bladder. Infection rates
increase for each day of use, with almost 95% incidence past one month of use239. Therefore, TUC
specimens, either intermittent or indwelling, are also not a viable or safe option to study the
longitudinal urinary microbiota.
Clean catch voided urine is much less invasive compared to TUC or SPA techniques for
obtaining a urine specimen. This requires the collection of voided urine in a sterile manner.
Although it is less invasive, there is a higher opportunity for contamination, both environmental
and from unintended body sites. There is also significant variability in the actual practice of the
techniques, making interpretation of the results even harder. Initial void versus mid-stream void,
use or no use of a genital cleansing wipe prior to urination, and type of urine collection cup are
examples of the variability seen among protocols. Recently, Aisen et al. examined clean catch
voided urine specimens (the explanation of collection technique was not shown) and paired TUC
urine specimens from 107 mostly post-menopausal women presenting UTI-like symptoms240.
Using SUC, a positive clean catch urine specimen was defined as having >104 CFU/mL of a single
bacterial species or a culture with multiple bacterial species and an abnormal urinalysis (UA); a
positive TUC specimen was defined as having any bacterial growth (i.e. >103 CFU/mL)240. All
patients had a positive clean catch voided urine specimen, but only 53 (49.5%) had a positive
paired TUC specimen240. Despite the differences in defining a positive culture, a clear distinction
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was observed in the microbiologic data from clean catch voided urine and TUC specimens. An
additional caveat of this study, however, was that the paired specimens were not collected at
the same visit; it is unclear how this affected the data.
Urine collection bags are used to obtain urine specimens primarily from children and the
elderly. This involves a collection bag applied to the perineum after cleansing the skin. The patient
urinates, the bag fills with urine, and then pulls away from the skin. This specimen type is at
significant risk for contamination with perineal and fecal bacteria. False positive cultures (i.e.,
SUC) are frequently obtained241.
Considering all of the data, I conclude that clean catch voided urine specimens are the
optimal collection type needed to study the urinary microbiota longitudinally due to the less
invasive nature, minimal risk for infection or complications with its use, and lower likelihood of
contamination compared to other non-invasive approaches.
MSU specimens are a type of clean catch voided urine specimen and are commonly used
to diagnose UTI. MSU specimens consist of voided urine collected after discarding the initial void,
typically the first 10 mL. These are commonly collected after use of a vaginal cleansing wipe242,
although not always. The cleansing wipe has no difference on the ability to properly interpret the
specimen243. Urine collected from an MSU specimen potentially contains bladder organisms,
urethral, peri-urethral, and possibly even vaginal. Therefore, from this point, I will refer to
microbiologic data collected using MSU specimens as the lower urinary tract (LUT) microbiota.
Additionally, it is difficult to standardize collection of an MSU specimen, although attempts have
been made. Recently, I studied the urinary microbiota collected from women using the Peezy®
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system, a self-contained device that collects a standardized MSU specimen and likely reduces
skin and environmental contamination244. The results from this study are described in detail in
Appendix J. But, all in all, the bacterial composition of MSU specimens relative to their starting
niche (e.g., bladder, urethra, peri-urethra, vagina) has not been extensively investigated.
Several groups have studied the differences between MSU and catheterized urine
specimens in the context of UTIs but present the differences as “contamination rates”.
Unfortunately, the “contamination” is typically regarded as any bacterial growth other than usual
Gram-negative uropathogens (e.g., E. coli, Klebsiella); this approach considers the normal flora
of the bladder as part of the “contamination”. Using data from 105 patients, Walter et al. found
that the concordance rates between MSU and catheterized urine specimens for urine cultures
(i.e., SUC), nitrites (using urine dipstick), leukocyte esterase (using urine dipstick), microscopic
bacteriuria (Gram-stain), and pyuria were 96%, 94%, 93%, 90%, and 90%, respectively245.
Therefore, they concluded that with proper technique, MSU and catheterized urine specimens
did not provide significantly different laboratory results or result in differences in UTI diagnosis.
This, of course, is potentially in contrast to work done by Aisen et al. described above, which
showed a 50% discrepancy between paired clean catch voided urine and TUC specimens in
women with UTI-like symtoms240. However, it is unclear from the manuscript if these were MSU
specimens. Ultimately, what I can conclude is that new research, done with the understanding of
the existence of the urinary microbiota, and using modern laboratory techniques (e.g., EQUC and
16S rRNA gene sequencing) is required to fully understand the data provided by MSU specimens.
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Some data exist that show that microorganisms obtained through MSU specimens are
mostly free from vaginal and peri-urethral contaminants. Recently, Gottschick et al. analyzed the
LUT microbiota of MSU and vaginal swab specimens collected from health women and women
with BV. 16S rRNA gene sequencing data showed that, in most patients, the correlation between
the microbiome identified in the two specimen types was not significant. The exception was in
women with BV who had an anaerobic urotype (e.g., Gardnerella vaginalis, Atopobium vaginae,
Sneathia amnii) in the MSU specimen (59%)73. These data show that, in healthy women, MSU
specimens do not sample the vagina.
I can also speculate that peri-urethral contamination in MSU specimens is low. Typically,
peri-urethral swabs from females are collected by separating the labia without prior cleansing
and swabbing the area around the external urethral orifice with a sterile swab. In a small cohort
of 19 female patients hospitalized for various diseases, Munir et al. collected MSU specimens and
assessed for bacterial content using a modified culture approach in which a non-standardized
quantity of urine was inoculated onto cystine-lactose-electrolyte-deficient (CLED) agar and
incubated under aerobic conditions for 48 hours246. Peri-urethral swabs specimens were also
collected on these patients and plated onto BAP and MacConkey agar and incubated under the
same conditions246. The MSU specimens contained primarily Gram-Negative bacteria, while the
peri-urethral swab had primarily Gram-Positive organisms246, showing that the two sites are
distinct, at least in this particular patient population. Cattell et al. collected MSU and peri-urethral
swab specimens weekly for six weeks from a variety of female patients: healthy women, patients
with symptomatic bacteriuria, patients with urethral syndrome (inflammation or swelling of the
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urethra), and patients with asymptomatic bacteriuria247. Peri-urethral swabs were cultured on
MacConkey agar and incubated aerobically for 24 hours. Though they only reported on
enterobacteria values, Cattell et al. found that there was no correlation in any of the cohorts
between detection of enterobacteria in the peri-urethral swab and the development of a UTI (as
defined by >104 CFU/mL of bacterial growth in the MSU specimen and UTI symptoms) during the
six-week study247. These data suggest that the peri-urethral area and MSU specimens sample
separate niches.
From these limited data, I conclude that MSU specimens primarily sample the bladder
and urethral bacterial communities. To my knowledge, however, no work has been done to
understand the precise contribution of either site in MSU specimens. Despite this lack of
knowledge, several groups have used MSU specimens to study the urinary microbiota (i.e., LUT
microbiota). In 2011, Siddiqui et al. used 16S rRNA gene sequencing of the V1-V2 and V6
hypervariable regions (similar results were obtained) to assess the microbiome of MSU
specimens (30mL) from eight culture-negative (<105 CFU/mL using SUC) healthy females248.
Demographics were not provided. Common genera detected included Lactobacillus, Prevotella,
and Gardnerella, as well as taxa with known pathogenic potential. But, overall, significant
variation among individuals was observed248. Lewis et al. also sampled a small cohort of female
participants, with a range in ages from 26 to 9069. MSU specimens were collected (2 mL) and using
16S rRNA gene sequencing of the V1-V3 hypervariable regions, as well as quantitative PCR to
provide relative enumerations of the bacteria, they found high diversity of bacterial genera
generally belonging to the Actinobacteria and Bacteroidetes phyla69. Additionally, higher
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abundance of anaerobic bacterial taxa were found to be associated with age69. Gottschick et al.
compared data collected from MSU and vaginal swab specimens of primarily pre-menopausal
women with (n=42) and without (n=49) BV73. DNA was extracted from 15 mL of urine and 16S
rRNA gene sequencing of the V1-V2 hypervariable regions was performed. They observed several
distinct urotypes (based on hierarchical clustering) in the MSU specimens including Lactobacillus,
Escherichia, Streptococcus, Enterococcus, Mixed/Diverse, and Anaerobic73. The anaerobic
urotype was more prevalent in the BV cohort of women, while the Lactobacillus urotype was
more prevalent in the non-BV cohort73. Curtiss et al. also performed a case-controlled study using
MSU specimens. They assessed the LUT microbiota between women with (n=63) and without
(n=35) OAB48. 5 mL of urine was centrifuged and resuspended in 50 µl of the supernatant; then 5
µl was plated onto two Chocolate agar plates and incubated in 5% CO2 and anaerobically for 48
hours; morphologically distinct colonies were selected, purified, lysed, and then the V9
hypervariable region of the 16S rRNA gene was amplified using PCR and sequenced48. Curtiss et
al. observed lower abundance of Lactobacillus in OAB patients, and higher abundance of Proteus.
But the mean number of distinct bacterial genera did not differ between cohorts48. Willner et al.
collected MSU specimens from women with acute UTI symptoms (n=38)43. Using 1 mL of urine,
they performed 16S rRNA gene sequencing of the V5-V8 hypervariable regions and found high
abundance of Escherichia, low abundance of anaerobic taxa, and overall low bacterial diversity43.
Additionally, they reported a correlation between Escherichia urotype and age43. Kramer et al.
assessed a cohort of 41 women with non-dialysis-dependent CKD53. 1 mL of MSU was analyzed
using 16S rRNA gene sequencing of the V4 hypervariable region. They found overall high bacterial
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diversity in these specimens, and these levels generally correlated to higher eGFR values
independent of demographics53. Finally, Coorevits et al. analyzed MSU specimens from 86
healthy females using a modified urine culture protocol [i.e., Expanded Urine Culture (EUC)]249.
This EUC method used a BAP and a Schaedler agar plate (commonly used for growth of anaerobic
GI tract bacteria) inoculated with 0.01 mL of urine and incubated at 35°C for seven days in aerobic
and anaerobic atmosphere, respectively249. Using MALDI-TOF MS for identification, EUC revealed
a total of 98 unique species including several in the Lactobacillus, Staphylococcus, Streptococcus,
and Corynebacterium genera249; these organisms are commonly identified as part of the
microbiota of TUC urine specimens.
All in all, data assessing the microbiota of the LUT using MSU specimens provides similar
results to those seen in the assessment of the urinary microbiota using TUC specimens. Though
a proper cross-sectional analysis has not been performed, similar taxa are identified and similar
patterns with various demographics and disease states can be seen. For example, in patients with
acute UTI, Willner et al. (using MSU) and Price et al. (using TUC) both found high abundance of
Escherichia and overall low diversity43 44. In patients with OAB, Curtiss et al. (using MSU) and
Pearce et al. (using TUC) both found lower abundance of Lactobacillus, higher abundance of
pathogenic taxa, and overall higher diversity48

. And, in healthy patients, Siddiqui et al.,
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Gottschick et al., and Lewis et al. (all using MSU) found distinct urotypes including Lactobacillus,
Gardnerella, and Anaerobic, as well as trends with age248
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. I find similar trends using TUC

specimens. These data suggest that use of MSU specimens are an appropriate alternative to TUC
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specimens when catheterization is not possible or is unsafe. This further supports the use of MSU
specimens for longitudinal microbiologic analysis.
Preliminary Findings
To my knowledge, no one has assessed the urinary or MSU microbiota for stability in
females. In a recent abstract, Forster et al. sampled voided urine specimens from six C57BL/6
mice month over a five-month period (mice started at 9 weeks of age)250. 16S rRNA gene
sequencing showed that the proportion of specific bacteria did not change in individual mice over
the five months250. Alpha diversity measures (i.e., Shannon Diversity) also did not change over
time. Mice were co-housed and fed identical diets over the five months250. These data show that,
in mice, the microbiota of the LUT are stable over a five-month period. The strength of these data
is that the mice are in an entirely controlled environment and, therefore, the influence of lifestyle
factors is negligible. Caveats include non-daily specimen collection and lack of information
describing the method of urine collection. Also, using non-daily specimen collection, Gottschick
et al. demonstrated that antibiotic use in women BV resulted in changes to the microbiome of
the LUT73.
In 2017, primarily as an assessment of feasibility, I recruited seven pre-menopausal
women who were instructed to collect MSU and peri-urethral swab specimens daily for about
two weeks. These data are described in Chapter III. I observed rapid temporal variation in the
microbiota of both specimen types in all participants. Some showed consistent variations over
time, while others were more random. These variations were in both composition and diversity.
Whether the variations relate to lifestyle factors is unclear from these data.
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Summary
At the time of writing this thesis, it has been almost a decade since the discovery of the
urinary microbiota. In that short amount of time, we have learned a lot about these communities
of microbes from the perspective of both health and disease. But, we have yet to implement
these findings into clinical patient care, largely because there is still so much that we do not know.
This thesis will serve to provide another piece of the puzzle - that is, how do these communities
of microbes change over time? Researching this question will not only provide insight into the
bladder and LUT environment at a microscopic level, but at a clinical level as well. By exploring
this question in relation to lifestyle factors that have associations with UTI risk, the hope is that
we will obtain a richer and more complete understanding of UTIs. We can no longer define a UTI
as a microbe entering and colonizing an otherwise sterile environment. The UTI-causing
organism(s) has(have) to compete with the normal flora to establish colonization and ultimately
infection. And, if the normal flora is subject to change over time, then it may be that certain
populations are better or worse at combating UTI-causing organisms. My data provide evidence
to support this claim. What this ultimately means is that it may be possible to alter the urinary
microbiota, possibly through lifestyle changes, to generate a more protective state. This is an
entirely novel approach to UTI therapies.
In the forthcoming chapters, I will describe a longitudinal study in which eight premenopausal female participants were recruited to self-collect urine and other biological
specimens on a daily timescale for approximately three months. Using daily lifestyle
questionnaires, I show that some factors are associated with temporal changes in the microbiota
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of the LUT. These are described in Chapters IV & V. One of the most interesting findings from this
work was an association between vaginal intercourse and microbiota alterations, particularly
because the changes were consistent within participants and similar among participants. Chapter
VI describes a follow-up study where one of the original participants and her male sexual partner
provided additional daily specimens to determine the biological and clinical significance of these
findings. I found evidence that the intercourse-associated microbiota originate from outside the
urogenital tract. I further found that these microbiota, in vitro, are not protective against UTIcausing organisms, which contrasts with the normal flora. Taken together, these data provide
evidence that the etiology of UTI risk factors, like sexual intercourse, may be grounded in the
microbiota. This creates a new avenue to provide therapeutic and preventative measures for
patients that are at risk of developing UTIs.
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CHAPTER II
MATERIALS AND METHODS
Overview of Clinical Studies
In this thesis, I present data for three clinical studies used to assess the temporal dynamics
of the microbiota of the female LUT. In Chapter III, I describe data obtained from my
pilot/feasibility project, the MAGnUM Study (Measuring the effects of Alcohol on the Genitourinary Microbiota). This work was done in collaboration with Danielle Johansen, MS, a former
Master’s student in the lab. The primary goals of the MAGnUM study were to assess the
feasibility of longitudinal urine specimen collection in community women, to determine the
short-term temporal dynamics of the microbiota of the LUT, and to determine the effects of one
lifestyle factor, alcohol consumption, on the temporal dynamics.
In Chapters IV and V, I describe data obtained from the primary project, the ProFUM
Study (Probiotics and the Female Urinary Microbiome). This work was done in collaboration with
Birte Wolff, MD, a urogynecology fellow at Loyola University Medical Center (Maywood, IL). The
primary goals of the ProFUM study were to measure the long-term temporal dynamics of the
microbiota of the LUT in pre-menopausal non-symptomatic women, to assess the relationship
between lifestyle factors and behaviors, as well as urine properties and constituents, on the
temporal dynamics, and to determine the effect of oral probiotic use on the microbiota
composition and diversity and temporal dynamics.
67

68
Data obtained from the ProFUM study led us to perform a follow-up project, the PARTNER
Study (Effect of Sexual Activity on the Urinary Microbiota of Sexual Partners), data from which is
described in Chapter VI. This work was also done in collaboration with Dr. Birte Wolff. The
primary goals of the PARTNER study were to further assess the effect of sexual intercourse on
microbiota temporal dynamics, and to determine whether compositional changes in the
microbiota were introduced from the male sexual partner.
MAGnUM Study
From October 2016 to March 2017, following Institutional Review Board (IRB) approval, I
recruited 10 community participants from the Loyola University Medical Center campus to
provide daily self-collected biological specimens for 18 days. This included both male (n=3) and
female (n=7) participants, with a mean age of 23. Recruitment was done by presenting the
research opportunity to the Department of Microbiology & Immunology. Interested participants
contacted a third-party study nurse to complete the recruitment process, which included
determining eligibility, providing instructions on the study design and proper specimen
collection, and supplying study materials. Demographics were collected including age,
race/ethnicity, and frequency of alcohol consumption. Participants currently taking antibiotics
were excluded. Eligible participants were assigned unique study ID numbers. As this was a study
to assess the feasibility of longitudinal urine specimen collection in community participants, no
power calculation was performed to determine appropriate sample size.
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Figure 4. MAGnUM Clinical Study Design Outline. Midstream Voided Urine (MSU) and periurethral swab specimens were self-collected daily from 10 participants (male: n=3; female n=7).
Total collection time was 17 or 18 days. Two female participants withdrew (Day 11 and Day 13).
Participants were instructed not to consume alcoholic beverages on weekdays (Monday-Friday)
as a measure of the effect on the LUT microbiota.
The clinical design for the MAGnUM study is described in Figure 4. MSU urine specimens
and peri-urethral/meatal swabs were self-collected each morning and delivered to the laboratory
for analysis (described below). Participants were given written instructions regarding proper
specimen collection. Contrary to some clinical protocols, the participants were instructed not to
use the genital cleansing wipe provided in the collection kits prior to specimen collection. The
purpose of this was to allow us to study the differences between the peri-urethral area and MSU
specimens to understand the microbial contributions of both. I was concerned that use of the
cleansing wipe would disrupt the bacterial communities and provide us with biases and
inaccurate data. Specimens collected on weekends, or on days when the participant was not at
the campus, were stored at room temperature until they could be turned in. Labels with the
participants’ unique study ID number, type of specimen, day of specimen collection (relative to
the study), and a place for the participant to record the date of specimen collection were given
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to each participant prior to the start of the study. The participants were instructed to attach the
appropriate filled-out label to each specimen prior to drop off.
The three male participants completed 17 days of specimen collection. Two female
participants (i.e., MAG03 and MAG08) completed 17 days, while three (i.e., MAG09, MAG10,
MAG11) completed 18 days of specimen collection. I did not receive specimens from MAG08 on
Day 10. Two female participants withdrew prior to study completion. MAG02 completed 11
consecutive days, while MAG05 completed 13 consecutive days of specimen collection.
As a preliminary assessment of lifestyle factors and behaviors on microbiota stability and
dynamics, the participants were instructed not to consume alcoholic beverages on weekdays
(i.e., Monday – Friday). It was the choice of the participant to consume alcohol on weekends (i.e.,
Saturday – Sunday). Participants completed a daily diary documenting alcoholic beverages
consumed. According to the diaries, no participants deviated from the given instructions.
Prior to study completion, I was notified that on the final day of specimen collection (Day
18), female participant, MAG09, reported to the third-party study nurse that she was
experiencing UTI symptoms. She was instructed to contact her clinical care physician to receive
medical care. Outside the context of this study, follow-up conversation with this participant
revealed that she was diagnosed with a laboratory-confirmed E. coli UTI.
ProFUM Study
From September 2017 to July 2018, following IRB approval, I recruited eight premenopausal female community participants from the Loyola University Medical Center campus
to provide daily self-collected biological specimens over 95 days. This is a registered clinical trial
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(NCT03250208): https://clinicaltrials.gov/ct2/show/NCT03250208. Recruitment was done by
presenting the research opportunity to the Department of Microbiology & Immunology, and by
word of mouth. Interested participants contacted a third-party study nurse. The study nurse then
informed the clinical team (i.e., Dr. Birte Wolff), who then coordinated a one-on-one meeting to
complete the recruitment process.
Potential participants completed an inclusion/exclusion questionnaire. Eligible
participants were female, over 18 years of age, not currently pregnant, taking antibiotics, or
taking probiotics, not planning a vacation for more than seven days during the time of specimen
collection (i.e., three months), and could read English and sign a consent form detailing the
requirements and voluntary nature of the study. Eligible participants were given a unique study
ID number and then completed a demographics questionnaire, which included the following: age,
race/ethnicity, height/weight, blood pressure, vaginal parity, birth control method, condom use,
typical length of menstrual cycles, use of menstrual hygiene products, prior urogynecologic
surgery, sexual activity (frequency, type, partners), dietary preferences, alcohol consumption,
number of bowel movements in an average week, use of cigarettes, frequency of bathing, current
medications, and history of UTI, kidney stones, urinary incontinence, and fecal incontinence.
Participants were then instructed on proper specimen collection by the clinical team. This was
done by having each participant watch a standardized video detailing proper collection of an MSU
specimen, a peri-urethral swab, and a combination vaginal and perineal swab. The clinical team
provided further explanation if the participant had questions. Consistent with the MAGnUM
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study, participants were instructed not to use the genital cleansing wipe provided in the urine
collection kits.
At the recruitment meeting, participants were given supplies and instructed on where to
leave the specimens. A locked drop-box was placed in an accessible room in the Center for
Translational Research and Education building at Loyola University Medical Center. Only the
research team had access to the drop-box. All participants had or were given access to this
building prior to the start of the study. Specimens were collected each morning and participants
were instructed to turn in the specimens by noon of that day. Specimens collected on weekends,
or on days when the participant was not at the campus, were stored at room temperature until
they could be turned in. Labels with the participants’ unique study ID number, type of specimen,
day of specimen collection (relative to the study), and a place for the participant to record the
date of specimen collection were given to each participant prior to the start of the study. The
participants were instructed to attach the appropriate filled-out label to each specimen prior to
drop off. Daily labeled specimens were put in a biohazard bag along with a daily questionnaire
(described below) and turned in to the drop-box.
A daily lifestyle questionnaire was completed and turned in with each day of specimen
collection. In reference to the previous day (i.e., previous 24 hours), primarily as yes/no-style
questions, the questionnaire queries alcohol consumption, menstruation, menstrual hygiene,
bathing, swimming, sexual activity (oral, vaginal, other), number of bowel movements, and diet
presented as 26 broad food categories. There was also a section to record any medical-related
comments including medications used. In reference to the current day (i.e., since waking up and
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before specimen collection), the questionnaire includes two yes/no-style questions regarding
urination and bowel movements. The final three participants completed a slightly modified
lifestyle questionnaire that included two additional questions regarding condom use with vaginal
intercourse and whether the partner was the same as the previous episode.
Participants first completed a three-day screening period to determine final study
eligibility. The purpose of this screening period was to assess proper specimen collection. As
described in Chapter I, MSU specimens should be sampling the microbial contents of the bladder
and urethra. Contribution of the peri-urethra should be minimal. Therefore, I excluded
participants who provided MSU and peri-urethral specimens with similar microbial contents.
Similarity was determined using the Bray-Curtis Dissimilarity test with a value of 0.8 as a cut-off
for eligibility. Eligible participants had to provide paired specimens with scores > 0.8 for two out
of the three collection days in the screening period. The rationale and determination of this cutoff
are explained in Chapter III using data from the MAGnUM study.
Eleven eligible participants were screened for final study eligibility using the three-day
screening period. Using the exclusion criteria described above, three participants were excluded
from the final study. These data are provided in Chapter IV. The remaining eight participants
were informed of their results and a second one-on-one meeting with the clinical team was
arranged in which the ProFUM study design was described and a W2-form was completed to
provide the participant with compensation following successful study completion. Participants
were compensated $800 for their time; this was prorated to $6 per day of completion if the
participant withdrew (none withdrew). To receive full compensation, the participant could not
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Figure 5. ProFUM Clinical Study Design Outline. Midstream Voided Urine (MSU) and periurethral swab specimens were self-collected daily from 8 participants from Days 1 – 74, followed
by weekly collection through Day 95. Daily lifestyle questionnaires were completed on each of
these days. Vaginal/perineal swabs were collected weekly from Days 25 – 95. The study design
was divided into three phases: Phase I (Days 1 – 20), Phase II (Days 21 – 60), and Phase III (Days
61-95). During Phase II, the participants were randomized (2:1) to take an oral probiotic or
placebo twice daily. This assignment was double-blinded.
miss more than seven collection days (all participants received full compensation). Participants
were not compensated for the three-day screening period.
The clinical design for the ProFUM study is described in Figure 5. MSU urine specimens
and peri-urethral swabs were self-collected each morning for 74 consecutive days followed by
weekly collection through Day 95. A combination vaginal and perineal swab was collected weekly
from Days 25 – 95. These were delivered each morning (as described above) for laboratory
analysis (described below). As this was an exploratory study to understand the temporal
dynamics and the influence of lifestyle on the microbiota of the LUT, no power calculation was
performed to determine appropriate sample size. The goal was to recruit nine participants into
the final study (I recruited eight).
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The study design (Figure 5) was divided into three phases. Phases I and III flanked an
experimental or treatment phase (i.e., Phase II) in which the participants were randomized in a
2:1 ratio to take an oral probiotic or placebo. The probiotic used was L. rhamnosus GR-1 and L.
reuteri RC-14 at a sum of 109 viable organisms (collectively known as Fem-Dophilus®) to be taken
twice daily. The probiotic capsules were purchased from www.iherb.com and were sent directly
to the Loyola University Medical Center inpatient pharmacy department where a randomization
scheme at a 2:1 ratio was chosen in a double-blinded manner. The capsules were stored at room
temperature as per the manufacturer recommendations. The probiotic was re-packaged in
capsules that were identical to the placebo capsules which contained a carbohydrate placebo.
Pill bottles were labelled with the participant’s name, date of packaging, and “Placebo/Probiotic”.
As an evaluation of the success of blinding, at the completion of the study, participants were
asked which study group they thought they were in. Following study completion, it was
determined that five participants were in the probiotic cohort, and three were in the placebo
cohort.
During Phase I, which was from Days 1 – 20, all participants collected daily MSU (n=20)
and peri-urethral (n=20) specimens as well as completed the daily lifestyle questionnaire (n=20).
During Phase II, which was from Days 21 – 60, all participants collected daily MSU (n=40) and
peri-urethral (n=40) specimens, provided weekly vaginal/perineal specimens (n=6), and
completed the daily lifestyle questionnaire (n=40). Probiotic/placebo pills were taken twice daily
during Phase II. As a measure of compliance, they turned in the pill bottle following Phase II
completion; the number of remaining pills was documented. During Phase III, which was from
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Days 61 – 95, all participants collected MSU (n=17) and peri-urethral (n=17) specimens as well as
completed the daily lifestyle questionnaire (n=17) on a daily-basis from Days 61 – 74, followed
by weekly collection from Days 74 – 95. Vaginal/perineal specimens (n=5) were collected weekly.
Necessary study materials were provided prior to each phase. Prior to Phase II, the participants
received their assigned pill bottles along with a description of the use and risks of taking the
probiotic, which was provided by the manufacturer.
PARTNER Study
From September 2018 to October 2018, following IRB approval, I enrolled one female
participant and her male sexual partner in a follow-up study to further investigate the effects of
sexual intercourse on the microbiota of the female LUT. The female participant was previously
enrolled in the ProFUM Study as participant ProFUM05. The clinical team (i.e., Dr. Birte Wolff)
coordinated a one-on-one meeting to complete the recruitment process. As part of the study
design (Figure 6), the male sexual partner of the female participant (PARTNER01) was also
enrolled in the study (PARNTER02), following consent.
Prior to study enrollment, the male participant completed an inclusion/exclusion
questionnaire. Eligible participants were in a sexual relationship with a female participant of the
ProFUM study, male, over 18 years of age, not currently taking antibiotics, not planning a
vacation for more than seven days during the time of specimen collection (i.e., three weeks), and
could read English and sign a consent form detailing the requirements and voluntary nature of
the study. Eligible participants then completed a demographics questionnaire, which included
the following: age, race/ethnicity, height/weight, blood pressure, circumcision status, condom
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Figure 6. PARTNER Clinical Study Design Outline. The female participant (PARTNER01) (i.e.
ProFUM05) self-collected Midstream Voided Urine (MSU) and peri-urethral and vaginal swab
specimens daily for 3 weeks (Days 1 – 21). The male participant (PARTNER02) self-collected MSU
and meatal and penile swab specimens before and after (within 30 minutes of) sexual
intercourse for 3 weeks. Additionally, both participants self-collected an oral/buccal swab once
per week for 3 weeks. The participants were instructed to engage in sexual intercourse once per
week for the duration of the study. Daily lifestyle questionnaires were completed for all 21 days
by both participants.
use, prior urologic surgery, sexual activity (frequency, type, partners), dietary preferences,
alcohol consumption, number of bowel movements in an average week, use of cigarettes,
frequency of bathing, current medications, and history of UTI, and kidney stones. The female
participant completed these forms as part of the ProFUM study and therefore was not required
to do so for the PARTNER study.
The male and female participants were then instructed on proper specimen collection by
the clinical team. This was done by having each participant watch a standardized video detailing
proper collection of an MSU specimen, a peri-urethral swab, a vaginal swab, and an oral/buccal
swab for the female, and an MSU specimen, a meatal swab, a penile swab, and an oral/buccal
swab for the male. The clinical team provided further explanation if the participant had
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questions. Consistent with the MAGnUM and ProFUM studies, participants were instructed not
to use the genital cleansing wipe provided in the urine collection kits.
At the recruitment meeting, participants were given supplies and instructed on where to
leave the specimens. A locked drop-box was placed in an accessible room in the Center for
Translational Research and Education building at Loyola University Medical Center. Only the
research team had access to the drop-box. All participants had or were given access to this
building prior to the start of the study. Specimens collected on weekends or on days when the
participant was not at the campus, were stored at room temperature until they could be turned
in. Labels with the participants’ unique study ID number, type of specimen, day of specimen
collection (relative to the study), and a place for the participant to record the date of specimen
collection were given to each participant prior to the start of the study. The participants were
instructed to attach the appropriate filled-out label to each specimen prior to drop off. Daily
labeled specimens were put in a biohazard bag along with a daily questionnaire (described below)
and turned in to the drop-box.
A daily lifestyle questionnaire was completed and turned in with each day of specimen
collection. The questionnaire was identical to the one used in the ProFUM study, but included
the following additional questions regarding sexual activity: type of sexual activity (oral, vaginal,
anal, manual), products used (condom and lubricant), brand of products used (if applicable), time
of day (morning, afternoon, evening), and habits immediately following the sexual activity (i.e.
within 30 minutes) (bathing and urination). The male and female participants completed
separate questionnaires. The questionnaires were identical except for questions regarding
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menstruation and menstrual hygiene, which were included in the female’s questionnaire only.
Responses to the questions regarding sexual activity were consistent between the participants
for each occasion (i.e., no discrepancies were noted).
Four female participants from the ProFUM study were eligible for enrollment in the
PARTNER study. These participants showed significant alterations to the microbiota of the LUT
following sexual intercourse in the ProFUM study (see Chapter V). Participant ProFUM05 was the
first of the four that the clinical team approached to determine her interest in the PARTNER
study. ProFUM05 and her male sexual partner agreed to participate in the PARTNER study. The
participants completed W2-forms to provide them with compensation following successful study
completion. Participants were each compensated $200 for their time; this was prorated to $6 per
day of completion if the participant withdrew (none withdrew).
The clinical design for the PARTNER study is described in Figure 6. The female participant
(PARTNER01) self-collected MSU specimens, and peri-urethral and vaginal swabs each morning
for 21 consecutive days. The male participant (PARTNER02) self-collected MSU specimens, and
meatal and penile swabs before and after sexual intercourse (i.e., within 30 minutes). Both
participants self-collected an oral/buccal swab once per week. The participants were instructed
to engage in sexual intercourse once per week (i.e., during Days 1-7, 8-14, and 15-21). Responses
to the lifestyle questionnaire showed compliance.
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Bacterial Identification Methods
Specimen Collection
For all clinical studies described above, appropriate specimen collection materials for athome collection by the participants were given at one time in bulk. Written (MAGnUM study)
and video (ProFUM and PARTNER studies) instructions were given to participants regarding
proper specimen collection.
MSU specimens were collected by voiding into a toilet to discard the initial void (i.e.,
approximately the first 10 mL of urine). The remaining specimen was then collected into a sterile
blue cap collection cup. A portion of each urine sample was placed in a sterile manner into a BD
Vacutainer® Plus C&S Preservative Tube for culturing. The tube contained a lyophilized boric acid
preservative to prevent bacterial overgrowth without causing cell death. Thus, specimens could
be held at room temperature for up to 72 hours without altering specimen integrity. Specimens
that were collected more than 72 hours prior to receipt were excluded from analyses.
Participants were instructed not to use the genital cleansing wipe included in each kit.
All swab specimens were collected using a BD ESwab® Liquid Amies Collection and
Transport System. The flocked swabs allow for optimal elution of the specimen into the medium.
Specimens stored at room temperature generally show bacterial viability up to 48 hours.
However, no preservative to prevent bacterial overgrowth was included in the collection tubes.
Therefore, specimens that were collected more than 48 hours prior to receipt were excluded
from analyses due to the possibility of bacterial overgrowth and thus inaccurate data. Periurethral swabs were collected by swabbing approximately 1 cm around the urethral opening.
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This was referred to as a meatal swab for the male participant in the PARTNER study. Vaginal
swabs were collected by inserting the swab approximately 2 cm into the vaginal opening and
rotating. Perineal/vaginal swabs (ProFUM study) were collected in the same manner as the
vaginal swabs but following removal from the vagina the swab was then moved down the
perineum towards the anus. Penile swabs were collected by swabbing the shaft of the penis.
Oral/buccal swabs were collected by swabbing the inner cheeks of the mouth.
Expanded Culture Protocol
I used a modified version of the Expanded Quantitative Urine Culture (EQUC) protocol to
identify the microbiota of the specimens34. For the MSU specimens, 0.01 mL (female specimens)
or 0.1 mL (male specimens) of urine was spread quantitatively onto diverse media types [BAP,
CNA agar, and CDC anaerobe 5% BAP (ABAP)] and incubated in appropriate environments at
appropriate temperatures (5% CO2 at 35°C for 48 hours or anaerobic conditions at 35°C for 48
hours). CNA agar contains approximately 10 mg/L colistin and 15 mg/L nalidixic acid for the
growth inhibition of Gram-negative organisms. ABAP contains additional growth factors required
by common obligate anaerobes including hemin (5 mg/L), L-cystine (400 mg/L), and vitamin K1
(10 mg/L). Each morphologically distinct colony type was counted and isolated on a different
plate of the same media to prepare a pure culture for identification by MALDI-TOF MS, using the
Bruker MALDI Biotyper Research (RUO) System. All swab specimens underwent the same
protocol using 0.01 mL of the liquid elution media after the swab was vortexed in the collection
tube for 10 seconds. The anaerobic condition was not used for the oral/buccal swabs. An
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overview of the specimen volumes used, and specimen types collected for each clinical study is
described in Table 2.
Table 2. Overview of specimens collected, and volumes assessed for bacterial culture.

Midstream Urine (MSU)
Peri-urethral/Meatal
swab
Perineal/Vaginal swab
Vaginal swab
Penile swab
Oral/Buccal swab*

MAGnUM Study
Female (n=7) Male (n=3)
0.01 mL
0.1 mL

ProFUM Study
Female (n=8)
0.01 mL

PARTNER Study
Female (n=1) Male (n=1)
0.01 mL
0.1 mL

0.01 mL

0.01 mL

0.01 mL

0.01 mL

0.01 mL

-

-

0.01 mL
-

0.01 mL
0.01 mL

0.01 mL
0.01 mL

All specimens were assessed using a modified EQUC protocol described above.
* Oral/Buccal swabs were not cultured under anaerobic conditions.
16S Sequencing Protocol
The remaining volumes of the MSU and swab specimen elution media after bacterial
culture were aliquoted for 16S rRNA gene sequencing. 10% (of the specimen volume)
AssayAssure (Sierra Molecular, Incline Village, NV) was added before storage at -80°C. Specimens
were assigned a unique Wolfe Lab identifier. Volume, color, turbidity, and pH were recorded for
all MSU specimens.
Each specimen was processed under a negative pressure laminar flow hood to prevent
environmental contamination. This is particularly relevant for low biomass samples such as
bladder specimens. All materials were bleached, and the hood was subjected to ultraviolet (UV)
light for 30 minutes prior to use. 70% ethanol was periodically used to sterilize gloves during the
early stages of the DNA extraction where exogenous bacteria could contaminate specimens.
DNA-away was used later in the extraction where exogenous DNA could contaminate specimens.
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Despite these precautions, I estimate from previous work that the detection threshold is about
1000 CFU/mL15

, meaning that specimens with <1000 CFU/mL of bacteria cannot be

35

distinguished from background contamination and are thus classified as “negative”.
Genomic DNA was extracted from the MSU and swab elution media with the Qiagen
DNeasy Blood and Tissue kit. 1 mL of urine or 0.5 mL of swab elution media were used. Briefly, 1
mL of urine was centrifuged at 13,500 rpm for 10 minutes, and the resulting pellet was
resuspended in 200 µl of a filter-sterilized DNA Extraction Buffer consisting of 20 mM Tris-Cl (pH
8), 2 mM EDTA, 1.2% Triton X-100, and 20 µg/ml lysozyme and supplemented with 30 µl of filtersterilized mutanolysin (5,000 U/ml; Sigma-Aldrich, St. Louis, MO). The addition of mutanolysin
and lysozyme ensures robust lysis of Gram-positive and Gram-negative species251. The mixture
was incubated for 1 hour at 37°C, and the lysates were processed through the DNeasy blood and
tissue kit (Qiagen, Valencia, CA), according to the manufacturer’s protocol. The DNA was eluted
into 50 µl of buffer AE (10 mM Tris-Cl, 0.5 mM EDTA), pH 8, and stored at -20°C. Negative controls
(no urine or swab elution media) were included in each extraction performed as an assessment
of contamination introduced during the protocol.
The hyper-variable region 4 (i.e., V4) of the bacterial 16S rRNA gene was amplified via a
two-step PCR protocol. In the first amplification, the V4 region was amplified using Illumina
MiSeq modified universal primers 515F and 806R. The extraction negative controls, as well as a
PCR-negative control (no template), were included to assess the contribution of extraneous DNA
from reagents. 10 µL aliquots of each reaction mixture were run on a 1% agarose gel. Samples
containing a band of approximately 360 base pairs were considered PCR-positive and subjected
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to further library preparation. Samples with no visible amplified product were considered PCRnegative and not processed further. The PCR-positive reaction mixtures were diluted 1:50 and
amplified for an additional 10 cycles, using primers encoding the required adapter sequences for
Illumina MiSeq sequencing and an 8-nucleotide sample index. The PCR reaction was purified, and
size selected using Agencourt® AMPure XP-PCR magnetic beads (Beckman Coulter, Pasadena,
CA). Each sample was quantified using the Qubit 2.0 Fluorometeric Bioanalyzer system (ThermoFisher, Waltham, MA). The samples were pooled, quantified to a standard volume, and placed in
the 2 X 250 bp sequencing reagent cartridge, according to the manufacturer’s instructions
(Illumina, San Diego, CA).
Sample barcodes and sequencing primers were removed using the Illumina proprietary
MiSeq post-sequencing software. The mothur program (v1.41.3) was used to process the raw
sequences by following the recommended MiSeq standard operating procedure252. Briefly,
mothur produced 16S contigs by combining the paired end reads based on overlapping
nucleotides in the sequence reads; contigs of incorrect length for the V4 region (<290 bp, >300
bp) and/or contigs containing ambiguous bases were removed. Chimeric sequences were
removed using UCHIME within the mothur package253. Subsampling at a depth of 5000 sequences
was performed to correct for different sequencing depth of each sample. The sequences were
clustered into species-level OTUs with identity cutoff at 97%254. The OTUs were classified using
RDP classifier (v2.11) at the genus level254 and BLCA11 at the species level.
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Dipstick Urinalysis
Each MSU specimen was characterized using a urine dipstick prior to being aliquoted and
stored. Approximately 1 mL of urine was pipetted onto a Siemens Multistix® 10 SG Reagent Strip.
Results were read and interpreted according to the manufacturer’s instructions. The reagent strip
tests for the presence and quantity (or relative quantity) of glucose, bilirubin, ketones,
hemoglobin (i.e., blood), protein, urobilinogen, nitrites, and leukocytes. pH and specific gravity
are also provided. A more detailed explanation of these tests is provided in Chapter I.
Storage of Bacterial Isolates
Several experiments described in Chapter VI rely on the use of bacterial strains isolated
from participants of the various clinical studies described. In particular, strains of L. jensenii and
Streptococcus mitis isolated from a female participant (ProFUM05 and PARTNER01) were used in
both genomic and in vitro assays (see Chapter VI). Following identification using MALDI-TOF MS,
certain bacterial strains were isolated for purity, stored in CryoSavr tubes pre-filled with Brucella
medium and glycerol (Hardy Diagnostics CS100BNB), and kept at -80°C. In some cases, multiple
isolates of the same species were stored.
Statistical Analyses
Statistical analyses of microbiota data were performed using SAS software version 9.4
(Cary, NC). Microbiota stability measures were calculated using Jensen-Shannon Divergence
(JSD). Wilcoxon rank sum tests and Mann-Whitney U tests were used to compare mean or
median JSD values with participant-reported lifestyle data. Frequency of bacterial detection was
compared to lifestyle data using either Pearson chi-square or Fisher’s exact tests, depending on
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assumption validity. Chi-square testing was used to compare categorical variables. One-way
analysis of variance (ANOVA) was used to compare continuous variables. Student t-tests were
performed to evaluate the association between microbial ratios and probiotic or placebo use, as
well as differences in average optical density (OD) and CFU values between groups. Correlations
between variables were determined using the Pearson Correlation test. All test results were
considered significant using a p-value of <0.05. Relative abundance graphs, alpha diversity
measures, PCoA, dendrograms, heatmaps, and dot plots were generated in RStudio.
Whole Genome Sequencing
DNA Extraction and Library Prep
In Chapter VI, I describe the rationale for sequencing the genomes of several isolates of
S. mitis. In brief, I sought to determine the origin of S. mitis isolates found in MSU specimens of
a female participant following sexual intercourse with her male sexual partner. To do this, I must
determine if MSU-isolated strains are clonally related to strains from other specimens (female or
male).
S. mitis isolates were grown in their preferred medium (described below) and pelleted.
Genomic DNA was extracted from pellets using a phenol-chloroform method. Briefly, pellets
were resuspended in 0.5 mL of a DNA Extraction Buffer (described above). 50 µL lysozyme (20
mg/mL), 30 µL mutanolysin, and 5 µL RNase (10 mg/mL) were then added, followed by a 1-hour
incubation at 37°C. Next, 80 µL of 10% sodium dodecyl sulfate (SDS) and 10 µL proteinase K were
added, followed by a 2-hour incubation at 55°C. Then, 210 µL 6M NaCl and 700 µL phenolchloroform were added for density separation. Following room temperature incubation and
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constant rotation for 1 hour, the samples were centrifuged at 13,500 rpm for 10 minutes. The
aqueous phase was aliquoted to a new tube and an equal volume of isopropanol was added
followed by an additional 10 min centrifugation. The supernatants were decanted and washed
with 600 µL of 70% ethanol. The DNA was pelleted, the supernatants were decanted, and the
tubes were left at room temperature to dry before being resuspended in 50 µL of TE buffer and
stored at -20°C.
The Illumina Nextera kit was used for whole genome library preparation255. Briefly, the
bacterial genome was fragmented and tagged using a transposon system. Illumina sequencing
adapters and dual-index barcodes were added to allow for multiplexing of samples. The resulting
fragments were purified and size-selected using AMPure XP beads, quantified via the Qubit 2.0
Fluorometer and Agilent Bioanalyzer, normalized to equimolar concentrations, and sequenced
using the Illumina MiSeq System. The concentrations of DNA loaded onto the sequencer were
calculated based on the expected genome size and average fragment size to achieve 100X
coverage of the entire genome. The Illumina MiSeq can cover 7500 mega base pairs (mbp) per
sequence run. Because the genome of S. mitis is approximately 2.5 Mbp, to achieve 100X
coverage 30 isolates were sequenced at once. Quality control and de-multiplexing of sequence
data was done with onboard MiSeq Control software and MiSeq Reporter (current version: 3.1).
Assembly and Annotation
Annotated assemblies were produced using the pipeline described previously256. For each
sample, sequence reads were used to create multiple assemblies using Velvet v1.2257 and
VelvetOptimiser v2.2.5. An assembly improvement step was applied to the assembly with the
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best N50 and contigs were scaffolded using SSPACE258 and sequence gaps ﬁlled using GapFiller259.
Assembly was repeated using the SPAdes assembler260. Automated annotation was performed
using PROKKA v1.11261.
To confirm accurate speciation, the 16S rRNA gene was extracted from the annotation
using Artemis262, and BLASTed for classification263. For phylogenetic analysis of the 16S gene,
alignments were generated using MAFFT264 in Galaxy, RAxML265 for bootstrapping and tree
generation, and Figtree and ITOL266 for tree visualization.
Bacterial Assays: Experimental Procedures
Bacterial Strains and Growth Conditions
Bacterial isolates from the ProFUM and PARTNER studies were isolated and stored for
future genomic and phenotypic assessments (see Chapter VI). A total of 135 isolates were
collected. The origins of these strains are summarized in Table 3. Briefly, 81 isolates were
collected from the ProFUM study from MSU specimens of participant ProFUM05 during
collection days 31-70. These isolates included one representative isolate of each collection day
for the following species: L. jensenii (n=34), G. vaginalis (n=28), S. mitis (n=16), and Streptococcus
agalactiae (n=3). The remaining 54 isolates were collected from the PARTNER study from both
the male and female participants. These strains included 1-3 representative isolates of each
collection day and specimen type. All 54 isolates were identified as S. mitis.
L. jensenii and S. mitis isolates were grown on CNA media incubated under 5% CO2
conditions at 37°C for 48 hours. G. vaginalis isolates were grown on ABAP media incubated
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anaerobically at 37°C for 48 hours. S. agalactiae isolates were grown on BAP media incubated
aerobically at 37°C for 48 hours. E. coli strains were grown on BAP media incubated aerobically

Table 3. Overview of bacterial isolates used.

Collection #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

Isolate #
LJ31
GV31
LJ32
GV32
LJ33
GV33
SM34
LJ35
GV35
LJ36
LJ37
GV37
LJ38
GV38
SM38
LJ39
GV39
LJ40
GV40
LJ41
GV41
LJ42
GV42
SM42
LJ43

Species
LJ
GV
LJ
GV
LJ
GV
SM
LJ
GV
LJ
LJ
GV
LJ
GV
SM
LJ
GV
LJ
GV
LJ
GV
LJ
GV
SM
LJ

Participant ID
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05

Specimen Type
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU

Collection Day
31
31
32
32
33
33
34
35
35
36
37
37
38
38
38
39
39
40
40
41
41
42
42
42
43
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26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59

GV43
SM43
LJ44
GV44
SM44
LJ46
LJ47
SM47
LJ48
GV48
SM48
LJ49
GV49
SM49
LJ50
GV50
LJ51
GV51
LJ53
GV53
SA53
LJ54
GV54
SM54
SA54
LJ55
GV55
SA55
LJ59
GV59
LJ60
GV60
LJ61
SM61

GV
SM
LJ
GV
SM
LJ
LJ
SM
LJ
GV
SM
LJ
GV
SM
LJ
GV
LJ
GV
LJ
GV
SA
LJ
GV
SM
SA
LJ
GV
SA
LJ
GV
LJ
GV
LJ
SM

ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05

MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU

43
43
44
44
44
46
47
47
48
48
48
49
49
49
50
50
51
51
53
53
53
54
54
54
54
55
55
55
59
59
60
60
61
61
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60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93

LJ62
GV62
SM62
LJ63
GV63
SM63
LJ64
GV64
LJ65
GV65
SM65
LJ66
LJ67
LJ68
GV68
SM68
LJ69
GV69
SM69
LJ70
GV70
SM70
SM01
SM02
SM03
SM04
SM05
SM06
SM07
SM08
SM09
SM10
SM11
SM12

LJ
GV
SM
LJ
GV
SM
LJ
GV
LJ
GV
SM
LJ
LJ
LJ
GV
SM
LJ
GV
SM
LJ
GV
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM

ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
ProFUM05
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER02

MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
MSU
PU
PU
OS
OS
OS
OS

62
62
62
63
63
63
64
64
65
65
65
66
67
68
68
68
69
69
69
70
70
70
1
1
1
2
2
2
2
2
2
2
2
WK1-B

92
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127

SM13
SM14
SM15
SM16
SM17
SM18
SM19
SM20
SM21
SM22
SM25
SM26
SM27
SM28
SM29
SM30
SM31
SM32
SM33
SM34
SM35
SM36
SM37
SM38
SM39
SM40
SM41
SM42
SM43
SM44
SM45
SM46
SM47
SM48

SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM
SM

PARTNER02
PARTNER02
PARTNER02
PARTNER02
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER02
PARTNER02
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER02

OS
OS
PS
PS
MSU
MSU
MSU
VS
MSU
MSU
MSU
OS
MSU
MSU
MSU
PU
PU
PU
OS
OS
MSU
MSU
MSU
MSU
OS
OS
OS
MSU
MSU
MSU
MSU
MSU
MSU
OS

WK1-B
WK1-B
WK1-A
WK1-A
3
3
3
3
4
5
7
8
9
9
9
9
9
9
WK2-B
WK2-B
10
10
10
15
15
15
15
16
16
16
17
17
17
WK3-B
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128
129
130
131
132
133
134
135

SM49
SM50
SM51
SM52
SM53
SM54
SM55
SM56

SM
SM
SM
SM
SM
SM
SM
SM

PARTNER02
PARTNER02
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01
PARTNER01

OS
OS
MSU
MSU
MSU
MSU
MSU
MSU

WK3-B
WK3-B
18
18
18
19
19
19

Abbreviations: L. jensenii (LJ), S. mitis (SM), G. vaginalis (GV), S. agalactiae (SA), Peri-urethral
swab (PU), Oral swab (OS), Vaginal swab (VS), Penile swab (PS)
at 37°C for 24 hours. Pure cultures of L. jensenii were transferred to De Man, Rogosa and Sharpe
(MRS) broth and incubated under 5% CO2 conditions at 37°C for 48 hours. Pure cultures of S. mitis
were transferred to Brain Heart Infusion (BHI) broth with 10% Fetal Bovine Serum (FBS) and
incubated under 5% CO2 conditions at 37°C for 48 hours. Pure cultures of E. coli were transferred
to Tryptic Soy Broth (TSB) and incubated aerobically at 37°C for 24 hours.
Urothelial Cell Adherence Assays
A non-malignant urothelial cell line (HURO23A) established by Dr. Phong Le267 was used
to assess the ability of bacterial strains to adhere to bladder tissue in vitro. Urothelial cells were
grown in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) with 5% FBS
in 5% CO2 conditions at 37°C. Cells were enumerated using a hemocytometer and approximately
105 cells/mL tissue culture media (i.e., DMEM/F-12 with 5% FBS) were seeded into 24 well
microtiter plates in triplicate. Cells were incubated overnight to promote adherence.
Urinary bacterial strains and uropathogenic E. coli (UPEC) strains were grown accordingly,
pelleted, washed twice with peptone buffered saline (PBS) and resuspended in PBS. Cell-free
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supernatants were collected from some strains using a 0.2-micron filter. Depending on the
experimental question, bacterial cells were either resuspended in tissue culture media and added
in a 1:1 volume ratio to the urothelial cells, or the bacterial cells were first pre-treated with
supernatants of other strains for 1 hour in a 1:1 volume ratio prior to adding the bacterial cells
to the urothelial cells. As negative controls, bacterial cells were also pre-treated with media
controls. Between 107 and 108 CFU/mL of bacterial cells were used.
The co-cultures of bacterial and urothelial cells were incubated at 5% CO2 in 37°C for 3
hours. Empty wells (i.e., no urothelial cells) were used as negative controls to determine the level
of bacterial adherence to the plastic surface of the 24 well microtiter plates. After 3 hours, the
wells were washed with PBS three times and 500 µL of 0.1% Triton-X was added to each well. The
contents of each well were then serially diluted and plated on BAP media and incubated in 5%
CO2 conditions at 37°C for 24-48 hours. CFUs were enumerated and average values obtained
from the negative controls were subtracted from the experimental conditions (i.e., wells with
urothelial cells).
Biofilm Assays
Urinary bacterial strains were grown accordingly, pelleted, and the cell-free supernatants
were collected using a 0.2-micron filter. Strains of UPEC were grown accordingly for overnight
cultures. UPEC clinical strains isolated from patients with cystitis (i.e., bladder infection) NU14268
and UTI89269 were used, as well as a mutant strain NU14∆fimH (also known as NU14-1)270, which
has a deletion of the fimH gene. The FimH protein forms part of the fimbriae that E. coli uses for
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surface attachment. Therefore, the fimH mutant strain adheres poorly to surfaces, cannot form
a biofilm, and was therefore used as a negative control270.
E. coli strains were diluted and 100 µL were placed into a 96 well microtiter plate. At
various timepoints (0, 0.5, 1, 2, 4, and 6 hours) after addition of E. coli, an equal volume of urinary
bacterial supernatants were added. Media controls and PBS were included as negative controls.
Plates were incubated aerobically for 24 hours total. E. coli biofilm formation was assessed using
a standard crystal violet assay. Wells were decanted and washed with PBS three times. 200 µL of
crystal violet stain was added to each well and left for 10 minutes. The crystal violet stain was
then decanted, and the plates were left to dry for 30 minutes before adding 200 µL of 70%
ethanol to each well. OD600 measurements were taken. Measurements were divided by two to
reflect the starting volume of E. coli.
Growth Competition Assays
Urinary bacterial strains and UPEC strains were grown accordingly for overnight cultures.
Separately, some strains were grown, pelleted, and the cell-free supernatants were collected
using a 0.2-micron filter. Depending on the experimental question, various combinations of
cultures and cell-free supernatants were combined in a 1:1 volume ratio, and bacterial cell
growth was periodically measured by optical density (i.e., OD600) and plated for viable CFUs.
These experiments assayed bacterial growth over 24 to 48 hours in the presence or absence of
bacterial cell-free supernatants with or without the addition of various chemicals.
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CHAPTER III
FEASIBILITY PROJECT: MAGnUM STUDY
Overview of MAGnUM Study
The MAGnUM Study (Measuring the effects of Alcohol on the Genito-urinary Microbiota)
was conducted from October 2016 to March 2017 as a pilot/feasibility project. The primary goals
of the MAGnUM study were to assess the feasibility of longitudinal urine specimen collection in
community women and men, to determine if short-term temporal dynamics of the microbiota of
the LUT exist, and to determine the effects of one lifestyle factor, alcohol consumption, on the
temporal dynamics. The study design is described in Figure 4. Three males and seven females
participated in the study. MSU and peri-urethral swab specimens were collected each day for
approximately 2.5 weeks. A modified EQUC protocol was used to determine the microbiota of
the specimens. 16S rRNA gene sequencing was not performed due to cost. Alcohol consumption
by the participants was self-reported.
Longitudinal Assessment of the Microbiota of the Male LUT
All three male participants completed 17 days of specimen collection. The median age of
the male participants was 23. All three participants identified as White/Caucasian. I identified 19,
26, and 30 unique species in the MSU specimens of MAG01, MAG04, and MAG06, respectively.
The predominant genera that I identified were Corynebacterium, Staphylococcus, and
Streptococcus.
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Participant MAG01

Participant MAG04

Participant MAG06

Figure 7. Microbiota Profiles of MSU Specimens of Male Participants MAG01, MAG04, and
MAG06 as determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting
the relative abundance of various genera (the 12 most abundance genera are described in key
above graphs) over time in chronological order. Bars that appear “black” refer to days where no
bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified taxa. Bars that
appear “white” refer to days where no specimen was collected. MSU microbiota of all three
male participants of the MAGnUM study are shown. Total bacterial counts (i.e., CFU/mL) are
shown on the secondary y-axes and are depicted by the black line graphs.
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Figure 7 shows the microbiota of the MSU specimens for all three male participants over
the 17 days. The y-axes depict the relative abundance, as percentage of CFUs, of the various taxa
identified within each specimen. The secondary y-axes show the total CFUs. When viewed
longitudinally, the data show a level of instability. Qualitatively, the MSU specimens of MAG01
vary in the abundance of Staphylococcus (light blue) and Corynebacterium (orange). The MSU
specimens of MAG04 are typically predominated by Corynebacterium, but various other genera,
primarily anaerobes, are found each day. The MSU specimens of MAG06 vary in their levels of
Corynebacterium, Staphylococcus, and Streptococcus (green).
Alcohol consumption was recorded by the participants throughout the study. The
rationale for studying alcohol consumption was that it is a relatively impersonal factor to report
and would likely be reported frequently by the particular participant population used in the
study. Alcohol consumption has varying effects on UTI risk in women, as described in Table 1A.
In men, little research has been done relating alcohol consumption and UTI risk, but one recent
study also showed varying effects on UTI risk and LUT symptoms regardless of the amount or
type of alcohol consumed271.
MAG01 and MAG04 reported alcohol consumption on only 1/17 days, thus making an
analysis of the effects on LUT microbiota stability difficult. MAG06 reported alcohol consumption
of 6/17 days. To determine the effects of alcohol consumption on microbiota stability, JSD values
were calculated on the MSU microbiota data for MAG06 and compared between alcohol
consumption and non-alcohol consumption days. Because specimens were collected in the early
morning, they reflect lifestyle factors of the previous day rather than the current day (this applies
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Figure 8. Principal Coordinate Analysis of Microbiota of MSU Specimens from Participant
MAG06. Analysis was done using MSU microbiota data collected from male participant MAG06.
Graph plots the 1st and 2nd principal coordinates of the data. Percent of total variance explained
by each principal coordinate is shown in the parentheses. Open circles represent the microbiota
on days when the participant reported “no alcohol consumption” and closed circles represent
“alcohol consumption”.
to all future data as well). Therefore, I compared JSD values between non-alcohol consumption
days and the days after alcohol consumption. For example, MAG06 reported alcohol
consumption on Days 6, 7, 11, 12, 13, and 14. The ‘alcohol-positive’ days for the analysis were
Days 7, 8, 12, 13, 14, and 15. Using a Mann-Whitney U test, I determined that the median JSD
values were not significantly different between alcohol and non-alcohol consumption days
(p=0.96). Consistent with these data, PCoA showed no separation of the microbiota by alcohol
consumption (Figure 8). There was also no significant difference in alpha-diversity scores
[Shannon (p=0.86); Simpson’s (p=0.99)]. Together, these data show that, in the male participant
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MAG06, alcohol consumption is not correlated with significant changes in MSU microbiota
stability, composition, or alpha diversity, respectively.
A secondary aim of the MAGnUM study was to determine if longitudinal assessment of
the LUT microbiota was feasible. A large component of this assessment concerned specimen
integrity. I sought to determine the level of microbiota similarity between MSU and peri-urethral
swab specimens. In the three male participants, the level of microbiota similarity between paired
specimens varied greatly. Using Bray-Curtis Dissimilarity measures between microbiota of
specimens collected on the same day, I found that the median value of all collection days was
vastly different among the male participants. For example, the median Bray-Curtis Dissimilarity
value for MAG01 was 0.38, but for MAG04 the value was 0.71. For this assessment, values closer
to 1 indicate dissimilarity between specimen types, while values closer to 0 indicate similarity.
Therefore, the microbiota of MSU and peri-urethral specimens were, in general, similar in MAG01
but distinct in MAG04. This trend is further verified by PCoA which shows clear separation of
microbiota between specimen types for MAG04 but not MAG01 (Figure 9).
Longitudinal Assessment of the Microbiota of the Female LUT
Two female participants (i.e., MAG03 and MAG08) completed 17 days, while three (i.e.,
MAG09, MAG10, MAG11) completed 18 days of specimen collection. I did not receive specimens
from MAG08 on Day 10. Two female participants withdrew prior to study completion. MAG02
completed 11 consecutive days, while MAG05 completed 13 consecutive days of specimen
collection.
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Figure 9. Principal Coordinate Analyses of Microbiota of Specimens from Participants MAG01
and MAG04. Analysis was done using MSU (closed circles) and peri-urethral (open circles)
microbiota data collected from two male participants: MAG01 (left) and MAG04 (right). Graphs
plot the 1st and 2nd principal coordinates of the data. Percent of total variance explained by each
principal coordinate is shown in the parentheses.
The median age of the female participants was 25. Five participants identified as
White/Caucasian, one as African American/Black (MAG02), and one as Asian (MAG03). All
participants were pre-menopausal. I identified 26, 15, 13, 18, 28, 31, and 19 unique species in
the MSU specimens of MAG02, MAG03, MAG05, MAG08, MAG09, MAG10 and MAG11,
respectively. The predominant genera identified were Lactobacillus and Gardnerella.
Similar to the male participants’ data, when viewed longitudinally, the microbiota of the
MSU specimens from the female participants show a level of instability. Figure 10 shows the
microbiota of the MSU specimens for three of the seven female participants over time.
Qualitatively, the MSU specimens vary in the abundance of Lactobacillus (blue) and Gardnerella
(red) and have rapid and brief disruptions consisting of Streptococcus (green), Staphylococcus
(light blue), Escherichia (yellow), Alloscardovia (dark orange), and/or Actinomyces (brown). Some
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Participant MAG03

Participant MAG08

Participant MAG10

Figure 10. Microbiota Profiles of MSU Specimens of Female Participants MAG03, MAG08, and
MAG10 as determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting
the relative abundance of various genera (the 12 most abundance genera are described in key
above graphs) over time in chronological order. Bars that appear “black” refer to days where no
bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified taxa. Bars that
appear “white” refer to days where no specimen was collected. MSU microbiota of all three
male participants of the MAGnUM study are shown. Total bacterial counts (i.e., CFU/mL) are
shown on the secondary y-axes and are depicted by the black line graphs.
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microbiota show very little variability over time (e.g., MAG08). Because the participants of the
MAGnUM study did not record lifestyle factors, it is unclear if the variability, or lack thereof,
relates to lifestyle.
Alcohol consumption, the only lifestyle factor recorded in the MAGnUM study, was
reported by several of the female participants. In those who reported alcohol consumption at
least three days during the study (i.e., MAG02, MAG03, MAG08), I compared JSD values between
non-alcohol consumption days and the days after alcohol consumption to determine if alcohol
consumption altered the stability of the microbiota. Consistent with the male data described
above, the JSD values were not significantly different between alcohol and non-alcohol
consumption days. Furthermore, there was no significant difference in alpha-diversity scores
(i.e., Shannon and Simpson’s indices).
Besides alcohol consumption, illness was inadvertently reported by one of the
participants. On Day 18, participant MAG09 reported to the study nurse coordinator that she was
experiencing UTI-like symptoms. Because this was the final day of specimen collection, the
participant was not withdrawn from the study. She was instructed to contact her primary care
physician as standard of care. The clinical team was later anecdotally notified that the participant
had a culture-confirmed UTI of E. coli. Microbiota data of the specimens from MAG09 show that
E. coli was found at 105 CFU/mL on Days 13, 14, 15, and 18 in the peri-urethra, and Days 15, 16,
17, and 18 in the MSU (Figure 11). Interestingly, E. coli was first detected on Day 8 in both
specimens in very low amounts, suggesting that a UTI may be a gradual process. However, it is
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MSU Specimens

Peri-urethral Specimens

Figure 11. Microbiota Profiles of MSU and Peri-Urethral Specimens of Participant MAG09 as
determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting the relative
abundance of various genera (the 12 most abundant genera are described in key above graphs)
over time in chronological order. MSU (top) and peri-urethral (bottom) microbiota of three of
the seven female participants of the MAGnUM study are shown. Bars that appear “black” refer
to days where no bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified
taxa. Bars that appear “white” refer to days where no specimen was collected. Total bacterial
counts (i.e., CFU/mL) are shown on the secondary y-axes and are depicted by the black line
graphs. The participant reported UTI-like symptoms on Day 18.

105

Figure 12. Bray-Curtis Dissimilarity Scores between MSU and Peri-urethral Specimens from
Female MAGnUM Participants. Box plots depict the range of Bray-Curtis Dissimilarity scores for
microbiota data of paired MSU and peri-urethral specimens from each of the seven female
participants. Mean scores are depicted by the dashed line. Median scores are solid lines. Outliers
appear as dots.
unclear if the strain of E. coli found on Day 8 was the same as the strain that was responsible for
the infection on Day 18. It is also unclear whether the participant had UTI-like symptoms prior to
Day 18. Nevertheless, the data show that the appearance of E. coli coincided with an altered
composition of the MSU and peri-urethral microbiota, in which there were lower abundances of
Lactobacillus, Corynebacterium, and Staphylococcus.
Like the male participants, I sought to determine the level of microbiota similarity
between MSU and peri-urethral swab specimens in the female participants. In the seven female
participants, the level of microbiota similarity between paired specimens was generally very low.
Using Bray-Curtis Dissimilarity measures between microbiota of specimens collected on the same
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Figure 13. Principal Coordinate Analyses of Microbiota of Specimens from Participants MAG02
and MAG08. Analysis was done using MSU (closed circles) and peri-urethral (open circles)
microbiota data collected from two female participants: MAG02 (left) and MAG08 (right).
Graphs plot the 1st and 2nd principal coordinates of the data. Percent of total variance explained
by each principal coordinate is shown in the parentheses.
day, I found that the median value of all collection days was above 0.8 for all seven female
participants. The median values ranged from 0.83 (MAG10) to 0.98 (MAG08). The range of values
is shown in Figure 12. These data indicate that the microbiota of MSU and peri-urethral
specimens are distinct. This trend is further verified by PCoA, which shows clear separation of
microbiota between specimen types. Two representative plots, for MAG02 and MAG08, are
shown in Figure 13.
Summary
These data show that longitudinal urine and genital specimen collection in community
participants is feasible. Only two participants withdrew from the study and these participants
cited personal reasons as the cause rather than complications or difficulties with the study.
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I also identified a method to determine specimen accuracy, which is vital for descriptive
longitudinal studies. I determined that, following clinical instruction, collection of MSU and periurethral specimens with distinct microbiota is possible in some pre-menopausal community
women. This finding allows us to make conclusions exclusive to the MSU microbiota. The median
Bray-Curtis Dissimilarity values of the microbiota of paired specimens for all seven women was
above 0.8 (Figure 12). Therefore, in future studies (e.g., ProFUM study), I will use 0.8 as a
threshold for determining whether a properly collected MSU specimen was obtained. This
protocol will be used to screen participants and ensure that only quality specimens are used for
longitudinal analyses. This is important because physiologically, the LUT is very different from the
peri-urethral area. Therefore, to properly study the effects of the microbiota on the health and
disease of the LUT, it’s vital to be sampling the microbiota of the LUT specifically.
Additionally, I found that daily variation in the microbiota exists, but a level of constancy
is also maintained (Figures 7&10). Several participants had MSU specimens where the microbiota
of a particular day did not resemble the microbiota of any of the other specimens collected during
the study. The changes I observed in the MSU microbiota may be due to the introduction and
subsequent decline of exogenous microorganisms, or due to a temporary change in the bladder
or LUT environment that allows for differentially adapted microorganisms to thrive.
I also determined that alcohol consumption does not correlate to changes in microbiota
stability, composition, or diversity, but whether other lifestyle factors, such as menstruation or
sexual activity, show correlations to microbiota changes remain unclear from these data.
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From a research perspective, these data show that single timepoint sampling of the LUT
microbiota may not be reflective of the average composition. This is an important conclusion
because most research on the urinary and LUT microbiota and microbiome has been performed
using single timepoint specimens. Should lifestyle factors correlate to these unrepresentative
microbiota, it may be possible to use lifestyle questionnaires as a screening tool to determine the
representativeness of patient urine specimens in a clinical setting.
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CHAPTER IV
EFFECT OF INTRINSIC LIFESTYLE FACTORS ON LUT MICROBIOTA
Overview of ProFUM Study
The ProFUM study (Probiotics and the Female Urinary Microbiome) was conducted from
September 2017 to July 2018. The primary goals of the ProFUM study were to measure the longterm temporal dynamics of the LUT microbiota in pre-menopausal non-symptomatic women, to
assess the relationship between lifestyle factors and behaviors, as well as urine properties and
constituents, on the temporal dynamics, and to determine the effect of oral probiotic use on the
LUT microbiota composition and diversity and temporal dynamics. The study design is described
in Figure 5. Eight pre-menopausal females participated in the study. Daily MSU and peri-urethral
swab specimens, as well as weekly perineal/vaginal swabs (not assessed in this thesis), were
collected by each participant for approximately three months. A modified EQUC protocol was
used to determine the microbiota of the specimens. 16S rRNA gene sequencing was performed
only on a subset of participants due to cost. Various intrinsic (Chapter IV) and extrinsic (Chapter
V) lifestyle factors were recorded by the participants each day. During collection Days 21-60,
participants were randomized, using a 2:1 randomization scheme, to taking an oral probiotic (or
placebo) as part of a registered clinical trial (NCT03250208) (Chapter V).
Screening Eligible Participants
Literature246 247 and data collected from the MAGnUM study show that the composition
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Table 4. Bray-Curtis Dissimilarity Values for Paired Specimens during Screening Phase.
Screen ID

Day 1

Day 2

Day 3

SCREEN01
SCREEN02
SCREEN03
SCREEN04
SCREEN05
SCREEN06

0.94
0.01
0.96
0.28
0.89
0.87

0.86
0.22
0.94
0.44
0.99
0.67

0.80
0.38
0.82
0.41
0.51
0.85

Result
✓
X
✓
X
✓
✓

Screen ID

Day 1

Day 2

Day 3

SCREEN07
SCREEN08
SCREEN09
SCREEN10
SCREEN11
SCREEN12

0.57
0.35
0.33
0.44
0.91
0.93

0.92
0.94
0.30
0.46
0.83
0.96

0.89
0.81
0.70
0.28
0.79
0.97

Result
✓
✓
X
X
✓
✓

✓ indicates that the participant was eligible for the ProFUM study; X indicates that the
participant was not eligible for the ProFUM study; Bray-Curtis Dissimilarity values < 0.80 are
highlighted in grey
of the peri-urethral microbiota can be distinct from MSU microbiota. Therefore, a properly
collected MSU specimen could differ from a peri-urethral swab specimen in terms of microbiota
composition. To assess for this difference, eligible participants were instructed, via oral and video
instruction, to collect MSU and peri-urethral specimens for three consecutive days as part of a
Screening Phase. Using Bray-Curtis Dissimilarity, I measured the level of dissimilarity between the
microbiota of the paired specimens. A value of 0.8, as determined from the MAGnUM study, was
used as a threshold to determine specimen collection compliance. Participants enrolled in the
ProFUM study provided paired specimens with Bray-Curtis Dissimilarity values above 0.8 for at
least two of the three collection days.
12 participants were screened for eligibility. Four did not meet eligibility criteria by failing
to supply distinct MSU and peri-urethral specimens, as described above. Eight participants were
ultimately enrolled in the ProFUM study. The Bray-Curtis Dissimilarity values for the Screening
Phase are summarized in Table 4.
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Table 5. Demographics and Clinical Characteristics of the ProFUM Participants.
ProFUM Participant Demographics
Age (years), mean (SD)
Race/Ethnicity
Caucasian/White
Asian
Black/African American
BMI, mean (SD)
Prior pregnancy
Vaginal delivery
Menstrual cycle
Regular (every 20-40 days)
Irregular
None
Menstrual hygiene product use:
-Tampons
-Pads
-Menstrual cups
-None
Sexually active
Frequency of sexual activity
Daily
Weekly
Monthly
Not in past year
Type of sexual activity (in past year): (N=6)
-Vaginal (penetrative with penis)
-Vaginal (penetrative with toy/fingers)
-External stimulation
-Cunnilingus (receiving)
-Anal (penetrative)
Current sexual partners
One male partner
Multiple male partners
No current partners
Method of birth control:
-Condom use
-Intrauterine device (IUD)
-Oral contraceptive
Hygiene
Showers (weekly), mean (SD)
Baths (weekly), mean (SD)
Bowel movements (weekly), mean (SD)
Diet
Follows a special diet
Alcohol consumption

Total cohort (n=8)
29 (± 5)
5 (62.5%)
2 (25%)
1 (12.5%)
24.6 (± 6.2)
1 (12.5%)
1 (12.5%)
5 (62.5%)
3 (37.5%)
0 (0%)
5 (62.5%)
4 (50%)
2 (25%)
0 (0%)
8 (100%)
1 (12.5%)
2 (25%)
3 (37.5%)
2 (25%)
6 (100%)
6 (100%)
2 (33.3%)
6 (100%)
0 (0%)
6 (75%)
1 (12.5%)
1 (12.5%)
2 (25%)
4 (50%)
2 (25%)
6 (± 1)
1 (± 1)
8 (± 3)
1 (12.5%)
8 (100%)
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Table 6. Overview of Bray-Curtis Dissimilarity Values Comparing MSU and Peri-urethral
Microbiota of the ProFUM Participants based on EQUC data.

ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06
ProFUM07
ProFUM08

Median

Interquartile Range (IQR)

0.98
0.91
0.80
0.86
0.86
0.85
0.80

0.97-1.00
0.73-0.99
0.69-0.84
0.66-0.96
0.68-0.99
0.62-0.96
0.52-0.92

Specimens of participant ProFUM06 were not cultured.
The demographics and clinical characteristics of the eight eligible participants are
described in Table 5. None of the participants had a prior history of gynecological surgery, kidney
stones, rUTI, or symptoms of UI.
ProFUM Specimen Integrity
The microbiota of the MSU and peri-urethral specimens were assessed using a modified
EQUC protocol for seven of the eight participants. Due to time constraints, the specimens of
participant ProFUM06 were not cultured. Instead, the MSU specimens of participant ProFUM06
were analyzed using 16S rRNA gene sequencing. The MSU specimens of participant ProFUM07
also were analyzed using 16S rRNA gene sequencing in addition to culture.
I continued to assess the integrity of the specimens collected during the ProFUM study in
a similar manner to the Screening Phase. Bray-Curtis Dissimilarity values were calculated for all
paired specimens of the seven applicable (cultured) participants. The median values for all
participants was ≥ 0.80. These data show that the participants deemed eligible by the Screening
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Figure 14. Bray-Curtis Dissimilarity Values Comparing MSU and Peri-urethral Microbiota of
Participants ProFUM01 and ProFUM08. Bray-Curtis Dissimilarity values were calculated for
paired MSU and peri-urethral microbiota data for each participant. Two representative plots are
shown: one showing little variation in the values over time (top) and one showing a lot of
variation (bottom). These data come from participants ProFUM01 and ProFUM08, respectively.
The median values are represented by the overlaid grey dotted lines.
Phase continued to provide quality specimens during the ProFUM study; participants remained
compliant throughout the study. Bray-Curtis Dissimilarity scores are summarized in Table 6.
Though median Bray-Curtis Dissimilarity scores were above 0.8, the scores varied
throughout the course of specimen collection for each participant. The data for some participants
varied more than others. Figure 14 shows representative data for two participants. The Bray-
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Figure 15. Principal Coordinate Analyses of Microbiota of Specimens from Participants
ProFUM01, ProFUM03, and ProFUM04. Analysis was done using MSU (closed circles) and periurethral (open circles) microbiota data collected from three participants: ProFUM01 (top left),
ProFUM03 (top right), and ProFUM04 (bottom). Graphs plot the 1st and 2nd principal coordinates
of the data. Percent of total variance explained by each principal coordinate is shown in the
parentheses.
Curtis Dissimilarity values for some participants (e.g., ProFUM01) showed little variation over
time, while values for other participants (e.g., ProFUM08) varied quite a bit (Figure 14). Whether
these variations can be explained by lifestyle factors is explored later in this chapter and in
Chapter V. Nevertheless, these data show that, when provided with clinical instruction, obtaining
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repeated and properly collected MSU and peri-urethral specimens is possible. PCoA also shows
that, in general, the microbiota composition of the specimen types represent two distinct
microbial populations with very little overlap. Three representative plots are shown in Figure 15.
Qualitative Description of the Longitudinal LUT Microbiota and Microbiome
Figure 16 shows the relative abundance of the microbiota or microbiome over time for
all participants. The MSU microbiota data are presented as stacked bar graphs (see description
of graphs in Chapter III). Figures 16F and 16H represent the longitudinal MSU microbiome, as
assessed by 16S rRNA gene sequencing, of participants ProFUM06 and ProFUM07, respectively.
Figure 16J shows the legend for each graph and describes the genus-color correspondence. All
other panels of Figure 16 represent data as assessed by modified EQUC. Below is a brief
qualitative description of the longitudinal MSU microbiota/microbiome data for each participant.
Participant ProFUM01 identified as White/Caucasian, with regular menses, and cited
condom use as the only form of birth control. Her data (Figure 16A) alternated between
Lactobacillus (blue) and Gardnerella (red) dominant MSU specimens with short periods of
elevated Streptococcus (green) and Corynebacterium (orange) abundance. The Lactobacillus
were exclusively identified as L. crispatus, while the Gardnerella were a mixture of G. vaginalis
and Gardnerella species.
Participant ProFUM02 identified as White/Caucasian, with irregular menses, and used an
IUD for birth control. Her data (Figure 16B) had primarily Lactobacillus-dominant MSU
specimens. The Lactobacillus species were a mix of L. jensenii and L. crispatus, with generally
higher abundances of L. crispatus. The primary exception to the Lactobacillus dominance was a
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roughly two-week period during the first month of specimen collection, where specimens were
dominated by G. vaginalis, and Corynebacterium tuberculostearicum.
Participant ProFUM03 identified as Asian, with regular menses, used an IUD for birth
control, and had one or more previous vaginal deliveries. Her data (Figure 16C) represented the
only participant without Lactobacillus identified as part of her longitudinal MSU microbiota or
microbiome. The MSU microbiota of ProFUM03 was a somewhat equal mix of S. agalactiae (i.e.,
Group B Streptococcus), Staphylococcus epidermidis (light blue), and a variety of
Corynebacterium species. During three separate, roughly one-week periods at the beginning,
middle, and end of specimen collection, there was an appearance of Actinomyces neuii (brown).
Participant ProFUM04 identified as White/Caucasian, with regular menses, and used a
daily oral birth control pill. Her data (Figure 16D) had almost exclusively Lactobacillus-dominant
MSU specimens, which were comprised of an equal abundance of L. jensenii and L. iners. Most
specimens also had low abundances of a variety of other microorganisms, including anaerobes
such as Finegoldia magna (yellow), and Anaerococcus species (bright red), facultative anaerobes
like A. neuii and Corynebacterium species, and aerobes such as Staphylococcus. In the majority
of the MSU specimens, these various microorganisms (i.e., non-Lactobacillus) did not exceed 50%
relative abundance.
Participant ProFUM05 identified as White/Caucasian, with no menses, and used an IUD
for birth control. Her data (Figure 16E), like ProFUM01, alternated between Lactobacillus and
Gardnerella-dominant MSU specimens. The Lactobacillus was a mix of L. jensenii and L. crispatus,
with higher abundances of L. jensenii, while the Gardnerella was exclusively G. vaginalis. The MSU
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microbiota also had periodic, but seemingly random instances of the appearance and/or
dominance of Streptococcus, which was primarily identified as S. mitis.
Participant ProFUM06 identified as White/Caucasian, with regular menses, and cited
condom use as the only form of birth control. Her MSU specimens were analyzed by 16S rRNA
gene sequencing exclusively. Figure 16F shows the relative abundance of the 20 most abundant
genera. The remaining taxa were grouped into the “other” category (grey), which represents
<20% relative abundance for all MSU specimens. Lactobacillus was the most abundant genus for
most MSU specimens. Levels of Corynebacterium and Prevotella (dark green) fluctuated over
time. Low abundances of various anaerobic genera [e.g., Anaerococcus, Finegoldia, Dialister
(bright blue), Peptoniphilus (light pink), Veillonella (dark pink)] were found in most specimens.
Participant ProFUM07 identified as Asian, with irregular menses, and used an IUD for birth
control. Her MSU specimens were analyzed by both 16S rRNA gene sequencing (Figure 16H) and
modified EQUC (Figure 16G). The two methods show similar results, where most MSU specimens
were dominated by Lactobacillus. Modified EQUC showed that the Lactobacillus was primarily L.
jensenii. Similar to ProFUM03, three separate one-to-two week-long periods at the beginning,
middle, and end of specimen collection were not dominated by the typical pattern of
microorganisms (i.e., Lactobacillus). Instead, modified EQUC showed the appearance of a mix of
Corynebacterium species, Actinomyces radingae, and various Staphylococcus and Streptococcus
species, while 16S rRNA gene sequencing showed elevated abundances of Corynebacterium and
Streptococcus and various anaerobes including Prevotella, Peptoniphilus, Anaerococcus, and
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Figure 16. Microbiota Profiles of MSU Specimens from all ProFUM Participants. Microbiota
profiles are shown as stacked bar graphs depicting the relative abundance (y-axes) of various
genera over time in chronological order (x-axes) from MSU specimens. Bars that appear ‘white’
refer to days where no specimen was collected, received, or stored. A legend containing the
most common genera is found in panel J. ‘Other’ refers to the combined relative abundance for
all taxa not included in the 20 most abundance taxa. Data were generated using modified EQUC
(panels A, B, C, D, E, G, and I) or 16S rRNA gene sequencing (panels F and H). *Other: only used
for panels F and H
Dialister. Furthermore, there were periodic, but seemingly random instances of the appearance
and very high abundances of Streptococcus, which included a variety of species.
Participant ProFUM08 identified as Black/African American, with regular menses, and
used an IUD as well as a daily oral birth control pill. Her data (Figure 16I) had almost exclusively
Lactobacillus-dominant MSU specimens, which were comprised of an equal abundance of L.
jensenii and L. crispatus. Most specimens also had low abundances (<20% relative abundance) of
G. vaginalis. The exceptions were three separate periods within the first month of specimen
collection, where the relative abundance of Lactobacillus and Gardnerella decreased while
various amounts of Streptococcus and Staphylococcus species appeared.
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Overall, the data show that the MSU microbiota and microbiome are fairly stable, or
unchanging, over time. Qualitatively, there are periods of disruption from the ‘normal’
compositional state for most participants. These periods seem to be consistent within a
participant, but not consistent among participants. Therefore, trends appear to be highly
individualized, which is consistent with other microbiome research findings.
Measuring the Overall Stability of the LUT Microbiota
JSD values were calculated as the primary measure of microbiota and microbiome
stability for both MSU and peri-urethral specimens. Essentially, JSD quantifies how
distinguishable two distributions are from one another. This can be interpreted as stability when
applied to a longitudinal dataset. JSD values were obtained as previously described272, by first
calculating a representative microbiota distribution for each participant. This was done by
averaging the abundance data for the microbiota across all collection days. JSD values were then
calculated between each day’s microbiota and the average microbiota (e.g., MSU microbiota of
Day 1 and average microbiota for participant ProFUM01). Values range from 0 to 1, where higher
values indicate less similarity, or instability when viewed longitudinally. Thus, I obtained values
unique for each specimen type and specimen collection day that quantitatively reflect how
distinct the microbiota was in comparison to an average for each participant. These values can
be graphed to view periods of stability and instability or they can be applied to metadata, such
as lifestyle questionnaire results, to determine if a statistical relationship exists between the
stability of the microbiota and lifestyle factors.
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Figure 17. Distribution of Jensen-Shannon Divergence Values for MSU and Peri-urethral
Microbiota from all ProFUM Participants. Box plots depict the range of JSD values of microbiota
(EQUC of ProFUM 1-5, 7-8) and microbiome (16S rRNA gene sequencing of ProFUM06 and
ProFUM07) data of MSU (A) and peri-urethral (B) specimens from all applicable ProFUM
participants. Median scores are depicted by the solid lines in each box. The distribution of raw
values are depicted by the overlaid circles.
Figure 17 shows the distributions of JSD values for MSU (Figure 17A) and peri-urethral
(Figure 17B) microbiota for all participants. The boxplots show that the median JSD values (i.e.,
solid line of each box) of the MSU microbiota for all participants are low (<0.2) (Figure 17A). The
median JSD values are significantly (p<0.001) higher for the peri-urethral microbiota (Figure 17B);
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Figure 18. JSD Values for MSU Microbiota of Participant ProFUM07 Obtained using Culture and
Sequencing. JSD values were calculated for MSU microbiota of participant ProFUM07.
Microbiota data was obtained using modified EQUC (solid line) and 16S rRNA gene sequencing
(dashed line). Data are plotted over time in days.
only two participants had median JSD values <0.2 (i.e., ProFUM02 and ProFUM03). These data
show that, overall, the peri-urethral microbiota are more variable within an individual than the
MSU microbiota. Nonetheless, the range of JSD values for the MSU microbiota is large, indicating
that periods of microbiota variability exist.
Microbiota stability was assessed by visualizing the JSD values over time. An example is
shown in Figure 18. The solid line graph shows the change in JSD values for the MSU microbiota
of participant ProFUM07 over time. In general, JSD values are low (i.e., nearing 0). On days with
low values, the microbiota show little variability from the microbiota of all other days, meaning
high stability. The exceptions are JSD values for the microbiota of roughly Days 1-4, 21-33, and
46-61. On these days, the JSD values are higher, meaning that the microbiota were more distinct
from the microbiota of all other days (i.e., higher instability). These data are complementary to
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the qualitative description of the MSU microbiota of ProFUM07 (Figure 16G), where one can
visualize three separate one-to-two weeklong periods at the beginning, middle, and end of
specimen collection that were not dominated by the typical pattern of microorganisms (i.e.,
Lactobacillus). These periods line-up well to the periods of higher JSD values in Figure 18, thus
providing a level of confidence in the JSD values.
Figure 18 also highlights the complementarity of modified EQUC and 16S rRNA gene
sequencing. Despite some compositional differences between the microbiota characterized by
the two methods (Figure 16G & H), the JSD values for the modified EQUC (solid line) and the 16S
rRNA gene sequencing (dashed line) techniques are almost identical (Figure 18).
Menstruation and LUT Microbiota Variability
I sought to determine if lifestyle factors are correlated to temporal changes in the
microbiota of the LUT. These changes, if any, could be related to stability, microbial composition,
or microbial diversity.
I hypothesized that menstruation relates to variable MSU microbiota possibly due to the
alteration of the LUT microenvironment or the introduction of exogenous organisms through
feminine hygiene product use (e.g., tampon, pad use). Menstruation was reported by all eight
participants. Three participants reported having irregular menstrual cycles, while five reported
having regular cycles defined as once every 20-40 days (Table 5). Furthermore, five participants
reported using a form of contraception/birth control other than condom use (Table 5). Due to
the small sample size, it is difficult to discern the impact of these demographic data on the
relationship between menstruation and MSU microbiota variability.
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Figure 19. Relationship Between Jensen-Shannon Divergence Values and Menstruation. JSD
values were calculated for MSU (solid lines) and peri-urethral (dashed lines) microbiota of
participants ProFUM07 (A), ProFUM08 (B), and ProFUM02 (C). Data are plotted over time in
days. Participant-reported menstruation is depicted by the grey bars.
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Table 7. Association between Jensen-Shannon Divergence Values for MSU and Peri-urethral
Microbiota and Participant-reported Menstruation.
Menstruation
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

MSU Microbiota
(Median JSD Values)

Peri-urethral Microbiota
(Median JSD Values)

“Yes” (n)

“No” (n)

p-value

“Yes” (n)

“No” (n)

p-value

0.200 (15)
0.316 (7)
0.137 (18)
0.122 (12)
0.101 (3)
0.094 (7)
0.078 (41)
0.070 (43)
0.098 (19)

0.145 (52)
0.127 (59)
0.100 (53)
0.059 (60)
0.129 (64)
0.072 (59)
0.052 (28)
0.048 (29)
0.068 (48)

0.109
0.039
0.041
0.023
0.989
0.540
0.014
<0.001
0.047

0.355 (15)
0.377 (7)
0.127 (16)
0.320 (10)
0.240 (3)
0.246 (41)
0.227 (19)

0.324 (50)
0.172 (55)
0.112 (47)
0.253 (56)
0.252 (57)
0.322 (28)
0.297 (47)

0.729
<0.001
0.313
0.088
0.873
0.095
0.051

Median JSD values shown for MSU (left) and peri-urethral (right) microbiota on days when the
participant reported (“Yes”) or did not report (“No”) menstruation. Mann-Whitney U test used
to determine significance. p-value < 0.05 is significant (green).
I first assessed whether menstruation is associated with MSU microbiota stability. Figure
19 plots the JSD values of the MSU and peri-urethral microbiota, as assessed by modified EQUC,
over time for participants ProFUM07 (Figure 19A), ProFUM08 (Figure 19B), and ProFUM02
(Figure 19C). Days shaded in grey reflect participant-reported menstruation. Qualitatively, many
peaks in the values exist, meaning higher levels of instability. A visual trend exists in which many
of these peaks occur during menstruation for the MSU microbiota data, suggesting that
menstruation is associated with MSU microbiota variability. This trend was not apparent for the
peri-urethral microbiota JSD values, except for participant ProFUM02 (Figure 19C).
Quantitatively, JSD values were significantly higher for the MSU microbiota during menstruation
for most participants (Table 7). JSD values for the peri-urethral microbiota were not significantly
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Table 8. Association between Alpha-Diversity Values for MSU Microbiota and Participantreported Menstruation.
Menstruation
MSU Microbiota

Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

(Median Shannon Diversity Values)

MSU Microbiota

(Median Simpson’s Diversity Values)

“Yes”

“No”

p-value

“Yes”

“No”

p-value

0.970
1.153
1.418
1.072
0.624
2.838
0.675
1.444
0.883

0.675
0.547
1.186
0.757
0.917
2.655
0.019
1.010
0.778

0.035
0.012
<0.001
0.026
0.168
0.148
<0.001
<0.001
0.037

0.500
0.557
0.714
0.584
0.338
0.841
0.362
0.552
0.526

0.429
0.307
0.642
0.489
0.509
0.796
0.005
0.447
0.486

0.040
0.021
<0.001
0.064
0.187
0.057
<0.001
0.008
0.049

Median Shannon Diversity (left) and Simpson’s Diversity (right) values shown for MSU
microbiota on days when the participant reported (“Yes”) or did not report (“No”) menstruation.
Mann-Whitney U test used to determine significance. p-value < 0.05 is significant (green).
Menstruation reported: ProFUM01 (15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71
days), ProFUM04 (12/72 days), ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07
(41/69 days), ProFUM08 (19/67 days).
higher during menstruation, except for participant ProFUM02 (Table 7). These data show that a
significant association exists between menstruation and variable MSU, but not peri-urethral
microbiota.
To determine the nature of the MSU microbiota instability during menstruation, I
assessed for differences in microbiota composition and diversity. Two measures of alphadiversity were calculated for each MSU microbiota: Shannon and Simpson’s diversity indices.
These values were assessed for a statistical association with menstruation (Table 8). Generally, I
found higher median alpha-diversity measures during menstruation. These values were
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Table 9. List of MSU Taxa with Significantly different Frequencies of Detection during
Participant-reported Menstruation.
Participants

Significant Taxa
Species

ProFUM01

Corynebacterium lipophile group F1
Corynebacterium tuberculostearicum
Staphylococcus epidermidis
Streptococcus agalactiae

Species

ProFUM02

Actinomyces neuii
Alloscardovia omnicolens
Corynebacterium amycolatum
Corynebacterium tuberculostearicum
Gardnerella vaginalis
Staphylococcus epidermidis
Streptococcus anginosus

Species
ProFUM03

ProFUM04
ProFUM05
ProFUM06 (16S)

ProFUM07

ProFUM07(16S)
ProFUM08

Actinomyces neuii
Corynebacterium amycolatum
Finegoldia magna

Species
Corynebacterium glucuronolyticum

Species
Genera
Species
Actinomyces radingae
Corynebacterium amycolatum
Corynebacterium aurimucosum
Corynebacterium tuberculostearicum
Finegoldia magna
Staphylococcus epidermidis
Staphylococcus hominis
Staphylococcus pettenkoferi

Genera
Finegoldia

Species

Frequency of Detection during Menstruation
“Yes” (n=15)
6 (40%)
7 (47%)
13 (87%)
12 (80%)
“Yes” (n=7)
4 (57%)
2 (29%)
2 (29%)
5 (71%)
4 (57%)
7 (100%)
6 (86%)
“Yes” (n=18)
17 (89%)
16 (84%)
7 (37%)
“Yes” (n=12)
3 (25%)
“Yes” (n=3)
“Yes” (n=7)
“Yes” (n=41)
14 (34%)
19 (46%)
17 (41%)
13 (32%)
8 (20%)
35 (85%)
12 (29%)
12 (29%)
“Yes” (n=43)
7 (16%)
“Yes” (n=19)

“No” (n=52)
4 (8%)
3 (6%)
30 (58%)
17 (33%)
“No” (n=59)
5 (8%)
0 (0%)
0 (0%)
11 (19%)
10 (17%)
17 (29%)
9 (15%)
“No” (n=53)
23 (43%)
28 (53%)
3 (6%)
“No” (n=60)
2 (3%)
“No” (n=64)
“No” (n=59)
“No” (n=28)
1 (4%)
0 (0%)
2 (7%)
2 (7%)
0 (0%)
9 (32%)
2 (7%)
2 (7%)
“No” (n=29)
0 (0%)
“No” (n=48)

p-value
0.006a
<0.001a
0.038a
0.002a
p-value
0.005a
0.010a
0.010a
0.007a
0.032a
<0.001a
<0.001a
p-value
<0.001a
0.027a
0.002a
p-value
0.030a
p-value
p-value
p-value
0.003a
<0.001a
0.002a
0.018a
0.018a
<0.001
0.033a
0.033a
p-value
0.037a
p-value

MSU microbiota listed, had significantly different (p<0.05) frequencies of detection between
menstruation and non-menstruation. Yellow cells indicate higher frequency. Chi-square used
unless otherwise indicated. a: Fisher’s exact test
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Figure 20. Fold Change of Average CFU/mL of MSU Microbiota for Participant ProFUM03
between Reporting of “Menstruation” and “No Menstruation”. Average CFUs of each species
found in the MSU specimens of Participant ProFUM03 were calculated. The fold change
between the values obtained on days after the participant reported “menstruation” versus “no
menstruation” were then measured. Species with red dots were found at higher CFUs following
menstruation. Bars indicate that the species was only found in one group. Average total CFU/mL
is in green and shows no difference. Species underlined had significantly (p<0.05) different
mean abundances between groups (Student’s t-test).
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significantly higher for most participants (Table 8), particularly those participants who previously
showed high MSU microbiota instability during menstruation (Table 7).
In addition to elevated alpha-diversity values, I observed numerous differences in the
frequency of detected taxa during menstruation. Table 9 lists the bacterial taxa that had
significantly different frequencies of detection between menstruation and non-menstruation
days. Five participants (ProFUM01, ProFUM02, ProFUM03, ProFUM04 and ProFUM07) had at
least one bacterial taxon that was statistically significant; three participants (ProFUM08,
ProFUM05, and ProFUM06) did not; the latter two previously showed no difference in alphadiversity (Table 8) or JSD values (Table 7) during menstruation. Interestingly, all of the statistically
significant bacterial taxa listed in Table 9 had higher frequencies of detection during
menstruation. These data suggest that the elevated alpha-diversity values during menstruation
(Table 8) may be a result of the increased detection of particular taxa. However, further analyses
show that this trend is more complex. Comparisons of the mean bacterial abundances between
menstruation and non-menstruation days show that many of the significant taxa in Table 9 are
also found at higher abundance during menstruation. An example of these findings is shown in
Figure 20. Figure 20 shows the fold change in mean bacterial abundance for each taxon between
menstruation and non-menstruation days for participant ProFUM03. F. magna, A. neuii, and
Corynebacterium amycolatum were found at significantly higher mean abundances during
menstruation; all three of which were also found to be more frequently detected during
menstruation (Table 9). These additional data now suggest that the elevated alpha-diversity
values during menstruation (Table 8) are likely a result of both more frequent detection and
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Table 10. Mean Total MSU Bacterial Abundance during Participant-reported Menstruation.
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

Mean Total Bacterial
Abundance during Menstruation
“Yes”

“No”

p-value

62600
40400
90000
28800
31700
41300
85300
47000
54800

83700
48800
74300
73900
55000
43000
71300
45600
46600

0.239
0.672
0.217
0.002
0.401
0.269
0.765
0.748
0.243

Mean total bacteria detected in MSU specimens between menstruation and non-menstruation.
Total bacterial abundance was calculated from CFUs or OTUs (if indicated by “16S”). Student’s
t-test (two-tailed) used. p-values <0.05 were significant. Menstruation reported: ProFUM01
(15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days),
ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67
days).
increased abundance of particular taxa. Yet, the mean total abundance of all detected bacteria
was not significantly different between menstruation and non-menstruation days for participant
ProFUM03 (Figure 20), or any of the other participants, with exception of ProFUM04 (Table 10).
Thus, while certain taxa tended to increase in abundance during menstruation, the abundance
of other taxa tended to decrease (though not significantly); thus, keeping the total bacterial
abundance relatively unchanged. This suggests that certain taxa replaced other taxa during
menstruation. Visually, this can be seen in Figure 16. For example, participant ProFUM03 has
increased relative abundance of Actinomyces during menstruation which co-occurs with
decreased relative abundance of Corynebacterium, Staphylococcus, and Streptococcus (Figure
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Table 11. Median Bray-Curtis Dissimilarity Values between Microbiota of Paired Specimens
during Participant-reported Menstruation.
Median Bray-Curtis Dissimilarity between
Participants Microbiota of Paired Specimens during Menstruation
“Yes”
“No”
p-value
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06
ProFUM07
ProFUM08

0.930
0.887
0.821
0.976
0.908
0.900
0.778

0.995
0.886
0.794
0.831
0.845
0.695
0.844

<0.001
0.944
0.106
0.004
0.507
0.037
0.625

Median Bray-Curtis Dissimilarity values shown for paired MSU and peri-urethral microbiota on
days when the participant reported (“Yes”) or did not report (“No”) menstruation. MannWhitney U test used to determine significance. p-value < 0.05 is significant (green). Yellow cells
indicate higher Bray-Curtis Dissimilarity. Menstruation reported: ProFUM01 (15/67 days),
ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days), ProFUM05 (3/67
days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67 days).
16C). Overall, I conclude that the influence of menstruation on the MSU microbiota is both
complex and dynamic.
Finally, I sought to determine if menstruation altered the dissimilarity of the microbiota
of paired MSU and peri-urethral specimens. This is important to know because if the microbiota
of the paired specimens are more similar during menstruation, this may suggest increased
microbial sharing, which could provide vital insight into the mechanism by which these trends
are occurring. Therefore, I calculated Bray-Curtis Dissimilarity values between microbiota of all
paired specimens for each participant. The median values are shown in Table 11. In general,
paired specimens had microbiota that were more dissimilar (i.e., higher median Bray-Curtis
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Table 12. Significance of Reporting Menstruation with Confounding Lifestyle Factors.

Probiotic/
Placebo (n)

Alcohol Use
(n)

Tampon Use
(n)

Pad Use (n)

Vaginal Sex
(n)

Oral Sex (n)

Bathing (n)

Illness (n)

# Bowel
Movements

Significance of Reporting Menstruation with Confounding Lifestyle Factors

ProFUM01

0.532
(10/40)

1.000a
(0/1)

<0.001a
(15/15)

<0.001a
(14/14)

-

-

1.000a
(15/66)

1.000a
(0/3)

0.918b

ProFUM02

<0.001a
(0/39)

0.617a
(2/13)

<0.001a
(6/6)

0.106a
(1/1)

1.000a
(0/2)

1.000a
(0/1)

0.442a
(2/30)

1.000a
(0/2)

0.623b

ProFUM03

0.105
(6/37)

-

-

<0.001a
(18/18)

-

-

0.789
(9/36)

1.000a
(3/11)

0.136b

ProFUM04

0.139
(4/38)

0.671
(6/32)

<0.001a
(12/12)

-

0.025a
(1/27)

-

0.047a
(11/47)

-

0.026b

ProFUM05

1.000a
(2/34)

1.000a
(1/27)

-

-

0.547a
(0/21)

1.000a
(0/4)

1.000a
(3/63)

1.000a
(0/4)

0.977b

ProFUM06

1.000a
(4/39)

0.426a
(5/32)

-

-

1.000a
(0/1)

1.000a
(0/2)

0.584a
(7/54)

-

0.032b

ProFUM07

<0.001
(29/37)

1.000a
(1/1)

-

<0.001a
(39/40)

0.642a
(3/4)

1.000a
(2/4)

1.000a
(41/69)

0.058a
(0/3)

0.057b

ProFUM08

0.081
(7/36)

0.411
(7/30)

<0.001a
(6/6)

-

1.000a
(1/3)

1.000a
(1/3)

0.850
(8/27)

1.000a
(0/1)

0.036b

Frequency of participant-reported lifestyle factors was assessed for an association with
participant-reported menstruation. p-values are shown in the table. Chi-square test used unless
otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as lifestyle
factors that were not reported by the corresponding participant. Significant p-values that are
underlined represent lifestyle factors reported at higher frequencies (or means) during
menstruation. Number of times each lifestyle factor was co-reported with menstruation out of
total is indicated in parentheses in each cell. Menstruation reported: ProFUM01 (15/67 days),
ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days), ProFUM05 (3/67
days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67 days).
a: Fisher’s exact test
b: Wilcoxon rank sum test
Dissimilarity values) during menstruation, but the trend was not always statistically significant.
Only participants ProFUM04, ProFUM07, and ProFUM01 had significantly different values
between menstruation and non-menstruation days, the latter of which was one of only two
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Table 13. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and
Peri-urethral Microbiota and Participant-reported Number of Bowel Movements.
Significance of Various Microbiota and Microbiome Measures
and Participant-reported Number of Bowel Movements
Participants
(mean number of
bowel movements)

ProFUM01 (3)
ProFUM02 (2)
ProFUM03 (2)
ProFUM04 (2)
ProFUM05 (2)
ProFUM06 (16S) (1)
ProFUM07 (1)
ProFUM07 (16S) (1)
ProFUM08 (1)

Alpha-diversity Values
(MSU)

MSU

Peri-urethra

Shannon
Index

Simpson’s
Index

Bray-Curtis
Dissimilarity
between Paired
Specimens

0.923

0.404

0.040

0.054

0.585

0.804

0.427

0.526

0.321

0.560

0.389

0.038

0.544

0.504

0.605

0.808

0.943

0.452

0.629

0.108

0.510

0.818

0.718

0.574

0.637

0.333

-

0.307

0.328

-

0.174

0.210

0.718

0.697

0.016

0.643

-

0.643

0.544

-

0.659

0.580

0.942

0.896

0.803

JSD Values

Mean JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or peri-urethral
(if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an association
with participant-reported number of bowel movements. p-values are shown in the table. Oneway ANOVA was used to determine significance. p-value < 0.05 is significant (green). Cells in
gray are not applicable.
participants with lower dissimilarity during menstruation (Table 11). These trends did not align
with any previous trends I observed with stability, diversity, or composition, suggesting that the
clinical significance is negligible.
As later discussed in Chapter V, other lifestyle factors show similar trends with the
microbiota as described above for menstruation. Therefore, I determined whether reporting of
other lifestyle factors could have confounded the menstruation data. Table 12 lists p-values
assessing the association between participant-reported menstruation and other lifestyle factors.
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Most lifestyle factors were not statistically associated with reporting of menstruation, but some
were. As expected, reporting of tampon and or pad use nearly always co-occurred with
menstruation (Table 12). Additionally, two participants had an association between
menstruation and probiotic/placebo use (Table 12). However, the two participants were in
separate treatment groups (ProFUM02 was in the placebo group; ProFUM07 was in the probiotic
group), suggesting that these data are not specifically related to the probiotic. Furthermore,
three participants (ProFUM04, ProFUM06, and ProFUM08) had associations between
menstruation and number of bowel movements reported, with all three participants reporting
higher mean number of bowel movements during menstruation (Table 12).
To determine if the association between number of bowel movements and menstruation
served as a significant confounder for the conclusions regarding the effects of menstruation on
MSU microbiota variability, I assessed whether number of bowel movements was also related to
MSU microbiota variability. Using an ANOVA, I determined if there was a statistical association
between number of bowel movements and JSD values for MSU and peri-urethral microbiota
(Table 13). I also assessed for an association between number of bowel movements and MSU
microbiota alpha-diversity indices, as well as Bray-Curtis Dissimilarity values between microbiota
of paired specimens (Table 13). Overall, very few statistical tests showed significance (i.e.,
p<0.05), suggesting that the influence of number of bowel movements does not contribute to
the findings on menstruation and MSU microbiota variability.
Finally, to better understand the mechanistic relationship between menstruation and
MSU microbiota variability, I determined whether urine properties and constituents, as
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Table 14. Significance of Participant-reported Menstruation with Urine Property and
Constituent Results.

Bilirubin (n)

Ketones (n)

Specific Gravity
(Osmolarity)

Blood (n)

pH

Protein (n)

Urobilirubin (n)

Nitrites (n)

Leukocytes (n)

Significance of Reporting Menstruation with Urine Properties and Constituents

ProFUM01

1.000a
(3/15)

0.164a
(1/14)

0.020b

<0.001a
(13/16)

0.046b

-

-

0.400a
(1/2)

0.181a
(3/7)

ProFUM02

0.407a
(1/24)

1.000a
(1/9)

0.647b

0.005a
(4/8)

0.965b

0.665a
(1/19)

1.000a
(0/1)

1.000a
(0/1)

-

ProFUM03

0.532
(5/24)

1.000a
(1/1)

0.939b

<0.001a
(17/40)

0.648b

0.166a
(3/9)

-

-

-

ProFUM04

0.722a
(3/16)

-

0.144b

0.705a
(3/15)

0.583b

1.000a
(0/4)

-

1.000a
(0/1)

0.581a
(0/6)

ProFUM05

1.000a
(3/52)

1.000a
(0/3)

0.772b

1.000a
(0/5)

0.667b

0.452a
(1/12)

-

1.000a
(1/2)

1.000a
(0/2)

ProFUM06

0.696a
(5/41)

1.000a
(0/1)

0.135b

0.003a
(3/8)

0.510b

-

-

1.000a
(0/1)

0.208a
(1/2)

ProFUM07

0.075a
(5/5)

1.000a
(1/2)

0.325b

<0.001a
(26/29)

0.512b

0.141a
(4/4)

-

1.000a
(1/1)

0.678
(9/14)

ProFUM08

0.850
(11/40)

0.318a
(2/14)

0.862b

0.030
(10/22)

0.856b

0.741a
(3/14)

-

-

0.320a
(2/14)

Frequency of urine property and constituent results was assessed for an association with
participant-reported menstruation. Positive urine test results were considered as any outcome
other than “negative”, except for Specific Gravity and pH which do not have “negative”
outcomes. p-values are shown in the table. Chi-square test used unless otherwise indicated. pvalue < 0.05 is significant (green). Urine properties and constituents for a given participant that
were always negative, or baseline, are gray. Significant p-values that are underlined represent
urine properties and constituents with “positive” results found at higher frequencies (or higher
mean values) during menstruation. Number of times each “positive” categorical test result was
co-reported with menstruation out of total is indicated in parentheses in each applicable cell.
Menstruation reported: ProFUM01 (15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71
days), ProFUM04 (12/72 days), ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07
(41/69 days), ProFUM08 (19/67 days).
a: Fisher’s exact test
b: Wilcoxon rank sum test
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assessed by urine dipsticks, were significantly different during menstruation. Not surprisingly,
with few exceptions, the only characteristic found to be significantly altered (i.e., frequency of
positive outcomes) was blood (Table 14). In all cases of statistical significance, the frequency of
positive blood results was higher during menstruation. No other urine property or constituent
was found to be related to menstruation among the participants (Table 14).
Urine Properties and Constituents and LUT Microbiota Variability
Urine dipsticks are colorimetric urine tests used clinically as indicators of disease.
However, useful information regarding the various properties and constituents of the urine are
provided by these tests. I performed urine dipstick tests on all MSU specimens. The daily
variability in the results was dramatic and, to my knowledge, has not been described in the
literature. An example is shown in Table 15, which documents the urine dipstick results for just
the first 10 days of MSU specimens provided by participant ProFUM01. The data, which are
variable, reflect the variability in the LUT environment on a daily basis. Therefore, I hypothesized
that these daily changes would correlate to MSU microbiota variability, thus providing a potential
mechanism to explain the trends with menstruation, for example.
I assessed for associations between urine properties and constituents, and microbiota
stability and alpha-diversity values. Measures of glucose were negative for all MSU specimens of
all participants and were thus excluded from the analysis. Urobilinogen measures were at
baseline levels (i.e., 0.2 mg/dL) for all MSU specimens of all participants, with the exception of
one day (Day 16) of participant ProFUM02 and were thus also excluded from the analysis. Of the
remaining tests, positive results for Bilirubin, Ketones, Blood, Protein, Nitrites, and Leukocytes

139
Table 15. Variation of Urine Properties and Constituents over Time.
Variation of Urine Properties and Constituents in ProFUM01 over Time
Time (Days)

1

2

3

4

5

6

7

8

9

10

Glucose
Bilirubin

-

-

-

-

-

-

-

-

-

-

+

+

-

-

-

-

-

-

-

+

-

-

-

-

-

-

-

5

5

-

1.005

1.015

1.005

1.000

1.000

1.000

1.005

1.020

1.015

1.020

-

H+++

H+++

H-Tr

H-Tr

H+

NH+

-

-

-

8.0

6.5

8.0

8.5

8.5

8.5

8.0

6.5

6.5

7.5

-

-

-

-

-

-

-

-

-

-

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

++

-

-

-

Ketones
Specific Gravity
(Osmolarity)
Blood
pH
Protein
Urobilinogen
Nitrites
Leukocytes

Glucose: Quantitative - range of 100mg/dL to 2000mg/dL; reaction with glucose oxidase and
peroxidase
Bilirubin: Qualitative - relative levels detected as erythrocyte breakdown; reaction with a
diazonium salt
Ketones: Detection of Acetoacetic acid; Quantitative - range of 5mg/dL to 160mg/dL; reaction
with sodium nitroprusside
Specific Gravity: Measurement of osmolarity; Quantitative – range of 1.000 to 1.030; reaction
with an anionic polyelectrolyte and detection by bromothymol blue
Blood: Detection of hemolyzed (H) or non-hemolyzed (NH) erythrocytes; Qualitative; reaction
with peroxidase and tetramethylbenzidine blue
pH: Quantitative – range of 5.0 to 8.5; detected by indicators (methyl red and bromothymol blue)
Protein: Quantitative – range of 30mg/dL to 2000mg/dL; detection by tetrabromphenol blue
Urobilinogen: Quantitative – range of 0.2mg/dL to 8mg/dL; reaction with Ehrlich’s reagent
Nitrites: Semi-quantitative – Negative (<0.075mg/dL), Positive (>0.075mg/dL); reaction with
para-arsanilic acid and a diazonium salt
Leukocytes: Detection of Leukocyte esterase; Qualitative – relative levels of leukocyte esterase
detected from catalysis of indolecarboxylic acid
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Table 16. Significance of JSD Values of MSU and Peri-urethral Microbiota and Selected Urine
Properties and Constituents.
Participants

Significance of Urine Properties and Constituents and
MSU JSD Values

(Number of Specimens)

Bilirubin
(n)

Ketones
(n)

Blood (n)

Protein (n)

Nitrites
(n)

Leukocytes
(n)

ProFUM01 (n=67)
ProFUM02 (n=66)
ProFUM03 (n=71)
ProFUM04 (n=72)

0.949 (15)
0.145 (24)
0.722 (24)
0.233 (16)

0.911 (14)
0.484 (9)
0.901 (1)
-

0.189 (16)
0.378 (8)
0.156 (40)
0.225 (15)

0.726 (19)
0.501 (9)
0.045 (4)

1.000 (2)
0.242 (1)
0.500 (1)

0.391 (7)
0.302 (6)

ProFUM05 (n=67)
ProFUM06 (16S) (n=66)
ProFUM07 (n=69)
ProFUM07 (16S) (n=69)
ProFUM08 (n=67)

0.618 (52)
0.632 (39)
0.198 (5)
0.477 (5)
0.671 (40)

0.875 (3)
0.156 (1)
0.145 (2)
0.692 (2)
0.118 (14)

0.538 (5)
0.727 (8)
0.011 (29)
0.890 (29)
0.214 (22)

0.452 (12)
0.558 (4)
0.093 (4)
0.909 (14)

0.039 (2)
0.750 (1)
0.377 (1)
0.551 (1)
-

0.521 (2)
0.671 (2)
0.903 (14)
0.492 (14)
0.011 (14)

Participants

Significance of Urine Properties and Constituents and
Peri-urethral JSD Values

(Number of Specimens)

Bilirubin
(n)

Ketones
(n)

Blood (n)

Protein (n)

Nitrites
(n)

Leukocytes
(n)

ProFUM01 (n=65)
ProFUM02 (n=62)
ProFUM03 (n=63)
ProFUM04 (n=66)
ProFUM05 (n=60)
ProFUM07 (n=69)
ProFUM08 (n=66)

0.231 (14)
0.331 (22)
0.985 (20)
0.046 (15)
0.999 (47)
0.347 (5)
0.430 (40)

0.425 (14)
0.227 (9)
0.889 (1)
0.975 (3)
0.692 (2)
0.323 (14)

0.511 (16)
0.011 (8)
0.646 (36)
0.406 (14)
0.736 (5)
0.599 (29)
0.241 (22)

0.554 (18)
0.002 (9)
0.806 (4)
0.211 (10)
0.795 (4)
0.056 (14)

0.809 (2)
0.903 (1)
0.303 (1)
0.854 (2)
0.638 (1)
-

0.138 (7)
0.394 (5)
0.734 (2)
0.751 (14)
0.221 (14)

Median JSD values of the MSU (top) and peri-urethral (bottom) microbiota or microbiome
(indicated by “16S”) were assessed for an association with selected urine properties and
constituents. p-values are shown in the tables. Mann-Whitney U test used to determine
significance. p-value < 0.05 is significant (green). Cells in gray are not applicable. Significant pvalues that are underlined had higher median JSD values when the corresponding urine test
result was “positive”. Number of “positive” results is indicated in parentheses in each cell.
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Table 17. Significance of Alpha-Diversity Values of MSU Microbiota and Selected Urine
Properties and Constituents.
Participants

Significance of Urine Properties and Constituents and
Shannon Diversity Values of MSU Microbiota

(Number of Specimens)

Bilirubin
(n)

Ketones
(n)

Blood (n)

Protein (n)

Nitrites
(n)

Leukocytes
(n)

ProFUM01 (n=67)
ProFUM02 (n=66)
ProFUM03 (n=71)
ProFUM04 (n=72)

0.415 (15)
0.645 (24)
0.795 (24)
0.273 (16)

0.718 (14)
0.152 (9)
0.028 (1)
-

0.011 (16)
0.033 (8)
0.096 (40)
0.721 (15)

0.323 (19)
0.953 (9)
0.859 (4)

0.023 (2)
0.909 (1)
0.528 (1)

0.205 (7)
0.517 (6)

ProFUM05 (n=67)
ProFUM06 (16S) (n=66)
ProFUM07 (n=69)
ProFUM07 (16S) (n=69)
ProFUM08 (n=67)

0.947 (52)
0.743 (39)
0.495 (5)
0.223 (5)
0.925 (40)

0.066 (3)
0.188 (1)
0.402 (2)
0.308 (2)
0.377 (14)

0.049 (5)
0.530 (8)
<0.001 (29)
0.011 (29)
0.945 (22)

0.904 (12)
0.122 (4)
0.419 (4)
0.377 (14)

0.023 (2)
0.125 (1)
0.609 (1)
0.464 (1)
-

0.418 (2)
0.131 (2)
0.809 (14)
0.429 (14)
0.188 (14)

Participants

Significance of Urine Properties and Constituents and
Simpson’s Diversity Values of MSU Microbiota

(Number of Specimens)

Bilirubin
(n)

Ketones
(n)

Blood (n)

Protein (n)

Nitrites
(n)

Leukocytes
(n)

ProFUM01 (n=67)
ProFUM02 (n=66)
ProFUM03 (n=71)
ProFUM04 (n=72)
ProFUM05 (n=67)
ProFUM06 (16S) (n=66)
ProFUM07 (n=69)
ProFUM07 (16S) (n=69)

0.515 (15)
0.576 (24)
0.695 (24)
0.559 (16)
0.715 (52)
0.913 (39)
0.495 (5)
0.206 (5)

0.629 (14)
0.250 (9)
0.028 (1)
0.124 (3)
0.313 (1)
0.384 (2)
0.491 (2)

0.098 (16)
0.040 (8)
0.241 (40)
0.602 (15)
0.079 (5)
0.373 (8)
<0.001 (29)
0.033 (29)

0.344 (19)
0.858 (9)
0.454 (4)
0.765 (12)
0.136 (4)
0.404 (4)

0.153 (2)
0.909 (1)
0.694 (1)
0.018 (2)
0.219 (1)
0.609 (1)
0.696 (1)

0.252 (7)
0.209 (6)
0.479 (2)
0.080 (2)
0.844 (14)
0.263 (14)

ProFUM08 (n=67)

0.687 (40)

0.585 (14)

0.209 (22)

0.265 (14)

-

0.361 (14)

Median Shannon (top) and Simpson’s (bottom) alpha-diversity values of the MSU microbiota or
microbiome (indicated by “16S”) were assessed for an association with selected urine properties
and constituents. p-values are shown in the tables. Mann-Whitney U test used to determine
significance. p-value < 0.05 is significant (green). Cells in gray are not applicable. Significant pvalues that are underlined had higher median alpha-diversity values when the corresponding
urine test result was “positive”. Number of “positive” results is indicated in parentheses in each
cell.
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Table 18. Significance of JDS and Alpha-Diversity Values of MSU and Peri-urethral Microbiota
and Categorical Urine Properties and Constituents.
A.
Significance of Urine Properties and Constituents and JSD Values
MSU Microbiota
Participants

Peri-urethral Microbiota

(Number of Specimens)

Specific
Gravity

pH

ProFUM01 (n=67)
ProFUM02 (n=66)
ProFUM03 (n=71)
ProFUM04 (n=72)
ProFUM05 (n=67)
ProFUM06 (16S) (n=66)

0.457
0.606
0.997
0.441
0.611
0.702

ProFUM07 (n=69)
ProFUM07 (16S) (n=69)
ProFUM08 (n=67)

Participants
(Number of Specimens)

Specific
Gravity

pH

0.605
0.841
0.135
0.405
0.030
0.731

ProFUM01 (N=65)
ProFUM02 (N=62)
ProFUM03 (N=63)
ProFUM04 (N=66)
ProFUM05 (N=60)

0.249
0.376
0.053
0.342
0.626

0.240
0.739
0.556
0.181
0.032

0.334
0.168

0.689
0.740

ProFUM07 (N=69)

0.238

0.536

0.459

0.779

ProFUM08 (N=66)

0.376

0.963

B.
Participants
(Number of Specimens)

Significance of Urine Properties and Constituents and
Alpha-Diversity Values of MSU Microbiota
Shannon Diversity Values

Simpson’s Diversity Values

Specific Gravity

pH

Specific Gravity

pH

ProFUM01 (n=67)

0.858

0.472

0.837

0.406

ProFUM02 (n=66)
ProFUM03 (n=71)
ProFUM04 (n=72)
ProFUM05 (n=67)
ProFUM06 (16S) (n=66)

0.302
0.736
0.033
0.062
0.418

0.403
0.815
0.901
0.096
0.245

0.267
0.536
0.083
0.171
0.539

0.444
0.906
0.806
0.138
0.381

ProFUM07 (n=69)

0.221

0.791

0.259

0.800

ProFUM07 (16S) (n=69)
ProFUM08 (n=67)

0.052
0.448

0.993
0.425

0.130
0.627

0.915
0.178

Mean JSD (A) values of MSU (left) and peri-urethral (right) microbiota or microbiome (indicated
by “16S”) were assessed for an association with categorical urine properties and constituents.
Alpha-diversity values (B) including Shannon (left) and Simpson’s (right) diversity values of the
MSU microbiota or microbiome are also shown. p-values are shown in the tables. One-way
ANOVA tests used to determine significance. p-value < 0.05 is significant (green).
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were grouped into one category (e.g., all Ketone results ranging from 5 mg/dL to 160 mg/dL were
considered positive) and compared to negative results. Specific gravity and pH were treated as
categorical variables and a one-way ANOVA was performed to determine if microbiota
differences existed amongst the categories.
Table 16 shows the p-values for the statistical tests measuring associations between
microbiota JSD values and non-categorical urine properties and constituents. I found that median
JSD values for MSU and peri-urethral microbiota were not significantly different between positive
and negative urine dipstick test results (Table 16). Some tests showed statistical significance, but
overall no trends were observed. The exception was in Table 17, which showed that a positive
blood test result was generally associated with higher mean alpha-diversity values for MSU
microbiota (Table 17). For the categorical variables (i.e., specific gravity and pH), I also observed
very few statistically significant trends between test results and microbiota stability (Table 18A)
or alpha-diversity values (Table 18B). Altogether, these data show that the MSU microbiota is
generally unaffected by the chemical environment of the LUT, at least relating to the urine
properties assessed here. This could also be interpreted to mean that the microbiota do not alter
the chemical environment of the LUT.
Summary
Using the findings from Chapter III, I measured specimen collection compliance by using
a pre-study Screening Phase. Of the 12 participants screened, I excluded four based on the use
of Bray-Curtis Dissimilarity between microbiota of paired specimens. This approach provided us
with quality specimens (i.e., distinct MSU and peri-urethral microbiota) in the primary study. I

144
found that all eight enrolled participants had median Bray-Curtis Dissimilarity values above 0.8
(Table 6), though the scores varied dramatically over time for some participants (Figure 14).
Nonetheless, the participants provided specimens with distinct microbiota (Figure 15). Use of a
specific standard measure allowed us to make stronger comparisons and conclusions among the
data and allowed us to make statements exclusively related to the LUT rather than the periurethral environment regarding microbiota stability and change.
The temporal variability in the MSU microbiota of the participants is graphically depicted
in Figure 16. I used JSD as the primary measure of longitudinal microbiota stability. I found that
the peri-urethral microbiota were, overall, more unstable than the microbiota of the MSU
specimens. The median JSD values for all participants were higher for the peri-urethral
microbiota compared to the MSU microbiota, indicating greater instability over time (Figure 17).
Physiologically, this is not surprising, as the peri-urethral area is exposed to the genital and
external environments, while MSU specimens and the majority of the LUT are not. Therefore,
exogenous introduction of microorganisms as well as movement of the normal flora of the periurethra may occur more frequently than in the LUT.
For participant ProFUM07, I performed both modified EQUC and 16S rRNA gene
sequencing. Qualitatively, the microbiota and microbiome of ProFUM07 were dominated by
Lactobacillus (blue) except for three, one to two-week periods during the beginning (i.e., week
1), middle (i.e., weeks 3 and 4), and end (i.e., weeks 7 and 8). During these non-Lactobacillus
dominant periods, the two identification methods conflicted slightly. However, the deviation
from Lactobacillus dominance occurred for the exact same specimens by both methods, and JSD
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values were elevated for both methods during these periods (Figure 18). These data show that
the two methods are complementary and validate the use of only one method to analyze the
specimens of the other seven participants.
The primary aim of Chapter IV was to determine if intrinsic lifestyle factors relate to
microbiota dynamics of the LUT. I found significant associations between microbial instability and
participant-reported menstruation (Table 7). The associations were only significant for the MSU
microbiota/microbiome data, suggesting that menstruation is associated with microbiota
changes in the LUT, but not the peri-urethra (Figure 19). Compositional differences existed during
menstruation, where higher frequencies and abundances of mainly Corynebacterium,
Staphylococcus, and Actinomyces, which are common skin flora, were found in the MSU
specimens of most participants (Table 9 and Figure 20). Median alpha-diversity values of the MSU
microbiota were also significantly higher during menstruation (Table 8), despite the total
bacterial abundance being largely unchanged (Table 10). Altogether, these data show that the
association between MSU microbiota variability and menstruation is dynamic, meaning that
several, likely related trends apply to the microbiota of the LUT.
As an assessment of confounding factors, I found that tampon and pad use were reported
at significantly higher frequencies during reporting of menstruation for all participants, as
expected (Table 12). The reported number of bowel movements was also significantly higher
during menstruation for several participants (Table 12), but further analyses showed no
association between number of bowel movements and MSU microbiota stability or alphadiversity measures (Table 13). Furthermore, I found that a positive blood result on the urine
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dipstick test was the only result correlated with menstruation (Table 14). This last finding serves
as an important positive control, because it suggests that the participants are reporting
menstruation appropriately and provides a level of confidence that the remaining questionnaire
was completed honestly.
I also used a urine dipstick test to determine if urine properties and constituents related
to MSU microbiota variability. By assessing these characteristics on a daily basis, I was able to
observe novel temporal variabilities in the data, an example of which is shown in Table 15.
However, the variability in urine characteristics did not relate to microbiota variability (Tables 16,
17, & 18). The exception was blood, which showed a similar pattern of trends as was seen with
menstruation, as expected (Table 14).
Altogether, these data suggest that, mechanistically, the MSU microbiota variability
associated with menstruation may relate to feminine hygiene product use, but likely not the
chemical composition of the urine (i.e., LUT environment), at least none of the parameters that I
assessed. The caveat to this hypothesis is that I did not observe a similar trend with the periurethral microbiota suggesting that exogenous introduction of microorganisms into the LUT due
to hygiene product use is unlikely. More research needs to be done exploring the peri-urethral
microbiota to understand if this is a plausible conclusion.

147

CHAPTER V
EFFECT OF EXTRINSIC LIFESTYLE FACTORS ON LUT MICROBIOTA
Sexual Activity and LUT Microbiota Variability
In this chapter, I sought to determine if extrinsic, or externally controlled, lifestyle factors
are correlated to temporal changes in the microbiota of the LUT. Similar to Chapter IV, these
changes could be related to MSU microbiota stability, composition, or alpha-diversity.
I hypothesized that sexual activity would alter the MSU microbiota, likely by introducing
exogenous microorganisms. Participants were queried regarding sexual activity on the lifestyle
questionnaire. If they reported sexual activity, they were then asked several follow-up questions
including type of sexual activity (e.g., penetrative vaginal intercourse, receiving oral intercourse,
other), condom use, and whether the partner was the same as the previous reported activity.
These latter two follow-up questions were added to the questionnaire during the study and were
therefore only completed by participants ProFUM06, ProFUM07, and ProFUM08.
Sexual activity was reported by six participants (Table 19). Of these six participants,
penetrative vaginal intercourse was reported by all at least once, and was the main type of sexual
activity for most. For the applicable participants (i.e., ProFUM06, ProFUM07, and ProFUM08),
condom use was reported on 100% of the reported instances of vaginal intercourse. One
participant, ProFUM07, reported being with the same male partner for all instances of vaginal
intercourse (5/5, 100%), while ProFUM08 reported different male partners for each instance of
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Table 19. Summary of Participant-reported Lifestyle Factors Relating to Sexual Activity.
Participant-reported Lifestyle Factors Relating to Sexual Activity
Participants

Sexual
Activity

ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06
ProFUM07
ProFUM08

0
3
0
29
22
4
15
3

Penetrative
Vaginal
Intercourse

Condom
Use

Same
Partner –
“Yes”

Received
Oral
Intercourse

“Other”
Sexual
Activity

N/A
2 (67%)
N/A
29 (100%)
22 (100%)
2 (50%)
5 (33%)
3 (100%)

2 (100%)
5 (100%)
3 (100%)

1 (50%)
5 (100%)
0 (0%)

N/A
2 (67%)
N/A
0 (0%)
4 (18%)
3 (75%)
5 (33%)
3 (100%)

N/A
1 (33%)
N/A
0 (0%)
0 (0%)
1 (25%)
15 (100%)
0 (0%)

N/A (Not applicable) refers to participants who did not report the lifestyle factor (i.e.
participants ProFUM01 and ProFUM03). Condom use and new partner were added to the
lifestyle questionnaire following the completion of participant ProFUM05.
vaginal intercourse (0/3, 0%). Oral intercourse was reported by five of the six participants (Table
19).
I first assessed whether sexual activity is broadly associated with MSU microbiota
stability. Figure 21 plots the JSD values of the MSU and peri-urethral microbiota over time for
participants ProFUM04 (Figure 21A), ProFUM05 (Figure 21B), and ProFUM08 (Figure 21C). Days
shaded in grey reflect participant-reported sexual activity. Penetrative vaginal intercourse is
depicted by the red triangles, and receiving oral intercourse is depicted by the blue circles.
Qualitatively, participants ProFUM05 (Figure 21B) and ProFUM08 (Figure 21C) have a clear trend
between reporting sexual activity and higher JSD values for the MSU microbiota. Visually, there
also appears to be a slight trend for the peri-urethral microbiota of participant ProFUM05 (Figure
21B), but this was determined to not be statistically significant (Table 20). Participant ProFUM04
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Figure 21. Relationship Between JSD Values and Sexual Activity. JSD values were calculated for
MSU (solid lines) and peri-urethral (dashed lines) microbiota of participants ProFUM04 (A),
ProFUM05 (B), and ProFUM08 (C). Data are plotted over time in days. Participant-reported
sexual activity is depicted by the grey bars. Vaginal intercourse is depicted by the red triangles.
Oral intercourse is depicted by the blue circles.

150
Table 20. Association between JSD Values for MSU and Peri-urethral Microbiota and
Participant-reported Sexual Activity.
Sexual Activity
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

MSU Microbiota
(Median JSD Values)

Peri-urethral Microbiota
(Median JSD Values)

“Yes” (n)

“No” (n)

p-value

“Yes” (n)

“No” (n)

p-value

N/A
0.549 (3)
N/A
0.057 (27)
0.200 (21)
0.172 (3)
0.057 (13)
0.063 (13)
0.279 (3)

N/A
0.139 (63)
N/A
0.063 (45)
0.108 (46)
0.122 (63)
0.057 (56)
0.053 (56)
0.071 (64)

0.207
0.373
0.036
0.042
0.707
0.136
<0.001

N/A
0.492 (3)
N/A
0.303 (25)
0.267 (20)
0.215 (13)
0.198 (3)

N/A
0.172 (59)
N/A
0.256 (41)
0.249 (40)
0.272 (56)
0.279 (63)

0.192
0.162
0.441
0.140
0.080

Median Jensen-Shannon Divergence (JSD) values shown for MSU (left) and peri-urethral (right)
microbiota on days when the participant reported (“Yes”) or did not report (“No”) sexual
activity. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant
(green). N/A (Not applicable) refers to participants who did not report the lifestyle factor.
(Figure 21A) did not have a visual trend between JSD values and sexual activity for either
specimen type; this was quantitatively confirmed in Table 20.
Significantly higher median JSD values of the MSU, but not peri-urethral, microbiota were
associated with participant-reported sexual activity for three of the six applicable participants:
ProFUM05, ProFUM06, and ProFUM08 (Table 20). Because sexual activity includes both/either
penetrative vaginal intercourse and/or receiving oral intercourse, I next separated the responses
by activity type and determined the relationship to microbiota stability. I found that four of the
six applicable participants (ProFUM02, ProFUM05, ProFUM07, and ProFUM08) had significant
associations between MSU microbiota JSD values and vaginal intercourse, while only two
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Table 21. Association between Jensen-Shannon Divergence Values for MSU Microbiota and
Participant-reported Vaginal and Oral Intercourse.
MSU Microbiota (Median JSD Values)
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

Penetrative Vaginal Intercourse

Receiving Oral Intercourse

“Yes” (n)

“No” (n)

p-value

“Yes” (n)

“No” (n)

p-value

N/A
0.559 (2)
N/A
0.057 (27)
0.200 (21)
0.173 (1)
0.242 (4)
0.057 (4)
0.279 (3)

N/A
0.136 (64)
N/A
0.063 (45)
0.108 (46)
0.123 (65)
0.057 (65)
0.054 (65)
0.071 (64)

<0.001
0.373
0.036
0.152
<0.001
0.150
<0.001

N/A
0.559 (2)
N/A
N/A
0.264 (4)
0.150 (2)
0.163 (4)
0.083 (4)
0.279 (3)

N/A
0.136 (64)
N/A
N/A
0.125 (63)
0.123 (64)
0.057 (65)
0.054 (65)
0.071 (64)

<0.001
0.078
0.183
0.094
0.117
<0.001

Median JSD values shown for MSU microbiota on days when the participant reported (“Yes”) or
did not report (“No”) vaginal intercourse (left) or oral intercourse (right). Mann-Whitney U test
used to determine significance. p-value < 0.05 is significant (green). N/A (Not applicable) refers
to participants who did not report the lifestyle factor.
participants (ProFUM02 and ProFUM08) had an association with oral intercourse (Table 21).
However, the two participants with significant associations between MSU microbiota JSD values
and oral intercourse were the only two participants who always co-reported oral intercourse with
vaginal intercourse, suggesting that the trend with sexual activity is due to vaginal intercourse.
To determine the nature of the MSU microbiota instability following vaginal intercourse,
I assessed for differences in microbiota diversity and composition. Two measures of alphadiversity were calculated for each MSU microbiota: Shannon and Simpson’s diversity indices.
These values were assessed for an association with participant-reported vaginal intercourse
(Table 22). I found that median alpha-diversity measures were significantly higher following
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Table 22. Association between Alpha-Diversity Values for MSU Microbiota and Participantreported Vaginal Intercourse.
Vaginal Intercourse
MSU Microbiota

Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

(Median Shannon Diversity Values)

MSU Microbiota

(Median Simpson’s Diversity Values)

“Yes”

“No”

p-value

“Yes”

“No”

p-value

N/A
1.247
N/A
0.748
0.757
1.809
1.643
0.909
1.895

N/A
0.567
N/A
0.810
0.925
2.675
0.249
1.264
0.804

0.242
0.532
0.163
0.212
<0.001
0.083
<0.001

N/A
0.642
N/A
0.496
0.450
0.682
0.753
0.379
0.820

N/A
0.318
N/A
0.488
0.529
0.800
0.123
0.508
0.488

0.303
0.817
0.223
0.333
<0.001
0.144
<0.001

Median Shannon Diversity (left) and Simpson’s Diversity (right) values shown for MSU
microbiota on days when the participant reported (“Yes”) or did not report (“No”) vaginal
intercourse. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant
(green). N/A (Not applicable) refers to participants who did not report the lifestyle factor.
Vaginal intercourse reported: ProFUM01 (0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71
days), ProFUM04 (27/72 days), ProFUM05 (21/67 days), ProFUM06 (1/66 days), ProFUM07
(4/69 days), ProFUM08 (3/67 days).
vaginal intercourse for two of the participants (i.e., ProFUM07 and ProFUM08) who previously
showed significant associations with MSU microbiota instability (Table 21).
In addition to elevated alpha-diversity values in some participants, I observed numerous
differences in the frequency of detected taxa following vaginal intercourse. Table 23 lists the
bacterial taxa that had significantly different frequencies of detection between reporting and not
reporting vaginal intercourse.
Four participants had at least one bacterial taxon that was statistically significant (Table
23). The exceptions were participants ProFUM02 and ProFUM06; however, these participants
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Table 23. List of MSU Taxa with Significantly different Frequencies of Detection following
Participant-reported Vaginal Intercourse.
Participants

Significant Taxa

ProFUM02

Species
Species

ProFUM04

Staphylococcus epidermidis

Species
ProFUM05
ProFUM06 (16S)
ProFUM07

ProFUM07 (16S)

Actinomyces neuii
Lactobacillus crispatus
Streptococcus agalactiae

Genera
Species
Staphylococcus hominis
Streptococcus mitis
Streptococcus salivarius

Genera
Campylobacter

Species

ProFUM08

Corynebacterium tuberculostearicum
Neisseria macacae
Staphylococcus hominis
Staphylococcus lugdunensis
Streptococcus gordonii
Streptococcus mitis
Streptococcus parasanguinis
Streptococcus salivarius
Streptococcus vestibularis

Frequency of Detection following
Vaginal Intercourse
“Yes” (n=2)
“No” (n=64)
p-value
“Yes” (n=27)
“No” (n=45)
p-value
22 (81%)
26 (58%)
0.039
“Yes” (n=21)
“No” (n=46)
p-value
4 (17%)
24 (52%)
0.016a
9 (43%)
34 (74%)
0.014
5 (24%)
2 (4%)
0.027a
“Yes” (n=1)
“No” (n=65)
p-value
“Yes” (n=4)
“No” (n=65)
p-value
4 (100%)
10 (15%)
0.001a
3 (75%)
0 (0%)
<0.001a
2 (50%)
0 (0%)
0.003a
“Yes” (n=4)
“No” (n=65)
p-value
1 (25%)
51 (78%)
0.044a
“Yes” (n=3)
“No” (n=64)
p-value
2 (67%)
7 (11%)
0.045a
1 (33%)
0 (0%)
0.045a
3 (100%)
8 (13%)
0.003a
2 (67%)
2 (3%)
0.008a
1 (33%)
0 (0%)
0.045a
3 (100%)
2 (3%)
<0.001a
2 (67%)
0 (0%)
0.001a
2 (67%)
0 (0%)
0.001a
1 (33%)
0 (0%)
0.045a

MSU microbiota listed, had significantly different (p<0.05) frequencies of detection between
vaginal intercourse and no vaginal intercourse. Yellow cells indicate higher frequency. Chisquare used unless otherwise indicated.
a: Fisher’s exact test
only reported vaginal intercourse on two and one day(s), respectively, thus making statistical
significance difficult to obtain. Participants ProFUM04, ProFUM05, ProFUM07, and ProFUM08 all
had significantly higher frequencies of detection of various Streptococcus and Staphylococcus
species following vaginal intercourse. Participant ProFUM02 also had higher frequencies of
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Figure 22. Fold Change of Average CFU/mL of MSU Microbiota for Participant ProFUM05
between Reporting of “Vaginal Intercourse” and “No Vaginal Intercourse”. Average CFUs of
each species found in the MSU specimens of Participant 05 were calculated. The fold change
between the values obtained on days after the participant reported “vaginal intercourse” versus
“no vaginal intercourse” were then measured. Species with red dots were found at higher CFUs
following menstruation. Bars indicate that the species was only found in one group. Average
total CFU/mL is in green and shows no difference. Species underlined had significantly (p<0.05)
different mean abundances between groups (Student’s t-test).
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Table 24. Mean Total MSU Bacterial Abundance following Participant-reported Vaginal
Intercourse.
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

Mean Total Bacterial
Abundance following Vaginal Intercourse
“Yes”

“No”

p-value

N/A
115900
N/A
85000
59800
44600
29300
32700
24700

N/A
45800
N/A
55200
51300
47500
42800
47200
77600

0.044
0.010
0.496
0.238
0.118
0.042

Mean total bacteria detected in MSU specimens between vaginal intercourse and no vaginal
intercourse. Total bacterial abundance was calculated from CFUs or OTUs (if indicated by “16S”).
Student’s t-test (two-tailed) used. p-value <0.05 were significant. N/A (Not applicable) refers to
participants who did not report the lifestyle factor. Vaginal intercourse reported: ProFUM01
(0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71 days), ProFUM04 (27/72 days), ProFUM05
(21/67 days), ProFUM06 (1/66 days), ProFUM07 (4/69 days), ProFUM08 (3/67 days).
Streptococcus species, although the statistical tests only approached significance (p=0.081).
Furthermore, the abundance of these significant species was generally elevated following vaginal
intercourse; an example of which is shown in Figure 22, which shows that, for participant
ProFUM05, S. mitis (p=0.002) and S. agalactiae (p=0.041) had significantly higher mean
abundances in the MSU specimens following vaginal intercourse.
Table 23 also shows that some species, none of which belong to the Streptococcus or
Staphylococcus genera, had significantly lower frequencies of detection following vaginal
intercourse. These data may relate to the mixed results seen in Table 22 regarding alpha-diversity
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Table 25. Significance of Reporting Vaginal Intercourse with Confounding Lifestyle Factors.

Probiotic/
Placebo (n)

Alcohol Use
(n)

Menstruation
(n)

Tampon Use
(n)

Pad Use (n)

Oral Sex (n)

Bathing (n)

Illness (n)

# Bowel
Movements

Significance of Reporting Vaginal Intercourse with Confounding Lifestyle
Factors

ProFUM01

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ProFUM02

1.000a
(1/39)

0.036a
(2/13)

1.000a
(0/7)

1.000a
(0/6)

1.000a
(0/1)

0.030a
(1/1)

0.203a
(2/30)

1.000a
(0/2)

0.215b

ProFUM03

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ProFUM04

0.903
(14/38)

0.142
(9/32)

0.025a
(1/12)

0.025a
(1/12)

-

-

0.749
(17/47)

-

0.673b

ProFUM05

0.479
(12/34)

0.409
(10/27)

0.546a
(0/3)

-

-

0.008a
(4/4)

1.000a
(20/63)

0.584a
(2/4)

0.473b

ProFUM06

0.418a
(0/39)

0.478a
(1/32)

1.000a
(0/7)

-

-

0.030a
(1/2)

1.000a
(1/54)

-

1.000b

ProFUM07

0.618a
(3/37)

1.000a
(0/4)

0.642a
(3/41)

-

0.634a
(3/40)

0.015a
(2/4)

1.000a
(4/69)

1.000a
(0/3)

0.399b

ProFUM08

1.000a
(2/36)

0.583a
(2/30)

1.000a
(1/19)

0.249a
(1/6)

-

<0.001a
(3/3)

0.226a
(2/27)

1.000a
(0/1)

1.000b

Frequency of participant-reported lifestyle factors was assessed for an association with
participant-reported vaginal intercourse. p-values are shown in the table. Chi-square test used
unless otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as
lifestyle factors that were not reported by the corresponding participant. N/A (Not applicable)
refers to participants who did not report vaginal intercourse. Significant p-values that are
underlined represent lifestyle factors reported at higher frequencies (or means) following
vaginal intercourse. Number of times each lifestyle factor was co-reported with vaginal
intercourse out of total is indicated in parentheses in each cell. Vaginal intercourse reported:
ProFUM01 (0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71 days), ProFUM04 (27/72 days),
ProFUM05 (21/67 days), ProFUM06 (1/66 days), ProFUM07 (4/69 days), ProFUM08 (3/67 days).
a: Fisher’s exact test
b: Wilcoxon rank sum test
values, as well as those in Table 24, which also showed varied results for differences in mean
total bacterial abundance following vaginal intercourse. Altogether, these data suggest that the
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variability of the MSU microbiota following vaginal intercourse is more complicated and
individualized than the trends described in Chapter IV for menstruation. It is likely that related
factors, such as co-reporting oral intercourse, condom use, and whether the partner was the
same, play a large role in the discrepancies of the trends described here. However, because the
latter two factors were only asked of participants ProFUM06, ProFUM07, and ProFUM08, one
can only speculate. I did seek to determine whether reporting of other lifestyle factors could have
confounded the data. The results in Table 25 confirm the significance between co-reporting oral
intercourse with vaginal intercourse. Significant values were obtained for five of the six applicable
participants; the remaining participant, ProFUM04, did not report oral intercourse (Table 25).
However, I previously showed that oral intercourse is generally not significantly associated with
MSU microbiota stability (Table 21). Participant ProFUM04 did show a trend with another
lifestyle factor. I found that vaginal intercourse was significantly less likely to be co-reported with
menstruation or tampon use (Table 25). Other relevant lifestyle factors such as condom use and
new sexual partners were not analyzed due to the small sample size of participants (i.e., three
participants). Furthermore, condom use was reported by all three applicable participants for all
incidences of vaginal intercourse. Without this information for the remaining participants, I have
no data to compare the results to. Participant ProFUM08 was the only applicable participant to
report multiple sexual partners, again making conclusions difficult to draw from such a small
sample size.
To better understand the mechanistic relationship between vaginal intercourse and MSU
microbiota variability, I next determined whether urine properties and constituents were
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Table 26. Significance of Participant-reported Vaginal Intercourse with Urine Property and
Constituent Results.

N/A

ProFUM02
ProFUM03

N/A

N/A

(2/24)

(2/9)

0.289b
N/A

1.000a
(0/8)
N/A

Leukocytes (n)

N/A

0.016a

Nitrites (n)

Blood (n)

N/A

0.129a

Urobilirubin (n)

Specific Gravity
(Osmolarity)

N/A

Protein (n)

Ketones (n)

ProFUM01

pH

Bilirubin (n)

Significance of Reporting Vaginal Intercourse with Urine Properties and
Constituents

N/A

N/A

N/A

N/A

N/A

0.484a

1.000a

1.000a

N/A

N/A

N/A

N/A

1.000a
(0/1)

1.000a
(2/6)

0.638b
N/A

(1/19)

1.000a

(0/1)

(0/1)

-

ProFUM04

1.000
(6/16)

-

0.542b

0.822
(6/15)

0.949b

ProFUM05

0.007
(12/52)

0.546a
(0/3)

0.054b

0.315a
(3/5)

0.008b

0.395
(5/12)

-

0.532a
(1/2)

1.000a
(0/2)

ProFUM06

1.000a
(1/41)

0.015a
(1/1)

0.125b

1.000a
(0/8)

0.250b

-

-

1.000a
(0/1)

1.000a
(0/2)

ProFUM07

0.265a
(1/5)

1.000a
(0/2)

0.534b

1.000a
(2/29)

1.000b

1.000a
(0/4)

-

1.000a
(0/1)

0.575a
(0/14)

ProFUM08

1.000a
(2/40)

0.511a
(1/14)

0.473b

0.545a
(0/22)

0.953b

1.000a
(0/14)

-

-

0.108a
(2/14)

(1/4)

-

Frequency of urine property and constituent results was assessed for an association with
participant-reported vaginal intercourse. Positive urine test results were considered as any
outcome other than “negative”, except for Specific Gravity and pH which do not have “negative”
outcomes. p-values are shown in the table. Chi-square test used unless otherwise indicated. pvalue < 0.05 is significant (green). Urine properties and constituents for a given participant that
were always negative, or baseline are gray. N/A (Not applicable) refers to participants who did
not report vaginal intercourse. Significant p-values that are underlined represent urine
properties and constituents with “positive” results found at higher frequencies (or higher mean
values) following vaginal intercourse. Number of times each “positive” categorical test result
was co-reported with vaginal intercourse out of total is indicated in parentheses in each
applicable cell. Vaginal intercourse reported: ProFUM01 (0/67 days), ProFUM02 (2/66 days),
ProFUM03 (0/71 days), ProFUM04 (27/72 days), ProFUM05 (21/67 days), ProFUM06 (1/66
days), ProFUM07 (4/69 days), ProFUM08 (3/67 days).
a: Fisher’s exact test
b: Wilcoxon rank sum test
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significantly different following vaginal intercourse. In general, I found few significant
associations between urine test results and participant-reported vaginal intercourse (Table 26).
The exception was for participant ProFUM05, who had two urine test results with significant
associations to vaginal intercourse. Frequency of positive bilirubin results and mean urine pH
were significantly higher following vaginal intercourse for participant ProFUM05 (Table 26). The
trend with pH, though it only applied to participant ProFUM05, may be relevant to data
presented in Chapter VI where I found that bacterial supernatants of urinary isolates found at
higher abundances following vaginal intercourse (i.e., Streptococcus) (Table 23) had higher pH
levels than supernatants of other urinary isolates (e.g., Lactobacillus).
All in all, clear associations exist between MSU microbiota variability and vaginal
intercourse. But these associations are complex and individualized, and it is likely that they
cannot fully be explained by the data that was collected in this study.
Hygiene and LUT Microbiota Variability
Participants were queried regarding hygiene practices on the lifestyle questionnaire. In
this section, I discuss data relating to bathing and showering. Data relating to feminine hygiene
product use is found in Chapter IV.
I hypothesized that bathing would alter the microbiota of the LUT possibly by physically
removing certain organisms or inhibiting others with the use of bathing products. In the pre-study
demographics questionnaire, participants reported a mean (SD) weekly number of showers as 6
(±1) and baths as 1 (±1) (Table 5). These statistics more or less agreed with the data reported in
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Table 27. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and
Peri-urethral Microbiota and Participant-reported Bathing.
Significance of Various Microbiota and Microbiome Measures
and Participant-reported Bathing
Participants

ProFUM01 (66)
ProFUM02 (30)
ProFUM03 (36)
ProFUM04 (47)
ProFUM05 (63)
ProFUM06 (16S) (54)
ProFUM07 (69)
ProFUM07 (16S) (69)
ProFUM08 (27)

Alpha-diversity Values
(MSU)

MSU

Peri-urethra

Shannon
Index

Simpson’s
Index

Bray-Curtis
Dissimilarity
between Paired
Specimens

0.746

0.031

0.776

0.985

0.119

0.510

0.839

0.047

0.067

0.316

0.482

0.097

0.017

0.083

0.363

0.365

0.342

0.428

0.851

0.217

0.949

0.706

0.272

0.362

0.418

0.266

-

0.231

0.172

-

N/A

N/A

N/A

N/A

N/A

N/A

-

N/A

N/A

-

0.027

0.189

0.536

0.503

0.627

JSD Values

(number of days
bathing reported)

Median JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or periurethral (if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an
association with participant-reported bathing. p-values are shown in the table. Mann-Whitney
U test was used to determine significance. p-value < 0.05 is significant (green). Cells in gray are
not applicable. N/A (Not applicable) refers to participants who always reported bathing.
the ProFUM study. However, the lifestyle questionnaire did not discriminate between showering
and bathing (i.e., either activity was reported broadly as “bathing”), nor did it discriminate
between number of bathing episodes per day. I also did not ask about time of day. The frequency
of reported daily bathing ranged from 40% (i.e., participant ProFUM08; 27/67 days) to 100% (i.e.,
participant ProFUM07; 69/69 days). Despite this broad range, data regarding microbiota
variability was generally not significantly associated to bathing frequencies (Table 27).
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Table 28. Significance of Reporting Bathing with Confounding Lifestyle Factors.

Probiotic/
Placebo (n)

Alcohol Use (n)

Menstruation
(n)

Tampon Use
(n)

Pad Use (n)

Vaginal Sex (n)

Oral Sex (n)

Illness (n)

# Bowel
Movements

Significance of Reporting Bathing with Confounding Lifestyle Factors

ProFUM01

0.403a
(40/40)

1.000a
(1/1)

1.000a
(15/15)

1.000a
(15/15)

1.000a
(14/14)

-

-

1.000a
(3/3)

1.000b

ProFUM02

0.715
(17/39)

0.498
(7/13)

0.442a
(2/7)

0.209a
(1/6)

0.455a
(1/1)

0.203a
(2/2)

0.455a
(1/1)

1.000a
(1/2)

0.268b

ProFUM03

0.074
(15/37)

-

0.945
(9/18)

-

0.945
(9/18)

-

-

0.705
(5/11)

0.506b

ProFUM04

0.371
(23/38)

0.293
(23/32)

0.047a
(11/12)

0.047a
(11/12)

-

0.749
(17/27)

-

-

0.147b

ProFUM05

1.000a
(32/34)

0.643a
(26/27)

1.000a
(3/3)

-

-

1.000a
(20/21)

1.000a
(4/4)

0.223a
(3/4)

0.239b

ProFUM06

0.748a
(31/39)

0.110a
(29/32)

0.334a
(7/7)

-

-

1.000a
(1/1)

1.000a
(2/2)

-

0.060b

ProFUM07

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

ProFUM08

0.800
(14/36)

0.339
(14/30)

0.850
(8/19)

0.211a
(4/6)

-

0.560a
(2/3)

0.560a
(2/3)

0.403a
(1/1)

0.047b

Frequency of participant-reported lifestyle factors was assessed for an association with
participant-reported bathing. p-values are shown in the table. Chi-square test used unless
otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as lifestyle
factors that were not reported by the corresponding participant. N/A (Not applicable) refers to
participants who always reported bathing. Significant p-values that are underlined represent
lifestyle factors reported at higher frequencies (or means) with bathing. Number of times each
lifestyle factor was co-reported with bathing out of total is indicated in parentheses in each cell.
Bathing reported: ProFUM01 (66/67 days), ProFUM02 (30/66 days), ProFUM03 (36/71 days),
ProFUM04 (47/72 days), ProFUM05 (63/67 days), ProFUM06 (54/66 days), ProFUM07 (69/69
days), ProFUM08 (27/67 days).
a: Fisher’s exact test
b: Wilcoxon rank sum test
I assessed for associations between bathing and MSU and peri-urethral microbiota
stability (i.e., JSD values), MSU microbiota alpha-diversity, and Bray-Curtis Dissimilarity between
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Figure 23. Principal Coordinate Analyses of MSU Microbiota of Select ProFUM Participants and
Relation to Bathing Habits. Analysis was done using MSU microbiota data collected from four
ProFUM participants: ProFUM02 (upper-left), ProFUM03 (upper-right), ProFUM04 (lower-left),
and ProFUM08 (lower-right). Graphs plot the 1st and 2nd principal coordinates of the data.
Percent of total variance explained by the principal coordinate is shown in the parentheses.
Closed circles indicate microbiota of days when no bathing was reported. Open circles indicate
bathing.
paired specimens. Overall, some participants had significant associations for some of these
statistical tests, but no general pattern was seen (Table 27). In an effort to explain these data, I
then asked whether other lifestyle factors were confounding the results. I found that
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Table 29. Summary of Randomization and Follow-up Survey Results.
Overview of Participant Randomization and Follow-up Survey Results
Participants
ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06
ProFUM07
ProFUM08

Cohort

# Pills Remaining

“Which cohort do you
think you were in?”

Probiotic
Placebo
Probiotic
Probiotic
Placebo
Probiotic
Probiotic
Placebo

0
20
7
0
6
4
4
2

Placebo
Probiotic
Placebo
Probiotic
Placebo
Probiotic
Placebo
Probiotic

Results for “which cohort do you think you were in?” listed in green indicate that the participant
was correct; results in red were incorrect. 3/8 participants correctly predicted the
randomization.
participant ProFUM04 had higher frequencies of reporting bathing during menstruation and
tampon use (Table 28), but this finding is not likely related to the MSU microbiota as this
participant showed no trends between bathing and MSU microbiota variability (Table 27).
Because the data were rather inconclusive, I then performed PCoA to broadly determine
if the MSU microbiota clustered by bathing habits. For participants ProFUM02, ProFUM03,
ProFUM04, and ProFUM08, all of whom had some significant associations described in Tables 27
& 28, there was no visual relationship between MSU microbiota and bathing (Figure 23).
Therefore, I concluded that bathing, as measured and defined in this study, was not related to
MSU microbiota variability.
Oral Probiotics and LUT Microbiota Variability
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Table 30. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and
Peri-urethral Microbiota and Probiotic or Placebo Use.
Significance of Various Microbiota and Microbiome Measures
and Probiotic or Placebo Use
Participants

ProFUM01
ProFUM02
ProFUM03
ProFUM04
ProFUM05
ProFUM06 (16S)
ProFUM07
ProFUM07 (16S)
ProFUM08

Alpha-diversity Values
(MSU)

MSU

Peri-urethra

Shannon
Index

Simpson’s
Index

Bray-Curtis
Dissimilarity
between Paired
Specimens

0.083

0.715

0.057

0.029

0.724

0.103

0.003

0.008

0.005

0.340

0.440

0.194

0.034

0.005

0.087

0.337

0.583

0.610

0.996

0.572

0.076

0.628

0.280

0.400

0.016

0.969

-

0.015

0.037

-

0.159

0.219

0.004

<0.001

0.122

0.335

-

0.029

0.089

-

0.906

0.360

0.878

0.615

0.055

JSD Values

Median JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or periurethral (if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an
association with probiotic use. p-values are shown in the table. Mann-Whitney U test was used
to determine significance. p-value < 0.05 is significant (green). Cells in gray are not applicable.
Participants in the probiotic cohort are in blue.
Participants were randomized in a 2:1 ratio to take an oral probiotic or placebo during
Days 21-60 (i.e. Phase II) of the study. Five participants were in the probiotic cohort, and three
were in the control/placebo cohort. All participants completed a short follow-up survey in which
they were asked how many pills remained after study completion (participants took two pills per
day for 40 days), and they were asked which cohort they thought they were in as a measure of
the effectiveness of the study blinding. These results are listed in Table 29. Overall the data show
high compliance with the given instructions and successful blinding of cohort placement.
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I hypothesized that oral Lactobacillus probiotic use would result in altered MSU
microbiota as a potential explanation for the link between probiotic use and decreased UTI risk158
, as described in Chapter I. I asked whether probiotic use was associated with microbiota
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stability and alpha-diversity values. The results showed several statistically significant trends
(most with alpha-diversity values), but the relation to probiotic use was not strong (Table 30). In
particular, several participants had increased (i.e., ProFUM06 and ProFUM07) or decreased (i.e.,
ProFUM01, ProFUM02, and ProFUM03) alpha-diversity values during Days 21-40, but there were
no general patterns between the cohorts (i.e., probiotic versus placebo).
Summary
The primary aim of the study reported in Chapter V was to determine if extrinsic lifestyle
factors relate to MSU microbiota variability. I found significant associations between microbial
instability and participant-reported sexual activity (Table 20). The associations were only
significant for the MSU microbiota/microbiome data, suggesting that sexual activity alters the
microbiota of the LUT but not peri-urethra (Figure 20). I found that the variability of the MSU
microbiota following sexual activity is complex and rather individualized. Some participants had
differences in median alpha-diversity values of MSU microbiota (Table 22), while others had
differences in microbiota composition, in particular an increase in the frequency and abundance
of Streptococcus and Staphylococcus species (Table 23 & Figure 22). Overall, the pattern of these
trends was very different from those seen in Chapter IV relating to menstruation. Therefore, it is
likely that the mechanisms underlying the variable MSU microbiota in response to menstruation
are separate from those relating to sexual activity.
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In an effort to understand the mechanism underlying the microbiota trends associated
with sexual activity, I first assessed for confounding factors. Unsurprisingly, I found that oral
intercourse was reported at significantly higher frequencies during vaginal intercourse for most
participants (Table 25). This finding makes it difficult to make conclusions regarding an individual
type of sexual activity. Interestingly though, participant ProFUM04, who only reported vaginal
intercourse (27/72 days), was one of the only participants who did not have significantly different
JSD values for the MSU microbiota following vaginal intercourse (Table 21). These data suggest
that the microbiota variability seen when broadly reporting sexual activity is more related to oral
intercourse. This conclusion is further supported by the fact that Streptococcus, one of the main
genera to appear at higher frequencies and abundances following sexual intercourse, are
commonly found as part of the oral flora273. However, if one considers the rest of the participants’
data, this conclusion does not withstand. For example, participant ProFUM05 reported sexual
activity 21/67 days; 17/21 days she reported vaginal intercourse only, while the other 4/21 days
she reported both vaginal and oral intercourse. Assessment of these four days alone shows no
significant association with MSU microbiota stability, while assessment of all 21 days does (Table
21). Similar findings are seen for other participants. Altogether, these data suggest that vaginal
intercourse, rather than oral intercourse, is associated with MSU microbiota variability, but the
inconsistencies in the trends suggest that other factors have a clear influence.
Besides oral intercourse, few lifestyle factors or urine properties and constituents were
significantly co-reported with vaginal intercourse, and none were consistent among participants
(Tables 25 & 26). Furthermore, condom use was reported 100% of the time when vaginal
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intercourse was reported in the three participants who were asked (i.e. ProFUM06, ProFUM07,
and ProFUM08) making it impossible to conclude how condom use contributes to the trends
between MSU microbiota variability and vaginal intercourse. A likely explanation for the
individualized-nature of the trends is sexual partner variability. However, these data were not
collected for every participant and timepoints are too few to allow for strong conclusions. I
explore this hypothesis further in Chapter VI by explicitly determining whether movement of
bacterial strains between sexual partners following vaginal intercourse occurs.
I also determined if hygiene practices related to MSU microbiota variability, specifically
frequency of showering and bathing. I observed no relationship between frequency of bathing
and microbiota characteristics (Table 27). This was confirmed using PCoA, which showed no
clustering of MSU microbiota based on bathing versus no bathing (Figure 23). I found no
relationship between frequency of bathing and peri-urethral microbiota variability (Table 27),
which was surprising considering that the peri-urethral environment would be directly affected
by this. Clearly, more information regarding bathing practices is necessary to understand these
data completely, and conclusions based on the findings alone should be cautioned.
Finally, I assessed for associations between probiotic use and MSU microbiota variability.
Although several significant trends were found for alpha-diversity values (Table 30), these trends
were not unique to the probiotic cohort, suggesting that the differences are unrelated to actual
use of the probiotic. Therefore, it seems that data relating oral probiotic use to decreased UTI
risk cannot be explained by changes to the microbiota of the LUT.
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CHAPTER VI
MECHANISTIC DETERMINATION AND SIGNIFICANCE OF LUT MICROBIOTA VARIABILITY AND
VAGINAL INTERCOURSE
Introduction and Rationale
In Chapter V, I described a significant trend between MSU microbiota variability and
participant-reported vaginal intercourse. Though most of the specifics of the microbiota
variability varied among participants, one consistent finding was an increase in frequency and/or
abundance of Streptococcus and Staphylococcus. In this chapter, I aim to determine the clinical
and biological significances of these data.
In regard to the clinical significance, I hypothesized that the MSU microbiota variability
following vaginal intercourse related to UTI risk. As described in Chapter I, vaginal intercourse is
a major risk factor for UTI in women179

180 181 182

. However, with some exceptions, it has been

shown that the UTI-causing pathogens (e.g., UPEC) are not introduced during intercourse.
Researchers have instead found other, mainly Gram-positive, non-pathogenic organisms in
female

urine

specimens

following

vaginal

intercourse

including

Corynebacterium,

Staphylococcus, and Streptococcus181 . These findings are consistent with the data from Chapter
V. Therefore, I wondered whether these findings were related to UTI risk. More specifically, I
hypothesized that Streptococcus and Staphylococcus that appear in high frequency and/or
abundance following vaginal intercourse are less inhibitory against UTI-causing pathogens in vitro
168
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than microorganisms of the normal LUT flora. I defined the normal LUT flora as the predominant
microorganisms present when vaginal intercourse and/or menstruation were not reported, as
these were the two lifestyle factors found to have the greatest association with MSU microbiota
variability. For all participants except ProFUM03, the normal LUT flora were dominated by
Lactobacillus; some participants also had high abundance of Gardnerella. Lactobacillus is
generally considered to be a health-associated genus. In the vagina, a variety of known probiotic
characteristics are associated with this genus, including the production of lactic acid and
hydrogen peroxide274, strong adhesion to epithelial cells275, ability to modulate the host immune
response276 277, and the production of bacteriocins and other antimicrobials278 279 280 281 282. These
characteristics not only apply to the vaginal environment, but also impact the LUT. Vaginal
Lactobacillus strains have been shown to be inhibitory towards UTI-causing pathogens283 284 285.
Recently, our group showed that Lactobacillus strains isolated from the urine and vagina are
phylogenetically similar57. Therefore, it is reasonable to hypothesize that urinary isolates of
Lactobacillus (i.e., the normal LUT flora) will have similar inhibitory activities against UTI-causing
pathogens as reported for vaginal isolates.
In regard to the biological significance, I hypothesized that the LUT microbiota variability
following vaginal intercourse originates from the male sexual partner. I designed a study in which
participant ProFUM05, and her male sexual partner, provided urine and genital specimens for
three additional weeks. I isolated multiple representative isolates of S. mitis and then performed
WGS and subsequent genomic analyses to determine the relatedness of the isolates. I
hypothesized that the S. mitis that appear in high abundance in MSU specimens of participant

170
ProFUM05 following vaginal intercourse are clonally related to S. mitis isolates isolated from her
male sexual partner.
In the first half of Chapter VI, I described a series of in vitro experiments to assess the
inhibitory properties of Streptococcus and Lactobacillus isolates against strains of UPEC.
Specifically, I used isolates of S. mitis and L. jensenii isolated from MSU specimens of participant
ProFUM05. In the second half of Chapter VI, I reported a follow-up study (i.e., PARTNER study)
to determine if S. mitis isolates that appear in high abundance in MSU specimens of participant
ProFUM05 following vaginal intercourse are clonally related to S. mitis isolates from her male
sexual partner. A list of strains used and isolated are found in Table 3.
Assessing the Clinical Significance of LUT Microbiota Variability Following Vaginal Intercourse
I hypothesized that S. mitis isolates that appear in high abundance in MSU specimens of
participant ProFUM05 following vaginal intercourse are less inhibitory against UTI-causing
pathogens in vitro than microorganisms of her normal LUT flora (e.g., L. jensenii). Positive findings
would suggest that the microbiota of the LUT following vaginal intercourse are less protective
against a UTI. I used isolates of S. mitis and L. jensenii isolated from MSU specimens of participant
ProFUM05 during the ProFUM study. I assessed the in vitro phenotypes of these isolates on two
previously characterized strains of UPEC: NU14 and UTI89.
Effect of Urinary Isolates on UPEC Adherence to Urothelial Cells
I first asked whether the urinary bacterial isolates (i.e., S. mitis and L. jensenii) affect the
ability of UPEC to adhere to urothelial cells. For a successful infection, UPEC must adhere to the
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Figure 24. Effect of Urinary Bacterial Supernatants on UPEC Adherence to Urothelial Cells.
UPEC (i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1,
pelleted, washed and resuspended in PBS. NU14 cells were pre-treated with supernatants from
an isolate of S. mitis (SM34) or L. jensenii (LJ35) at a 1:1 volume ratio for 1 hour. NU14 cells
were then pelleted, washed, and resuspended in DMEM/F-12 (approximately 108 CFU/mL
DMEM/F-12). 1mL of the NU14 cultures were added to microtiter plates containing urothelial
cell monolayers (approximately 104 cells/well) and incubated at 5% CO2 for 3 hours. Figure
depicts the amount of NU14 recovered from Triton-X-treated urothelial cell cultures following
the incubation. White bars indicate NU14 binding to empty wells (i.e., without urothelial cells);
black bars indicate binding to wells containing urothelial cell monolayers. Experiment was
performed in triplicate.
urothelial tissue of the bladder and form a biofilm to be protected from immune detection and
allow for dissemination. A non-malignant urothelial cell line (HURO23A) established by Dr. Phong
Le267 was used for these experiments. One strain of UPEC, NU14268, was grown in TSB overnight
in aerobic conditions. The cells were diluted to an OD600 of 0.1, pelleted, washed with PBS and
then resuspended in PBS. Cell free supernatants of S. mitis and L. jensenii were added to the
NU14 cells in a 1:1 ratio and left for 1 hour. Briefly, the S. mitis cells were grown in BHI broth at
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5% CO2 conditions for 48 hours. L. jensenii cells were grown in MRS broth at 5% CO2 conditions
for 48 hours. Cells from both cultures were pelleted and the supernatants were filtered using a
0.2-micron filter. In this experiment, I used one isolate of L. jensenii, LJ35 (isolated from an MSU
specimen collected by participant ProFUM05 on Day 35; no vaginal intercourse reported) and
one isolate of S. mitis, SM34 (isolated from an MSU specimen collected by participant ProFUM05
on Day 34; vaginal intercourse reported). After the incubation with the urinary isolate
supernatants, the NU14 cells were pelleted again, and resuspended in DMEM/F-12 (i.e.,
urothelial cell culture media). NU14 counts were approximately 108 CFU/mL DMEM/F-12. 1mL of
cultures were added to a 24 well plate containing approximately 104 urothelial cells per well. The
plates were incubated in 5% CO2 for 3 hours. The wells were then washed with PBS three times,
500µL of Triton-X was added to each well, and then the contents were plated on BAP media and
incubated aerobically for 24 hours to assess for NU14 CFUs.
Figure 24 shows the results of this experiment. I hypothesized that the L. jensenii
supernatants would have an inhibitory effect on UPEC urothelial adherence, while the S. mitis
supernatants would not. This finding would support the theory that the S. mitis increase in
abundance following vaginal intercourse relates to elevated UTI risk. In Figure 24, the white bars
(i.e., without urothelial cells) show the basal amount of NU14 binding to the plastic microtiter
plate, while the black bars (i.e., with urothelial cells) show binding in the presence of urothelial
cells. The data show no difference in adherence of NU14 alone (i.e., no pre-treatment) compared
to pre-treatment with either urinary isolate supernatant (Figure 24). These data show that the
bacterial supernatants did not affect the ability of UPEC to bind to urothelial cells in vitro.
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Effect of Urinary Isolates on UPEC Biofilm Formation
I next asked whether the urinary bacterial isolates affect the ability of UPEC to form a
biofilm in vitro. NU14, L. jensenii, and S. mitis cells were grown as previously described. An NU14
strain with a deletion in the fimH gene was used as a negative control (i.e., NU14∆fimH)270. The
FimH protein forms part of the fimbriae of E. coli that is used for surface attachment. Therefore,
the fimH mutant adheres poorly to surfaces and subsequently forms a less robust biofilm286. The
NU14 strains were grown in TSB overnight in aerobic conditions. The cells were diluted to an
OD600 of 0.1 and 100uL were plated into a 96 well microtiter plate. At various timepoints (0, 0.5,
1, 2, 4, and 6 hours) at or after addition of the NU14 strains, an equal volume (i.e., 100uL) of
urinary bacterial supernatants were added. Two isolates of L. jensenii, LJ35 and LJ70 (isolated
from an MSU specimen collected by participant ProFUM05 on Days 35 and 70, respectively; no
vaginal intercourse reported on either day) and two isolates of S. mitis, SM34 and SM69 (isolated
from an MSU specimen collected by participant ProFUM05 on Days 34 and 69, respectively;
vaginal intercourse reported on both days) were used. Plates were incubated aerobically for 24
hours total. NU14 biofilm formation was assessed using a standard crystal violet assay. Briefly,
wells were decanted and washed with PBS three times, 200uL of crystal violet stain was added
to each well and left for 10 minutes. The crystal violet stain was then decanted, and the plates
were left to dry for 30 minutes before adding 200 µL of 70% ethanol to each well. OD600
measurements were taken.
I hypothesized that the L. jensenii supernatants would have an inhibitory effect on UPEC
biofilm formation, while the S. mitis supernatants would not. Again, this finding would relate S.
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Figure 25. Effect of Urinary Bacterial Supernatants on UPEC Biofilm Formation in vitro. UPEC
(i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1 and 100µL
were plated into a 96 well microtiter plate. Plates were incubated at 5% CO2. An equal volume
of bacterial supernatants or media controls were added to each well at 0, 0.5, 1, 2, 4, and 6
hours after addition of the NU14. After 24 hours, biofilm formation was assessed using a
standard crystal violet assay. OD600 values were collected. An NU14 mutant lacking the fimH
gene (i.e. NU14∆fimH) was used as a negative control. Figures show the data for the 0-hour
addition only. Supernatants from two L. jensenii (i.e., LJ35 and LJ70) and two S. mitis (i.e., SM34
and SM69) isolates were used. (A) Depicts the OD600 values for WT NU14 over the ∆fimH mutant.
T-tests were used to determine significance of data compared to media control (i.e., MRS or
BHI). * p<0.05; ** p<0.01. (B) Depicts the OD600 values for the WT NU14 (black bars) and the
NU14∆fimH (white bars). Experiments were performed in triplicate.
mitis to increased UTI risk. Figure 25 shows the 0-hour timepoint data. Data for other timepoints
are not shown h ere but, in general, showed similar patterns. In Figure 25A, the y-axis shows the
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OD600 of the WT NU14 over the mutant (i.e., NU14∆fimH). In most conditions, the NU14 strain
had OD600 values that were twice t hose of the mutant, meaning twice as much biomass. The
exception was when the NU14 strains were grown in the presence of the L. jensenii supernatants
(i.e., LJ35 and LJ70), which gave OD600 values that were significantly different from the MRS media
control (Figure 25A). The S. mitis supernatants (i.e., SM34 and SM69) did not show the same
effect (Figure 25A). These data show that the L. jensenii isolates have inhibitory effects on NU14
biofilm formation in vitro, while the S. mitis isolates do not. Furthermore, the raw NU14∆fimH
OD600 data for the L. jensenii conditions were lower than other conditions (Figure 25B). These
data suggest that the L. jensenii supernatants are not affecting NU14 biofilm formation, but
rather NU14 growth in general because they are affecting NU14 irrespective of the presence of
fimH.
Effect of Urinary Isolates on UPEC Growth
To determine if the L. jensenii isolates affect UPEC growth, I tested the supernatants
inhibitory capacity on two UPEC strains: NU14 and UTI89269. UTI89 was grown similarly to NU14.
UPEC cells from overnight cultures were diluted to an OD600 of 0.1 and then added in a 1:1 volume
ratio with supernatants from six different S. mitis strains: SM34, SM43, SM54, SM65, SM68, and
SM69 (isolated from an MSU specimen collected by participant ProFUM05 on Days 34, 43, 54,
65, 68, and 69, respectively; vaginal intercourse reported on all days) and six different L. jensenii
strains: LJ35, LJ44, LJ55, LJ66, LJ69, and LJ70 (isolated from an MSU specimen collected by
participant ProFUM05 on Days 35, 44, 55, 66, 69, and 70, respectively; no vaginal intercourse
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Figure 26. Effect of Urinary Bacterial Supernatants on UPEC Growth. UPEC (i.e., NU14 or UTI89)
cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1. Supernatants from
bacterial isolates or media controls were added to UPEC cells in a 1:1 volume ratio. Two strains
of UPEC were used: NU14 (A and C) and UTI89 (B and D). OD600 measurements of UPEC growth
were taken at 0, 2, 4, 6, 8, and 24 hours (A and B). UPEC CFUs were measured at 0 (black bars)
and 24 (white bars) hours (C and D). Figures show data using one L. jensenii (LJ35) and one S.
mitis (SM34) isolate. Experiments were performed in triplicate. Supernatants from five
additional L. jensenii (i.e., LJ44, LJ55, LJ66, LJ69, and LJ70) and five S. mitis (SM43, SM54, SM65,
SM68, and SM69) isolates were also used. Data not shown.
reported on all days). The cultures were incubated aerobically for 24 hours and OD600
measurements were taken periodically. CFUs were measured at 0-hours and 24-hours.
I hypothesized that the L. jensenii supernatants would have an inhibitory effect on UPEC
growth, while the S. mitis supernatants would not, which can be related to UTI risk. Figure 26
shows the data for the SM34 and LJ35 supernatants. Similar results were seen for all other
isolates tested. In the presence of the L. jensenii supernatants, both UPEC strains showed no
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Figure 27. Effect of Diluted L. jensenii Supernatants on UPEC Growth. UPEC (i.e., NU14) cells
were grown overnight in TSB. Cells were diluted to an OD600 of 0.1. Supernatants from one L.
jensenii isolate (LJ35) were added undiluted or diluted with PBS in a 1:1 volume ratio with the
NU14. Bars depict log CFU/mL of NU14 growth on BAP at 0 hours (black bars) and 24 hours
(white bars) after incubation. Experiment was performed in triplicate.
additional growth, as measured by OD600, over 24 hours (Figure 26A & B). CFUs also remained
steady (Figure 26C & D). However, in the presence of the S. mitis supernatants, both UPEC strains
showed comparable growth to the BHI media control. The data were similar between both UPEC
strains: NU14 (Figure 26A) and UTI89 (Figure 26B). These data show that the supernatants of L.
jensenii are inhibitory towards UPEC growth, while supernatants of S. mitis are not. These
findings could be interpreted to reflect differences in UTI risk or susceptibility.
From these data, I can also conclude that the L. jensenii supernatants are bacteriostatic,
not bactericidal, meaning that they inhibit the growth of UPEC, but do not kill or lyse the cells. I
can make this conclusion primarily from the CFU data of Figure 26, which shows that while the
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CFUs of the UPEC strains did not increase over the 24 hours in the presence of the L. jensenii
supernatants, they did not decrease either. This suggests that the cells remained viable but were
not able to grow. This is supported by data from Figure 24, which showed that after 1 hour in the
presence of the L. jensenii supernatants, the number of viable NU14 cells (i.e., black bars) was
unaffected.
If the bacteriostatic activity is directly related to the L. jensenii supernatants, then I would
expect a dose-dependent effect when the supernatant is diluted, which is what I observed in
Figure 27. When I diluted the LJ35 supernatant with PBS and then added the mixtures in a 1:1
volume ratio with NU14 (OD600 = 0.01), I found that the bacteriostatic effects were only applicable
to the undiluted supernatants (Figure 27). The 1:1 dilution with PBS condition was not
bacteriostatic against NU14 suggesting that the inhibitory compound(s) of the L. jensenii
supernatant are at their minimum inhibitory concentration (MIC) in the undiluted supernatant.
In an effort to determine the mechanism underlying the inhibition of UPEC growth by the
L. jensenii supernatants, I first assessed for differences in the properties of the supernatants. I
found that the average pH of the supernatants of the six L. jensenii isolates used in the
experiment in Figure 26 was 5.1, while the supernatants of the six S. mitis isolates was 7.5. This
is potentially clinically relevant because I previously found a statistically significant trend between
urine pH and reporting vaginal intercourse for participant ProFUM05 (Table 26). On days when
vaginal intercourse was not reported, the average pH of the MSU specimens was 6.5. I found a
significantly higher (p=0.013) average pH of 7.5 on days when vaginal intercourse was reported.
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Figure 28. Effect of Addition of Catalase on Inhibition of UPEC Growth by L. jensenii
Supernatants. UPEC (i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an
OD600 of 0.1. Supernatants from one L. jensenii isolate (LJ35) were added in a 1:1 volume ratio
with the NU14. 0.5mg/mL of catalase were added to select cultures. MRS was used as a media
control for the LJ35 supernatant. Bars depict log CFU/mL of NU14 growth on BAP at 0 hours
(black bars) and 24 hours (white bars) after incubation. Experiment was performed in triplicate.
It has been well described in the literature that Lactobacillus species create acidic
environments through their production of lactic acid and hydrogen peroxide (H2O2)287

. To
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determine if these compounds contribute to the bacteriostatic effect, I assessed UPEC growth in
the presence of the L. jensenii supernatant with or without the addition of catalase288. I found
that this reversed the inhibitory phenotype of the supernatant (Figure 28). These data suggest
that H2O2 production by L. jensenii is involved in the bacteriostatic effects against UPEC.
To determine if H2O2 itself is causing the growth inhibition of UPEC, I first measured H2O2
levels produced by the L. jensenii strains. I also measured levels in the S. mitis
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Table 31. Measured Concentrations of H2O2 in Supernatants of Bacterial Isolates.
Bacterial Isolates

H2O2 Concentration (mM)

L. jensenii (LJ35)
L. jensenii (LJ70)

2.12 ± 0.25
2.39 ± 0.34

S. mitis (SM34)
S. mitis (SM69)

0.12 ± 0.11
0.18 ± 0.07

Supernatants from two L. jensenii (i.e., LJ35 and LJ70) and two S. mitis (i.e., SM34 and SM69)
isolates were assessed for their H2O2 concentration using a colorimetric assay. Supernatants
were diluted 1:10 in 100 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer. 100µL
were added to 100µL of 10mM 3,3′,5,5′-tetramethylbenzidine (TMB). 2µL of horseradish
peroxidase (1 mg/mL) were added. Reaction mixtures were incubated at 14°C for 10 min.
Absorbance readings were measured at 620nm. Measurements were compared to a standard
curve made using known concentrations of H2O2. Table shows mean H2O2 concentrations for
the bacterial supernatants. Experiment was done in triplicate.
supernatants as a control. To measure H2O2 levels, I used a colorimetric assay involving
horseradish peroxidase and tetramethylbenzidine (TMB), as previously described287. In the
presence of H2O2, the peroxidase will oxidize the TMB, which acts as a chromophore that is
measured by assessing absorbance at 620nm. By comparing the results of the bacterial
supernatants to standard concentrations of H2O2, I was able to estimate the quantity of H2O2 in
the supernatants. I found substantially higher concentrations of H2O2 in the supernatants of the
L. jensenii isolates compared to the S. mitis isolates (Table 31).
I then asked whether addition of similar concentrations of H2O2, as seen in Table 31 for L.
jensenii, result in the same bacteriostatic phenotype of UPEC. H2O2 concentrations similar to
those produced by S. mitis isolates (i.e., 0.15 mM) had no effect on NU14 growth, while
concentrations similar to those produced by L. jensenii isolates (i.e., 2 mM) had a bacteriostatic
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Figure 29. Effect of Addition of H2O2 on UPEC Growth. UPEC (i.e., NU14) cells were grown
overnight in TSB. Cells were diluted to an OD600 of 0.1. Varying concentrations of H2O2 were
added in a 1:1 volume ratio with the NU14. Bars depict log CFU/mL of NU14 growth on BAP at
0 hours (black bars) and 24 hours (white bars) after incubation. Experiment was performed in
triplicate. Data for TSB, LJ35 supernatant, and SM34 supernatant are shown for a comparison.
These data come from Figure 26C. ND=Not Detectable (i.e., <103 CFU/mL).
effect on NU14 comparable to that of the L. jensenii supernatants (Figure 29). These data,
together with the findings from Figure 28, strongly suggest that H2O2 production by L. jensenii
isolates is bacteriostatic to UPEC.
Assessing the Ability of Urinary Isolates to Adhere to Urothelial Cells
I hypothesized that the lack of an inhibitory phenotype against UPEC by S. mitis relates to
elevated UTI risk when S. mitis is found in high abundance in the LUT. The high abundance of S.
mitis in the LUT flora of participant ProFUM05 is transient, as is the heightened risk for UTI
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Figure 30. Bacterial Isolate Adherence to Urothelial Cells. Bacterial isolates of S. mitis (SM34)
and L. jensenii (LJ35) were grown for 48 hours in BHI or MRS broth, respectively. OD600
measures were around 0.8. This corresponded to approximately 5x107 CFU/mL of SM34 and
2x108 CFU/mL of LJ35. Cells were pelleted, washed, and resuspended in DMEM/F-12. 1mL of the
bacterial cultures were added to microtiter plates containing urothelial cell monolayers
(approximately 104 cells/well) and incubated at 5% CO2 for 3 hours. Figure depicts the number
of cells recovered from Triton-X-treated urothelial cell cultures following the incubation. White
bars indicate bacteria binding to empty wells (i.e., without urothelial cells); black bars indicate
binding to wells containing urothelial cell monolayers. Experiment was performed in triplicate.
following vaginal intercourse, according to literature136 179 180 181 182. This may suggest that the S.
mitis is ill-adapted to the LUT environment compared to L. jensenii.
To determine whether S. mitis isolates are not adapted to persist in the LUT environment,
I assessed whether the bacterial isolates could adhere to urothelial cells, in vitro. Using a similar
experimental design as used in Figure 24, I tested the adherence of LJ35 and SM34 to urothelial
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cells. I found that L. jensenii, but not S. mitis, could adhere to the urothelial monolayers (Figure
30). These data support my hypothesis that the S. mitis isolates are not adapted to persist in the
LUT environment.
Assessing the Biological Significance of LUT Microbiota Variability Following Vaginal
Intercourse
Significantly higher abundances of S. mitis are found in the MSU specimens of participant
ProFUM05 following vaginal intercourse (Figure 22). In the first part of this chapter, I showed
that these findings have clinical significance as they may relate to UTI risk due to the difference
in phenotypes against UPEC compared to L. jensenii isolates. In the second part of this chapter, I
will described experiments to determine the biological significance of these data by assessing the
mechanism by which the S. mitis abundance is increased following vaginal intercourse. I
hypothesize that the S. mitis cells are exogenously introduced during vaginal intercourse by the
male sexual partner. I designed a follow-up study to test this.
Overview of PARTNER Study
I enrolled one female participant and her male sexual partner in a follow-up study (i.e.,
PARTNER Study) to further investigate the effects of vaginal intercourse on the female MSU
microbiota. The female participant was previously enrolled in the ProFUM Study as participant
ProFUM05. As part of the study design (Figure 6), the male sexual partner of the female
participant (PARTNER01) was also enrolled in the study (PARNTER02), following consent. I
hypothesized that the S. mitis isolates that appear in the female MSU specimens in high
abundance following vaginal intercourse originate from her male sexual partner. To test this, I
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assessed for the presence of S. mitis in several specimen types collected from the male (i.e., MSU,
peri-urethral/meatal swab, penile swab, oral swab). I isolated and stored several representative
isolates of S. mitis identified from the specimens for genomic analyses.
Description of Microbiota Findings
Figure 31 shows the relative abundance of the microbiota, as assessed by modified EQUC,
over time for the two participants. The data are presented as stacked bar graphs, where each bar
represents a specimen on a given day; each color represents a unique bacterial taxon (i.e., genus),
and the relative amount of each color within each bar refers to the relative abundance of the
taxon found in the specimen. The x-axes are in chronological order. White bars refer to specimen
collection days in which the specimen was not collected, received, or stored. S. mitis CFUs are
depicted on the secondary y-axes. Figures 31A-D represent the longitudinal MSU, peri-urethral,
vaginal, and oral microbiota, respectively, for the female participant. Oral swabs were collected
once per week. Vaginal intercourse was reported on Days 2, 9, and 17. Condom use was not
reported on each instance. Lubricant use was also not reported. Oral intercourse was reported
on Day 9 only. Figures 31E-H represent the microbiota of MSU, peri-urethral/meatal, penile, and
oral specimens, respectively, for the male participant. The male participant’s specimens were
collected once per week (e.g., WK1) <30 minutes before intercourse (e.g., WK1-B) and <30
minutes after intercourse (e.g., WK1-A). The oral swabs were collected once per week. Figure 31I
shows the legend for each graph and describes the genus-color correspondence. Below is a
qualitative description of the data.
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A. PARTNER01 (MSU)

B. PARTNER01 (Peri-urethral Swab)

C. PARTNER01 (Vaginal Swab)

D. PARTNER01 (Oral Swab)
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E. PARTNER02 (MSU)

F. PARTNER02 (Peri-urethral/Meatal Swab)

G. PARTNER02 (Penile Swab)

H. PARTNER02 (Oral Swab)
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Figure 31. S. mitis Abundance and Microbiota Profiles of Specimens from PARTNER
Participants. Microbiota profiles are shown as stacked bar graphs depicting the relative
abundance (y-axes) of various genera over time in chronological order (x-axes) from various
specimens. Bars that appear ‘white’ refer to days where no specimen was collected, received,
or stored. A legend containing the most common genera is found in panel I. ‘Other’ refers to the
combined relative abundance for all taxa not included in the 20 most abundance taxa. Data were
generated using modified EQUC. S. mitis levels, if applicable, are shown on the secondary y-axes.
Participants were instructed to engage in vaginal intercourse only once per week. Vaginal
intercourse was reported on Days 2, 9, and 17 in reference to the previous evening. Oral
intercourse was reported on Day 9. Panels A, B, C, and D show data for participant PARTNER01
(i.e., female participant). Specimens for PARTNER01 were collected daily for 21 days, except oral
swabs which were collected once per week (i.e., Days 2, 8, and 15). Panels E, F, G, and H show
data for participant PARTNER02 (i.e., male participant). Specimens for PARTNER02 were
collected bi-weekly within 30 minutes of vaginal intercourse [before (e.g., WK1-B) and after
(e.g., WK1-A)], except oral swabs which were collected once per week before vaginal
intercourse.
Consistent with data from the ProFUM study, PARTNER01 (i.e., ProFUM05) had visual
trends in the microbiota associated with reporting of vaginal intercourse. Interestingly, these
trends, which were a significant increase in Streptococcus, applied to both the MSU (Figure 31A)
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Table 32. Association between JSD Values for Microbiota of PARTNER01 and Participantreported Vaginal Intercourse.
Vaginal Intercourse
Specimen Type
MSU
Peri-Urethral Swab
Vaginal Swab

Microbiota
(Median JSD Values)
“Yes” (n)

“No” (n)

p-value

0.155 (3)
0.252 (3)
0.067 (3)

0.130 (16)
0.165 (13)
0.068 (13)

0.109
0.296
1.000

Median JSD values shown for MSU, peri-urethral, and vaginal microbiota of participant
PARTNER01 on days when the participant reported (“Yes”) or did not report (“No”) vaginal
intercourse. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant
(green).
and vaginal (Figure 31B) microbiota. I did not observe an increase in Streptococcus following
vaginal intercourse in the peri-urethral microbiota (Figure 31B) which was consistent with the
findings from the ProFUM Study. However, the Streptococcus that appeared in the MSU and
vaginal microbiota were different species. S. mitis was consistently found in the MSU microbiota
(Figure 31A) in high abundances following vaginal intercourse but was only found once in the
vaginal microbiota (Figure 31C). I primarily found S. agalactiae, or Group B Streptococcus, in the
vaginal microbiota following vaginal intercourse. Fascinatingly, the S. mitis in the vaginal
microbiota was found in very high abundance but was not in a specimen following vaginal
intercourse. Instead, I found the S. mitis one day after vaginal intercourse was reported (i.e., Day
3). In contrast to the ProFUM study, I detected, although in very low abundance, S. mitis in the
peri-urethral microbiota on Days 2 and 9, both of which were after participant-reported vaginal
intercourse (Figure 31B). In the ProFUM study, S. mitis was detected in the peri-urethral
microbiota of participant ProFUM05 on three days (i.e., Days 13, 21, and 64), two of which were
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following vaginal intercourse (2/21 days). I also detected S. mitis in the oral swab of participant
PARTNER01 on all three days (Figure 31D). Furthermore, I measured JSD values for the MSU, periurethral, and vaginal microbiota of PARTNER01 and found a disruption in the stability of the MSU
microbiota following vaginal intercourse that approached statistical significance (i.e., p=0.109)
(Table 32). These data are consistent with the findings for participant ProFUM05 (Table 20) and
additionally show that the vaginal microbiota is unaffected.
I hypothesized that the male sexual partner (i.e., PARTNER02) was providing the source
of the S. mitis. However, I did not detect S. mitis in the MSU samples (Figure 31E) or genital swabs
(Figure 31F&G) in those specimens collected prior to vaginal intercourse (e.g., WK1-B). I detected
S. mitis in low abundance in the penile swab collected after intercourse during week 1 (Figure
31G). The exception was the oral swabs which had high levels of S. mitis each week (Figure 31H).
I detected other species of Streptococcus in the genital swab specimens (Figures 31G&H); these
species were primarily S. agalactiae. Whether the isolates of S. agalactiae were clonally related
to those isolates found in the vaginal swab of PARTNER01 (Figure 31C) are unclear from the data.
All in all, I can conclude from these data that the S. mitis species that appear in high
abundance in the MSU microbiota of participant PARTNER01 (i.e., ProFUM05) following vaginal
intercourse may originate (i.e., are clonally related to isolates) from the oral cavity of her male
sexual partner (i.e., PARTNER02).
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Measuring Clonal Relatedness of S. mitis Isolates
I collected a total of 54 isolates of S. mitis from the specimens of PARTNER01 and
PARTNER02 (Table 3). These isolates are from a variety of specimens throughout the study period
and, in several cases, include multiple isolates from a single specimen. Pure cultures of S. mitis
isolates were grown, genomic DNA was extracted, and all 54 genomes were sequenced, as

Figure 32. Dendrogram based on Average Nucleotide Identity of S. mitis Isolates. The genomes
of six isolates of S. mitis isolated on Day 17 were compared using ANI. Three isolates were from
the MSU specimen of PARTNER01 (red) and three isolates were from the oral swab specimen of
PARTNER02 (blue). Hierarchical clustering was performed in R studio. Figure depicts
dendrogram showing relatedness of isolates.
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described in Chapter II. Annotations and genome relatedness analyses are currently (May, 2019)
ongoing. However, early findings support my hypothesis. I measured the relatedness of the
genomes of S. mitis isolates isolated on Day 17 from MSU specimens of PARTNER01 and oral
swab specimens of PARTNER02. Figure 32 shows these data using hierarchical clustering based
on the ANI between the six isolates analyzed. The genomes of the three isolates isolated from
the MSU specimen of PARTNER01 on Day 17 (red) are highly similar to one another suggesting
that the S. mitis bacteria in these specimens represent one clonal population. This is in contrast
to the genomes of the three isolates isolated from the oral swab specimen of PARTNER02 (blue)
which are different from one another suggesting that there are at least three genomically distinct
populations of S. mitis in this specimen. Interestingly, one of these isolates, SM49, has a genome
that is highly similar to the genomes of the MSU-isolated isolates from PARTNER01. These data
show that some isolates of S. mitis found in the oral cavity of PARTNER02 are clonally related to
isolates found in the LUT of PARTNER01. Therefore, I have strong evidence to support my
hypothesis that the S. mitis is moving between sexual partners. However, these data alone are
not sufficient to describe the direction of this movement (i.e., male to female, or vice versa).
Summary
In Chapter VI, I sought to determine the clinical and biological significance of the trend
between MSU microbiota variability and participant-reported vaginal intercourse described in
Chapter V.
In regard to clinical significance, I hypothesized that the microbiota of the LUT facilitates
the literature-described relationship between vaginal intercourse and UTI risk179

180 181 182

. To
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assess this, I used bacterial isolates isolated from MSU specimens of participant ProFUM05.
These included S. mitis, which were found at higher abundance following vaginal intercourse, and
L. jensenii, which were found in the microbiota of the LUT regardless of lifestyle data. To assess
UTI risk in vitro, I measured various characteristics relating to UPEC pathogenesis in the presence
of either bacterial isolate (i.e., S. mitis or L. jensenii). I found that supernatants of L. jensenii
isolates were inhibitory towards UPEC biofilm formation, while supernatants of S. mitis isolates,
isolated from MSU specimens collected on days following vaginal intercourse, were not (Figure
25). Further assessment revealed that the L. jensenii supernatants were actually bacteriostatic
towards UPEC strains (i.e., NU14 and UTI89) (Figure 26). In an effort to understand the
mechanism underlying this clinically significant inhibition, I determined whether hydrogen
peroxide or lactic acid production by the L. jensenii isolates were involved. I found that addition
of catalase prevented the bacteriostatic phenotype (Figure 28) suggesting a role for hydrogen
peroxide. I measured hydrogen peroxide production in the supernatants of the L. jensenii and S.
mitis isolates and found significantly higher levels in the former (Table 31). I then assessed
whether these concentrations of hydrogen peroxide were sufficient to cause the bacteriostatic
phenotype against UPEC in the absence of the L. jensenii supernatants and found similar results
(Figure 29). In the context of the microbiota data, these findings show that the normal LUT flora
(i.e., L. jensenii) of participant ProFUM05 has inhibitory properties against UTI-causing pathogens
(i.e., UPEC) while the MSU microbiota that appear following vaginal intercourse (i.e., S. mitis)
does not. These data provide a novel explanation for the association between vaginal intercourse
and increased UTI risk; one which is mediated by the microbiota of the LUT.
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I also asked about the biological significance of the association between vaginal
intercourse and MSU microbiota variability. I hypothesized that S. mitis, which is found at
significantly higher abundance in MSU specimens following vaginal intercourse, are exogenously
introduced during vaginal intercourse by the male sexual partner. To test this, I designed a followup study in which ProFUM05 (i.e., PARTNER01) and her male sexual partner (i.e. PARTNER02)
provided additional specimens, allowing us to determine the relatedness of S. mitis isolates
between the participants. The additional specimen types also allowed us to explore the trend
with vaginal intercourse further. I found that median JSD values were different following vaginal
intercourse for the MSU microbiota (Table 32). Furthermore, with few exceptions, S. mitis
isolates were only identified in the female’s MSU specimens and the oral swab specimens of both
participants (Figure 31). I asked whether the MSU isolates of S. mitis were clonally related to S.
mitis isolates from the male’s oral swab. By comparing the isolates isolated from specimens on
Day 17, I found that the genome of one isolate (i.e., SM49) from the male’s oral swab prior to
vaginal intercourse was highly similar to the genomes of three isolates (i.e., SM45, SM46, and
SM47) from the female’s MSU specimen collected the morning after vaginal intercourse (Figure
32). These data show that the S. mitis is moving between sexual partners. Together with the in
vitro clinical findings, these data show that it may be possible to reduce UTI risk by some manner
of clinical interference to ensure maintenance of the female LUT flora and prevention of the
transfer of non-protective Streptococcus strains. Whether this would involve targeted
prophylactic antimicrobial treatments or simply using proper sexual protection, remains to be
determined.
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CHAPTER VII
DISCUSSION
Brief Summary
In this thesis, I used three clinical studies to (1) define the feasibility and methodology of
longitudinal urogenital specimens (i.e., MAGnUM Study), (2) characterize the temporal dynamics
of the microbiota of the LUT and their relation to lifestyle (i.e., ProFUM Study), and (3) determine
the biological mechanism for observed microbiota variability following reporting of one particular
lifestyle factor, vaginal intercourse (i.e., PARTNER Study). Through these studies, I identified a
novel method to collect and ensure quality of longitudinal urine specimens, provided the first
characterization of the temporal dynamics of the microbiota of the LUT in pre-menopausal
women, identified two potential causes of this microbiota variability (i.e., menstruation and
vaginal intercourse), identified a mechanism to explain the association between microbiota
variability and vaginal intercourse, and provided a novel hypothesis for the relationship between
vaginal intercourse and UTI risk.
Discussion of Chapter III
The primary aim of Chapter III was to determine if longitudinal urine specimen collection
in community women and men for microbiota research analyses was feasible. The data show
that both longitudinal urine and genital specimen collection in community participants is feasible.
Only two participants withdrew from this study and these participants cited personal reasons as
194
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the cause rather than complications or difficulties with the study. As this was the first effort to
obtain and analyze longitudinal urine specimens for research purposes by our research group at
Loyola University Chicago, the study design and clinical workflow will serve as a framework to
guide future projects.
A large part of assessing the feasibility was to identify a method and subsequently apply
that method to assess specimen collection accuracy. Literature suggests that the microorganisms
of the peri-urethral area and MSU are distinct73

. Therefore, I hypothesized that properly
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collected specimens would contain distinct or dissimilar microbiota. Using a Bray-Curtis
Dissimilarity test, I quantified the level of dissimilarity of the microbiota between paired
specimens of individual participants over time. I found that the median Bray-Curtis Dissimilarity
values of the microbiota of paired specimens for all seven female participants was above 0.8. I
then used this value as a threshold for determining whether a properly collected MSU specimen
was obtained (i.e., the microbiota of the MSU specimen was dissimilar from the microbiota of
the peri-urethral specimen). Bray-Curtis Dissimilarity values range from 0 to 1. Intuitively, it may
seem appropriate to choose 0.5 (i.e., the middle value) as a proper threshold. However, this may
not be biologically meaningful when applied to certain data. In this case, using 0.5 would not be
appropriate because the basal median level of dissimilarity between the microbiota of the two
specimen types in this particular participant population is well above 0.5. Therefore, an
improperly collected specimen may be considered acceptable if a threshold of 0.5 was used. It is
also important to consider that the level of dissimilarity of the microbiota between the specimen
types may naturally vary over time, possibly correlating with certain lifestyle factors. By
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measuring the median value over several time points, the impact of confounding factors is
lessened, and the conclusion that a threshold of 0.8 should be used is strengthened.
The importance of obtaining distinct MSU and peri-urethral specimens should not be
understated. A small number of studies have assessed the microbiota or microbiome of the
urinary and LUT environment using MSU specimens, but none have properly controlled for
specimen contamination and collection bias248 69 73 48 43 53 249. Without a proper understanding of
the quality of the MSU specimen, the microbiota data generated from these specimens lose all
interpretability. Therefore, my approach in this study (i.e., to quantify the differences in the
microbiota of paired specimens) is a novel and innovative method that ensures proper specimen
interpretability and should set the standard for future studies. Furthermore, collection of distinct
MSU specimens allows one to make conclusions unique to the LUT. Physiologically, the LUT is
very different from the peri-urethral area. Health and disease factors affect each site differently.
Thus, to properly study the effects of the microbiota on the health and disease of the LUT, it is
vital to specifically sample the microbiota of the LUT.
Few studies have directly compared the microbiota of male and female MSU specimens,
and none have done so longitudinally. The data highlight differences between the microbiota of
male and female MSU specimens. Male MSU specimens primarily contained species from the
genera Streptococcus, Staphylococcus, and Corynebacterium, as well as several species from
anaerobic genera, whereas female MSU specimens largely contained species from the genera
Lactobacillus and Gardnerella. The total abundance of bacteria also was quite different between
male and female MSU specimens, where males generally had 102-103 CFU/mL urine, while
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females generally had 104-106 CFU/mL urine. Although these data come from a small sample size,
the longitudinal aspect of this study shows that these findings are consistent within an individual
over time and thus not the result of random sampling. The dramatic differences between the
male and female data are likely reflective of fundamental differences in anatomy, where the
bladder urine of males is not readily exposed to other microbiologic niches; whereas in females
the bladder urine is exposed to other niches (e.g., vaginal microbiota, skin microbiota). Thus, it is
surprising that the microbiota of MSU and peri-urethral specimens were, in general, more distinct
(i.e., higher Bray-Curtis Dissimilarity values) in females than males. More research needs to be
done to confirm these findings, but preliminarily these data could suggest that male MSU
specimens sample the microbiota of the distal LUT rather than the bladder and thus more closely
resemble the peri-urethral microbiota, while female MSU specimens more distinctly sample the
microbiota of the LUT (if properly collected).
A secondary aim of Chapter III was to determine if short-term temporal dynamics of the
MSU microbiota exist, and to determine the effects of one lifestyle factor, alcohol consumption,
on the temporal dynamics. I found that daily variation in the MSU microbiota exists, but a level
of constancy is also maintained. Several participants had MSU specimens in which the microbiota
of a particular day did not resemble the microbiota of any of the other specimens collected during
the study. Whether there is a biological or clinical significance behind these abrupt changes is
unclear from these data alone. In general, these data are consistent with microbiota findings in
other body sites. There is typically a baseline level of stability to the microbiota, but the bacterial
populations are subject to change. These changes are usually brief and not maintained, meaning
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that the populations readily return to a baseline state. Though I sampled a relatively short period
of time, the data seem to follow a similar trend, which is not surprising. The human microbiota
co-evolved with us and have thus adapted to each niche of our bodies2. For each niche, the
microbiota that reside there are essentially in their optimal growth environment. While other
microorganisms can colonize that niche, the resident microbiota are better adapted to the
environment and ultimately will regain dominance over time, unless the environment itself is
changing. Therefore, the temporary changes I observed in the MSU microbiota may be due to
the introduction and subsequent decline of exogenous microorganisms, or due to a temporary
change in the bladder or LUT environment that allows for differentially adapted microorganisms
to thrive.
From a research perspective, these data show that single timepoint sampling of the MSU
microbiota may not be reflective of the average state. This is an important conclusion because
most research on the microbiota and microbiome of the bladder and LUT have been performed
using single timepoint specimens. With larger sample sizes, the influence of this bias is less
relevant, but for studies with smaller sample sizes, we must now interpret their conclusions with
caution. As shown in later experiments, some lifestyle factors correlate to days with
unrepresentative MSU microbiota. Therefore, it may be possible to use questionnaires about
lifestyle as a screening tool to determine whether the MSU specimen should be excluded from
analyses. Even more broadly, it may be relevant to screen patient urine specimens with a similar
type of approach prior to urinalysis and culture in a clinical setting. The extent to which lifestyle
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can alter the clinical, rather than research interpretability of MSU specimens is unclear from
these data but is an important future direction to consider.
Discussion of Chapter IV
One of the aims of Chapter IV was to measure the long-term temporal dynamics of the
microbiota of the LUT in pre-menopausal non-symptomatic community women. To properly
assess the long-term dynamics, I first had to apply my findings from Chapter III and measure MSU
specimen accuracy. Due to the high cost and time necessary to measure the microbiota of daily
specimens over approximately three months, ensuring that the specimens were obtained
properly was essential. I measured specimen collection compliance by using a pre-study
Screening Phase. During the Screening Phase, eligible participants collected MSU and periurethral specimens, as instructed by video and verbal explanation from the clinical team, for
three consecutive days. Of the 12 participants screened, I excluded four based on the use of BrayCurtis Dissimilarity between microbiota of paired specimens. The four excluded participants
failed to provide specimens with Bray-Curtis Dissimilarity values above 0.8 for at least two of the
three days of specimen collection. While this approach ultimately provided us with quality
specimens (i.e., distinct MSU and peri-urethral microbiota) in the primary study (Table 6), it may
have biased the participant population. Though literature suggests that the microorganisms of
the peri-urethra and MSU are distinct73 246 247, rigorous and properly controlled studies assessing
this distinction have yet to be performed. Therefore, excluding participants based on lack of
distinct microbiota between paired specimens may not actually relate to specimen collection
compliance. It is possible that some pre-menopausal women naturally have significant overlap in
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the microbiota of properly collected peri-urethral and MSU specimens. To further complicate this
issue, data from Chapter IV show that Bray-Curtis Dissimilarity values between microbiota of
paired specimens are associated with lifestyle factors in some participants. Menstruation was the
only lifestyle factor I assessed that showed significant trends with Bray-Curtis Dissimilarity values
of microbiota of paired specimens. Though these values are usually higher (i.e., more dissimilar)
during menstruation, this is not always the case (Table 11). Participants in the Screening Phase
completed the daily lifestyle questionnaire each day. Two participants (SCREEN09 and SCREEN12)
reported menstruation and feminine hygiene product use on all three and two of the three days,
respectively. Despite this, only one of the two participants was excluded from the final study (i.e.,
SCREEN09). Though a sample size of two participants is small, these data suggest that reporting
of menstruation did not affect the screening criteria. Nonetheless, whether exclusion of
participants based on the criteria is biologically appropriate or not, use of a specific standard
measure allowed us to make stronger comparisons and conclusions from the data that I collected
on the microbiota from the final study population of participants. Furthermore, the criteria allows
us to make statements regarding microbiota stability and change that exclusively relate to the
LUT rather than the peri-urethral environment.
Using JSD, a common approach to measure longitudinal stability, I found that the periurethral microbiota were more unstable than the microbiota of the MSU specimens. The median
JSD values for all seven applicable participants were higher for the peri-urethral microbiota
compared to the MSU microbiota, indicating greater instability over time (Figure 17). Biologically,
these findings mean that the peri-urethral microbiota have greater daily variability than the MSU
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microbiota. Physiologically, this is not surprising, as the peri-urethral area is exposed to the
genital and external environment, while voided urine and the LUT are not. Therefore,
introduction and movement of flora may occur more frequently in the peri-urethra than the LUT.
Vaginal swabs were not collected from the participants in this study, so I cannot conclude
whether bacterial interplay between the peri-urethra and vaginal tract occurred. The participants
collected combination perineal and vaginal swabs once per week, but this was not frequent
enough to make conclusions about temporal dynamics and bacterial interplay. As this is the first
study to assess the peri-urethral microbiota temporal dynamics, I cannot compare these findings
to others. It is also possible that the instability of the peri-urethral microbiota relate to specimen
collection variability. Participants were instructed verbally and visually to collect the peri-urethral
specimen by swabbing 1 cm around the urethral opening. Without clinical supervision, it is
impossible to know whether variability resulted from the collection method used by the
participants. The rigor of the force used on the swab, the number of rotations of the swab, and
the area of swabbing could all affect the sampled microbiota, none of which are applicable to the
collection of an MSU specimen. These variabilities of collection were no doubt different between
individuals, but they may also apply to the same individual over time. However, one would expect
that with repeated collection over three months, the personal technique used to collect the periurethral specimen would become more standard and consistent by the participant. Therefore, if
specimen collection variability relates to JSD values and microbiota instability, one would expect
the JSD values to become lower (i.e., more stable) throughout the study. Qualitatively, this did
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not occur (e.g., Figure 19). This suggests that the daily variability of the peri-urethral microbiota
is biologically meaningful and not likely due to collection inconsistencies.
Modified EQUC was the primary method used to identify and characterize the microbiota
in this study. However, 16S rRNA gene sequencing was used on the MSU specimens of
participants ProFUM06 and ProFUM07. ProFUM07 was unique because both methods, culture
and sequencing, were used to characterize the MSU microbiota over time. The microbiota
profiles of the culture and sequencing results are shown in Figures 16G & H, respectively.
Qualitatively, the microbiota and microbiome were dominated by Lactobacillus (blue) except for
three, one to two-week periods during the beginning (i.e., week 1), middle (i.e., weeks 3 and 4),
and end (i.e., weeks 7 and 8). During these non-Lactobacillus-dominant periods, the two
identification methods conflicted slightly; modified EQUC showed increases in relative
abundance of Staphylococcus (light blue), and Actinomyces (brown) (Figure 16G), while 16S rRNA
gene sequencing showed increases in Prevotella (dark green), Dialister (bright blue), and
Anaerococcus (bright red) (Figure 16H). These data are not surprising because we have previously
seen that detection of obligate anaerobes by EQUC is significantly lower than 16S rRNA gene
sequencing. Both methods showed increases in relative abundance of Streptococcus (green) and
Corynebacterium (orange). Nonetheless, a deviation from Lactobacillus dominance occurred for
the exact same specimens by both methods. Appropriately, JSD values were elevated for both
methods during these periods. In fact, JSD values for the two methods followed an almost
identical pattern over time (Figure 18). These data show that the two methods are
complementary and validate the use of only one method to analyze the specimens of the other
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seven participants. Despite the differences in composition, the two methods were consistent in
their assessment of bacterial stability over time. Therefore, in future studies assessing MSU
microbiota dynamics, it seems reasonable that either method can be used to make conclusions
regarding stability.
The other aim of Chapter IV was to determine if intrinsic lifestyle factors relate to MSU
microbiota dynamics. I found significant associations between microbial instability and
participant-reported menstruation (Table 7). The associations were only significant for the MSU
microbiota/microbiome data, suggesting that menstruation alters the microbiota of the LUT but
not peri-urethra. Menstruation also alters the vaginal microbiota, as described by multiple
research groups188 189 190 191. Therefore, the findings were surprising because the peri-urethral area
is anatomically closer to the vaginal tract than is the LUT. Nonetheless, I observed trends in the
microbiota of the LUT similar to what has been described in the vaginal microbiota during
menstruation. The trends showed clear variability (i.e., JSD values), but were highly
individualized. Median alpha-diversity values were significantly higher during menstruation
(Table 8) for all participants who had significantly different MSU microbiota JSD values during
menstruation (Table 7). Furthermore, compositional differences existed during menstruation,
where higher frequencies and abundances of mainly Corynebacterium, Staphylococcus, and
Actinomyces were found in the MSU specimens of most participants (Table 9 and Figure 20).
Overall, I found that the microbiota of the LUT are more diverse and compositionally distinct
during menstruation, but these trends differ slightly among participants.
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It is difficult to determine the mechanistic relationship between menstruation and MSU
microbiota variability. The microorganisms found at higher frequencies and abundances during
menstruation (e.g., Corynebacterium, Staphylococcus, Actinomyces) are primarily skin flora2. It is
possible that these bacteria are introduced exogenously into the LUT during menstruation,
perhaps via the use of feminine hygiene products. Tampon and pad use were reported at
significantly higher frequencies during menstruation for all participants (Table 12). Whether use
of these products alone is sufficient to induce MSU microbiota changes is unclear from the data.
However, if the bacteria were introduced by the hygiene product, one would expect similar
microbiologic changes to the peri-urethral area, as it is more readily exposed, but I observed no
change in peri-urethral microbiota stability with menstruation, or hygiene product use.
Furthermore, only a few participants had significant differences in the median Bray-Curtis
Dissimilarity values between microbiota of paired specimens during menstruation (Table 11), and
most of those participants had significantly higher dissimilarity during menstruation, whereas I
would expect the opposite result. Thus, the data do not support a model in which the use of
feminine hygiene products during menstruation results in the observed MSU microbiota
variability during these times. An alternative explanation is that the LUT environment changes
during menstruation, thus allowing for colonization and/or growth of different microorganisms.
However, there were no significant changes in the frequency of positive urine property and
constituent results during menstruation, except for blood (Table 14). The blood is likely a
contaminant from the vaginal tract and thus not directly relevant to the LUT environment. I also
determined that other reported lifestyle factors did not confound the data. Besides feminine
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hygiene product use only reported number of bowel movements was found to have a significant
association with menstruation, where three participants had significantly higher numbers of daily
bowel movements during menstruation (Table 12). However, when I assessed for associations
between number of bowel movements and microbiota characteristics, I found no significant
trends, suggesting that this was not confounding the trends seen with menstruation. All in all,
these data do not point to a clear mechanism to explain the association between menstruation
and MSU microbiota variability. It is possible that other urine properties, not measured by the
urine dipstick, were altered during menstruation to allow for microbiota alterations. For example,
in pre-menopausal women, hormones associated with the menstrual cycle remain at low levels
during menses followed by a spike in some during ovulation and an increase in others during the
subsequent luteal phase. One of these cyclical hormones, estrogen, can have a profound effect
on the LUT. Estrogen receptors are found throughout the LUT and researchers have found
correlations between elevated estrogen levels and urodynamic variables and LUTS289. As a result,
it is common for women to experience greater frequency of urination during menses. This
increased urinary frequency could affect the microbiota of the LUT, where planktonic cells are
more likely to be expelled from the bladder, while tissue-attached cells remain behind. If
competition normally exists between these two bacterial cell types, the increased urination
frequency would give a selective growth advantage to tissue-attached cells. This could explain
the greater abundance of certain organisms seen during menstruation. Though it is not
uncommon for Gram-positive bacteria, like those seen in elevated frequencies during
menstruation (e.g., Corynebacterium, Staphylococcus, Actinomyces), to have molecular
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mechanisms to promote surface attachment (e.g., pili, fimbriae), the strain variability is too high
to make generalized conclusions regarding these particular urinary species. Furthermore, I did
not query the participants regarding urination frequency. Therefore, this remains a likely
mechanistic explanation for the findings, but the data are not sufficient to support or refute it.
Though the finding that positive blood results on the urine dipstick relate to menstruation
is not likely relevant to the LUT environment, it serves as an important positive control. All
lifestyle factors reported in this study are self-documented by the participant and, as such, are
not validated by a clinical or research professional. Furthermore, there is no incentive to answer
the questionnaire honestly. Menstruation serves as the only recorded lifestyle factor that can be
validated, although indirectly, in a research setting. Six of the eight participants had statistically
significant correlations between reporting menstruation and positive blood results on the urine
dipstick (Table 14). These data suggest that the participants are reporting menstruation
appropriately and provide a level of confidence that the remaining questionnaire was completed
honestly. Of the two participants without statistical significance, participant ProFUM05 only
reported menstruation on three total days. Participant ProFUM04 reported menstruation on 12
total days, and although a positive blood result did not always co-occur with these days, a closer
look at the data show that all positive blood results occurred within 5 days (before or after) of
reported menstruation.
The finding presented above represents an important caveat to the analyses. In this
thesis, I have limited the approach to assessing the relationship between lifestyle factors and the
microbiota of the subsequent day. It is difficult to discern whether it would be biologically
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appropriate to expand the analyses beyond just the following day’s microbiota. It is possible that
some lifestyle factors take longer than one day to show significant impacts on the microbiota. To
my knowledge, research has shown that for other body sites, lifestyle factors usually have an
immediate impact on the microbiota. Whether this can be broadly applied to the LUT remains to
be seen. The correlations between lifestyle factors and UTI risk for example, were studied across
weeks, months, and even years, and thus do not provide relevant information regarding the
timeliness of their effects. Though I did not assess this here, the dataset represents a novel means
to determine this relationship and is an important future direction to consider.
In this chapter, I also determined if urine properties and constituents relate to MSU
microbiota dynamics. I used a semi-quantitative urine dipstick test to measure 10 clinically
important urine characteristics, most of which are applicable to disease diagnosis but
nonetheless act to describe the urinary microenvironment. By assessing these characteristics on
a daily basis, I was able to observe novel variabilities in the data. To my knowledge, no one has
described urine dipstick test result variabilities over time in healthy people. The results, an
example of which is shown in Table 15, are highly variable from day-to-day. These findings call
into question the validity of this test for disease diagnosis, as it is possible that false-positive
results could be part of the normal temporal variability in the urine. Interestingly, this variability
in urine characteristics did not relate to microbiota variability. I determined that, in general, no
relationship existed between urine properties and constituents and MSU or peri-urethral
microbiota stability (Table 16 and Table 18A), or MSU microbiota alpha-diversity values (Table
17 and Table 18B). The exception was blood, which showed a similar pattern of trends as was
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seen with menstruation. Because these two factors co-occur (Table 14), these results are not
surprising. The finding that urine properties and constituents do not relate to MSU microbiota
variability is noteworthy because it shows that potential mechanisms underlying trends with
lifestyle factors (e.g., menstruation) likely do not involve alterations to the urinary environment.
Discussion of Chapter V
The primary aim of Chapter V was to determine if extrinsic lifestyle factors relate to MSU
microbiota dynamics. I found significant associations between microbial instability and
participant-reported sexual activity (Table 20). Sexual activity was reported by six of the eight
participants. The associations were only significant for the MSU microbiota/microbiome data,
suggesting that sexual activity alters the microbiota of the LUT but not the peri-urethra.
Compared to menstruation, the other lifestyle factor to show trends with the MSU microbiota,
the data for sexual activity were more complicated. During menstruation, the MSU microbiota
had higher instability, were more diverse, and several taxa appeared more frequently in the
specimens, whereas these trends were more variable among participants for sexual activity. For
sexual activity, some participants only showed significantly altered microbiota stability for
particular types (e.g., vaginal intercourse), some were actually more stable during sexual activity
(e.g., ProFUM07 in Table 21), and some participants had significantly different alpha-diversity
values (Table 22), whereas a separate group of participants had significantly different mean total
bacterial abundances (Table 24). The only consistent finding among the participants was an
elevated frequency and abundance of Streptococcus and Staphylococcus species following
vaginal intercourse. Interestingly, this one consistency was the one trend that did not necessarily
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apply to the menstruation data from Chapter IV, where the type of altered taxa varied among
the participants. Nonetheless, it is clear from these comparisons that the mechanisms underlying
the altered MSU microbiota in response to menstruation are separate from those relating to
sexual activity.
Participants who responded “yes” to the question relating to sexual activity were then
asked if they engaged in penetrative vaginal intercourse, received oral intercourse, or engaged
in another (i.e., “other”) form of sexual activity (e.g., masturbation, anal intercourse). The
lifestyle questionnaire prompted a written explanation if “other” was chosen. On the lifestyle
questionnaire, the “sexual activity: other” category was not proceeded by examples of inclusive
activities and is therefore possible that it was interpreted differently among the participants.
Most participants, with the exception of ProFUM07, did not report “other” forms of sexual
activity. Participant ProFUM07 reported masturbation on all 15 days she reported sexual activity.
Initial assessments of microbiota stability and sexual activity showed no significance for
participant ProFUM07 (Table 20). Only when I separated the data for vaginal intercourse (4/15)
did I find significance (Table 21). These data suggest that masturbation did not affect MSU
microbiota stability, although the sample size is only one participant. Of the remaining types of
sexual activity recorded, all applicable participants, except for participant ProFUM04 who did not
report oral intercourse, significantly co-reported vaginal and oral intercourse (Table 25). This
finding makes it difficult to make conclusions regarding an individual type of sexual activity.
Interestingly though, participant ProFUM04 who only reported vaginal intercourse (27/72 days),
did not have significantly different JSD values for either MSU or peri-urethral microbiota (Table
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21), suggesting that the microbiota variability seen when broadly reporting sexual activity might
be more related to oral intercourse. This conclusion is further supported by the fact that species
of Streptococcus, one of the main genera to appear at higher frequencies and abundances
following sexual intercourse, are commonly found as part of the oral flora273. However, if one
considers the rest of the participants’ data, this conclusion does not hold up. For example,
participant ProFUM05 reported sexual activity 21/67 days; 17/21 days she reported vaginal
intercourse only, while the other 4/21 days she reported both vaginal and oral intercourse.
Assessment of these four days alone shows no significant association with MSU microbiota
stability, while assessment of all 21 days does (Table 21). Furthermore, participant ProFUM07
reported sexual activity 6/69 days; 2/6 days she reported only vaginal intercourse, 2/6 only oral
intercourse, and 2/6 both. Again, only an assessment of days including vaginal intercourse (4/6)
showed significant associations with MSU microbiota stability (Table 21). The microbiota of the
MSU specimens collected on the two days that she reported only oral intercourse (i.e., Days 11
and 18) contained only L. jensenii. Altogether, these data suggest that vaginal intercourse, rather
than oral intercourse, are associated with MSU microbiota variability, but other factors clearly
influence the trend.
From the data alone, it is difficult to determine what other factors influence the trend
between vaginal intercourse and the variability of the microbiota of the LUT. I sought to
determine this by asking which lifestyle factors and urine properties co-occurred with vaginal
intercourse. Besides oral intercourse, which was reported significantly more frequently during
vaginal intercourse for all participants, except ProFUM04 who did not report oral intercourse
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(Table 25), few factors showed significant trends, and none were consistent among participants
(Tables 25 & 26). Follow-up work revealed that at least one of these significant trends may be
biologically meaningful. The significantly higher mean pH of the MSU specimens of participant
ProFUM05 following vaginal intercourse likely relate to data shown in Chapter VI. The in vitro pH
of culture supernatants of S. mitis strains isolated from the MSU specimens of participant
ProFUM05 have higher pH levels than those of L. jensenii isolates. This could relate to vaginal
intercourse because S. mitis was detected at higher abundances (p=0.018) following vaginal
intercourse. Interestingly, I did not find higher frequencies of detection of S. mitis. These data
suggest that the act of vaginal intercourse causes increased abundance of S. mitis, which
subsequently decrease, but remain present, over time. One possible explanation for this is that
the environment of the LUT changes following vaginal intercourse. However, aside from pH,
which seems to be a result of the bacteria and not the cause of its increase, the only other urine
property for participant ProFUM05 found to be significantly more positive following vaginal
intercourse was bilirubin (Table 26). Bilirubin in the urine relates to liver function and has not
been linked to UTI risk. Another possibility for the increased abundance, but not frequency, of S.
mitis is that it is physically introduced during vaginal intercourse. Though basal levels of S. mitis
exist in the LUT, the abundance could increase following the exogenous introduction of more
bacterial cells. The levels of S. mitis then appear to decrease in the LUT, either because it is not
adapted to the environment or it is being actively inhibited in some way. This is the case until the
next incidence of vaginal intercourse when more cells are introduced, and levels increase again.
However, if the S. mitis are introduced during vaginal intercourse, one would expect to see it
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appear in the peri-urethra as well. S. mitis was only identified in the peri-urethral specimens of
participant ProFUM05 on three days (i.e., Days 13, 21, and 64); vaginal intercourse was reported
(i.e., the day before) for two of those days. It is possible that in the time between vaginal
intercourse and collection of specimens the following morning, S. mitis cells in the peri-urethral
area were disrupted in some way. Anatomically, this makes logical sense as the peri-urethra is
more subject to environmental influence than the LUT. Bathing could be an explanation, but as I
showed later in Chapter V, frequency of bathing did not relate to peri-urethral microbiota
instability (Table 27). Furthermore, bathing was reported on both days (i.e., Days 13 and 64)
when S. mitis appeared in the peri-urethral specimens of participant ProFUM05 following vaginal
intercourse. It is possible that the timing of the bathing is relevant, as are other factors such as
urination frequency and factors relating directly to the vaginal intercourse. These are explored in
Chapter VI as part of the PARTNER study. Unfortunately, for participant ProFUM05 in the ProFUM
study, I did not collect information relating to condom use or new sexual partners; this
information may have provided crucial details to explain the S. mitis trends observed.
In the three participants who were asked (i.e., ProFUM06, ProFUM07, and ProFUM08),
condom use was reported 100% of the time when vaginal intercourse was reported. Therefore,
it is impossible from these data alone to make a conclusion regarding the influence of condom
use on the relationship between MSU microbiota variability and vaginal intercourse. Sexual
partner variability was different among the applicable participants. Whereas participant
ProFUM07 reported the same male sexual partner for each instance of vaginal intercourse (N=4),
participant ProFUM08 reported different male partners (N=3). Qualitatively, one could
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tentatively conclude from the raw data that the pattern of Streptococcus species that appear
following vaginal intercourse are more consistent for participant ProFUM07 than participant
ProFUM08, thus suggesting a role by the sexual partner, but the timepoints are too few, and
there are other confounding factors (e.g., oral intercourse) that interfere with my ability to make
strong conclusions. To conclusively show a role for the male sexual partner in the MSU microbiota
variability of the female, it would be necessary to show movement of genomically related isolates
between the partners following vaginal intercourse. I attempted this in the PARTNER study of
Chapter VI. These data and their implications on a potential mechanism to explain the association
between vaginal intercourse and MSU microbiota variability are discussed in the section below.
Interestingly, the findings on the variability of the MSU microbiota following vaginal
intercourse are quite different from data on the vaginal microbiota. Using only 16S rRNA gene
sequencing, researchers have found that disruptions to the stability of the vaginal microbiome
occur with vaginal intercourse188. The changes to the vaginal microbiome are consistently shown
to be an increase in Gardnerella188 290 291 292 and this is sometimes accompanied by a decrease in
Lactobacillus, particularly L. iners290 and L. crispatus292. These changes are not seen when condom
use is reported290 . The current theory of the mechanism behind these changes is that the altered
microbiome comes from the male ejaculate. The microbiome of semen has been very recently
characterized and found to contain low but detectable abundances of bacteria, many of which
are part of the vaginal microbiome (e.g., Lactobacillus, Veillonella, Streptococcus,
Porphyromonas, Atopobium), including Gardnerella292. The alpha-diversity of the semen
microbiome is higher than the vaginal microbiome292. Mandar et al. recently showed that in 23
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heterosexual couples, the semen microbiome, collected several days prior to intercourse, was
more similar to the partner’s vaginal microbiome after vaginal intercourse292. However, they did
not analyze the data further using metagenomics or WGS of cultured strains to verify the clonal
relatedness of taxa found between the male and female specimens. Nonetheless, when
comparing these data to the findings in the LUT, several differences are seen. I did not observe
increases in Gardnerella in the MSU specimens following vaginal intercourse, even by 16S rRNA
gene sequencing. The trends I found were with Streptococcus and Staphylococcus. Streptococcus
is a predominant taxon in the semen microbiome; Staphylococcus is present but not as often292.
However, I observed these trends even when condom use was reported (e.g., ProFUM07 and
ProFUM08) and therefore the bacteria are not likely from the male ejaculate. I also generally did
not observe a decrease in abundance of Lactobacillus following vaginal intercourse. Overall, the
only comparable finding is that both the vaginal and MSU microbiota have decreased stability
following vaginal intercourse, but the mechanisms underlying these changes may be very
different, which is surprising considering the anatomical proximity.
Another lifestyle factor that I assessed in Chapter V was hygiene – specifically bathing. As
this was largely an exploratory study, I defined bathing rather broadly and without additional
details. The lifestyle questionnaire did not discriminate between showering and bathing. In
hindsight, this may have biased the data, as bathing (e.g., tub bath) but not showering has been
shown to relate to UTI risk131. This was possibly reflected in the results, which showed somewhat
inconsistent trends among participants (Table 27). It is possible that the type of bathing, number
of bathing times per day, and time of day may have influenced the association between bathing
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and the MSU microbiota. Time of day would be most relevant. Bathing in the morning prior to
specimen collection could result in vastly different specimens than those collected from someone
who only bathed the night before. For example, if bathing and particularly soap use act to inhibit
bacterial growth, then one would expect specimens collected immediately after use to have
lower biomass and lower overall alpha-diversity of the microbiota. Nonetheless, I used PCoA to
broadly analyze MSU microbiota based on the limited bathing-related data that I collected and
found no observable trends.
Discussion of Chapter VI
In Chapter VI, I sought to determine the clinical and biological significance of the trend
between MSU microbiota variability and participant-reported vaginal intercourse described in
Chapter V.
With respect to the clinical significance, I hypothesized that the microbiota of the LUT
facilitates the relationship between vaginal intercourse and UTI risk179 180 181 182. To assess this, I
used bacterial isolates from MSU specimens of participant ProFUM05, including S. mitis, which
were found at higher abundance following vaginal intercourse, and L. jensenii, which were found
in the microbiota of the LUT regardless of lifestyle data. I found that supernatants of L. jensenii
isolates exhibited a bacteriostatic phenotype on UPEC biofilm formation and growth, in vitro.
Furthermore, I determined that hydrogen peroxide production by L. jensenii was likely
responsible for this because addition of exogenous catalase prevented the phenotype.
Interestingly, both strains of UPEC that were used (i.e., NU14268 and UTI89269) have annotated
genomes that contain catalase-peroxidase-like genes293 269. NU14 has two genes with predicted
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protein structures suggestive of catalase activity293, while UTI89 has one gene269 with high
sequence homology to the katG gene (i.e., encodes KatG catalase enzyme) of Mycobacterium
tuberculosis294. Furthermore, in data not shown, I performed a simple qualitative bacterial
catalase test in which one drop of 30% hydrogen peroxide was added to UPEC cells on a glass
slide. I observed production of bubbles for both UPEC strains, which is suggestive of the release
of oxygen from the catalysis of hydrogen peroxide by a catalase enzyme. These data suggest that
the UPEC strains used in the in vitro experiments are able to produce functional catalase
enzymes. These findings seem to conflict with the findings from Chapter VI. Why is hydrogen
peroxide production by L. jensenii bacteriostatic towards UPEC if these strains can produce an
enzyme to prevent the oxidative damage caused by the chemical? It is possible that the
concentrations of hydrogen peroxide produced by the L. jensenii (Table 31), are too high for the
catalase to reduce completely. However, the hydrogen peroxide levels in the supernatant are
static, so there should be a point in time when the levels are completely reduced. It is possible
that that point in time was beyond the time assayed in the experiments. I only measured UPEC
growth in the presence of the supernatants for 24 hours. It is also possible that the enzymatic
activity of the catalase enzyme is diminished in the presence of the L. jensenii supernatants. It
has been demonstrated that catalase activity towards hydrogen peroxide is greatly diminished at
pH levels below 4295. I measured the pH of all of the L. jensenii supernatants used in the
experiments and none had pH levels below 5 suggesting that the enzymatic activity should not
be affected (by the pH alone). It could also be possible that the production rather than the activity
of the catalase enzyme is reduced in the presence of the L. jensenii supernatants. It is possible
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that some component or property of the supernatant prevents the transcription or translation
of the catalase genes or mRNA. In concordance with this theory, I did not observe bubble
formation in the cultures of UPEC with the supernatants (data not shown) suggesting that the
breakdown of hydrogen peroxide and release of oxygen was not occurring. Regardless of the
precise explanation, these findings are complementary to previous findings in literature. For
example, Gupta et al. reported an inverse association between the presence of hydrogen
peroxide-producing vaginal strains of Lactobacillus and UPEC vaginal colonization and UTI
recurrence222. Furthermore, several groups have shown bacteriostatic effects of vaginal
Lactobacillus strains against UPEC296 297. Cadieux et al. found reduced UPEC growth and increased
promoter activity of outer membrane stress response proteins in the presence of Lactobacillus
supernatants, and the phenotype was reversed by the addition of catalase296. Interestingly, this
group used the two Lactobacillus strains that make up the oral probiotic (i.e., L. rhamnosus GR-1
and L. reuteri RC-14) that I used in the ProFUM study296. Similarly, Atassi et al. found bacteriostatic
effects on UPEC in response to hydrogen peroxide production by vaginal Lactobacillus strains,
but also found that the additional presence of lactic acid in the supernatants resulted in a more
severe phenotype where the UPEC cells were no longer viable297. This finding suggests that the
urinary L. jensenii strains did not produce lactic acid, as I did not observe a bactericidal affect on
UPEC in the experiments. Lactic acid concentrations need to be measured in these supernatants
to confirm. All in all, these findings are unique because they show that these bacteriostatic
phenotypes are applicable to urinary strains of Lactobacillus as well as vaginal strains, which have
been described in literature. Furthermore, in combination with the longitudinal microbiota data
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and lifestyle data, I can form a novel hypothesis in that the MSU microbiota changes following
vaginal intercourse (e.g., reduction in L. jensenii and an increase in S. mitis) are clinically related
to UTI risk, due to differences in protective phenotypes from UPEC growth and colonization.
Clearly more needs to be done to further understand these phenotypes, to determine if they are
broadly applicable to urinary Lactobacillus strains, and to determine if these phenotypes can be
reproduced in an in vivo system.
I also asked about the biological significance of the association between vaginal
intercourse and MSU microbiota variability. I hypothesized that S. mitis, which is found at
significantly higher abundance in MSU specimens following vaginal intercourse, are exogenously
introduced during vaginal intercourse by the male sexual partner. To test this, I designed a followup study in which ProFUM05 (i.e., PARTNER01) and her male sexual partner (i.e. PARTNER02)
provided additional specimens, allowing us to determine the relatedness of S. mitis isolates
between the participants. I found similar temporal dynamics of the female microbiota as in the
ProFUM study in relation to vaginal intercourse. However, in the PARTNER study I obtained
additional relevant data. I found increases in Streptococcus in the vaginal swabs following
intercourse, but the species were primarily S. agalactiae, not S. mitis. Interestingly, S. agalactiae
but not S. mitis were found on the penile swab of the male, and I know from the questionnaires
that condom use was not reported for any of the three instances of vaginal intercourse.
Therefore, it is possible that the vaginal Streptococcus was directly transferred from the male
during vaginal intercourse through direct skin contact. In literature, vaginal microbiota changes
appear to originate from the male ejaculate292, but these data, like mine, are only correlative.
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Nonetheless, these data show that the S. mitis in the LUT of the female are not originating from
the male’s genitals (at least not from an area that I assessed). This suggests that two distinct
mechanisms are responsible for the microbiota changes between the LUT and vagina of the
female following vaginal intercourse.
S. mitis is a commensal member of the oral flora298, although outside of the oral cavity, it
can behave as a pathogen causing infective endocarditis, bacteremia, and septicemia299. Because
of this, I included the collection of oral/buccal swabs in the PARTNER study. I detected high
abundance of S. mitis from all oral swabs obtained by both participants (i.e., swabs were obtained
once per week for three weeks). Therefore, it seemed likely that the S. mitis in the LUT of the
female may have originated from the oral cavity of the male. This agrees with the findings from
Chapter V which showed that vaginal and oral intercourse were frequently co-reported by the
ProFUM participants. However, I also determined in Chapter V that vaginal intercourse, rather
than oral intercourse, was related to the MSU microbiota trends. In the PARTNER study, oral
intercourse was reported on only one of the three instances of vaginal intercourse (i.e., Day 9),
despite clear increases in S. mitis abundance in the MSU specimens following all three instances
of vaginal intercourse (i.e., Days 2, 9, and 17). These data show that the S. mitis elevated
abundance, as well as the higher microbiota instability on these days, is related to vaginal
intercourse, not oral intercourse. Thus, it seems like the S. mitis from the female MSU specimens
did not originate from the oral cavity. However, I used ANI to compare the genomes of S. mitis
isolates isolated from female MSU specimens following vaginal intercourse (i.e., Day 17) to
isolates from the male oral swab collected before intercourse that day. I found that one oral
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isolate had high genome similarity to all three urinary isolates, suggesting that the S. mitis is
moving between the oral cavity of the male and the LUT of the female following vaginal
intercourse. This is difficult to explain without more details regarding the practices or behaviors
of the participants during and following vaginal intercourse. The most likely explanation is that
saliva from the male was used as a lubricant source and thus introduced the oral S. mitis isolates
in this manner. Lubricant use was not reported by the participants. However, this does not
necessarily disprove my hypothesis, as it is possible that saliva was simply not reported as a
lubricant by the participants. This would need to be explicitly asked in future studies. If saliva was
the source, it remains to be seen why the S. mitis isolates did not appear in the vagina or periurethra of the female. Similarly confounding data was previously discussed in this chapter and
several possible explanations were described, including hygiene and bathing practices following
the lifestyle factor in question. Hygiene and bathing practices may affect the peri-urethral and
vaginal environments more than the LUT, thus creating an opportunity for microorganism (e.g.,
S. mitis) to be physically removed or inhibited from these areas while remining in the LUT.
Furthermore, the findings fail to describe the direction of S. mitis movement between the
participants. Further genomic comparisons of other S. mitis isolates are needed, and these
analyses are currently ongoing.
Significance and Implications
The discovery of the urinary microbiota and microbiome occurred barely a decade ago. In
the short period of time that has followed, we have learned an immense amount of information
about these microbiota, ranging from their associations with diseases to differences among
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demographics. It is becoming clear that the way we identify and diagnose urinary infections as
well as the way we treat LUT diseases, is on the verge of dramatic change. However, before these
much-needed changes can be implemented, a few more questions need to be answered. For
example, mechanistic links between the microbiota and disease need to be demonstrated. These
mechanisms may be directly connected to the bacteria, possibly through proteins or other
molecules produced by the microorganism, or they may involve indirect and complex pathways
incorporating the host immune cells or tissue. But most importantly, we need to understand why
these associations with disease occurred to begin with. If the bacteria really are mechanistically
involved in the etiologies, then how did they come to colonize the bladder and LUT? In other
words, can the urinary microbiota change over time? And if temporal changes do exist, as they
do for other human microbiota, what is driving those changes? These are the questions that I
sought to address in this thesis and have been thoroughly described above. In this section, I
highlight some key findings and expound upon their significance.
I found that in pre-menopausal healthy women, temporal changes in the microbiota of
the LUT exist and relate to lifestyle factors. This is an incredibly significant and novel finding that
has many implications. First, it provides merit to the idea that the urinary microbiota can cause
LUT diseases because it shows that the microbiota can transition from one state to another (e.g.,
a healthy state to a disease-associated state). If this were not true, then the associations between
disease and the urinary microbiota would have to involve alterations to the host’s response to
the bacteria rather than alterations to the bacteria themselves. Second, it raises questions about
methodologies. Can one accurately characterize the urinary microbiota through the use of a
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single timepoint specimen? And how do we incorporate this natural variability in the microbiota
into power analyses and study design when designing clinical studies? Third, it verifies that the
bladder and LUT environments are dynamic and subject to external influence. This has been
suggested by data relating lifestyle factors to UTI risk. My data further support these claims.
Fourth, it shows that we have influence on the ability of the urinary microbiota to change. Should
women with a history of UTI avoid unprotected heterosexual vaginal intercourse? Should they
avoid using certain types of feminine hygiene products for menstrual care? I found that these
types of lifestyle factors significantly altered the urinary microbiota and thus may be clinically
relevant for disease or infection prevention. Lastly, it provides us with new insight into
understanding UTIs. Bacteria naturally compete for space and resources. This is relevant for an
infectious microorganism as it has to compete against the resident microbiota for these features.
If these resident microbiota are subject to change, that would affect the infectious
microorganism’s efficacy at colonizing. If we can understand this relationship better, then we can
use the type of lifestyle data described here as means to prevent or decrease risk for UTI.
One of the reasons why the work presented in this thesis had not been done before is
because of urine specimen interpretability. As I described in Chapter I, the less invasive the urine
collection method is, and subsequently the easier it is to acquire these specimens from
participants and patients, the less interpretable the urine specimen will be. Longitudinal studies
requiring repeated specimen collection cannot rely on invasive methods. My approach to
handling this problem is unique and provides a novel tool for the field. By pairing a less invasive
and interpretable urine specimen (i.e., MSU) with a more interpretable genital specimen (i.e.,
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peri-urethral swab) and then measuring the concordance of the microbiota between the paired
specimens, I was able to provide a measure of quality for the MSU specimen, thus increasing its’
interpretability. This allows for stronger conclusions regarding the microbiota of the LUT from
MSU specimens and reduces the risk of specimen variability over time.
I also found a novel link between the microbiota of the LUT and UTI risk. In an effort to
understand the mechanistic basis for one of the observed trends between lifestyle and
microbiota variability, I found that certain members of the MSU microbiota are differentially
protective from UTI-causing pathogens, in vitro. Moreover, the difference in isolate phenotypes
relate to lifestyle (i.e., vaginal intercourse). Culture supernatants of S. mitis isolates isolated from
participant ProFUM05, which are found at higher mean abundance following vaginal intercourse,
have no observed inhibitory capacity towards UPEC strains. This is in contrast to L. jensenii
isolates, whose supernatants are bacteriostatic towards UPEC, likely through production of
hydrogen peroxide. These findings are intriguing because they provide an alternate hypothesis
to explain why vaginal intercourse is related to UTI risk179

180 181 182

. Rather than directly

introducing the UTI-causing pathogen, which is not entirely supported by literature, I hypothesize
that vaginal intercourse alters the microbiota of the LUT to a less protective state. This less
protective state is less capable of preventing colonization by an exogenous uropathogen. The
clinical implication of this alternative mechanism would be that methods should be explored
aimed at maintaining the protective normal flora of the LUT (e.g., Lactobacillus) following vaginal
intercourse rather than using preventative measures aimed at the UTI-causing pathogen. The
data showed that these Streptococcus species (i.e., S. mitis) likely originated from the oral cavity
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of the male sexual partner due to a high genomic relatedness of female MSU isolates. However,
I have yet to determine which direction the bacteria are moving. Considering that a spike in
Streptococcus is consistently seen in the MSU microbiota of the female following vaginal
intercourse, it seems reasonable to hypothesize that the Streptococcus is moving to the female,
thus increasing the abundance. Though the exact mechanism of transfer to the female LUT
remains unclear (i.e., was not related to oral intercourse), this creates an opportunity for some
manner of clinical interference to ensure maintenance of the female LUT flora regardless. What
exactly that entails requires more insight into the mechanism of Streptococcus strain transfer
between sexual partners but may be as simple as using protective measures such as condoms.
Future Directions
The findings presented in this thesis represent a novel description of the temporal
dynamics of the microbiota of the LUT in pre-menopausal healthy women. Researchers should
use these findings to guide the design, methodology, and interpretation of future studies
assessing this topic.
The data obtained in the studies described in this thesis are vast and contain incredible
detail. The analyses that were done are not by any means all-encompassing. I limited the analyses
of these data to what I believed to be the most clinically important questions. Nonetheless, more
questions can certainly be addressed using these data. I restricted the approach to assessing the
relationship between lifestyle factors and the microbiota of the subsequent day. Whether it is
biologically appropriate to expand the analyses beyond just the following day’s microbiota is
arguable. This should be done more for the sake of scientific curiosity rather than necessity. I also
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did not assess the relationship between diet and MSU microbiota variability. Diet would
ultimately impact the microbiota of the LUT by altering the composition of the urine, which I
measured using the urine dipstick. I assessed for associations between urine dipstick results and
MSU microbiota variability in Chapter IV, and therefore felt it was unnecessary to evaluate diet
as well. I also did not assess for changes in peri-urethral microbiota composition and diversity. In
this dissertation, the peri-urethral microbiota data served as a control. If lifestyle factors altered
the microbiota stability of the MSU specimens but not the peri-urethral specimens, then I could
make conclusions regarding the LUT specifically. This was the case for most lifestyle factors
discussed in Chapters IV & V. However, subtle but significant changes in the peri-urethral
microbiota could still have occurred and should be explored further.
Future studies assessing the urinary microbiota longitudinally should include more
rigorous and detailed lifestyle questionnaires. In regard to sexual activity, it would be important
to collect information on condom use, including brand, whether it contains spermicide, and
whether it was removed prior to ejaculation. Information on hygiene practices (e.g., urination
habits and bathing habits) during the time between sexual activity and specimen collection
should be obtained. Information on the sexual partner should be included. It may be interesting
to compare the MSU microbiota variability between male and female (i.e. heterosexual and
homosexual) partners, as this could provide more insight into the mechanism(s) behind the
trends described here. In regard to bathing, showering and baths should be reported separately.
Number of bathing episodes and time(s) of day should be recorded. Use and type of soap may
also be useful information to collect. Finally, it would be important to record overall frequency
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of urination each day. It is likely that this will relate to total bacterial abundance and alphadiversity, but additional trends may be found. It is also possible that this will relate to
menstruation and menstrual hormone levels289. These future studies should focus initially on a
similar participant population to confirm the trends described here. It would be useful to
eventually assess a more clinically relevant participant population such as post-menopausal
women who have higher incidences of LUTS. A subsequent comparison of this population with
these data would also be revealing.
Whether performed on the samples collected here, or on newly collected longitudinal
samples, it would be fascinating to assess the microbiome of the LUT using a metagenomic
approach. This would go beyond taxonomic classification and provide us with insight into
genomic content and genomic variations over time. I have described strong associations between
MSU microbiota variability and lifestyle, but, with the exception of the in vitro experiments in
Chapter VI relating the microbiota, vaginal intercourse, and UTI risk, we have no idea if these
trends are clinically or biologically relevant. For example, it may be the case that the MSU
microbiota during menstruation has a similar genotype to the normal microbiota. If this were the
case, then the microbiota variability during menstruation may not be clinically meaningful at all.
Another benefit of taking a metagenomic approach is the ability to observe strain-specific change
over time. In this thesis I limited the approach to measuring changes in genera and species. It is
likely the case that individual strains of the LUT flora are evolving over time and this may relate
to lifestyle. Many of the lifestyle factors and urine properties that I assessed showed no
association with MSU microbiota variability, but this does not mean that the lifestyle factor did
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not have an influence on the bacteria. It is entirely possible that an altered LUT environment
creates a selective pressure for certain adaptive bacterial traits. The ongoing analyses of the S.
mitis genomes may provide some important insight into strain variability over time.
Continued assessment of MSU urine specimens is also necessary. In these studies, I
compared the microbiota of MSU specimens to peri-urethral specimens and enrolled participants
based on the dissimilarity of the two. Though this provided us with a comparable participant
population, it may have also introduced bias. I do not currently know how much overlap there
normally is in the microbiota of MSU and peri-urethral specimens. It is crucial to understand this
so the field can move away from the use of catheterized urine specimens which greatly limit the
study of the urinary microbiota in community women and men. A comprehensive study
comparing the microbiota of several urogenital specimen types in pre-menopausal and postmenopausal women is greatly needed.
Eventually, we need to develop an appropriate animal model to study the urinary
microbiota in more relevant context. In this thesis, I showed associations between the MSU
microbiota and several lifestyle factors, but it is incredibly difficult to determine how and why
these associations exist. Without the ability to study the lifestyle factor and the microbiota in an
in vivo model, I can only speculate as to the causes and relevance of these trends.
The two lifestyle factors that showed the greatest variability in the microbiota of the LUT
were menstruation and vaginal intercourse. More should be done to understand the
mechanism(s) underlying these trends; much of which can be done without an animal model.
Regarding menstruation, the mechanism underlying the MSU microbiota variability likely lies
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with feminine hygiene product use or hormone fluctuations. A case-controlled study should be
performed comparing the MSU microbiota over time during menstruation in populations of
women who do and do not use feminine hygiene products. In my data, I could not separate
menstruation from hygiene product use because of the high frequency of co-reporting the two.
Hygiene products have not been shown to alter the vaginal microbiota164 165 166, and I found that
they did not alter the peri-urethral microbiota stability which suggests that the variability in the
MSU microbiota during menstruation may not relate to hygiene products. An alternate
mechanism could relate to hormone fluctuations, specifically estrogen which has been shown to
relate to increased urination frequency289. Menstrual hormone levels could be measured using
commercially available enzyme-linked immunosorbent assay (ELISA) kits and assessed for an
association with MSU microbiota variability over time. Furthermore, as mentioned above, it is
essential that in future longitudinal studies of the MSU microbiota, urination frequency needs to
be measured. This could relate to menstruation and may provide vital insight into a mechanism
for the MSU microbiota variability.
Vaginal intercourse was the other lifestyle factor that showed significant associations with
MSU microbiota variability. I was able to show that the variable microbiota (i.e., Streptococcus)
may have clinical relevance for UTI risk. I found contrasting phenotypes for UPEC growth
inhibition between S. mitis, part of the variable MSU microbiota, and L. jensenii, a likely member
of the normal LUT flora. This is interesting from the perspective of either bacteria. From the S.
mitis perspective, it would be interesting to ask whether prophylactic antibiotic use against
Streptococcus following vaginal intercourse results in reduced UTI risk. Similar studies have been
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performed using antibiotics targeting typical Gram-negative uropathogens, and the results have
been somewhat mixed150 151 235. From the L. jensenii perspective, I found that hydrogen peroxide
was the cause of the UPEC inhibition. Because hydrogen peroxide is a common byproduct of
Lactobacillus species, it would be important to know if other urinary species of Lactobacillus have
similar phenotypes. Furthermore, it is important to understand how these findings relate to the
in vivo environment of the bladder. High concentrations of hydrogen peroxide production in
bacterial cultures may not relate to high concentrations in the bladder. Additionally, hydrogen
peroxide production only occurs when Lactobacillus are in low oxygen environments. We
recently showed that oxygen levels in the bladder vary greatly300, and therefore it is important to
understand how this relates to the data.
Ultimately, the goal is to figure out how to take the findings described here and improve
clinical care. As a whole, these data suggest that alterations to the LUT microbiota relate to
lifestyle factors and may affect UTI risk. Clearly more research needs to be performed to greater
understand the relationship among these findings. Nonetheless, they provide support for novel
preventative and therapeutic measures aimed at maintaining the protective normal LUT flora.
Whether this is achieved through alteration of lifestyle factors or microbiologic-focused means,
such as pre/probiotic therapies, remains to be determined. All in all, the urinary microbiota is an
intriguing and novel therapeutic target that has the potential to improve the health of millions of
women.
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This appendix provides the texts of most current and in-process publications that are not
directly related to this dissertation. At the beginning of each appendix section, the manuscript
citation will be listed, followed by a short summary of the work. The full manuscript text, all
figures and tables, both primary and supplementary, as well as complete methods are included.
Additional work not included in the publication will be listed in the addendum following each
appendix. Some appendices provide topic-specific data that are not published, but again are not
directly related to topics in this dissertation.
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APPENDIX B
BLADDER MICROBE DIVERSITY RELATES TO URINARY INCONTINENCE SEVERITY IN A
UROGYNECOLOGIC POPULATION
Price T.K., Thomas-White K.J., Hilt E.E., Lin H., Gao X., Wolfe A.J., Mueller E.R., Dong Q.,
Brubaker L. Bladder Microbe Diversity Relates to Urinary Incontinence Severity in a
Urogynecologic Population. 41st American Urogynecologic Society (AUGS) Meeting, Nashville,
TN, October 2019.
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Overview of Appendix B
This abstract assesses the relationship between the urinary microbiota and UI symptom
severity. We found that UI symptom severity increased with species richness values of the urinary
microbiota. Thus, symptom severity appears to relate to the identity and number of urinary
species. Whether these microbiologic differences are a potential cause of UI or are a result of it,
is unclear.
My contributions to these data include project development and study design, data
acquisition, data interpretation and analysis, and manuscript writing. This work was done from
2014 to 2019. As of Spring 2019, this manuscript is currently in progress.
Abstract Text
Objective
To identify relationships between the bladder microbiome and urinary incontinence (UI)
symptom severity in a urogynecologic population.
Methods
With IRB oversight, transurethral catheterized urine specimens were collected from 309
adult women categorized into 3 groups using response to the Pelvic Floor Distress Inventory
(PFDI): Urgency Urinary Incontinence (UUI), Stress Urinary Incontinence (SUI), and continent
controls. Symptom severity was assessed with the Urinary Distress Inventory (UDI) subscale
score. Bacterial presence was assessed using an Expanded Quantitative Urine Culture (EQUC)
protocol and 16S rRNA gene sequencing.
Results
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Participant mean age was 53 (range 22-90); most were Caucasian (65%). Women with UI
were older (Control= 47, SUI=54, UUI=61). UDI symptom scores were as follows: control =
8.43(10.1), SUI = 97.95(55.36) and UUI = 93.71(49.12) and the differences were significant
(p<0.001). Bacteria were detected by EQUC (216 [70%]) and sequencing (111 [36%]); 96 (31%)
urine specimens were positive by both methods. The mean abundance of numerous taxa was
significantly associated with UDI score. Multiple alpha diversity indices of species richness (i.e.
number of unique taxa) strongly associated with symptom severity (increased diversity
associated with increased symptoms); species evenness (i.e. distribution of taxa) did not differ
significantly (Figure B.1).
Conclusions
Composition and species richness of the urinary microbiome relates to both the presence
of UI and symptom severity, regardless of UI subtype. Symptom severity increased with species
richness but not evenness. Thus, symptom severity appears to relate the identity and number of
bladder species, but not the distribution of those species. The potential etiologic role of these
findings warrants further study.
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Figure B.1. Correlation between Alpha Diversity and UDI Scores. Scatter plots depict the
distribution of various alpha diversity scores calculated from EQUC data (x-axes) versus the
distribution of UDI Scores (y-axes). Fitted regression lines are in yellow. The area between the
confidence bands is shaded in grey. Each data point is colored according to cohort, where red
is Control, green is SUI, and blue is UUI. Alpha diversity measures tested include Chao1 (A), ACE
(B), Shannon (C), Simpson (D), and Pielou (E). Pearson, Kendall, and Spearman correlation tests
were used to determine the statistical significance between UDI score and alpha diversity
measure for each scatter plot. P-values (not shown) were significant (p<0.05) or approached
significance for all alpha diversity measures except Pielou, which is the only index that
measures only evenness (E).
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APPENDIX C
FEMALE LOWER URINARY TRACT MICROBIOTA DO NOT ASSOCIATE WITH IC/PBS SYMPTOMS: A
CASE-CONTROLLED STUDY
Bresler L., Price T.K., Hilt E.E., Joyce C., Fitzgerald C.M., Wolfe A.J. Female Lower Urinary Tract
Microbiota Do Not Associate with IC/PBS Symptoms: A Case-Controlled Study. Int. Urogynecol. J.
2019 Apr 16. doi: 10.1007/s00192-019-03942-9 [Epub ahead of print] PMID: 30993388
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Overview of Appendix C
This paper assesses the urinary and vaginal microbiota of women with and without
IC/PBS. IC/PBS is a complex and poorly understood disease with multiple etiologies. Several
groups have assessed the urinary microbiota in this patient population but found generally
conflicting results. Our data, which is case-controlled, includes vaginal swab specimens, and uses
two complementary methods (i.e. EQUC and 16S rRNA gene sequencing) to characterize the
microbiota, shows that there is no difference in the composition or diversity of the urinary
microbiota between women with and without IC/PBS. Therefore, a microbial etiology to IC/PBS
seems unlikely.
My contributions to these data include project development and study design, data
acquisition, data interpretation and analysis, and manuscript writing. This work was done from
2015 to 2019.
Abstract
Objective
Current etiology of interstitial cystitis/painful bladder syndrome (IC/PBS) is poorly
understood and multifactorial. Recent studies suggest the female urinary microbiota (FUM)
contribute to IC/PBS symptoms. This study was designed to determine if the FUM, analyzed using
mid-stream voided urine samples, differs between IC/PBS patients and controls.
Materials and Methods
This prospective case-controlled study compared the voided FUM of women with
symptoms of urinary frequency, urgency, and bladder pain for greater than 6 months to the
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voided FUM of healthy female controls without pain. Bacterial identification was performed
using 16S rRNA gene sequencing and EQUC, a validated enhanced urine culture approach.
Urotype was defined by a genus present at >50% relative abundance. If no genus was present
above this threshold, the urotype was classified as ‘mixed’. Group comparisons were performed
for urotype and diversity measures.
Results
A mid-stream voided specimen was collected from 21 IC/PBS patients and 20
asymptomatic controls. The two groups had similar demographics. Urotypes did not differ
between cohorts as assessed by either EQUC or 16S rRNA gene sequencing. We detected no
significant differences between cohorts by alpha-diversity. Cohorts also were not distinct using
Principle Component Analysis or hierarchical clustering. Detection by EQUC of bacterial species
considered uropathogenic was high in both cohorts, but detection of these uropathogenic
species did not differ between groups (p=0.10).
Conclusions
Enhanced culture and DNA sequencing methods provide evidence that IC/PBS symptoms
may not be related to differences in the FUM, at least not its bacterial components. Future larger
studies are needed to confirm this preliminary findings.
Introduction
Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) affects nearly 7.9 million US adult
women301. The AUA and SUFU define IC/PBS as “an unpleasant sensation (pain, pressure,
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discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract
symptoms of more than six weeks duration, in the absence of infection or other identifiable
causes”302.
The etiology of IC/PBS is multifactorial, poorly understood, and assumes that the female
urinary tract is sterile in the absence of clinical infection. However, our research team and others
have shown that the female urinary tract is not sterile; it possesses communities of microbes
called the female urinary microbiota (FUM)29
various lower urinary tract symptoms15

. Furthermore, the FUM is associated with
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. These findings present a new avenue for
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studying the etiologies of IC/PBS.
Few groups have reported on the FUM of IC/PBS patients. The few existing studies used
various urine collection methods and bacterial detection methods, in general had small sample
sizes and, therefore, the data conflict36

. Our prospective case-controlled study sought to

42 33

determine if the FUM of women with and without IC/PBS differs using mid-stream voided urine
specimens to avoid pain provocation and analyzed them with expanded techniques. Secondarily,
we sought to describe the vaginal microbiota of the IC/PBS cohort.
Materials and Methods
Study Design and Patient Population
Following Institutional Review Board (IRB) approval, we enrolled 41 female patients; 21
with IC/PBS (i.e., IC Cohort) and 20 without (i.e., Control Cohort). Women in the IC Cohort
experienced symptoms of urinary frequency, urgency, and bladder pain for greater than 6
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months, meeting the AUA IC/PBS definition. For both cohorts, basic demographics were
collected. The members of the IC cohort completed validated questionnaires including the-Beck
Anxiety Inventory, Beck Depression Inventory, the Pain Disability Index, the Female Genitourinary
Pain Index, the Pain Catastrophizing Scale, the IC Symptom Index Score and the IC Problem Index
Score.
Sample Collection
Midstream voided urine specimens were collected from both cohorts. A vaginal swab
specimen was collected from the IC Cohort. A portion of each urine sample was placed in a BD
Vacutainer® Plus C&S Preservative Tube for culturing. A separate portion for 16S rRNA gene
sequencing was placed at 4°C for less than 4 hours following collection; 10% AssayAssure (Sierra
Molecular, Incline Village, NV) was added before storage at -80°C. Puritan Opti-Tranz® Liquid
Stuart Swabs were used to collect two aerobic vaginal swab specimens. Each swab was vortexed
and diluted in 1ml phosphate buffered saline (PBS). One aliquot was used for culture and one
was stored for 16S rRNA gene sequencing, as described above.
Urine Culture Protocols
A variation of the Expanded Quantitative Urine Culture (EQUC) protocol34 was used to
culture the biological specimens. 10µL of urine sample or vaginal swab aliquot was spread
quantitatively onto BAP, Chocolate, and Colistin Naladixic Acid (CNA) agars (BD BBL™ Prepared
Plated Media) and incubated in 5% CO2 at 35°C for 48 hours; onto BAP incubated aerobically at
35°C for 48 hours; and onto CDC Anaerobic 5% sheep blood (Anaerobic BAP) agar (BD BBL™
Prepared Plated Media) incubated anaerobically at 35°C for 48 hours. The vaginal swab aliquots
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were also plated on Thayer-Martin media and incubated in 5% CO2 at 35°C for 48 hours. Each
distinct colony morphology was sub-cultured at 48 hours to obtain pure culture for microbial
identification. Microbial identification was determined using a Matrix-Assisted Laser
Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDI-TOF MS, Bruker Daltonics,
Billerica, MA).
DNA Isolation and 16S Sequencing
DNA isolation, polymerase chain reaction (PCR) amplification, and 16S rRNA gene
sequencing of urine cultures have been described previously15. Genomic DNA was extracted from
1 ml of urine or 500ul of the vaginal swab aliquot, using previously validated protocols developed
for the Human Microbiome Project251

34 15

. To isolate genomic DNA from these samples, this

protocol includes the addition of mutanolysin and lysozyme to ensure robust lysis of Grampositive and Gram-negative species251.
The hyper-variable region 4 (V4) of the bacterial 16S rRNA gene was amplified via a twostep PCR protocol, as described previously34 15. Extraction negative controls (no urine or swab
suspension) and PCR-negative controls (no template) were included to assess the contribution of
extraneous DNA from reagents. Ten-microliter aliquots of each reaction mixture were run on a
1% agarose gel. Samples containing a band of approximately 360 bp were considered PCRpositive and subjected to further library preparation. Samples with no visible amplified product
were considered PCR-negative and not processed further. The PCR-positive reaction mixtures
were diluted 1:50 and amplified for an additional 10 cycles, using primers encoding the required
adapter sequences for Illumina MiSeq sequencing and an 8-nucleotide sample index. The PCR
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reaction was purified, and size selected using Agencourt AMPure XP-PCR magnetic beads
(Beckman Coulter, Pasadena, CA). Each sample was quantified using the Qubit fluorometeric
system (Thermo-Fisher, Waltham, MA). The samples were pooled, quantified to a standard
volume, and placed in the 2 X 250 bp sequencing reagent cartridge, according to the
manufacturer’s instructions (Illumina, San Diego, CA).
Sample barcodes and sequencing primers were removed using the Illumina proprietary
MiSeq post-sequencing software. The mothur program (v1.37.4) was used to process the raw
sequences by following the recommended MiSeq standard operating procedure252. Briefly,
mothur produced 16S contigs by combining the paired end reads based on overlapping
nucleotides in the sequence reads; contigs of incorrect length for the V4 region (<290 bp, >300
bp) and/or contigs containing ambiguous bases were removed. Chimeric sequences were
removed using UCHIME within the mothur package253. Subsampling at a depth of 5000 sequences
was performed to correct for different sequencing depth of each sample. The sequences were
clustered into species-level operational taxonomic units (OTUs) with identity cutoff at 97%254. The
OTUs were classified using RDP classifier (v2.11) at the genus level254. Specimens designated as
“undetectable” had <1000 total sequence reads.
Statistical Analyses
Continuous variables were reported as means with standard deviations (SD); categorical
variables were reported as frequencies and percentages. Pearson Chi-square tests or Fisher’s
Exact Tests and 2-sample t-tests or Wilcoxon Rank Sum tests were used to compare categorical
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Table C.1. Demographic and Clinical Variables for the IC and Control Cohorts.

and continuous demographics and culture results, respectively. Data were plotted using R
(version 3.4.3). Cluster analysis was performed using hierarchical clustering. All statistical
analyses were conducted using SAS software v9.4 (SAS Institute, Cary, NC) or SYSTAT software
version 13.1 (SYSTAT Software Inc., Chicago, IL).
Results
Demographics
Table C.1 displays the demographic characteristics of the two cohorts (IC and Control).
The entire population had a mean age of 49 ± 13 years and was predominately White/Caucasian
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Table C.2. Demographic, Clinical Variables, and Symptom Questionnaire Results for IC
Patients with Lactobacillus and non-Lactobacillus Urotypes determined by 16S rRNA Gene
Sequencing.

(70%) consistent with our clinical patient’s population. The two groups had similar demographics
and percentage of EQUC and 16S sequence-positive specimens (p>0.05 for all comparisons
except vaginal parity).
Description of the Lower Urinary Tract and Vaginal Microbiomes in IC Patients
16S rRNA gene sequencing was performed on all (21) IC voided urine and vaginal swab
specimens. The majority of voided urine specimens of IC patients had a Lactobacillus (11/21;
53%) or Mixed (6/21; 29%) urotype, a measure of bacterial community structure as determined
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Figure C.1. Principle Component Analysis of Mid-Stream Voided Urine Specimens from IC and
Control Patients. Principle component analysis comparing 16S rRNA gene sequence data
between IC patients (21), blue, and Control patients (C patients) (19), red.
by 16S rRNA gene sequencing (Supplemental Figure C.S1). For most IC patients, the urotype
matched the dominant taxa present in the paired vaginal swab specimen (19/21; 90%)
(Supplemental Figure C.S1). The specimen types (IC vaginal swab, IC urine, control urine) did not
significantly differ by several mean alpha diversity measures that report on the richness,
evenness and abundance of community members (Supplemental Figure C.S2).
Table C.2 displays the demographics and validated questionnaire results of the IC cohort
stratified by Lactobacillus versus non-Lactobacillus urotype. IC Patients with a Lactobacillus
urotype were younger (p=0.01) and more likely to be pre-menopausal (p=0.03) than IC patients
with a non-Lactobacillus urotype, which were more likely to be post-menopausal (p=0.009);
neither the Lactobacillus urotype nor the non-Lactobacillus urotypes had significantly different
mean scores for any of the validated clinical questionnaires.
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Figure C.2. Heatmap of Relative Abundance Values for Common Bacterial OTUs among
Cohorts and Specimen Types. Heatmap of the relative abundance of 16S rRNA gene sequence
data classified by otu's. The y-axis lists common bacterial otu classifications in alphabetical
order. The x-axis describes the specimen type and patient cohort of the corresponding sample.
Specimens listed in red are mid-stream voided urine specimens from IC patients, orange are
vaginal swab specimens from IC patients, and black are mid-stream voided urine specimens
from Control (C) patients. Data are grouped by hierarchical clustering using the corresponding
dendogram.
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Table C.3. List of Uropathogenic Bacterial Taxa Identified in Mid-Stream Voided Urine
Specimens of IC and Control patients using EQUC.

Comparison of Lower Urinary Tract Microbiome of IC and Control Patients
16S rRNA gene sequencing was performed on voided urines from 19 of 20 Control
specimens. Consistent with the IC Cohort, the Control patients had predominately Lactobacillus
(9/19; 47%) or Mixed (6/19; 32%) urotypes by 16S rRNA gene sequencing. Mean alpha diversity
measures did not differ between the voided urine specimens of the IC and Control cohorts
(Supplemental Figure C.S2). When plotted, principal component analysis did not show visual
separation between the cohorts (Figure C.1). A hierarchical cluster analysis of specimens
classified at the OTU-level from both cohorts is shown in Figure C.2, which does not reveal any
clear apparent clustering of specimen types or cohort-specific specimens.
Detection of Uropathogenic Bacteria between Cohorts
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EQUC was performed on all Control (20) and 18 of the 21 IC urine specimens. Using EQUC,
we detected 39 and 51 unique species in the IC (N=18) and Control (N=20) cohorts, respectively.
Frequency of detection of Staphylococcus lugdunensis (0% IC versus 25% control, p=0.04) and
Streptococcus agalactiae (i.e. Group B Streptococcus) (6% IC versus 35% control, p=0.04) differed
by group (Table C.3). Detection of Escherichia coli was higher in the IC cohort (28% IC versus 5%
control, p=0.08). Detection of bacterial species typically considered uropathogenic was high in
both groups (IC=15/18, 83%; C=20/20, 100%, p=0.10) (Table C.3).
Discussion
This study failed to detect significant differences in the voided FUM of women with and
without IC/PBS. Despite the study limitation of small sample size, our data suggest that
microbiota of the lower urinary tract may not contribute to the symptoms in women meeting the
clinical definition of IC/PBS. This contradicts recent work by others, who have argued for a link
between clinical symptoms of IC/PBS and the FUM36

. Abernathy et al. hypothesized a
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protective role of a more diverse and Lactobacillus-dominant microbiome. Catheterized urine of
women with IC were found to have fewer OTUs and less likely to contain Lactobacillus species,
particularly L. acidophilus.

Furthermore, Abernathy et al. found that the presence of

Lactobacillus was associated with improved scores on two IC-specific symptom severity indices,
suggesting that the urinary microbiome may influence lower urinary tract symptoms. Although
our collection techniques differed and our expanded culture technique additive, these findings
were not reproduced in our study nor were the differences in Lactobacillus dominance indicative
of symptom burden. Siddiqui et al. found that Lactobacillus predominance was associated with
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IC/PBS patients (i.e., the opposite trend) using clean catch voided urine specimens. Finally, Nickel
et al. analyzed a larger cohort of IC/PBS participants (n=233) using clean catch urine during flare
vs non-flare pain states and showed no difference in species composition. However, this study
did indicate that the IC group had a higher prevalence of fungi. Fungi were not directly analyzed
in our cohort. However, we did detect Candida species in both cohorts using EQUC.
Strengths of this study were the use of two complementary identification methods:
sequencing and culture, as well as the use of vaginal swabs as a comparative specimen to voided
urine in the IC cohort. Voided specimens were chosen intentionally so as not to create an IC pain
flare by obtaining a catheterized specimen. Furthermore, contemporary urological guidelines do
not require a catheterized urine specimen as a part of the diagnostic IC work up (AUA guideline)
and not routinely performed in this patient population due to catheterization discomfort and
poor patient’s compliance302. Limitations include small sample size for both cohorts, lack of
vaginal swabs in the controls, and lack of other clinical data in the control group. Although, we
did not have an a priori sample size estimation, our cohort sizes were similar to those of the
Abernethy et al. study, which did show differences in the urinary microbiome between groups,
so we felt our sample size was adequate for this preliminary analysis. We agree with Nickel et al.
that the voided urine does not represent the bladder microbiome in our study, but rather the
genitourinary tract. Additionally, we also recognize that we did not control antibiotic exposure,
similar to Abernethy et al.
This case-control study of the FUM in predominantly middle-aged women with IC/PBS
compared to controls without pain showed no significant differences in the voided FUM between
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groups. These findings suggest that microbes may not directly contribute to IC/PBS unlike
previously reported literature. Larger scale studies using complementary microbial detection
techniques similar to ours and assessing multiple urine collection methods (voided and
catheterized) would contribute to deeper understanding of the FUM as a potential etiology in
IC/PBS.
Supplemental Materials

Supplemental Figure C.S1. Histogram of Paired Voided Urine and Vaginal Swab Specimens
from IC Patients. Histogram depicts the genus or family-level taxonomic classification of 16S
rRNA gene sequence reads from voided urine (left bar) and vaginal swab (right bar) specimens
collected from IC patients (N=21). Data are presented as relative abundance values. Taxa
present at <10% relative abundance in all specimens were grouped into “other”. Specimens
designated as “undetectable” had <1000 total 16S rRNA gene sequence reads.
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Supplemental Figure C.S2. Alpha Diversity Values among Patient Cohort and Specimen Types.
Boxplots depict the distribution of various alpha diversity indices measured from 16S rRNA gene
sequencing data for the control patients (orange) and the IC patients (blue – voided urine; green
– vaginal swab). Values for the Shannon Index (A), Simpson’s Index (B), and Pielou’s Evenness
(C) are shown. Tables below each plot show the P-values comparing data between each group.
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APPENDIX D
CULTIVABLE BACTERIA IN URINE OF WOMEN WITH INTERSTITIAL CYSTITIS: (NOT) WHAT WE
EXPECTED
Jacobs K.M., Price T.K., Thomas-White K.J., Davies A., Myers D.L., Wolfe A.J. Cultivatable
Bacteria in Urine of Women with Interstitial Cystitis: (Not) What we Expected. 41st American
Urogynecologic Society (AUGS) Meeting, Nashville, TN, October 2019.
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Overview of Appendix D
This abstract assesses the urinary microbiota of women with and without IC/PBS. Unlike
the data presented in Appendix C, these data were obtained from catheterized urine specimens.
In this case-controlled study, we found very few differences between patients with and without
IC/PBS, consistent with the conclusions made in Appendix C. Therefore, a microbial etiology to
IC/PBS seems unlikely.
My contributions to these data include data acquisition, data interpretation and analysis,
and manuscript writing. This work was done from 2017 to 2019. As of Spring 2019, this
manuscript is currently in progress.
Abstract Text
Objective
Interstitial cystitis (IC)/Painful Bladder Syndrome (PBS) is a diagnosis of exclusion
predicated on a negative standard urine culture. Studies into the urinary microbiome, utilizing
expanded quantitative urine culture (EQUC), demonstrate that most women in the general
population have cultivatable bacteria in their urine. The existence of these bacteria challenges
the diagnosis of IC/PBS, which presumes a sterile bladder. No data are available regarding
cultivatable bacteria in the IC/PBS population utilizing the comprehensive EQUC technique. The
objectives of this study were: (1) to use EQUC to compare the female urinary microbiome (FUM)
in women with IC/PBS to controls and (2) to correlate baseline FUM composition with IC/PBS
symptoms.
Methods
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In this cross-sectional study, we enrolled 89 women 49 IC/PBS and 40 unaffected controls;
all provided catheterized urine specimens and completed validated questionnaires. Women were
excluded if they were less than 18 years old, had received antibiotics or undergone bladder
instrumentation in the 28 days prior to enrollment, or had known bladder anomalies. We
assessed the FUM of both cohorts using EQUC and compared the resultant data. Statistical
comparisons were performed using Fisher’s exact test, Ttest, and ANOVA.
Results
Mean age (yrs) of the IC/PBS cohort was 50.5 (SD 15.9) and 44.5 (SD 12.8) for the controls
(p=0.062). The average score on the Genitourinary Pain Index (GUPI) was 26.1 (SD 11.3) for the
IC/PBS cohort versus 3.0 (SD 4.9) for the controls (p<0.0001). Of the 89 women, only 40 had
detectable FUM by EQUC. For the IC/PBS cohort, the primary detectable urotypes were
Lactobacillus (11/49), Streptococcus (8/49), and Escherichia (2/49); 25/49 were undetectable. For
the control cohort, the primary detectable urotypes were Lactobacillus (8/40) and Gardnerella
(2/40); 24/40 were undetectable. The overall distribution of urotypes was significantly different
(p=0.029), with Streptococcus found in 16% of the IC/PBS cohort versus 0% of controls (p=0.007).
For the IC/PBS cohort, the mean GUPI score varied by urotype with scores of 31.1 (SD 6.7) for the
Lactobacillus urotype, 29.3 (SD 9.6) for the undetectable urotype, and 15.2 (SD 12.7) for the
Streptococcus urotype; this was statistically significant (p=0.0013).
Conclusions
For both cohorts of women, when bacteria were detected, the most common urotype
was Lactobacillus. Streptococcus was only present in the IC/PBS cohort and was the only urotype
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that differed with statistical significance; however, interestingly, it was associated with lower
GUPI scores. More research is needed to address EQUC findings in women with IC/PBS and its
impact on symptom severity.
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APPENDIX E
THE CLINICAL URINE CULTURE: ENHANCED TECHNIQUES IMPROVE DETECTION OF CLINICALLY
RELEVANT MICROORGANISMS
Price T.K., Dune T., Hilt E.E., Thomas-White K.J., Kliethermes S., Brincat C., Brubaker L., Wolfe
A.J., Mueller E.R., Schreckenberger P.C. The Clinical Urine Culture: Enhanced Techniques
Improve Detection of Clinically Relevant Microorganisms. J Clin Microbiol. 2016
May;54(5):1216-22. doi: 10.1128/JCM.00044-16. PMID: 26962083

256

257
Overview of Appendix E
This paper compares the use of EQUC and SUC for the detection of uropathogens in
women with and without acute UTI symptoms as assessed by a validated symptom
questionnaire. EQUC detected uropathogens in 84% of women who thought they had a UTI, while
SUC only detected uropathogens in 33% of those women. A streamlined version of EQUC is
recommended by this paper and a current clinical trial, described in the Addendum, is ongoing
to determine the clinical efficacy of its use.
Abstract
Enhanced quantitative urine culture (EQUC) detects live microorganisms in the vast
majority of urine specimens reported as “no growth” by the standard urine culture protocol.
Here, we evaluated an expanded set of EQUC conditions (expanded-spectrum EQUC) to identify
an optimal version that provides a more complete description of uropathogens in women
experiencing urinary tract infection (UTI)-like symptoms. One hundred fifty adult urogynecology
patient-participants were characterized using a self-completed validated UTI symptom
assessment (UTISA) questionnaire and asked, “Do you feel you have a UTI?” Women responding
negatively were recruited into the no-UTI cohort, while women responding affirmatively were
recruited into the UTI cohort; the latter cohort was reassessed with the UTISA questionnaire 3 to
7 days later. Baseline catheterized urine samples were plated using both standard urine culture
and expanded-spectrum EQUC protocols: standard urine culture inoculated at 1μl onto 2 agars
incubated aerobically; expanded-spectrum EQUC inoculated at three different volumes of urine
onto 7 combinations of agars and environments. Compared to expanded-spectrum EQUC,
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standard urine culture missed 67% of uropathogens overall and 50% in participants with severe
urinary symptoms. Thirty-six percent of participants with missed uropathogens reported no
symptom resolution after treatment by standard urine culture results. Optimal detection of
uropathogens could be achieved using the following: 100 μl of urine plated onto blood (blood
agar plate [BAP]), colistin-nalidixic acid (CNA), and MacConkey agars in 5% CO2 for 48 h. This
streamlined EQUC protocol achieved 84% uropathogen detection relative to 33% detection by
standard urine culture. The streamlined EQUC protocol improves detection of uropathogens that
are likely relevant for symptomatic women, giving clinicians the opportunity to receive additional
information not currently reported using standard urine culture techniques.
Introduction
The diagnostic gold standard for clinically relevant urinary tract infection (UTI) continues
to be questioned for both clinical and research purposes. Since the 1950s, clinical practice has
relied on detecting ≥105 CFU/ml of a known uropathogen using the standard clinical urine culture
protocol18. The standard urine culture was initially described for detection of patients at risk for
pyelonephritis19; interpretation has been generalized to diagnose lower urinary tract infection
despite studies reporting limitations of the ≥105 CFU/ml threshold25 304 305 26. While the clinical
focus has centered on various cutoff thresholds, the basic uropathogen detection method
remains unchanged.
Given emerging evidence that documents the presence of urinary microbiota in many
adult women29 35 34 32 30 249 37 306 50 15, it is clear that the mere presence of an organism should
not prompt antibiotic treatment. However, clinicians are likely to benefit from a more complete
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report of organisms present within a symptomatic patient's urine. Recent evidence reports
bacteria in ∼90% of “no-growth” standard urine cultures34 15. We hypothesized that, in women

experiencing UTI-like symptoms, an improved culture protocol would provide a more complete
description of potentially treatable, clinically relevant uropathogens. This study evaluated

various combinations of urine volumes, media, atmospheric environments, and incubation
durations to determine conditions that optimally balance uropathogen detection with feasibility.
Materials and Methods
Study Design and Patient Population
Following institutional review board (IRB) approval, we enrolled 75 women who reported
UTI symptoms and 75 who did not based on their yes/no response to the question “Do you feel
you have a UTI?” Participants were seeking clinical care at Loyola University Medical Center's
Female Pelvic Medicine and Reconstructive Surgery center between June 2014 and August 2015.
Participants gave verbal and written research consent and provided permission for
abstraction of their demographic and clinical information from the electronic medical record. At
baseline, urinary symptoms were characterized using a self-completed, validated UTI symptom
assessment (UTISA) questionnaire, completed by both cohorts307. Participants were
dichotomized based on their yes/no response to the question “Do you feel you have a UTI?”
Those who responded affirmatively (UTI cohort) completed the UTISA questionnaire again by
phone 3 to 7 days post enrollment and were queried about the magnitude of symptom
resolution, if any. All clinical treatment was individually based on physician assessment of patient
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Table E.1. Summary of Urine Cultivation Protocols for Catheterized Urine Specimens.

symptoms and standard urine culture results. Exclusion criteria included age of <18 years,
pregnancy, catheterization (indwelling or intermittent), or insufficient English skills to complete
study measures.
Sample Collection and Analysis
Consistent with patient care clinical protocol, urine was collected via transurethral
catheter and then placed into two BD Vacutainer Plus C&S preservative tubes: one sent to the
clinical microbiology laboratory for diagnostic purposes and one sent to the researchers for
testing.
Table E.1 displays all culture protocols used by the clinical microbiology laboratory staff
and the researchers. The standard urine culture protocol used 1 μl of urine, spread quantitatively
(i.e., pinwheel streak) onto 5% sheep blood (blood agar plate [BAP]) and MacConkey agars (BD
BBL Prepared Plated Media; Cockeysville, MD) and incubated aerobically at 35°C for 24 h. The
modified standard urine culture used the same agars and temperature but changed the
incubation condition to 5% CO2; if pinpoint growth was seen at 24 h, the agars were held for
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another 24 h under the same conditions. Unrelated to this study, the clinical microbiology
laboratory adopted the modified standard urine culture for diagnosis during patient recruitment
for this study. Thus, diagnostic testing for patients 1 to 107 was the standard urine culture, while
the modified standard urine culture was used for patients 108 to 150. However, this change did
not impact data presented in this study, as standard urine culture data for patients 108 to 150
were obtained by analyzing the corresponding subset of expanded enhanced quantitative urine
culture (EQUC) conditions (i.e., 1 μl BAP and MacConkey agars; aerobic, 35°C; 24 h).
The conditions of the original enhanced quantitative urine culture (EQUC) protocol were
described previously34. In this study, we expanded those conditions (i.e., expanded-spectrum
EQUC protocol), using three urine volumes (1 μl, 10 μl, and 100 μl) and additional plating
conditions (Table E.1). Each urine sample was spread quantitatively onto BAP, chocolate, and
colistin-nalidixic acid (CNA) agars (BD BBL Prepared Plated Media) and incubated in 5% CO2 at at
35°C for 48 h; BAP and MacConkey agars were incubated aerobically at 35°C for 48 h; two CDC
anaerobic 5% sheep blood (anaerobic BAP) agars (BD BBL Prepared Plated Media) were incubated
either in microaerophilic Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobically at 35°C
for 48 h.
Three sets of these conditions were used for each urine sample, each using one of the
urine volumes, for a total of 21 agars per sample. All agars were documented for growth (i.e., for
morphologies and CFU per milliliter) at 24 and 48 h, except the two anaerobic BAP conditions.
Each distinct colony morphology was sub-cultured at 48 h to obtain pure culture for microbial
identification.
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Microbial identification was determined using a matrix-assisted laser desorption
ionization–time of flight mass spectrometer (MALDI-TOF MS; Bruker Daltonics, Billerica, MA) as
described previously34. Only clinically relevant microbes (i.e., known and emerging
uropathogens) were used to calculate uropathogen detection. These uropathogens were
selected based on previously published case reports of UTI.
UTISA Questionnaire
This questionnaire asks the participant to rate the degree of severity and bother for seven
common UTI symptoms: frequency of urination, urgency of urination, incomplete bladder
emptying (urinary retention), pain or burning during urination (dysuria), lower abdominal
discomfort or pelvic pain/pressure, lower back pain, and blood in the urine (hematuria). Scores
for each symptom range from 0 to 3; a 0 corresponds to no symptom present, whereas a 3
indicates highest severity or bother. The seven symptoms can be clustered into four symptom
domains: urination regularity (frequency and urgency), problems with urination (incomplete
bladder emptying and pain or burning), pain associated with the UTI (abdominal or pelvic pain
and lower back pain), and blood in the urine307.
Statistical Analyses
Continuous variables were reported as means and standard deviations (SDs) or medians
and interquartile ranges (IQRs); categorical variables were reported as frequencies and
percentages. Pearson chi-square tests (or Fisher's exact tests, when necessary) and 2-sample t
tests (or Wilcoxon rank sum tests, when appropriate) were used to compare demographics and
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Table E.2. Demographic Characteristics and Symptoms.

culture results (e.g., abundance and diversity) between cohorts. Measures of alpha diversity
(diversity within a population) were represented as Shannon diversity indices and/or graphically
by species accumulation curves (which plot accumulation of unique species per group for each
additional sample included). All statistical analyses were conducted using SAS software v9.4 (SAS
Institute, Cary, NC) or Systat software version 13.1 (Systat Software Inc., Chicago, IL).
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Results
Participant Demographic and Symptoms
Table E.2 describes demographics of the two cohorts (75 no-UTI and 75 UTI patients).
Most participants were white (81%) and overweight (mean body mass index [BMI] = 29.3 kg/m2).
Most participants (92%, 138/150) reported at least one urinary symptom; as expected, women
in the UTI cohort had higher UTISA questionnaire scores.
Expanded-Spectrum EQUC: Urinary Microbiota Characteristics
Nearly all (93% [139/150]) catheterized urine samples grew bacterial colonies with at
least one combination of the expanded-spectrum EQUC protocol's conditions (Table E.1). The
no-UTI and UTI cohorts had similar proportions of cultivatable urine samples (89% [67/75] versus
96% [72/75]; P = 0.12), similar numbers of total unique species detected per cohort (75 versus
66), and similar median numbers of species detected per urine sample (3 [IQR = 1 to 5] versus 2
[IQR = 1 to 4]; P = 0.12) (see Table S1 in the supplemental material). However, the cohorts differed
in organism diversity, genus-level composition, and species-level composition. The no-UTI cohort
had more diversity with greater species richness as depicted by species accumulation curves (see
Figure E.S1 in the supplemental material) and greater alpha diversity as measured by the
Shannon diversity index (no-UTI = 3.89 versus UTI = 3.49). The genera Streptococcus (P = 0.003)
and Gardnerella (P = 0.04) were more prevalent in the no-UTI cohort, while the genus Escherichia
(P < 0.001) was detected more often in the UTI cohort (see Figure E.S2). Five species, namely,
Gardnerella vaginalis (P = 0.4), Streptococcus mitis/oralis/pneumoniae (P = 0.01), Streptococcus
parasanguinis (P = 0.02), Streptococcus salivarius (P = 0.05), and Streptococcus sanguinis (P =
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0.01), were detected more often in the no-UTI cohort; in contrast, the species Escherichia coli (P
< 0.001) was more prevalent in the UTI cohort (see Figure E.S3).
The genera Streptococcus (P = 0.003) and Gardnerella (P = 0.04) were more prevalent in
the no-UTI cohort, while the genus Escherichia (P < 0.001) was detected more often in the UTI
cohort (see Figure E.S2). Five species, namely, Gardnerella vaginalis (P = 0.4), Streptococcus
mitis/oralis/pneumoniae (P = 0.01), Streptococcus parasanguinis (P = 0.02), Streptococcus
salivarius (P = 0.05), and Streptococcus sanguinis (P = 0.01), were detected more often in the noUTI cohort; in contrast, the species Escherichia coli (P < 0.001) was more prevalent in the UTI
cohort (see Figure E.S3).
Uropathogen Detection
We next modeled our evaluation to uropathogen detection by the expanded-spectrum
EQUC protocol with regard to the following parameters: detection compared to standard urine
culture, detection with different urine volumes, and detection using different plating conditions.
With these findings, we then identified an optimal subset of expanded-spectrum EQUC
conditions for improved detection of uropathogens, which we call the streamlined EQUC
protocol.
Expanded-Spectrum EQUC Versus Standard Urine Culture
The expanded-spectrum EQUC protocol detected a total of 182 uropathogens in all the
catheterized urine samples, 110 uropathogens in the UTI cohort urine samples, and 72
uropathogens in in the non-UTI cohort urine samples. Whereas the expanded-spectrum EQUC
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Figure E.1. Average CFU per milliliter of uropathogens between the UTI and no-UTI cohorts.
Depicted are the average CFU per milliliter with which the various uropathogens were cultured
for both cohorts: UTI (blue bars) and no-UTI (red bars). Average CFU of Klebsiella pneumoniae
(P = 0.04) and Streptococcus agalactiae (P = 0.02) are significantly higher in the UTI cohort (*).
Several uropathogens had substantially lower average CFU-per-milliliter values in the no-UTI
cohort than in the UTI cohort: Aerococcus urinae (P = 0.12), Enterococcus faecalis (P = 0.09),
Escherichia coli (P = 0.08), Staphylococcus aureus (P = 0.06), and Streptococcus anginosus (P =
0.08). Independent t test (*, P < 0.05). Black bars depict common UTI thresholds (≥105 CFU/ml
and ≥103 CFU/ml).
did not miss any uropathogen detected by standard urine culture, the standard urine culture
protocol detected 33% (60/182) of all detected uropathogens, 50% (55/110) of those detected
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Table E.3. Optimal Detection of Specific Uropathogens by the Expanded-Spectrum EQUC
Protocol.

aListed are the uropathogens and the number of times that each was cultured under each
expanded-spectrum EQUC plating condition. The condition(s) that best detected each
uropathogen is shaded.
in the UTI cohort, and only 7% (5/72) of those detected in the non-UTI cohort.
The expanded-spectrum EQUC protocol detected all uropathogens at a higher average
CFU per milliliter in the UTI cohort than in the no-UTI cohort (Figure E.1). This protocol detected
E. coli in a total of 50 samples obtained from both cohorts; of these, standard urine culture
detected E. coli in 88% (44/50). From the UTI cohort alone, expanded-spectrum EQUC detected
E. coli in 43 samples; of these, standard urine culture detected E. coli in 91% (39/43). In contrast,
standard urine culture detected a strikingly low fraction (12% [16/132]) of the non- E. coli
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uropathogens detected in the two cohorts by the expanded-spectrum EQUC protocol.

This

percentage was only slightly better in the UTI cohort alone, where standard urine culture
detected 24% (16/67) of the non-E. coli uropathogens detected by the expanded-spectrum EQUC
protocol. Therefore, standard urine culture's capacity to detect E. coli dramatically skewed its
overall uropathogen detection value.
Expanded-Spectrum EQUC: Urine Volumes
Uropathogen detection differed greatly based on expanded-spectrum EQUC urine
volumes: for 100 μl, 96% detection (174/182); for 10 μl, 65% detection (118/182); and for 1 μl,
52% detection (95/182) versus standard urine culture (33% [60/182]). Some uropathogens were
detected equally by all volumes (e.g., E. coli and Pseudomonas aeruginosa); others most often
required 100 μl for detection (e.g., Aerococcus urinae, Alloscardovia omnicolens, Enterococcus
faecalis, and Streptococcus anginosus) (see Figure E.S4).
Expanded-Spectrum EQUC: Plating Conditions
Table E.3 displays uropathogens and the number of times that each was cultured under
the various expanded-spectrum EQUC plating conditions. After 48 h incubation, CDC anaerobic
BAP incubated anaerobically detected the most uropathogens (63% [115/182]), followed by BAP
in 5% CO2 (62% [112/182]), CDC anaerobic BAP incubated microaerophilically (54% [98/182]),
chocolate agar in 5% CO2 (53% [96/182]), BAP incubated aerobically (52% [94/182]), CNA agar in
5% CO2 (43% [79/182]), and MacConkey agar incubated aerobically (34% [62/182]). Although the
CNA agar condition detected fewer uropathogens, it ideally detected Gram- positive
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Table E.4. Detection of Uropathogens in UTI Cohort without Symptom Improvement.

uropathogens when Gram-negative bacteria overwhelmed other agars. For example, of the 47
samples where a Gram-negative uropathogen was present at ≥50,000 CFU/ml, the CNA agar
condition detected 27 underlying Gram-positive uropathogens, all of which were missed by
standard urine culture (see Table S2A in the supplemental material). Conversely, of the seven
samples where a Gram-positive uropathogen was present at ≥50,000 CFU/ml, the MacConkey
condition detected two underlying Gram-negative uropathogens (see Table E.S2B).
Streamlined EQUC Protocol
One hundred microliters of urine plated on a combination of BAP and CNA agars in 5%
CO2 and MacConkey agar under aerobic conditions would have detected 84% (152/182) of all
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uropathogens detected by the expanded-spectrum EQUC protocol. This is vastly superior to the
33% (60/182) uropathogen detection by standard urine culture. In the UTI cohort alone, the
streamlined EQUC protocol (Table E.1) would have detected 91% (100/110) of uropathogens,
compared to only 52% (57/110) by standard urine culture.
Symptom Resolution
Seventy-nine percent (59/75) of the participants in the UTI cohort completed the followup UTISA questionnaire. Following clinically selected treatment based on standard urine culture
(or modified standard urine culture), 59% (35/59) of participants reported symptom
improvement, while 41% (24/59) reported no improvement (same or worse) (Table E.4). Half
(12/24) of the 24 participants who did not improve had at least one uropathogen detected only
by the expanded-spectrum EQUC protocol, and 13 (54%) had microorganisms of unknown
pathogenicity, which were detected only by the expanded-spectrum EQUC protocol (see Table
S3 in the supplemental material). Importantly, all of these missed uropathogens would have also
been detected using the streamlined EQUC protocol. Ten of the 24 patients who did not improve
had been clinically treated with antibiotics based on the finding of a standard urine culturedetected uropathogen. However, in 3 (30%) of these 10 patients, the expanded-spectrum EQUC
(as well as streamlined EQUC) detected an additional Gram-positive uropathogen (Aerococcus
urinae, Corynebacterium riegelii, or Streptococcus anginosus).
Discussion
Accurate diagnosis for women with UTI symptoms is critical, both to target appropriate
therapy and to limit inappropriate antibiotic use. Our study demonstrates deficiencies in the
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standard urine culture protocol that limit potentially important information that should be
provided to clinicians. Our findings suggest that improved detection of clinically relevant urinary
microbes can be achieved in all diagnostic clinical laboratories using the following conditions: a
100-μl urine sample obtained by transurethral catheter plated onto BAP, CNA, and MacConkey
agars, with incubation of all agars in 5% CO2 for 48 h. While incubation of MacConkey agar in 5%
CO2 may not improve Gram-negative bacillus recovery, we recommend that all agars be
incubated in 5% CO2 for the convenience of using a single incubator. All detected uropathogens
will grow under the conditions described in the streamlined EQUC protocol.
Our findings support the use of the streamlined EQUC protocol to more fully describe
uropathogens. We also recommend that 1μl of the catheterized urine be plated onto BAP and
MacConkey agars and incubated in 5% CO2 for 24 h with an option to incubate for 48 h (modified
standard urine culture). The streamlined EQUC protocol provides the most thorough detection
of uropathogens, while the modified standard urine culture ensures accurate colony count
assessment and is beneficial for species detection of underlying uropathogens when bacterial
colony counts of a predominant uropathogen exceed 105 CFU/ml. The need for modified
standard urine culture inclusion is apparent from the observation that the expanded- spectrum
EQUC (and the streamlined EQUC) protocols were not 100% sensitive. In the expanded-spectrum
EQUC protocol, the use of 100 μl urine detected the most microbes and the most uropathogens.
However, a small number of uropathogens were detected only with the use of a smaller urine
volume (10 μl). This apparent paradox likely results from microbial overcrowding in samples
containing high numbers of CFU; in these circumstances, 100 μl was not ideal for distinguishing

272
morphologies. While addition of selective media (i.e., CNA and MacConkey agars) helped detect
underlying uropathogens, some samples contained both Gram-positive and Gram-negative
bacteria at high CFU numbers, likely making the 100-μl expanded-spectrum EQUC volume less
efficient.
Streamlined EQUC would provide more information to clinicians who are considering the
clinical need for uropathogen(s) treatment; many of these are currently missed by the standard
urine culture protocol. Until better information is available concerning the relationship between
clinically important UTI and CFU per milliliter, we recommend that these testing conditions (i.e.,
streamlined EQUC) be used for patients with recurrent UTIs or patients with clear UTI-like
symptoms despite a negative standard urine culture result. Nonetheless, it is clear that treatment
based on standard urine culture results limits diagnostic information that may be useful for
symptom resolution. This study did not assess symptom relief in patients whose uropathogens
were detected only with the streamlined EQUC protocol. Such studies are clearly needed.
Compared to the expanded-spectrum EQUC, the standard urine culture missed 67%
(122/182) of all detected uropathogens and 88% (116/132) of non-E. coli uropathogens.
Detection of uropathogens by the standard urine culture was slightly better for the UTI cohort
alone (50% total missed [55/110]; 76% non-E. coli missed [51/67]). This improvement may result
from the higher average uropathogen CFU per milliliter in the UTI cohort (Figure E.1), making
detection by standard urine culture more likely. The data in Table E.1 also reveal that the use of
one threshold for UTI diagnosis is likely incorrect. Use of the ≥105-CFU/ml threshold would result
in untreated uropathogens in the UTI cohort (Figure E.1). Lowering the threshold to ≥103 CFU/ml,
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however, creates other concerns. While use of the ≥103-CFU/ml threshold would leave fewer
uropathogens in the UTI cohort untreated, it would detect some uropathogens in the no-UTI
cohort. Since individuals in the no-UTI cohort presumably do not have an infection (i.e., no/low
severity of urinary symptoms), it is unlikely that they would benefit from antibiotic use. This
creates a problem in diagnosis and treatment of UTIs and is likely the reason for the current
ambiguity surrounding urine cultures. From these data, we suggest the possibility that, for UTI
diagnosis, each uropathogen may have its own unique threshold (e.g., ≥102 CFU/ml for
Aerococcus urinae, ≥103 CFU/ml for Streptococcus agalactiae, and ≥104 CFU/ml for Klebsiella
pneumoniae).
Our findings in a selected, health care-seeking population of women should be
generalized with caution to community-dwelling women who may or may not have similar
microbial profiles in health or during UTI. Microbial characterization of women longitudinally may
provide additional context for interpretation of standard and streamlined culture results.
It appears that simple changes to the commonly performed standard urine culture
protocol have the capacity to provide potentially useful clinical information. Importantly, the
urine must be collected by catheter, as we have previously shown that vulvovaginal
contamination renders clean-catch voided specimens obsolete4. At this time, we suggest that
the recommended culture conditions (i.e., streamlined EQUC) be considered both as a
supplemental test when individuals with UTI-like symptoms have “no growth” via standard urine
culture and for use with individuals with persistent UTI-like symptoms (i.e., recurrent UTI).
Supplementary Materials
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Figure E.S1. Species accumulation curves of UTI and No-UTI Cohorts. Species accumulation data
depicts the number of unique species cultured (using the Expanded Spectrum EQUC) with each
new patient sampled. When the curve plateaus, it indicates that the community is fully sampled
and few, if any, new species will be identified. Therefore, it also measures the overall diversity
of the population in terms of species richness. The UTI cohort (blue line) is comprised of 66
species. The No-UTI cohort (red line) is comprised of 75 species.
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Figure E.S2. Frequency of detection of genera in the UTI and No-UTI cohorts. Depicts the
frequency (i.e., percentage) of detection (using the Expanded Spectrum EQUC) of the urine
samples containing each genus between the UTI (blue bars) and No-UTI (red bars) cohorts.
Streptococcus (p=0.003), Gardnerella (p=0.04), and Escherichia (p<0.001).
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Figure E.S3. Species significantly different between the UTI and No-UTI cohorts. Depicts the
frequency (i.e., percentage) of detection (using the Expanded Spectrum EQUC) of the species
that are statistically associated with either the UTI (blue bars) and No-UTI (red bars) cohorts.
Gardnerella vaginalis (p=0.04), Streptococcus mitis/oralis/pneumoniae (p=0.01), Streptococcus
parasanguinis (p=0.02), Streptococcus salivarius (p=0.05) and Streptococcus sanguinis (p=0.01)
are associated with the No-UTI cohort. Escherichia coli (p<0.001) is associated with the UTI
cohort. Pearson chi-square and Fisher’s exact test (* p<0,05; **p<0.01,*** p<0.001). The species
S. mitis, S. oralis, and S. pneumoniae were grouped together because they cannot accurately be
distinguished using MALDI-TOF MS.
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Figure E.S4. Detection of Uropathogens by each expanded spectrum EQUC urine volume.
Depicts the total number of times each uropathogen was identified by each of the urine volumes
(1 µL, 10 µL, 100 µL) in the Expanded Spectrum EQUC protocol as well as the Standard Urine
Culture protocol: Standard Urine Culture (blue bars), 1µL Expanded Spectrum EQUC (purple
bars), 10 µL Expanded Spectrum EQUC (green bars), and 100 µL Expanded Spectrum EQUC (red
bars).
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Table E.S1. Urinary Microbiota Characteristics.

Cultivatable Urine Samples
Total number of unique species
Median number of unique specie per isolate, mdn (IQR)
Shannon Diversity index
IQR = Interquartile Range. Mdn = median
* Chi-Square Test
**Wilcoxon Rank Sum Test

UTI
(n=75)
72 (96%)
66
2 (1-4)
3.49

No-UTI
(n=75)
6 (89%)
75
3 (1-5)
3.89

p-value
0.12*
0.12 **
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Addendum
Data collected from this project was used as a rationale and to power a clinical trial
designed to determine if the recommended, “Optimal EQUC”, protocol results in improved
patient care. We are currently recruiting patients at the Loyola University Medical Center
Urogynecology Clinic for this trial. Our goal is to recruit 225 women, who respond “yes” when
asked, “Do you feel you have a urinary tract infection today?”. TUC specimens are being collected
from these patients, and symptoms are characterized using the UTISA questionnaire. The
questionnaire was slightly modified to include an additional question asking the patient to choose
which symptom is most severe/bothersome. Participants are randomized, doubled-blinded, in a
2:1 ratio to receiving SUC or Optimal EQUC, performed by the hospital clinical microbiology
laboratory. A treatment algorithm in which all uropathogens, regardless of CFU/mL, are
considered for symptom etiology. Clinical treatment is provided (clinicians are blinded to method
used). A post-treatment questionnaire is sent to all participants; this includes the UTISA
questionnaire, and a series of questions to determine if the patient feels “better”. Patients who
do not report feeling “better” are asked to return to the clinic, a follow-up TUC specimen is
collected, and Optimal EQUC is performed regardless of starting cohort. Clinical treatment is
provided again, if prompted. A second post-treatment questionnaire is sent to the follow-up
participants.
This study will help us determine if use of Optimal EQUC improves patient care. We
predict that some patients who originally receive SUC will report no symptom resolution
following treatment (if any). They will return, receive Optimal EQUC and then symptoms will
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resolve following a more appropriate treatment. This study is a registered clinical trial
(NCT03190421).

More

information

can

be

found

at

the

following

link:

https://clinicaltrials.gov/ct2/show/NCT03190421?cond=UTI&cntry=US&state=US%3AIL&draw=
1.
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APPENDIX F
URINARY SYMPTOMS AND THEIR ASSOCIATIONS WITH URINARY TRACT INFECTIONS IN
UROGYNECOLOGIC PATIENTS
Dune T., Price T.K., Hilt E.E., Thomas-White K.J., Kliethermes S., Brincat C., Brubaker L.,
Schreckenberger P., Wolfe A.J., Mueller E.R. Urinary Symptoms and their Associations with
Urinary Tract Infections in Urogynecologic Patients. Obstet. Gynecol. 2017 Oct;130(4):718-725.
doi: 10.1097/AOG.0000000000002239.
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Overview of Appendix F
This paper compares three methods for UTI diagnosis and the relationship of each to
urinary symptoms, as characterized by the use of the UTISA questionnaire307. These three
methods are: self-report (a non-culture-based UTI diagnosis) which was defined by the Yes/No
response to the query “Do you think you have a UTI?”, and two culture-based UTI diagnoses,
including the Standard Urine Culture (≥104 CFU/mL of any uropathogen) and the Enhanced
Quantitative Urine Culture (≥10 CFU/mL of any uropathogen). We found that the presence of
frequency and urgency did not differ between “UTI-positive” and “UTI-negative” women defined
by any of the three methods used. Conversely, the presence of dysuria (pain during urination)
was significantly more common in the “UTI-positive” women by all three methods used.
Abstract
Objective
The goal of this study was to assess urinary symptoms associated with urinary tract
infection (UTI) in a urogynecologic population of women. The primary measure (i.e. UTI diagnosis)
was defined in three ways: self-report, Standard Urine Culture and Enhanced Quantitative Urine
Culture.
Methods
We enrolled 150 urogynecologic patients, who completed the validated UTI Symptom
Assessment questionnaire and contributed transurethral catheterized urine samples. Three
methods for diagnosis of UTI were compared to symptoms. Self-report (a non-culture-based UTI
diagnosis) was defined by the Yes/No response to the query “Do you think you have a UTI?” Two
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culture-based UTI diagnoses also were analyzed: Standard Urine Culture (≥104 CFU/mL) and
Enhanced Quantitative Urine Culture (≥10 CFU/mL) of any uropathogen. Statistical analyses were
performed on patient demographics and urinary symptom prevalence among patient groups.
Results
The presence of the urinary symptoms of frequency and urgency did not differ between
‘UTI-positive’ and ‘UTI-negative’ women, regardless of the UTI diagnosis method (self-report,
Standard Urine Culture, or Enhanced Quantitative Urine Culture). However, the presence of
dysuria during urination was significantly more prevalent in ‘UTI-positive’ women for all UTI
definitions. Furthermore, women reporting dysuria had statistically higher severity and bother
scores for all other urinary symptoms assessed by the UTI Symptom Assessment questionnaire,
compared to women not reporting dysuria.
Conclusion
Our findings show that in women seeking urogynecologic care, presence of frequency and
urgency of urination do not confirm a culture-based UTI diagnosis. Instead, clinicians can more
readily detect UTI using the presence of dysuria, which more effectively discriminates UTIpositive and UTI-negative individuals, regardless of the culture-based method used to diagnose
UTI.
Introduction
Clinicians typically rely on patient-reported symptoms to diagnose UTI in ambulatory
adult women. Seven classic UTI symptoms, including frequency and urgency of urination are
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included in the only validated UTI symptom survey307. Yet many clinicians accept that frequency
and urgency are non-specific for a culture-based UTI diagnosis and frequency and urgency may
add little or nothing to a UTI diagnosis in a urogynecologic population.
Clinicians face a dilemma when assessing UTI in urogynecologic patients with chronic
frequency and/or urgency. In this population, Fitzgerald et al. found that chronic frequency and
incontinence of urine were unlikely to be symptoms reliably associated with UTI308. Thus, despite
scant evidence, patients and clinicians may rely on changes in baseline symptoms to detect UTI
(e.g., worsened urgency and/or frequency, dysuria). In the urogynecologic population, clinicians
typically assume a non-bacteriologic etiology for urgency and/or frequency when standard UTI
testing is negative. However, recent advances in understanding the female urinary microbiota29
32 30 50 306 37 35 34 44

demonstrate that most women have detectable bacteria present using an

Enhanced Quantitative Urine Culture protocol despite a negative Standard Urine Culture34 44. This
new knowledge complicates our understanding of bladder health and disease, including UTIs.
We assessed the proportion of patients with symptoms using three different definitions
of UTI (self-report, Standard Urine Culture, and Enhanced Quantitative Urine Culture). Our goal
was to determine if urinary symptoms differ among the diagnosis methods, as well as to identify
symptoms that are the strongest indicators of UTI regardless of diagnosis method.
Materials and Methods
Our a priori sample size of 150 urogynecologic patients was enrolled following
Institutional Review Board (IRB) approval. Participants were volunteers from consecutively
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approached adult women seeking clinical urogynecologic care at Loyola University Medical
Center’s Female Pelvic Medicine and Reconstructive Surgery center between June 2014 and
August 2015. Exclusion criteria included age <18, pregnancy, catheterization (indwelling or
intermittent) or insufficient English skills to complete study measures. Participants contributed
demographic and questionnaire data, as well as a single transurethral catheterized urine sample.
Two cohorts, each with 75 women, were formed based on their self-report of UTI presence using
the query: “Do you feel you have a UTI?” (Yes/No). All participants completed the validated UTI
Symptom Assessment questionnaire307, in which the participant rates the severity and bother for
seven common UTI symptoms (frequency and urgency of urination, dysuria, difficulty urinating,
lower abdominal/pelvic pain or pressure, low back pain, blood in urine); the UTI Symptom
Assessment questionnaire further groups the 7 symptoms into four domains. Scores for each
symptom range from 0 (no symptom) to 3 (highest severity or bother). Participants who reported
UTI symptoms (Yes cohort) were also asked to qualitatively document any UTI-related symptoms.
Participants were clinically characterized using standard urogynecologic history and
physical assessments. Consistent with the patient care clinical protocol, each patientparticipant’s urine was collected aseptically via transurethral catheterization and placed into BD
Vacutainer Plus C&S preservative tubes. Each specimen was processed by two clinical laboratory
methods: The Standard Urine Culture method and an expanded spectrum version of the
Enhanced Quantitative Urine Culture method. The Enhanced Quantitative Urine Culture method
was developed by our team and has been previously described34

. Table F.1 displays the

44
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Table F.1. Summary of Urine Cultivation Protocols and Urinary Tract Infection Diagnosis
Definitions.

parameters of these two culture-based methods. The Standard Urine Culture protocol used 1µL
of urine, spread quantitatively (i.e., pinwheel streak) onto 5% sheep blood (BAP) and MacConkey
agars (BD BBL™ Prepared Plated Media, Cockeysville, MD) and incubated aerobically at 35°C for
24 hours. The limit of microbial detection for standard urine culture is 103 CFU/mL. The UTI
diagnosis definition for Standard Urine Culture was ≥104 CFU/mL of a uropathogen. The
Expanded Spectrum Enhanced Quantitative Urine Culture protocol used 1, 10, and 100µL of
urine, spread quantitatively (i.e., pinwheel streak) onto 5% sheep blood (BAP), MacConkey,
Chocolate, CNA, and CDC Anaerobic BAP (BD BBL™ Prepared Plated Media, Cockeysville, MD) and
incubated aerobically, in 5% CO2, anaerobically, or in microaerophilic conditions at 35°C for 48
hours, although some plates were documented for growth at 24 hours. The limit of microbial

287
Table F.2. Patient Demographics and Symptoms by Self-Report or Dysuria.

detection for the enhanced quantitative urine culture is 10 CFU/mL. The UTI diagnosis definition
for Enhanced Quantitative Urine Culture was ≥10 CFU/mL of a uropathogen.
Continuous variables were reported as means with standard deviations (SD) or medians
with ranges; categorical variables were reported as frequencies and percentages. Pearson Chisquare tests (or Fisher’s Exact Tests, when necessary) and 2-sample t-tests (or Wilcoxon Rank
Sum tests, when appropriate) were used to compare demographics and culture results (e.g.,
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Table F.3. List of Uropathogens.

abundance and diversity) between cohorts. All statistical analyses were conducted using SAS
software v9.4 (SAS Institute, Cary, NC) or SYSTAT software version 13.1 (SYSTAT Software Inc.,
Chicago, IL).
Results
The study population (150 participants) had an average age of 62.3 years ± 14.9 years;

most were Caucasian (81%) and overweight (mean body mass index 29.3 kg/m2 ± 6.3 kg/m2)
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(Table F.2). Nearly all participants (92% [138/150]) endorsed symptoms on the UTI Symptom
Assessment questionnaire. Additional patient and clinical demographics were previously
published44.
Using Standard Urine Culture, only 38% (57/150) of samples grew microbial colonies (11
different species from 10 different genera, median number of 1 microbial species per urine
sample). Using the Expanded Spectrum Enhanced Quantitative Urine Culture, nearly all samples
[139/150 (93%)] grew microbial colonies (98 different species from 36 different genera, median
number of 2 microbial species per urine sample). Consistent with the current clinical uropathogen
literature, we classified all 11 species detected by Standard Urine Culture and 23 of the species
detected by the Expanded Spectrum Enhanced Quantitative Urine Culture as uropathogens
(Table F.3).
Of the 150 participants, by our a priori study design, 75 were in each self-reported cohort
(Yes/No); these two groups were similar demographically (Table F.2). We did not detect
significant differences in the proportions of urine samples with detected bacteria [No selfreported UTI=89% (67/75) vs. self-reported UTI=96% (72/75); p=0.12] or total unique species per
urine sample (75 vs. 66; p=0.31). Although the no self-reported UTI cohort had a larger median
number of detected species per urine sample when compared to the self-reported UTI group,
the difference was not statistically significant [3 (IQR=1-5) vs. 2 (IQR=1-4); p=0.12].
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Table F.4a. Patient Demographics and Symptoms Defined by Standard or Expanded Spectrum
Enhanced Quantitative Urine Culture.

Table F.2 also displays the percentage of patients reporting each UTI symptom. Symptoms
were endorsed by all women who self-reported UTI (100%, 75/75) and most women in the no
self-reported UTI population (84%; 63/75). However, women who self-reported UTI had higher
average scores (severity and bother scores combined) for the seven symptoms and four domains
of the UTI Symptom Assessment questionnaire. In addition to the UTI symptom assessment
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Table F.4b. Patient Demographics and Symptoms Defined by Standard or Expanded Spectrum
Enhanced Quantitative Urine Culture (continued).

questionnaire-measured symptoms, 64/75 women in the self-reported UTI population
qualitatively reported their UTI symptoms and 19% (12/64) indicated the presence of malodorous
urine. The presence of frequency and urgency of urination did not differ between the cohorts;
however, dysuria was significantly more prevalent in the self-reported UTI population.
Fifty-seven individuals (38%) met the criterion for UTI using Standard Urine Culture, most
(91%) of whom also self-reported UTI (Table F.4). Except for age, the Standard Urine Culture
defined UTI-positive population did not differ demographically from the UTI-negative population.
Table F.4 displays the proportion of patients reporting UTI symptoms and dichotomized
by culture-based UTI diagnoses. Nearly all (98%) of the Standard Urine Culture defined UTIpositive and a majority [88% (82/93)] of the UTI-negative population endorsed symptoms on the
UTI Symptom Assessment questionnaire. Similar to results by self-reported UTI (Table F.2), the
presence of frequency and urgency of urination did not differ largely between the cohorts, while
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dysuria was significantly more prevalent in the Standard Urine Culture defined UTI-positive
population. Twenty percent (9/44) of women who were both Standard Urine Culture defined UTIpositive and self-reported UTI reported malodorous urine.
One hundred and ten (73%) women met the criterion for UTI as defined by the Enhanced
Quantitative Urine Culture (Table F.4); most also self-reported UTI (63%, 69/110). The Enhanced
Quantitative Urine Culture defined UTI-positive population did not differ demographically from
the UTI-negative population (Table F.4). Most of the Enhanced Quantitative Urine Culture
defined UTI-positive and UTI-negative women endorsed symptoms on the UTI Symptom
Assessment questionnaire [92% (101/110) and 93% (37/40), respectively]. The presence of
frequency and urgency of urination did not differ largely between the cohorts, while dysuria was
significantly more prevalent in the Enhanced Quantitative Urine Culture defined UTI-positive
population. Nineteen percent (11/57) of women who were both Enhanced Quantitative Urine
Culture defined UTI-positive and self-reported UTI reported malodorous urine.
Discussion
Our findings suggest that, in urogynecologic patients, dysuria is a better clinical clue to
UTI than urinary frequency or urgency or both. While clinicians and validated UTI measures that
include urinary urgency and frequency have utilized the Standard Urine Culture as the current
standard for UTI diagnosis, this approach has not been evaluated in urogynecologic patients. In
our participants, urgency and frequency correlated poorly with culture-based UTI diagnostic tests
and did not contribute to a correct UTI diagnosis. Dysuria, however, appeared relevant and more
specific; therefore, the use of dysuria as a key UTI symptom warrants further assessment.
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Abnormal urinary odor is not included in the currently validated UTI assessment tool, yet
participants often reported this symptom as a sign of UTI; this correlates with our clinical
experience. We suggest that odor be included in a modified tool, at least for urogynecologic
populations. Conversely, hematuria was rarely reported and may have less importance as a UTIrelated symptom in this population.
It is critical that we improve current UTI detection methods. In response to patientreported symptoms, clinicians consider it proper to empirically treat acute uncomplicated UTIs
in pre-menopausal women who experience infrequent episodes of UTI with typical symptoms,
e.g. urgency and frequency20 309 310. In urogynecologic populations, however, the chronic presence
of these symptoms complicates UTI diagnosis. Clinicians often rely on Standard Urine Culture,
which requires growth of at least one uropathogen above a certain threshold. However, our
group has found that this method misses most non-E. coli uropathogens44. This and other
emerging knowledge about urinary microbiota may provide information about the absence of
good bacteria, as well as the presence (or overabundance) of bad bacteria. In a companion to
this study44, we reported that urine samples from women who did not self-report UTI were likely
to be predominated by Lactobacillus, Streptococcus, and Gardnerella, an observation that is
consistent with previous reports37 35 15. In contrast, the urine of women with UTI were more likely
to contain traditional uropathogens at the expense of Gardnerella, Streptococcus and
Lactobacillus44, which may be a clue to the composition of healthy microbiota, consistent in part
with previous observations35 15. Given its beneficial role in the genito-urinary tract162

,

311 199 312

Lactobacillus in the bladder may prevent UTI or facilitate microbial restoration following UTI
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treatment. Thus, clinicians must balance appropriate, selective UTI testing with the risk of
antibiotic overuse. Given the beneficial protective role of certain bacteria in the bladder50 37,
improved UTI testing and treatment algorithms in urogynecologic patients may improve patient
care.
The colony count threshold has been debated extensively. In this study, we tested a
traditional threshold with the standard method, as well as a lower threshold with an enhanced
culture protocol. The former was chosen because it is the most widely used threshold and
method for UTI diagnosis in this patient population. We chose the latter to detect as many
potential pathogens as possible.
Strengths of our study include various definitions of UTI, including simple self-report, two
different thresholds for culture methods and the Enhanced Quantitative Urine Culture technique.
Our study also benefits from an enhanced means of describing patient symptoms through the
validated UTI Symptom Assessment questionnaire. Finally, we reduced vulvo-vaginal
contamination through standardized urethral catheterization collection techniques.
Limitations of this study include a lack of ethnic diversity of the study population. We
recommend caution in generalizing our findings beyond this subspecialty population. In addition,
we did not complete an a priori power calculation due to a lack of effect size estimates in the
literature. We hope our findings will inform these aspects of future studies.
Clinicians may wish to include microbial assessment using the streamlined version of the
Enhanced Quantitative Urine Culture, which we recently recommended for patients with
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negative Standard Urine Culture results and persistent or refractory urinary symptoms44. Good
antibiotic stewardship in this population may need to incorporate a more personalized approach
to antibiotics use that aligns more closely with specific symptoms. Such techniques will help
clinicians and patients move away from the simplistic approach of kill the uropathogen and better
understand the role of good and bad bacteria that inhabit the female bladder. Also, certain
women may benefit from an approach that ensures restoration of a healthy urinary microbiota
following UTI treatment. Further research into these compelling areas of women’s urinary health
may reduce the morbidity and costs associated with poorly controlled bladder symptoms and
improve diagnostic precision and treatment.
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APPENDIX G

URINE TROUBLE: SHOULD WE THINK DIFFERENTLY ABOUT UTI?
Price T.K., Hilt E.E., Dune J., Mueller E.R., Wolfe A.J., Brubaker L. Urine Trouble: Should we think
Differently about UTI? Int. Urogynecol. J. 2018 Feb;29(2):205-210. doi: 10.1007/s00192-0173528-8. Epub 2017 Dec 26.

296

297
Overview of Appendix G
This in an opinion paper, primarily describing the works from Appendix E and Appendix
F. The goal of this paper is to question the current methods and understanding of UTI in the
context of more recently presented research (e.g. the urinary microbiome).
Abstract
Urinary tract infection (UTI) is clinically important, given that it is one of the most common
bacterial infections in adult women. However, the current understanding of UTI remains based
on a now disproven concept that the urinary bladder is sterile. Thus, current standards for UTI
diagnosis have significant limitations that may reduce the opportunity to improve patient care.
Using data from our work and numerous other peer-reviewed studies, we identified four major
limitations to the contemporary UTI description: the language of UTI, UTI diagnostic testing, the
Escherichia coli-centric view of UTI, and the colony-forming units (CFU) threshold-based
diagnosis. Contemporary methods and technology combined with continued rigorous clinical
research can be used to correct these limitations.
Introduction
Urinary tract infection (UTI) is the most common bacterial infection in adult women, with
50% of women experiencing at least one UTI in their lifetime and as many as 10% having at least
one UTI annually. UTI is among the most common reasons for antibiotic treatment20

229

. The

nomenclature and concepts of UTI, based on the now disproven dogma that the lower urinary
tract is a sterile environment, have remained stagnant over many decades. This older dogma has
been informed with scientific evidence that some bacteria are present in the absence of urinary
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symptoms or a positive result of traditional UTI tests (urinalysis or standard urine culture).
Although discovery of the urinary microbiota should clearly affect the care of women with UTI,
specific clinical changes occur slowly. It is already clear that the widely used standard urine
culture methods for detecting urinary bacteria have significant limitations compared with 16S
rRNA gene sequencing29

30 15

and more sensitive enhanced culture techniques15

35 32 34

. These

more sensitive assays have demonstrated that the female urinary bladder contains its own
community of microbes, or microbiota. It is increasingly evident that alterations to the microbiota
throughout the human body can have an impact on health.
We believe that it is time to advance UTI diagnosis and treatment. The first step in this
process is a clear discussion of the limitations of the current standards in the context of the new
knowledge about the female urinary microbiota. Although empiric treatment is currently
pragmatic and highly effective for symptom resolution in uncomplicated, infrequent UTI, we
anticipate that increasing recognition of the collateral effects of this regimen may cause a change
in this practice. Our therapeutic goal should be to provide an optimal treatment, with high
efficacy and few, if any, undesired effects. We highlight four major limitations in current UTI
thinking: the language of UTI, UTI diagnostic testing, the Escherichia coli-centric view of UTI, and
the colony-forming units (CFU) threshold-based diagnosis. Future research to overcome these
limitations using rigorous clinical testing is paramount.
The Limitations of the Language of UTI
The widely used UTI nomenclature is based on a dichotomous clinical scenario—infected
or not (with the odd exception of asymptomatic bacteriuria). The traditional view of UTI envisions
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uropathogens invading a previously sterile environment (the bladder) to cause infection.
Antibiotics come to the rescue to rid the person of the invading microbes and the bladder returns
to the previously uninfected state. This language is grossly inconsistent with our current scientific
knowledge about UTI. More importantly, this language does not recognize changes in the
community of microbes that reside in the bladder. This microbial community can have beneficial
functions in warding off infection. Furthermore, disruption to the resident microbial community
(i.e., dysbiosis) could plausibly result in UTI symptoms, as is the case with several other disorders
(see below). In adult women, such dysbioses could result from an invading microbe in the urinary
system, an antimicrobial treatment, or some change to the host’s metabolism or immune system.
Nonetheless, our current language does not place the “UTI-causative microbe invades” concept
in the context of non-causative microbes. The goal of UTI treatment should not be to eradicate
every microbe in the bladder, especially given the evidence that some members of the urinary
microbiota are beneficial and/or protective15.
The Limitations of UTI Testing
The Standard Urine Culture (SUC) is currently the diagnostic gold standard for confirming
the presence of bacteriuria for UTI diagnosis. Unfortunately, SUC has significant limitations that
have resulted in a profound detection bias. This bias has caused fundamental misunderstandings
of the bacterial contributions to urinary health and disease.
Typically, SUC is performed in a clinical laboratory by plating 1 μL of urine onto Blood and
MacConkey agar plates and incubating aerobically at 35 °C for 24 h. Since the original description
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Figure G.1. Patient Schematic of Price et al, 2016. (Price et al, 2016).
of this technique in the 1950s19, this protocol has been adopted as the standard diagnostic tool
for the detection of UTIs, despite numerous limitations reported by many different
investigators25

26
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. These limitations include: the inability to detect slow-growing

microorganisms, the inability to grow fastidious and non-aerobic microorganisms, the inability to
detect microorganisms present at less than 103 CFU/mL, and the difficulty of detecting underlying
Gram-positive bacteria due to a lack of selective media.
More sensitive culture techniques, such as Expanded Quantitative Urine Culture (EQUC),
have repeatedly shown that SUC possesses a 90% false-negative rate15 35 34. Relative to SUC, this
enhanced urine culture protocol uses 100x more urine plated onto several different media and
environmental conditions with twice the incubation time34. EQUC has provided compelling
evidence that almost every adult female studied to date is bacteriuric229.
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In 2016, we demonstrated that SUC even fails to detect “clinically relevant
microorganisms” in symptomatic patients44. We prospectively enrolled 150 urogynecology
patients and dichotomized the group based on their UTI perception by asking,
“Do you feel you have a UTI?” (Figure G.1) Transurethral catheterized urine specimens were
collected and urinary symptoms were documented using the validated UTI Symptoms
Assessment (UTISA) questionnaire307.
We assessed the microbiota using both SUC and EQUC. In the catheterized urine sample
of most women in the UTI cohort (69 out of 75), EQUC detected one or more bacteria that the
literature classifies as uropathogens. In these 69 urine samples, EQUC identified a total of 110
uropathogens. In contrast, SUC only detected 50% (55 out of 110) of these uropathogens.
Seventy-nine percent (59 out of 75) of the participants in the UTI cohort completed the followup UTISA questionnaire. Following clinically selected treatment based on SUC, 59% (35 out of 59)
of participants reported symptom improvement, while 41% (24 out of 59) reported no
improvement. Half (12 out of 24) of the 24 participants who did not improve had at least one
uropathogen detected by EQUC, but not SUC. Collectively, these data show that SUC fails to
detect microorganisms that may be contributing to UTI symptoms. Thus, sole reliance on SUC in
these patients could lead to a suboptimal clinical outcome. It is reasonable to test whether the
use of EQUC would have led to improved symptom resolution.
Other commonly used diagnostic tests are also severely limited. Dipstick and urinalysis
tests are commonly used in the replacement of or in conjunction with SUC, but the efficacy of
these rapid tests has been questioned, especially for Gram-positive infections313. Current studies
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continue to highlight the limitations of these tests; our own unpublished data reveal a lack of
utility for these tests. For example, we collected transurethral catheterized urine samples from a
population of urogynecologically treated women (N = 199) with and without lower urinary tract
symptoms (LUTS). In this population, 17 out of 199 (8.5%) had a positive dipstick result (i.e., the
presence of white blood cells, nitrates, and/or red blood cells). Of these, one (5.9%) had bacteria
detected by SUC whereas 13 (76.5%) had bacteria detected by EQUC. In the 182 (91.5%) with a
negative dipstick, SUC detected bacteria in 17 samples (9.3%), whereas EQUC detected bacteria
in 122 (67.0%). The percentage of bacteriuric samples diagnosed by SUC (p = 0.23) or EQUC (p =
0.63) were not statistically different in the dipstick-positive or dipstick-negative groups, showing
that a positive urine dipstick test has no association with the presence of microorganisms, in this
patient population (Price, unpublished data).
The Limitations of an Escherichia coli-centric View of UTI
Standard Urine Culture was used to establish that E. coli is the most common cause of
uncomplicated UTI20

314

. Yet, other Gram-negative bacteria such as Pseudomonas aeruginosa

and several species within the Enterobacteriaceae family (e.g., species of the genera Proteus and
Klebsiella) also can cause UTIs314

315

. In addition, a few Gram-positive bacteria, like

Staphylococcus saprophyticus and Enterococcus faecalis, as well as some fungi, such as Candida
sp., have been linked to UTIs314 315. In some patients with complicating factors, the commonality
of these organisms depends on other comorbidities and demographics315. The list of
uropathogens has grown longer with the availability of more sophisticated identification tools.
Several additional microorganisms have now been classified as “emerging uropathogens”316 317.
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These microorganisms have been found in high colony counts in patients with UTI symptoms
and/or acute cystitis, but knowledge regarding their pathophysiology is unavailable.
Given that SUC was designed to detect E. coli, its results affect broad epidemiological
statements concerning UTI. For example, it is commonly stated that E. coli accounts for 80– 95%
of all uncomplicated UTIs20 314. Indeed, in the Price et al. study (Figure G.1), we showed that most
(71%) of the SUC identified pathogens were E. coli (39 out of 55). However, the biases of SUC
showed through; it identified only 24% (16 out of 67) of the non-E. coli uropathogens in this group
of women44. Furthermore, although EQUC detected E coli in 57% (43 out of 75) of women in the
UTI cohort, rarely (8 out of 43) was E. coli the only microorganism detected in these samples44.
Most patients with E. coli also had other species (35 out of 43), and frequently these additional
species were uropathogens (24 out of 35). Similarly, Wolfe et al. detailed a case study of a woman
with a positive SUC of >105 CFU/ mL of E. coli. However, 16S rRNA sequencing showed that
sequence reads of Actinobaculum and Aerococcus far exceeded those of E. coli29. Traditionally,
bacteriuria caused by multiple species (i.e., a polymicrobial UTI) has been identified at a higher
incidence in the elderly and children under the age of 10 years318. These tend to co-occur with
multispecies bacteremia318. The new data described above suggest that polymicrobial UTI might
be both common and frequently overlooked.
The presence of polymicrobial UTIs has been greatly underestimated because the
presence of multiple colony morphologies on an SUC typically prompts clinical laboratories to
dismiss these as “contamination”316. This common practice, combined with the clear screening
inadequacies of SUC, has resulted in a flawed, one-species perspective of UTIs. Although it is
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unlikely that all bacteria associated with a polymicrobial UTI are causative agents of the patient’s
symptoms, this has not been explicitly tested. It is possible that a bacterial dysbiosis is present.
Bacterial dysbioses have been associated with several other health disparities such as bacterial
vaginosis (BV) in the vagina, and inflammatory bowel disease (IBD) in the gut. Whether urinary
dysbiosis can cause UTI symptoms or results in colonization of the UTI causative organism(s)
requires further study.
The Limitations of a CFU Threshold-Based Diagnosis
Current research calls into question the utility of thresholds in UTI diagnosis and
treatment. With the incorporation of SUC in the 1950s, physicians have relied on a threshold of
≥105 CFU/mL of urine to distinguish between significant bacteriuria and bacterial contamination.
This threshold was set to identify women with pyelonephritis19. That diagnostic threshold was
subsequently applied to women with acute cystitis. Yet, multiple investigators have
demonstrated that 30– 50% of women do not meet this threshold, despite symptoms of dysuria
and urgency and frequency of urination319. Numerous recommendations have since been made
to alter this threshold44 319. Stamm demonstrated that for women with acute cystitis, use of ≥105
CFU/mL resulted in high specificity, but low sensitivity in detecting bacteriuria, whereas a lower
threshold, such as ≥102 CFU/mL, had a much higher sensitivity25. UTI symptoms and pyuria often
persist when bacteriuria at <105 CFU/mL is left untreated319 and, in catheterized patients, the
presence of bacteria between 102 and 104 CFU/mL is reported to increase to ≥105 CFU/mL if left
untreated25. All this work, however, predated the newly discovered urinary microbiota.
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Figure G.2. Average CFU/mL of Common and Emerging Uropathogens. (Price et al, 2016).
In a population of women seeking urogynecological care (Figure G.1), we found that a
single overall threshold did not distinguish between women who self-reported UTI and those
who did not. EQUC demonstrated that significant differences in CFU/mL exist between
uropathogens identified in women and that the mean CFU/mL for E. coli was near 105 CFU/mL
for both patient cohorts (Figure G.2)44. Collectively, these data suggest that not only is the ≥105
CFU/mL threshold insufficient to detect most uropathogens but lowering this threshold does not
solve the problem either and may lead to unnecessary treatment. Importantly, the presence of
uropathogens at levels that exceed the threshold, as with E. coli, does not necessarily result in
symptoms.
Figure G.3 shows a schematic of the uropathogen composition and patient symptom
resolution of the women in the self-report UTI cohort, grouped by CFU threshold. Ninety-two
percent of women (69 out of 75) had a common or emerging uropathogen present. Forty-two
percent of these women had a polymicrobial infection (defined here as at least one Gram-positive
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Figure G.3. Schematic of the uropathogen composition and patient symptom resolution of the
women in the self-report UTI cohort. Abx. antibiotics. (Price et al, 2016).
and one Gram-negative bacterium), whereas 38% had a single Gram-negative bacterium present.
Uropathogens were present at ≥105 CFU/mL in only 61% of women (46 out of 75). Of the women
with at least one uropathogen present at ≥105 CFU/mL, 83% had a single Gram-negative
bacterium present. Thirty-seven out of 46 of these women were treated with antibiotics and 1
week later, 62% reported feeling “better”. 23 women had uropathogens present at <105 CFU/mL.
Fifteen of these 23 women were not given antibiotics, and 1 week later, only 33% reported feeling
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“better”. This finding is certainly possible and entirely consistent with our thoughts about urinary
dysbioses. Like other human microbial niches, we expect an individual to be able to restore a
dysbiotic niche—i.e., some women may be able to resolve “UTI” without antibiotic treatment.
Yet, these data demonstrate that use of the ≥105 CFU/mL threshold for UTI diagnosis and
treatment is not appropriate for all women; specifically, those with polymicrobial or Grampositive bacterial infections. Importantly, by not treating these patients, their clinical outcome is
suboptimal (i.e., fewer reports feeling “better”).
Next Steps
Research efforts to improve diagnosis are expanding as the limitations of SUC become
more apparent. Clinical laboratories can immediately incorporate the EQUC technique; however,
clinicians may be challenged to interpret EQUC findings. Clinical trials to develop treatment
algorithms based on EQUC findings are needed to promote good antibiotic stewardship to
safeguard the overall health and well-being of patients being treated for UTI.
In recent years, other nonculture-based screening assays have been and are being
developed. Immunology-based diagnostics, such as the RapidBac, rely on antibody-based
detection of common uropathogens at ≥103 CFU/mL with high specificity and sensitivity320. PCR
assays, such as SeptiFast, have been assessed for use on urine samples with mild success320. And,
several kits using fluorescence in situ hybridization (FISH) previously developed for blood and
other specimens are being considered for use on urine for identification of pathogens320.
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Ongoing research will help to evaluate new treatment algorithms that incorporate the
presence of previously undetected bacteria in UTI patients. Meanwhile, the role of the SUC must
move away from the “gold standard” status. We believe that we will transition away from SUC
to more sensitive testing that balances detection of organisms with appropriate therapies,
designed to restore and maintain healthy microbial communities.
Conclusion
Should we think differently about UTI? Absolutely. We are entering a new age in UTI
diagnosis and treatment. No longer can we define a UTI microbiologically as uropathogens
invading a sterile environment. We must now acknowledge that previously ignored populations
of bacteria are contributing to urinary health, both positively and negatively. How these findings
ultimately change our precise definition of UTI remains to be seen but will certainly be profound.
The status quo clearly needs to change so that patients benefit from this updated
understanding of UTI. Improved treatment algorithms should be able to offer a spectrum of
treatment with clear goals that reduce bothersome symptoms, the risk of serious infections and
systemic illness, and unwanted collateral effects of UTI therapy. With appropriate adoption of
evidence-based research, patients should benefit from more precise diagnosis and targeted
treatment with limited deleterious collateral effects. Future research should advance our
understanding of the role of the urinary microbiota in the context of both health and disease,
and among women of differing demographics.
As with every major transition in clinical care, old habits are slow to fade away and
adjustments will be needed as we enter this new era of UTI care. Clinicians need to learn new
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methods of interpretation of UTI testing, such as EQUC. No single study will provide guidance for
all clinical situations and clinical judgment will remain a valued tool in patient care. Although
stepping away from long-held clinical patterns of care takes time, our patients deserve better
and it is time to improve care for these patients.
Addendum
This manuscript was originally intended to be a review of the literature surrounding the
misconceptions of UTIs and modern interpretations. However, it was later changed to be an
opinion paper. As a result, large portions of the paper were removed, including a section
discussing “emerging uropathogens” that included a table of relevant literature citations. This is
described below.
Emerging uropathogens are microorganisms that can be isolated and identified from
urine specimens of patients with UTI symptoms. Unlike typical urine pathogens, these are usually
but not always Gram-positive, found in lower counts, and are harder to identify. Because of the
recent advancement and availability of microbial identification technologies such as MALDI-TOF
MS, these emerging uropathogens are now being identified more frequently, despite an overall
lack of knowledge surrounding their pathogenesis317. We also frequently identify these
organisms as part of the urinary microbiota in patients with urinary symptoms44.
Common causes of UTI include Escherichia coli, Klebsiella pneumoniae, Pseudomonas
aeruginosa, Proteus sp., Enterobacter sp., Staphylococcus aureus, Staphylococcus lugdunensis,
Staphylococcus saprophyticus, and Streptococcus agalactiae (i.e. Group B Streptococcus). These
are not included in the following discussion of emerging uropathogens.
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Acinetobacter is genus of Gram-negative bacteria that have been attributed to hospitalacquired infections, particularly Acinetobacter baumannii. A comprehensive review of
nosocomial infections with Gram-negative bacilli list Acinetobacter sp. as responsible for about
1% of UTIs out of over 16,000 nosocomial UTI cases examined in the United States321. Gospodarek
et al. describe 39 isolates of Acinetobacter sp. isolated from patients with UTI, using analytical
profile index (API) strips322, and Solak et al. describes a case of a UTI with community-acquired
carbapenem-resistant A. baumannii following a renal transplant323.
Actinotignum schaalii (formerly called Actinobaculum schaalii) is Gram-positive
facultative anaerobe that was first described in the 1990s and has now been linked to UTIs
primarily in the elderly (i.e. >60 years old) and patients with underlying urological conditions324.
Only a few dozen cases of A. schaalii UTI have been described; most of these required growth
conditions, or diagnostic testing beyond the standard clinical practices325, suggesting that the
frequency of A. schaalii infection may be dramatically underrepresented. For example, Tavassoli
et al. describe a case of an A. schaalii UTI in an elderly man where the urine culture was negative,
despite evidence of Gram-positive bacilli on the Gram stain; this prompted further workup and
eventual identification and treatment of the infection326.
Aerococcus is a genus of Gram-positive alpha-hemolytic cocci that include species such as
Aerococcus urinae, Aerococcus sangunicola, and Aerococcus viridans. Morphologically, these
organisms resemble Streptococcus on BAP and are frequently mis-identified327. A study by Cattoir
et al. found 30 strains of Aerococcus sp. isolated from elderly UTI patients (average age of 73
years old), several of whom had underlying urological (31%) or systemic (48%) diseases328. Other
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case reports327 329 have shown that Aerococcus UTIs are primarily found in an elderly population.
Clinically, Aerococcus is significant, as it frequently can progress to urosepsis and infectious
endocarditis if left untreated327.
Alloscardovia omnicolens are Gram-positive bacilli, closely related to Bifidobacterium sp.
Typically, A. omnicolens are commensal members of the GI tract and mouth, but more recent
data show that they may be clinically significant in the context of the bladder and LUT.
Morphologically, A. omnicolens are similar to Actinomyces and are frequently mis-identified330.
When properly identified, studies have found A. omnicolens present at high abundance in
patients with UTI symptoms330 and, in one case, failure to initially identify and treat the organism
resulted in bacteremia in an elderly patient with uterine cancer331.
Candida is a genus of yeast, and is a common cause of fungal infections, including those
in the urinary tract. In fact, one study from the 1990s found that it was the fourth most common
cause of nosocomial UTIs in the United States332. Unlike most of the other emerging
uropathogens, Candida UTIs are not mostly limited to the elderly population333. However,
Candida sp. are not frequently grown using standard microbiologic practices and require longer
incubation times. Therefore, the Candida UTI commonly goes unnoticed and leads to
complications, such as fungal sepsis334.
Citrobacter is a genus of Gram-negative bacteria that belongs to the Enterobacteriaceae
family, which includes several common UTI-causing organisms like E. coli and K. pneumoniae.
Citrobacter includes several clinically relevant species including: Citrobacter koseri, Citrobacter
freundii, and Citrobacter braakii. Although these organisms can cause a variety of infections in
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humans, one study found that UTIs were the most common type of infection with Citrobacter sp.
(53%)335. Citrobacter should grow well under the normal laboratory conditions, but failure to
treat the organism can lead to severe complications including kidney abscesses336.
Corynebacterium riegelii is a Gram-positive aerobic bacilli that is considered to be part of
the human microbiota but can be associated with UTIs. Coryneform bacteria have traditionally
been ignored in a clinical setting (other than Corynebacterium diptheriae) and are thus not
routinely identified on clinical cultures. However, numerous case reports and studies now exist337
338

showing high abundance of C. riegelli in a range of patient demographics, some of which have

led to fatal urosepsis339. Corynebacterium urealyticum is closely related to C. riegelii and is also
associated with UTIs340 341. C. urealyticum secretes the urease enzyme to breakdown the urea in
urine, thus making the urine more alkaline. As such, it is also associated with kidney stone
formation342.
Enterococcus faecalis is a Gram-positive cocci, formerly classified as a species of
Streptococcus. E. faecalis is a common cause of nosocomial infections, including UTIs343. Unlike
most of the other emerging uropathogens, some aspects of Enterococcus pathogenesis is known,
including the presence of several virulence factors, such as cytolysin (a type of hemolysin toxin)
and adhesins for tissue attachment344. Additionally, Enterococcus sp. are clinically important due
to the presence of Vancomycin-resistant Enterococcus (VRE), which are intrinsically resistant to
several common antibiotics used to treat UTIs.
Morganella morganii is a Gram-negative rod and is usually considered a commensal
organism of the GI tract but is also associated with post-operative nosocomial infections including
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UTIs. Like C. urealyticum, M. morganii can produce urease resulting in a more alkaline urine
environment, and also the consequent production of ammonia. In one case study, this led to
hyperammonemia in an elderly patient where M. morganii was ultimately found in the urine345.
Oligella urethralis (formerly known as Moraxella urethralis) is a Gram-negative aerobic
coccobacilli that commonly presents as urosepsis in immunocompromised patients346 347.
Raoultella is a genus of Gram-negative facultative anaerobic rods that are part of the
Enterobacteriaceae family. Clinically relevant species include: Raoultella planticola and
Raoultella ornithinolytica. Like most of the emerging uropathogens, Raoultella is not normally
identified in biological specimens, but use of more advanced diagnostic instruments, like MALDITOF MS have increased detection. Resultantly, Raoultella has been found to be the causative
agent of not only UTIs, but also GI infections, skin infections, and sepsis348. These cases are
typically in immunocompromised patients, or are acquired post-operatively, and have been
found in elderly349 and pediatric patients350.
Serratia marcescens is also a member of the Enterobacteriaceae family, and it a rodshaped Gram-negative aerobic species. Morphologically, S. marcescens appears strikingly reddish
due to production of a pigment called prodigiosin. S. marcescens is a common cause of
nosocomial infections, including catheter-associated bacteremia, wound, respiratory, GI, and
urinary infections351.
Streptococcus anginosus is a Gram-positive cocci that is naturally part of the oral flora but
has been attributed to abscess formation throughout the body. Although rare, it has been
associated with UTIs in a few reported cases352 353.
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This list of emerging uropathogens is not exhaustive and will likely change as our
understanding of the pathogenesis of these organisms increases, as well as our comprehension
of the urinary microbiota becomes more complete.
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Overview of Appendix H
The following papers present data collected from WGS of several urinary bacterial isolates
that were isolated from the female urinary microbiota. The first paper compares the genomic
content of two E. coli isolates, one from a patient with UTI symptoms (E78) and one from a
patient without (E75). Both were isolated from TUC specimens using EQUC. E78 most closely
resembled UTI-associated strains of E. coli, while E75 was related to an avian strain. The second
and third papers are genome announcements of Nosocomiicoccus ampullae and Lactobacillus
crispatus, both isolated from TUC specimens using EQUC. N. ampullae could not be identified by
MALDI-TOF MS, and prior attempts to characterize it genomically showed the possibility of a
novel species. However, WGS analysis revealed that the isolate belonged to the taxon N.
ampullae. L. crispatus was isolated from a healthy control patient. Prior work shows that L.
crispatus is more abundant in healthy women compared to women with UUI15 . Therefore, this
strain has been used in several in vitro laboratory experiments aimed at understanding its
beneficial properties.
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Appendix H1: Genome Sequences and Annotation of Two Urinary Isolates of E. coli.
Abstract
The genus Escherichia includes pathogens and commensals. Bladder infections (cystitis)
result most often from colonization of the bladder by uropathogenic E. coli strains. In contrast, a
poorly defined condition called asymptomatic bacteriuria results from colonization of the bladder
with E. coli strains without symptoms. As part of an on-going attempt to identify and characterize
the newly discovered female urinary microbiota, we report the genome sequences and
annotation of two urinary isolates of E. coli: one (E78) was isolated from a female patient who
self-reported cystitis; the other (E75) was isolated from a female patient who reported that she
did not have symptoms of cystitis. Whereas strain E75 is most closely related to an avian
extraintestinal pathogen, strain E78 is a member of a clade that includes extraintestinal strains
often found in the human bladder. Both genomes are uncommonly rich in prophages.
Introduction
Clinicians typically equate the presence of bacteria in urine with infection, or, less
commonly, an ill-defined phenomenon termed “asymptomatic bacteriuria.” These and other
existing concepts are based on the long-held “sterile urine” paradigm. Recently, however,
bacterial communities (microbiota) have been discovered in the female bladder50 306 30 34 32 69 15 248
. Thus, the “sterile urine” paradigm is no longer valid.
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In an effort to provide a comprehensive view of the newly discovered female urinary
microbiota, we have established an Enhanced Quantitative Urine Culture protocol. This enhanced
culture protocol isolates bacteria from 75 to 90 % of urine samples deemed ‘no growth’ by the
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standard clinical microbiology urine culture method34 15 44. We have begun to the sequence and
annotate the genomes of these isolated bacteria.
Here, we report the full genome sequences and annotations of two of those bacteria,
Escherichia coli strains E75 and E78 isolated from female patients pursuing urogynecologic clinical
care. Strain E75 was isolated from a patient who thought that she did not have a urinary tract
infection, while E78 was isolated from a patient who thought that she did. The strains were subcultured to purity and then identified as E. coli by Matrix-Assisted Laser Desorption/IonizationTime-of-Flight Mass Spectrometry44. Strain E75 is most closely related to APEC O1, an avian
extraintestinal pathogen. In contrast, strain E78 is a member of a clade that includes
extraintestinal strains often associated with the human bladder, including uropathogenic strains
UTI89 and J89 and asymptomatic bacteriuric strain ABU83972. Both genomes are uncommonly
rich in prophages.
Organism Information
Classification and Features
Escherichia coli is a non-sporulating, Gram-negative, rod shaped bacterium. It is a
facultative anaerobe found commonly in the environment and the lower intestines of mammals
and other endotherms. Extra-intestinal strains can colonize other organs, including the urinary
bladder. Most E. coli strains are harmless constituents of the normal microbiota, but others cause
disease. For example, uropathogenic E. coli is the major case of urinary tract infections in
humans; other E. coli strains colonize the bladder without causing symptoms, a condition called
asymptomatic bacteriuria.
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Figure H1.1. Transmission Electron Microscopy Images of E78 (A) and E75 (B). E75 tended to
have electron poor intracellular inclusions (black arrow).
Transmission electron microscopy images were generated for both E75 and E78 (Figure
H1.1). Cell pellets were fixed with 0.1 % Ruthenium Red en bloc with sequential glutaraldehyde
and osmium tetroxide fixation steps. These fixed samples were dehydrated with Ethanol and
embedded in Resin. Ultrathin sections of 80 nm were mounted on copper grids, post-stained with
uranyl acetate and lead citrate and observed in a Hitachi H-600 transmission electron microscope
at 75 kV. Films were taken, negatives developed and scanned via a Microtek i800 film scanner.
PhotoShop was used to convert negatives to positive images and adjust for brightness and
contrast. The transmission electron micrographs revealed the typical E. coli rod-shape
morphology. Strain E75 tended to possess electron poor intracellular inclusions (Figure H1.1b,
black arrow). The general features of E. coli strains E75 and E78 are presented in Table H1.1.
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Table H1.1. Classification and general features of E. coli strains E75 and E78.

E. coli strains E75 and E78 were isolated from patients who sought clinical care at Loyola
University Medical Center’s Female Pelvic Medicine and Reconstructive Surgery center in
September 2014. Patients were asked the question: Do you feel that you have a urinary tract
infection? E75 was isolated from a patient who answered ‘no,’ whereas E78 was isolated from a
patient who answered ‘yes.’ Both patients were white, post-menopausal women seeking care for
Pelvic Organ Prolapse. Neither patient was taking antibiotics; both were using daily vaginal
estrogen supplement. The UTI Symptoms Assessment Questionnaire was used to characterize
the degree of severity and bother of the patients’ symptoms307. Both E. coli strains were identified
at >100,000 colony forming units per milliliter, using an Expanded Spectrum version of the
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Enhanced Quantitative Urine Culture protocol44. After they were sub-cultured to purity, MatrixAssisted Laser Desorption/Ionization-Time-of- Flight Mass Spectrometry was used to confidently
identify them as E. coli. For E75, the identification score was 2.530; for E78, the score was 2.265.
No other microbes were detected in the urine sample containing strain E75. In the urine sample
containing strain E78, Alloscardovia omnicolens (10 colony forming units per milliliter) and
Lactobacillus rhamnosus (10 colony forming units per milliliter) were also detected. Figure H1.2
shows a phylogenetic tree of the 16S rRNA sequences. 16S rRNA gene sequences include Yersinia
enterocolitica (NR_104903), E. coli IAI39 (NC_011750), E. coli O157:H7 str. Sakai (NR_074891), E.
coli K-12 substr. MG1655 (NR_102804), E. coli O157:H7 str. EDL933 (AE005174), E. coli CFT073
(AE014075), E. coli VR50 (CP011134), E. coli UMN026 (NC_011751), E. coli RRL-36 (JQ398845), E.
coli NBRC 102203 (NR_114042), E. coli U 5/41 (NR_024570), E. coli B str. REL606 (CP000819), E.
coli O104:H4 str. 2011C-3493 (NC_018658), E. coli XA04 (KR080744), E. coli APEC O1 (CP000468),
E. coli E75, E. coli E78, E. coli J96 (ALIN02000018), E. coli TOP379 149 (AOQB01000139), E. coli
UMEA 3314-1 (AWDE010000004), E. coli UTI89 (CP000243), E. coli ABU 83972 (CP001671), and
E. coli UM146 (CP002167). E. coli genome sequences typically include seven copies354.
Genome Sequencing Information
Genome Project History
The sequencing and quality assurance was performed at the Loyola Genome Facility at
Loyola University Chicago, Maywood, IL, USA. The assemblies and finishing were done at the
Lakeshore Campus of Loyola University Chicago, Chicago, IL, USA. Functional annotation was
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Figure H1.2. Phylogenetic tree based on 16S rRNA sequences. The alignment length was 1189
bp. Sequences were retrieved from NCBI and aligned using Muscle. The tree was generated by
FastTree using the GTR model. Support values are shown for branches leading to the placement
of the two bladder isolates presented here.
produced by the RAST service355 and in-house scripts for COG classification356. Table H1.2 presents
the project information and its association with MIGSversion2.0- compliance357.
Growth Conditions and Genomic DNA Preparation
E. coli strains E75 and E78 were isolated from transurethral catheterized urine specimens
of adult women with urinary symptoms44 using an Expanded Spectrum version of the previously
described Enhanced Quantitative Urine Culture protocol34. Three urine volumes (1 μL, 10 μL, and
100 μL) of each urine sample was spread quantitatively (i.e., pinwheel streak) onto 5% sheep
blood (BD BBL™ Prepared Plated Media, Cockeysville, MD), Chocolate, and Colistin Naladixic Acid

323
agars (BD BBL™ Prepared Plated Media) and incubated in 5 % CO2 at 35 °C for 48 h; 5 % sheep
blood and MacConkey (BD BBL™ Prepared Plated Media) agars incubated aerobically at 35 °C for
48 h; two CDC Anaerobic 5 % sheep blood agars (BD BBL™ Prepared Plated Media) incubated in
either Microaerophilic Campy gas mixture (5 % O2, 10 % CO2, 85 % N), or anaerobically at 35 °C
for 48 h. All agars were documented for growth (i.e., for morphologies and colony forming units
per milliliter) at 24 and 48 h. Each distinct colony morphology was sub-cultured at 48 h to obtain
pure culture for microbial identification.
Microbial

identification

was

determined

using

a

Matrix-Assisted

Laser

Desorption/Ionization-Time-of-Flight Mass Spectrometer (Bruker Daltonics, Billerica, MA) as
described34. Pure cultures were stored at -80 °C in a 2 ml CryoSaver Brucella Broth with 10 %
Glycerol, no beads, Cryovial, for preservation (Hardy Diagnostics). For genome extraction and
sequencing, the preserved pure culture isolates were grown on 5 % sheep blood agar under
aerobic conditions at 35 °C for 24 h.
Genomic DNA extraction was performed using a phenol-chloroform extraction protocol.
Briefly, cells were resuspended in 0.5 mL DNA Extraction Buffer (20 mMTris-Cl, 2 mM EDTA, 1.2
% Triton X-100 [pH 8]) followed by addition of 50uL Lysozyme (20 mg/mL), 30uL Mutanolysin,
and 5uL RNase (10 mg/mL). After a 1 h incubation at 37 °C, 80uL 10 % SDS, and 20µL Proteinase
K were added followed by a 2 h incubation at 55 °C. 210µL of 6 M NaCl and 700µL phenolchloroform were then added. After a 30-min incubation with rotation, the solutions were
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Table H1.2. Project information.

centrifuged at 13,500 RPM for 10 min, and the aqueous phase was extracted. An equivalent
volume of Isopropanol was then added, and solution was centrifuged at 13,500 RPM for 10 min
after a 10-min incubation. The supernatant was decanted, and the DNA pellet was precipitated
using 600µL 70 % Ethanol. Following ethanol evaporation, the DNA pellet was resuspended in
Tris-EDTA and stored at -20 °C.
Genome Sequencing and Assembly
DNA samples were diluted in water to a concentration of 0.2 ng/µl as measured by a
fluorometric-based method (Life Technologies, Carlsbad, CA) and 5 ul was used to obtain a total
of 1 ng of input DNA. Library preparation was performed using the Nextera XT DNA Library
Preparation Kit (Illumina, San Diego, CA) according to manufacturer’s instructions. The isolates
were barcoded, pooled and each isolate was sequenced twice, on two separate runs, using the
Illumina MiSeq platform and the MiSeq Reagent Kit v2 (300-cycles) to produce 150 bp paired-end
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reads. Sequencing reads were parsed into individual folders according to the respective
barcodes.
Sequence assembly was conducted using Velvet358 (Table H1.2). The tool VelvetOptimiser
was used to determine the best hash length; 99 was used in the two assemblies performed here.
The scaffolding software SSPACE258 was utilized for scaffold finishing. The genome of strain E75
was assembled into 463 contigs. The genome of strain E78 was assembled into 62 contigs. To
confirm that the contigs were Enterobacteriaceae (i.e. not the result of contamination), each
contig was BLASTed locally against all publicly available bacterial genomes (obtained from NCBI).
Coverage across all contigs was on average 50.95-431.17X (for E75) and 52.59-30,723.61X (for
E78). The high coverage observed within the E78 sequencing is the result of two contigs, one
4083 bp in length (coverage 72,734X) and the other 2113 bp in length (99,530X). Assembly was
repeated using the SPAdes assembler260, given its recent success in producing full plasmid
sequences359. Two plasmids were identified by the SPAdes assembler with high coverage.
Querying these two contigs against the Gen-Bank nr/nt database revealed sequence homology
to the annotated E. coli plasmids p2PCN033 (GenBank: CP006634) and pVR50G (GenBank:
CP011141) (among other E. coli plasmids), respectively. These two plasmids are listed in Table 3
as Plasmid pE78.1 and Plasmid pE78.2, respectively. All 62 E78 contigs were also assessed for
putative plasmid sequences using Plasmid-Finder360. While PlasmidFinder recognized pE78.2, it
did not detect pE78.1. The complete genome of the E78 chromosome is thus represented within
60 contigs (mean coverage 272X).
Genome Annotation
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Table H1.3. Summary of genomes: two chromosomes and two plasmids.

Genes were identified using GLIMMER using the g3-from-scratch.csh script included in
the package361. The predicted CDSs were translated using the transeq script within the EMBOSS
suite362. rRNA genes were identified by RNAmmer363 using the parameter set to identify bacterial
rRNA sequences. The program tRNA-Scan364 identified tRNA sequences, using the parameter for
bacterial tRNAs. Trans-membrane proteins were identified using TMHMM with standard
parameters365. SignalP366 predicted signal peptides. All CDSs were queried (blastp) locally against
the COG sequence dataset356 and assigned based upon their sequence homologies. CRISPR
elements were detected through CRISPR-db367. Genes with Pfam domains were ascertained via
searches of the Pfam database (E-value threshold 1.0)368.
Genome Properties
Tables H1.4 and Table H1.5 include the summaries of the properties and statistics of each
genome. Sequencing of the E78 isolate identified two plasmids (Table H1.3); the E75 isolate did
not contain any identifiable plasmid sequences. The E75 and E78 chromosomes are similar in
length and GC content: E75 is 5,032,328 bp (GC content 50.4 %), while E78 is 5,021,201 bp (GC
content 50.3 %). The genomes for E75 and E78 are predicted to include 4587 and 4743 protein
coding genes, respectively. A similar coding density is observed within the two genomes. The 85
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Table H1.4. Genome statistics.

RNA genes identified within the E75 genome include 78 tRNAs and 7 rRNAs. The E78 genome
encodes for more RNA genes: 83 tRNAs and 13 rRNAs. The scaffolds of E75 and E78 are only
annotated as having a single 16S rRNA gene, an underestimation due to recognized challenges of
assembling sequences containing genes with multiple copies such as the rRNA genes369. Thus, we
fully expect that the E75 and E78 genomes harbor rRNA gene numbers on par with the genus.
Insights from the Genome Sequence
Although E75 was isolated from a woman who reported that she did not have symptoms
of cystitis, its genome encodes proteins associated with E. coli pathogenesis, including the P pilus,
RTX toxin, and α-fimbriae. These genes were not found in E78. While the E75 strain did not
include plasmid sequences, genome sequencing of the E78 isolate contained two. Plasmid pE78.2
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Table H1.5. Number of genes associated with general COG functional categories.

was nearly identical (one mismatch) to the E. coli plasmid pVR50G, collected from urine obtained
from an individual with asymptomatic bacteriuria370.
Both genomes included a number of prophages. Each prophage sequence within the
genomes was BLASTed (blastx) to the nr/nt database revealing numerous hits to phage
sequences annotated as infecting Escherichia spp. Annotations within the genomes of the
temperate phages Lambda and P4 were identified most frequently within the E75 and E78
genomes, respectively. Table H1.6 lists the statistics of this search. The vast majority of the hits
were to phages annotated as infectious for Escherichia, Salmonella, and/or Shigella spp.
Nevertheless, prophage sequences for both temperate as well as lytic phages were identified.
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Table H1.6. Predicted sequences of phage origin and putative origin.

The abundance of prophage sequences within these two genomes exceeds that previously
identified in E. coli genomes.
Conclusions
The genome of E75, isolated from a woman who reported no symptoms of cystitis, is more
closely related to the avian extraintestinal pathogen APEC 01. The genome of E75, isolated from
a woman who reported cystitis symptoms, resides in a clade populated by human extra-intestinal
strains that are either uropathogenic or asymptomatic bacteriuric. Both genomes contain an
unusually large number of prophage sequences.
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Appendix H2: Draft Genome Sequence for a Urinary Isolate of Nosocomiicoccus ampullae
Abstract
A draft genome sequence for a urinary isolate of Nosocomiicoccus ampullae (UMB0853)
was investigated. The size of the genome was 1,578,043 bp, with an observed G+C content of
36.1%. Annotation revealed 10 rRNA sequences, 40 tRNA genes, and 1,532 protein-coding
sequences. Genome coverage was 727X and consisted of 32 contigs, with an N50 of 109,831 bp.
Manuscript
As part of an attempt to characterize the newly discovered female urinary microbiota50
, we report here the genome sequence and annotation of a strain of
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Nosocomiicoccus ampullae isolated from a female pursuing urogynecologic clinical care. This is
the first report of a human isolate of N. ampullae, a species that has not been associated with
pathogenesis.
N. ampullae strain UMB0853 was isolated from urine obtained by transurethral
catheterization of an adult woman with urinary symptoms, using the described enhanced
quantitative urine culture protocol34. Strain UMB0853 was sub-cultured to purity and analyzed
by matrix-assisted laser desorption ionization time of flight mass spectrometry44, which could not
provide an assignment. In contrast, 16S rRNA gene sequence analysis identified the isolate as N.
ampullae. A pure culture was stored at -80°C in a 2-ml CryoSaver brucella broth with 10% glycerol,
and no beads (Hardy Diagnostics). For genome extraction and sequencing, the preserved pure
culture isolate was grown on 5% sheep blood agar (BD BBL prepared plated medium) under 5%
CO2 at 35°C for 48 h.
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To extract genomic DNA, cells were resuspended in 0.5 ml of DNA extraction buffer (20
mM Tris HCl, 2 mM EDTA, 1.2% Triton X-100 [pH 8]), followed by the addition of 50 µl of lysozyme
(20 mg/ml), 30 µl of mutanolysin, and 5 µl of RNase (10 mg/ml). After a 1-h incubation at 37°C,
80 µl of 10% SDS and 20 µl proteinase K were added, followed by a 2-h incubation at 55°C. Two
hundred ten microliters of 6 M NaCl and 700 µl of phenol-chloroform were added. After a 30min incubation with rotation, the solutions were centrifuged at 13,500 rpm for 10 min, and the
aqueous phase was extracted. An equivalent volume of isopropanol was added, and the solution
was centrifuged at 13,500 rpm for 10 min after a 10-min incubation. The supernatant was
decanted, and the DNA pellet precipitated using 600µl of 70% ethanol. Following ethanol
evaporation, the DNA pellet was resuspended in Tris-EDTA (TE) and stored at -20°C.
Genomic DNA was diluted in water to a concentration of 0.2 ng/µl, as measured by a
fluorometric-based method (Life Technologies); 5 µl was used to obtain a total of 1 ng of input
DNA. Library preparation of the isolated DNA was performed using the Nextera XT DNA library
preparation kit. Two libraries were prepared and sequenced during separate runs on the MiSeq
sequencer (Illumina) using the MiSeq reagent kit version 2 (300 cycles). The two runs produced
11,221,884 reads in total. Assembly was performed using Velvet358 (k = 99), followed by SSPACE258
for scaffolding, producing 32 contigs, which varied from 2,642 bp to 337,531 bp (N50, 109,831
bp), with an average coverage of 727X. The NCBI Prokaryotic Genome Annotation Pipeline355
detected 10 rRNA genes, 40 tRNA genes, 1,532 protein-coding sequences, and 35 pseudogenes.
Six clustered regularly interspaced short palindromic repeat sequences (CRISPRs) were found367.
The genome size was 1,578,043 bp, with an observed G+C content of 36.1%.
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Accession Number(s)
The draft whole-genome project for N. ampullae strain UMB0853 has been deposited at
DDBJ/EMBL/ GenBank under accession number MBFG00000000. Raw sequence reads are
deposited at DDBJ/EMBL/GenBank under accession number SRR3828836.
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Appendix H3: Draft Genome Sequence of a Urinary Isolate of Lactobacillus crispatus
Abstract
While Lactobacillus crispatus contributes to the stability of normal vaginal microbiota, its
role in urinary health remains unclear. As part of an on-going attempt to characterize the female
urinary microbiota, we report the genome sequence of an L. crispatus strain isolated from a
woman displaying no lower urinary tract symptoms.
Manuscript
As part of an attempt to characterize the newly discovered female urinary microbiota30 34
32 69 306 248 29 15

we report the genome sequence and annotation of a strain of Lactobacillus crispatus

isolated from the bladder of an adult female. This is the first genome report of a urinary isolate
of L. crispatus, a species associated with bladder health15.
Using the expanded spectrum version44 of the enhanced quantitative urine culture
protocol34, L. crispatus strain C037 was isolated from a healthy female not displaying any urinary
symptoms. The strain was sub-cultured to purity, analyzed by matrix-assisted laser
desorption/ionization-time-of-flight mass spectrometry, and pure cultures were stored at -80°C
in 2 mL CryoSaver Brucella broth with 10% glycerol, no beads, cryovials (Hardy Diagnostics). For
genome extraction, the preserved pure culture isolate was grown on 5% sheep blood agar
(BDBBL™ prepared plated media) under 5% CO2 at 35°C for 24 h.
To extract genomic DNA, cells were resuspended in 0.5 mL DNA extraction buffer
(20mMtris-Cl, 2mMEDTA, 1.2% Triton X-100 [pH8]) followed by addition of 50µL lysozyme (20
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mg/mL), 30 µL mutanolysin, and 5 µL RNase (10 mg/mL). After a 1-h incubation at 37°C, 80 µL
10% SDS and 20 µL proteinase K were added followed by a 2-h incubation at 55°C. Then, 210 µL
of 6M NaCl and 700 µL phenol-chloroform were added. After a 30-min incubation with rotation,
the solution was centrifuged at 13,500 rpm for 10 min, and the aqueous phase extracted. An
equivalent volume of isopropanol was added; after a 10-min incubation, the solution was
centrifuged at 13,500 rpm for 10 min. The supernatant was decanted, and the DNA pellet
precipitated using 600 µL 70% ethanol. Following ethanol evaporation, the DNA pellet was
resuspended in tris-EDTA and stored at -20°C.
Genomic DNA was diluted in water to a concentration of 0.2 ng/µl. Library preparation
was performed using the Nextera XTDNA library preparation kit (Illumina) according to
manufacturer’s instructions with 1 ng of input DNA. The isolate was sequenced twice, on two
separate runs, using the Illumina MiSeq platform and the MiSeq reagent kit v2 (300-cycles).
Sequence assembly was performed using Velvet257 (k = 99) followed by SSPACE258 for scaffolding.
L. crispatus C037 was assembled into 96 scaffolds with a genome coverage of 113X. The scaffolds
include 2.147 Mbp of sequence with a G+C content of 36.6%. Gene annotations were performed
using GLIMMER361 and tRNAScan364 identifying 2,096 protein coding genes, 65 RNA (tRNA and
rRNA) genes, and four clustered regularly interspaced short palindromic repeats (CRISPR)367. The
16S rRNA gene sequence of the urinary isolate C037 was identical to that of the species’ type
strain L. crispatus ST1 (NR_074986), an avian enteric strain. One scaffold (10,704 bp in length)
produced a hit to the 16,663 bp L. crispatus plasmid pLc17 (KR052811); while a significant
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proportion of the plasmid sequence was detected, a complete, circularized assembly was not
possible.
Accession Number(s)
The draft whole-genome project for L. crispatus C037 has been deposited at
DDBJ/EMBL/GenBank under accession number MAKH00000000.
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APPENDIX I
GENOMES OF GARDERELLA STRAINS REVEAL AN ABUNDANCE OF PROPHAGES WITHIN THE
BLADDER MICROBIOME
Malki K., Shapiro J.W., Price T.K., Hilt E.E., Thomas-White K., Sircar T., Rosenfeld A.B., Kuffel G.,
Zilliox M.J., Wolfe A.J., Putonti C. Genomes of Gardnerella Strains Uncover an Abundance of
Prophages within the Bladder Microbiome. PloS one 2016;11:e0166757, PMID: 27861551.
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Overview of Appendix I
This paper assessed the genomic content of four Gardnerella isolates from the female
urinary microbiota and compared the data to other available genomes. The data show high
abundance of prophage-like sequences within these genomes. Some of the phage sequences are
unique to certain Gardnerella genomes suggesting that phages may be involved in the evolution
of urinary bacteria.
Abstract
Bacterial surveys of the vaginal and bladder human microbiota have revealed an
abundance of many similar bacterial taxa. As the bladder was once thought to be sterile, the
complex interactions between microbes within the bladder have yet to be characterized. To
initiate this process, we have begun sequencing isolates, including the clinically relevant genus
Gardnerella. Herein, we present the genomic sequences of four Gardnerella strains isolated from
the bladders of women with symptoms of urgency urinary incontinence; these are the first
Gardnerella genomes produced from this niche. Congruent to genomic characterization of
Gardnerella isolates from the reproductive tract, isolates from the bladder reveal a large
pangenome, as well as evidence of high frequency horizontal gene transfer.
Prophage gene sequences were found to be abundant amongst the strains isolated from
the bladder, as well as amongst publicly available Gardnerella genomes from the vagina and
endometrium, motivating an in-depth examination of these sequences. Amongst the 39
Gardnerella strains examined here, there were more than 400 annotated prophage gene
sequences that we could cluster into 95 homologous groups; 49 of these groups were unique to
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a single strain. While many of these prophages exhibited no sequence similarity to any lytic phage
genome, estimation of the rate of phage acquisition suggests both vertical and horizontal
acquisition. Furthermore, bioinformatic evidence indicates that prophage acquisition is ongoing
within both vaginal and bladder Gardnerella populations. The abundance of prophage sequences
within the strains examined here suggests that phages could play an important role in the species’
evolutionary history and in its interactions within the complex communities found in the female
urinary and reproductive tracts.
Background
Gardnerella, a member of the Bifidobacteriaceae family, is a genus of facultative
anaerobes within the vaginal microbiota of both healthy women and those diagnosed with
bacterial vaginosis (BV)371 372 373 374. Similarly, our group found Gardnerella in urine collected from
adult female bladders by transurethral catheter29

35 34 37.

This corresponds with microbiome

studies of voided urine: Gardnerella was present regardless of sex or symptom status69 30 67 248
375.

Furthermore, the bladders of healthy individuals include other bacterial taxa also detected

within the vaginal microbiota29 35 34 69 32 30 37 248 375. To date, thirty-nine G. vaginalis isolates from
the vagina or endometrium have been sequenced376

377 378 379 380,

including four complete

genomes; the remaining genomes are represented as scaffolds or contigs. Analysis of G. vaginalis
genomes found evidence of a large pangenome that consists of a modestly sized core genome in
addition to strain-specific genes376 381.
Prior investigations of G. vaginalis genomes from the reproductive tract have uncovered
indications of substantial horizontal gene transfer (HGT), including the acquisition of genes from

339
other human-associated taxa376 381 382. In addition to natural competence, G. vaginalis may also
include phage-mediated gene transfer, as coding regions of bacteriophage (phage) origin are
ubiquitous within these genomes381. Similarly, genomic sequences from other bacterial taxa
within the vaginal microbiota also contain parts of or entire temperate phage genomes383 384.
Prior studies have posited that lysogenic lactobacilli phages could contribute to a shift in
the vaginal microbiota leading to BV (for a review, see Turovskiy et al 2011374). Phages have been
found to play a crucial role in the structuring of microbial communities, including those residing
within the human body385, driving bacterial genetic diversity386 and adaptation to changes in the
environment387. Although several phages induced from vaginal lactobacilli have been
identified388

389,

currently no phages have been characterized for Gardnerella. While evidence

suggests that phages are likely contributors to HGT in commensal communities383

387 390,

the

extent of their effect on the human microbiome is just now being explored391 392 393. Within many
other microbiota, including the bladder, the virome remains largely unexplored.
Herein, we present the genomic sequences of four Gardnerella strains isolated from the
bladders of adult women with symptoms of urgency urinary incontinence (UUI). Comparative
genomics between these strains and publicly available isolates revealed a highly conserved core
genome across the bladder and vaginal isolates. Analogous to prior observations for this species,
the Gardnerella strains isolated from the bladder also contain a large number of prophage gene
sequences. The pervasiveness of prophage sequences in Gardnerella genomes from both the
female urinary and reproductive tracts motivated our thorough bioinformatic investigation. A
comprehensive interrogation of the over 400 annotated prophage gene sequences identified
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here provides insight into the adaptive ability of Gardnerella, as well as the larger community of
phages within the female urinary community.
Materials and Methods
Strain Isolation and DNA Extraction
The Gardnerella and Gardnerella vaginalis isolates were isolated from transurethral
catheterized urine specimens of adult women with UUI35 using the previously described
Enhanced Quantitative Urine Culture (EQUC) protocol34. Microbial identification was determined
using a Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDITOF MS, Bruker Daltonics, Billerica, MA) as described34. Pure cultures were stored at -80°C in a 2
ml CryoSaver Brucella Broth with 10% Glycerol, no beads, Cryovial, for preservation (Hardy
Diagnostics).
The preserved pure culture isolates were grown on CDC Anaerobic 5% sheep blood
(Anaerobic BAP) agar (BD BBL™ Prepared Plated Media) under anaerobic conditions at 35°C for
48 hours. MALDI-TOF MS was performed for species/genus verification. An isolated colony was
transferred to 5mL tryptic soy broth (TSB) supplemented with 10% fetal bovine serum (FBS) and
grown under anaerobic conditions at 35°C for 48 hours. 1 mL of culture was collected, and cells
were resuspended in 1 mL of buffered saline peptone (PBS).
Genomic DNA extraction was performed using a phenol-chloroform extraction protocol.
Briefly, cells were resuspended in 0.5 mL DNA Extraction Buffer (20 mM Tris-Cl, 2 mM EDTA, 1.2%
Triton X-100, pH 8) followed by addition of 50 μL Lysozyme (20mg/mL), 30 μL Mutanolysin, and
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Table I.1. Genomic characteristics of four Gardnerella strains isolated from female bladders.

5 μL RNase (10 mg/mL). After a 1-hour incubation at 37°C, 80 μL 10% SDS, and 20 μL Proteinase
K were added followed by a 2-hour incubation at 55°C. 210 μL of 6 M NaCl and 700 μL phenolchloroform were then added. After a 30-minute incubation with rotation, the solutions were
centrifuged at 13,500 RPM for 10 minutes, and the aqueous phase was extracted. An equivalent
volume of Isopropanol was then added, and solution was centrifuged at 13,500 RPM for 10
minutes after a 10-minute incubation. The supernatant was decanted, and the DNA pellet was
precipitated using 600 μL 70% Ethanol.
Genome Sequencing, Assembly, and Annotation
DNA samples were diluted in water to a concentration of 0.2 ng/μl as measured by a
fluorometric-based method (Life Technologies) and 5 μl was used to obtain a total of 1 ng of input
DNA. Library preparation was performed using the Nextera XT DNA Library Preparation Kit
(Illumina) according to manufacturer’s instructions. The isolates were barcoded, pooled and each
isolate was sequenced twice, on two separate runs, using the Illumina MiSeq platform and the
MiSeq Reagent Kit v2 (300-cycles) to produce 150 bp paired-end reads. Sequencing reads were
parsed into individual folders according to the respective barcodes.
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The following protocol produced an assembly with the least number of scaffolds and the
highest overall coverage (Table I.1). Reads were paired using Geneious (Biomatters Ltd.,
Auckland, New Zealand) for each isolate for each sequencing run. De novo assembly was
performed, combining the two runs per isolate, using the Geneious plug-in for Velvet257 (k = 99).
Sequence contigs were then extended and scaffolds were constructed using the tool SSPACE258.
Resulting contigs were again assembled using the Geneious de novo assembler at the MediumLow sensitivity setting. Annotations were performed for each of the contigs using the RAST
annotation pipeline394, as well as the BASys bacterial annotation system395. CRISPR arrays were
predicted using CRISPRdb396. A local nucleotide database was created for each strain using the
protein coding regions predicted by RAST. Each predicted coding region was then reciprocally
BLASTed (blastn). Genes were determined to be homologs if the query coverage and the
sequence identity were both greater than 70%.
Raw sequencing reads as well as assembled contigs are available through NCBI: Gv18-4
(SRA: SRX1688291, WGS: LWSP00000000), Gv23-12 (SRA: SRX1688198, WGS: LWSQ00000000),
G26-12 (SRA: SRX1688301, WGS: LWSR00000000), and G30-4 (SRA: SRX1688300, WGS:
LXJL00000000). Table I.S1 lists the annotated protein functionalities within the four strains;
annotations are available and can be queried through NCBI.
Phylogenetic Analysis
Single Gene Trees: 16S rRNA gene sequence analysis was performed by excising the full
length 16S sequence from the assembled genomes and querying each against the NCBI nr/nt
database via blastn. Sequences producing full-length hits were collected and aligned using
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MUSCLE253. The phylogenetic tree was constructed using RAxML265 and visualized using
PhyloWidget397. Phylogenetic analysis of the VLY gene sequences was aligned using ClustalW398.
As before, RAxML and PhyloWidget were used to derive and visualize the tree, respectively.
Core Genome Tree. While 43 strains are presently publicly available through NCBI for G.
vaginalis, this study considered only those that were (1) isolated from the vagina or endometrium
and (2) are documented within the literature399 376 377 378 379 380. Table I.S3 lists the 35 publicly
available strains meeting these criteria. The species tree was derived by first identifying the core
set of genes within the 39 Gardnerella strain sequences (genome, scaffold, or contig collections).
Incomplete genomes (scaffold or contig status) were retrieved from NCBI. Their sequences were
individually submitted to the RAST server and annotated394. For the three complete genomes, G.
vaginalis 409–05 (NC_013721), 14019 (NC_014644), and HMP9231 (NC_017456), the ffn format
files were retrieved from NCBI’s FTP site. The core gene set was determined by first creating a
local nucleotide BLAST database with the coding regions annotated for the G. vaginalis 14019
strain. Annotated coding regions in other sequences were BLASTed locally (using BLASTn, evalue<10-5), returning the top hit only. Genes producing hits in all other 38 genomes were
identified as members of the core genome. The core gene set contains 183 genes (Table I.S4), a
significantly smaller group than previously used when considering smaller numbers of strains376
381.

Each core gene and its orthologs were aligned using ClustalW398. Alignments were

concatenated producing a concatenated gene alignment (super-gene alignment) using an inhouse script in R (available upon request). The Maximum-likelihood tree was derived using
RAxML265. Trees were visualized using PhyloWidget397.

344
Assessing Presence/Absence of Coding Regions of Interest
The absence of coding regions identified with key carbohydrate metabolism
functionalities within the G26-12 and G30-4 genome analyses was experimentally verified via
PCR. Coding regions within the Gv18-4 genomic sequence with the following functional
annotations were retrieved: (1) chitin and N-acetylglucosamine utilization, (2) deoxyribose and
deoxynucleoside catabolism, (3) D-gluconate and ketogluconates metabolism, (4) formaldehyde
assimilation, (5) lactose and galactose uptake and utilization, (6) trehalose biosynthesis, uptake
and utilization, and (7) xylose utilization. In total, 22 genes were identified. Each was BLASTed
against the nr/nt database, specifying the genus Gardnerella, to retrieve orthologs from other
strains. All annotations within the GenBank files retrieved were manually inspected verifying
similar confirmed/predicted protein functions. Primers were designed for each gene, targeting
conserved regions amongst all orthologs, and obtained from Eurofins MWG Operon (Huntsville,
AL). In total, 66 PCR reactions were conducted, testing each of the primer pairs against: Gv18-4
(serving as a positive control), G30-4, and nuclease-free water (serving as a negative control). All
Gv18-4 reactions produced amplicons of the expected sizes. G30-4 and the negative controls did
not produce amplicons. Primer sequences are listed in Table I.S6.
Prophage Identification
Genes annotated as phage or viral in origin were extracted from each of the genome
sequence annotations. Local BLAST databases were used for both identifying the orthologous
clusters of prophage sequences, as well as the putative origin of prophage clusters. First, a local
nucleotide database was created, including all of the sequences predicted as phage from all 39
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Gardnerella strains. Each individual putative phage coding region sequence was then BLASTed
(blastn) against this local database (maximum 100 results), detecting identity to itself, as well as
similarity to other sequences. Each hit was further qualified; hits with a sequence identity and
query coverage greater than or equal to 80% were considered homologous. Once clusters were
identified, the sequences within the cluster were aligned using ClustalW and manually inspected
to guarantee correct clustering (File S1 [not included here due to size]).
Identification for the origin of each cluster was performed similar to above; the local
database used for conducting blastn searches was the complete collection of viral RefSeq coding
regions. The all.fna.tar.gz file was retrieved from ftp://ftp.ncbi.nlm.nih.gov/genomes/Viruses/.
Homologs were called when query coverage was ≥80%. The sequence identity threshold was
considerably lower ≥35%. A cluster was considered to show no homology to any RefSeq coding
region if it did not meet both of these conditions.
Estimating Rates of Phage Acquisition
Rates of phage acquisition were estimated using the R package corHMM400, which
implements a Hidden Markov Model to estimate the rate of evolution of traits occurring across
a phylogeny. Each phage was encoded as a binary trait according to its presence/absence as
visualized in Figure I.3. Using this method to estimate the “rate of evolution,” therefore, provides
a meaningful proxy for the rate of phage acquisition across the tree. For any given phage, the
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Figure I.1. Characterization of predicted coding regions. (A) Homology and (B) annotated
frequency within the four bladder Gardnerella strains. (**p value <0.05 between the two
predicted Gardnerella strains and the two predicted G. vaginalis strains; *p value <0.1). Strains
are represented using the same colors in both panels.
rate of acquisition is expected to scale with its total number of occurrences in the tree, and
horizontally transmitted phages are expected to have faster relative rates than vertically
transmitted phages (as seen in Figure I.4).
Results
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Figure I.2. Phylogenetic analysis of Gardnerella strains. Maximum Likelihood species tree of
Gardnerella strains based upon sequence homology within the core gene set. (A) Phylogenetic
tree listing branch supports and distinction of the four clades within the tree. Numbers within
black circles indicate the number of homologous genes within each clade and the core
Gardnerella genome. (B) Maximum Likelihood tree including branch lengths and isolation
information with respect to location and diagnosed symptom. Strains isolated from the bladder
and sequenced in this study are labeled in red; strains listed in green were isolated from the
vagina/endometrium of BV+ patients; strains in light blue were isolated the
vagina/endometrium of STD+ patients. All remaining strains (indicated in black font) were
isolated from the vagina or endometrium.
Genome Features
Four Gardnerella strains were previously isolated from the bladders of four different
female patients with symptoms of urgency urinary incontinence15 35. While MALDI-TOF identified
two of these strains as G. vaginalis (henceforth denoted as Gv18-4 and Gv23-12), it did not
resolve the other two strains to the species level (G26-12 and G30-4). 16S rRNA gene sequencing
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for each isolate confirmed the strains belong to the genus Gardnerella (Figure I.S1). All four
isolates were sequenced, assembled, and annotated and are publicly available via NCBI. The
genomic sequences varied slightly in size from 1.48 to 1.62 Mbp (Table I.1).
Homologs, as well as strain-specific coding regions, were identified within the genomes
of these bladder Gardnerella strains (Figure I.1A). Although Gv18-4 and Gv23-12 were
indistinguishable on the basis of their 16S rRNA sequences (Figure I.S1), instances of both strainspecific gene acquisition and loss within their genomes were detected (Table S1 [Not included
here due to size]). Annotation also revealed the type I CRISPR/Cas system in all four genomes,
with multiple CRISPR loci per genome (Table I.1).
Comparison between the two strains identified by MALDI-TOF analysis to the species level
(Gv18-4 and Gv23-12) and those identified to the genus level (G26-12 and G30-4) revealed
disparity in the number of genes with the annotated functionalities of carbohydrate metabolism,
membrane transport, and cell wall and capsule synthesis (Figure I.1B); however, the genetic
variation observed between the Gv and G strains is statistically significant only for loci that
regulate carbohydrate metabolism. Consistent with previous studies that illustrated the ability of
different Gardnerella strains to ferment and use different carbohydrates399, annotation of the
genome for G26-12 and G30-4 suggest that they lack coding regions with the following
functionalities: chitin and N-acetylglucosamine utilization, trehalose biosynthesis, trehalose
uptake and utilization, lactose and galactose uptake and utilization, lactose utilization,
formaldehyde assimilation, xylose utilization, deoxyribose and deoxynucleoside catabolism, Dgluconate and ketogluconates metabolism. The absence of these coding regions within the G26-
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12 and G30-4 genome sequences was confirmed experimentally via PCR.
The genomes of these bladder strains were further examined with respect to the
presence/absence of coding regions associated with virulence, as previously defined by Yeoman
et al.381 (Table I.S2). Genes associated with biofilm formation (glycosylases and
glycosyltransferases) and epithelial adhesion (fimbria/pili) were identified in all four genomes;
however, type-1 fimbrial precursors were found only within the genomes of G26-12 and G30-4.
Genes associated with antibiotic/antimicrobial resistance, including those that encode the ABCtype multidrug transport system and the DedA protein (which has been shown to be required for
drug resistance in E. coli)401 were present within all four genomes. However, tetracycline
resistance proteins were encoded within the Gv18-4, Gv23-12, and G26-12 strains, but not in the
G30-4 strain. Genes associated with protection or evasion from the immune response (alkyl
hydroperoxide reductase and Rib-family surface protein) were found within all four of the
bladder strains. Furthermore, the coding region for the vaginolysin (VLY) gene, which is selective
for human cells381 402, was highly conserved within all four strains, in spite of the two amino acid
substitutions that separate the Gv18-4 strain from the type strain for the genus ATCC 14019
(Figure I.S2). Finally, the Gardnerella strains G26-12 and G30-4 contained an annotated rRNA
methyltransferase associated with Gardnerella cytotoxicity381 and with hemolytic activity in other
bacterial species403. Interestingly, only the Gv18-4 and Gv23-12 strains contained genes that
encode sialidase, which has been experimentally proven to contribute to mucin degradation in
BV377, although presence of the gene is not predictive of actual sialidase activity404 and thus
warrants further investigation.
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Phylogenetic Analysis and the Gardnerella Pangenome
In an effort to assess the similarity/difference between Gardnerella strains isolated from
the female bladder and those isolated from the female reproductive system, all publicly available
sequenced strains isolated from the vagina or endometrium were retrieved from NCBI (Table
I.S3). This set includes 35 complete, scaffold, or contig genome sequences. Extending beyond the
16S rRNA gene marker, the evolutionary history of this genus was considered by investigating
sequence homologies within the “core” Gardnerella genome (Methods; Table I.S4. In total, 183
genes were identified as belonging to this core gene set, less than identified in prior studies of
far fewer genomes376

381.

As shown in Figure I.2, the strains isolated from the bladder are not

monophyletic, establishing that the Gardnerella core genome does not correlate with a single
isolation location. Examination of all coding sequences for all 39 investigated genomes revealed
no gene(s) exclusive to the bladder strains. While the vast majority of the genes within the core
set demonstrated an evolutionary history identical to that of the species tree (Figure I.2), genes
indicative of intragenic recombination, such as VLY (Figure I.S2), were also identified.
Nevertheless, the species tree (Figure I.2) we derived largely concurs with the tree produced by
Ahmed et al376. In comparison to the phylogeny of Ahmed et al., which included 17 genomes and
a core genome of 473 genes, their Group 3 and 4 are both contained within Clade A in Figure I.2.
Our Clade B corresponds to their Group 2 and our Clade C is within their Group 1; only two of the
genomes within Clade C were included in the prior analysis of Ahmed et al. As expected, each
clade had significantly more homologous genes (404, 799, 762 and 635 for Clades A through D,
respectively) (Figure I.2A), a likely residual of under sampling, biased sampling, and/or clade-
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specific functional conservation.
The bladder strains G26-12 and G30-4 were determined to belong to Clade A, which also
includes three strains isolated from BV+ patients (Figure I.2B). While the phylogeny based upon
the core gene set does not correspond with isolation location, some clades appear to have a
higher incidence of strains isolated from patients diagnosed as BV+. Because genes associated
with virulence are not exclusively present within genomes isolated from symptomatic patients376
381,

it is not surprising that several are included within the core gene set identified here. The lack

of correspondence between phylogenetic history and symptoms is supported by prior studies,
which hypothesized that gene expression variation within G. vaginalis strains may trigger BV
development405 and single point mutations may result in greater potential for cytotoxicity399.
Thus, there appears to be no single gene that correlates with BV symptoms. This is, however, not
surprising given that G. vaginalis strains are present within both the BV- and BV+ vagina406, and
it is but one of the taxa that coincides with BV symptoms373.
Mobile Elements
The four bladder Gardnerella genomes varied in their number of ORFs predicted to be
viral (bacteriophage) in origin. The number of prophage gene sequences per genome had no
correspondence to evolutionary history (Figure I.2). This is true for the four Gardnerella strains
isolated from the bladder, as well as for the 35 strains isolated from the reproductive system. For
example, the G. vaginalis strain JCP8522, a vaginal BV+ strain377, has only one ORF annotated as
a phage gene. In contrast, the Gv18-4 strain sequenced as part of this study contains the most,
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Figure I.3. Presence/absence of prophage gene sequences from larger clusters. Clusters of
orthologous prophage genes found within five or more of the 39 Gardnerella genomes are
shown using a distinct color. Open circles indicate that the prophage sequences belonging to the
particular cluster show no/poor sequence homology to characterized lytic phages. Closed circles
indicate moderate (query coverage ≥80%, nucleotide sequence identity ≥35%) to high homology
to a phage genome sequence record in NCBI. Nucleotide sequence identity for the prophage
genes in each cluster is indicated by the bar chart at the top of the figure.
33, phage-like gene sequences within a Gardnerella genome to date. Table I.S5 (not included due
to size) lists the 442 annotated prophage genes within the 39 genomes examined. Due to the
incomplete (scaffold/contig) status of the majority of the genomes included in the analysis here,
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we evaluated predicted prophage genes (median length 939 bp) individually.
To identify homologs, the nucleotide sequences for all annotated prophage genes across
all Gardnerella genomes were examined. Based upon the combination of sequence identity and
query coverage, 104 clusters of orthologous prophage genes were identified. Within larger
clusters, prophage homolog sequences were highly conserved between genomes. Forty-nine
clusters, however, included only a single prophage gene sequence, indicative of frequent
independent acquisition of viral sequences. This is further supported by the variation in prophage
genes identified within strains isolated from the same patient. While the genomes of JCP8481A
and JCP8481B (both isolated from a single patient as denoted by A and B377) contain the same
set of prophage gene sequences, the genomes of JCP8151A/B and JCP8017A/B do not (Figure I.3,
Table I.S5); this captures the likely prevalence of lysogenic phage excision, as well as gene loss,
events. Likewise, the genomes of 00703Bmash, 00703C2mash, and 00703Dmash, which are from
sequential isolates from the same patient376, vary in their prophage gene content (Figure I.3,
Table I.S5). This diversity, even within a single patient, suggests intra-host prophage gene
gain/loss.
Examination of the 37 largest prophage gene clusters suggested that prophage
introduction within the Gardnerella genus has occurred by both vertical and lateral inheritance.
These larger clusters include orthologous prophage gene sequences present within five or more
Gardnerella genomes; the most pervasive prophage gene sequences were present within 21 of
the 39 Gardnerella genomes examined here. As shown in Figure I.3, several of the larger
prophage gene clusters have representatives across the entire phylogenetic tree and some sets
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of clusters appeared to have been lost within particular lineages. Half of the 104 prophage gene
clusters identified exhibit little to no resemblance to any sequence within the current GenBank
nr/nt nucleotide database of characterized phage sequences; this includes several of the
prophage genes within the larger clusters (represented as open circles in Figure I.3). For those
prophage gene sequences that exhibit homology to characterized phage genes, hits were
frequently identified to the genomes of Bacillus-, Mycobacterium-, and Staphylococcus- infecting
phages. Previous targeted gene surveys of the bladder have routinely found Staphylococcus
within the community34 37 15.
Although Gardnerella-infecting phages have yet to be isolated, the abundance of
prophage gene sequences in the genomes (Table I.S5) and the presence of the CRISPR/Cassystem (Table I.1) suggests that phages capable of infecting Gardnerella spp. exist. This
assumption is corroborated by prior analyses of spacer sequences within 21 G. vaginalis
genomes, in which 70.7% of the spacers showed no homology to sequences within the GenBank
database382. While many of the clusters exhibiting homology to sequences in GenBank identified
lytic phages annotated as infecting an array of different bacterial genera, analysis of eleven of
the 104 clusters resulted in the description of phages thought to infect a single taxon. These
included several of the larger clusters shown in Figure I.3: clusters 12, 15, and 30 were found to
have homology to Bacillus-infecting phages; clusters 22 and 35 were determined to be similar to
phages infecting Mycobacterium species; while cluster 29 exhibited a likeness to Staphylococcusinfecting phages (Table I.S5). Yet, all of these phages are of the family Siphoviridae. Homologies
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Figure I.4. Determining mechanisms of prophage gene acquisition. Colors correspond with the
cluster colors in Figure L.3. Dashed lines are the mean value for each axis.
identified for these prophage sequences provide a foundation for future work in the isolation of
Gardnerella-specific phages. More broadly, these prophage gene sequences provide insight into
the phage community within the human microbiota.
Lateral gene acquisition is ubiquitous; however, there is a strong discordance between
the evolutionary tree (Figure I.2; Figure I.S1) and trees derived from strain:prophage gene
presence/absence profiles (results not shown). To distinguish clusters acquired via HGT from
those linearly inherited from a common ancestor, the genomes of 39 Gardnerella strains were
examined. Clusters were compared given the number of occurrences and the rate of evolution
of viral infection (Figure I.4). From this analysis, two groups can be observed. The phage gene
clusters in the top right quadrant appear to have evolved quickly relative to their prevalence
across strains and have likely been integrated into the Gardnerella genomes via HGT. In contrast,
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the four clusters in the bottom right quadrant appear to have been acquired by vertical
transmission. Thus, we hypothesize that prophage integration has been occurring over a long,
time scale.
Given this evidence of phage-host interactions and the results of recent studies
illuminating the vital contributions of viruses within other human microbiota407 392 393, one can
surmise that phages are playing a significant role within both the bladder and reproductive
system communities.
As the bladder microbiota have only recently been discovered and subsequently
surveyed29 35 34 32 30 37 50 15, their microbiome remains largely uncharacterized. The presence of
the CRISPR/Cas system within the four Gardnerella strains sequenced here suggest phages are
present and prolific within the bladder. Given the existence of both Gardnerella and Lactobacillus
within both the female bladder29 35 34 37 15 and the vaginal226 408 409 microbiota, some insight can
be gleaned from the latter. It is likely that phages play an important role in bacterial genome
evolution and potentially disease in both niches. Evidence of phages has previously been found
within the vaginal microbiota388

410.

The incidence of Lactobacilli phages may have medical

significance, as vaginal lactobacilli may be culled or repressed by phages within the microbiota
leading to BV388 374. Increased prophage numbers within L. crispatus genomes from the human
vagina relative to avian isolates suggests high frequency of phage within the human
microbiota384. Phage-like sequences within both the bladder and vaginal bacterial microbiomes–
prophage sequences as well as CRISPR spacer sequences–often show little to no homology to
characterized sequenced phage species, insinuating that numerous genetically diverse phages
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have yet to be discovered.
Conclusion
Comparison of four new bladder-associated Gardnerella genomes to genomes from the
reproductive system identifies strain-specific and lineage-specific genes, suggesting a large
Gardnerella pangenome may exist. There is, however, no distinct difference between strains
isolated from a particular niche. Of particular interest is the high incidence of prophages within
the Gardnerella genomes and the variability in the number per strain, as well as their putative
origin. While prior studies into the prophages of vaginal lactobacilli propose that phage may play
a significant role in community dynamics within the vagina, this proposal has yet to be empirically
tested. The Gardnerella genome analyses conducted here find evidence of ancient, as well as
contemporary, phage infection; the fact that isolates from the same individual vary in their
prophage gene sequences supports the latter. Bioinformatic inspections of prophage and CRISPR
spacer sequences find little to no correspondence with characterized phage sequences,
suggesting that Gardnerella-infecting phages exist, although they have yet to be isolated in the
laboratory.
Nonetheless, evidence presented here suggests that phages play a role within the
complex microbial communities of both the reproductive tract and the bladder, warranting
future exploration of their viromes. The continued isolation and empirical characterization of
Gardnerella species from the human microbiota is necessary to learn whether microbiomevirome interactions help to establish and maintain ones’ bladder health and, if so, how
perturbations of this equilibrium result in bladder pathologies.
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Supplemental Materials

Figure I.S1. Phylogenetic tree based on the 16S rRNA gene.
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Table I.S2. Presence/absence of virulence genes within the four bladder isolates.
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Figure I.S2. Phylogenetic analysis of VLY gene. (A) Amino acid sequence alignment of four
bladder Gardnerella isolates and representatives from other clades; clades are indicated to the
left of each strain/isolate name. Mismatches within the alignment are highlighted (red/blue
text). (B) Maximum likelihood phylogenetic tree for the VLY gene. Bran supports are indicated.

361
Table I.S3. List of 35 genomes retrieved from NCBI for genome comparisons.
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APPENDIX J
A CROSS-SECTIONAL PILOT COHORT STUDY COMPARING STANDARD URINE COLLECITON TO
THE PEEZY MIDSTREAM DEVICE FOR RESEARCH STUDIES INVOLVING WOMEN
Southworth E., Hochstedler B., Price T.K., Joyce C., Wolfe A.J., Mueller E.R. A Cross-Sectional
Pilot Cohort Study Comparing Standard Urine Collection to the Peezy Midstream Device for
Research Studies Involving Women. Female Pelvic Med Reconstr Surg. 2019;25(2):e28-e33,
PMID: 30807432
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Overview of Appendix J
This paper assessed the efficacy of the Peezy midstream urine collection device. MSU
specimens are the simplest type of urine specimen to obtain, but unlike TUC specimens, the
contribution of the bacteria are less clear, and the level of standardization is low. Therefore, use
of a device like Peezy could provide an improved and standardized MSU specimen. Use of Peezy
to study the urinary microbiota or provide more accurate specimens for UTI diagnosis is
promising. Our data show that MSU specimens collected by use of Peezy have lower bacterial
abundance, similar to TUC specimens. These findings suggest that use of Peezy provides a more
bladder-centric urine specimen compared to regular MSU specimens.
Abstract
Objectives
An expanded quantitative urine culture (EQUC) protocol was used to compare the
microbial abundance and diversity of voided urines obtained using a standard urine collection
and using the Peezy midstream device.
Methods
62 female participants were assigned to 1 of 3 cohorts. One cohort used a standard cleancatch mid-stream urine protocol that included a castile soap wipe, the second cohort used a
Peezy mid-stream collection device with castile soap wipe and the third used the Peezy device
without a castile soap wipe. Each participant watched a video that detailed the collection
method. Prior to using the castile soap wipe, a peri-urethral swab was obtained to measure periurethral microbe abundance. Demographics and pelvic floor symptoms were assessed by

364
validated questionnaires. Microbes were detected using EQUC. Diversity within each sample was
analyzed using alpha diversity measures.
Results
Paired peri-urethral and urine samples for each woman were analyzed and compared for
species abundance, richness, and diversity. Bacterial abundance in voided urine was significantly
lower in both Peezy cohorts compared to standard clean catch. Bacterial profiles of Peezycollected urines differed significantly in diversity indices and had significantly reduced colonyforming units. In contrast, within the standard clean-catch cohort, the urine and peri-urethral
profiles only differed significantly by abundance and species richness with higher abundance and
richness in voided urine.
Conclusions
Compared to standard clean catch method, the Peezy urine collection device with and
without the castile soap wipe resulted in urine with lower bacterial abundance. Voided urine
collected by Peezy may reduce post-bladder microbial contribution.
Introduction
Contrary to long-held dogma, the bladder is not sterile; instead, it contains communities
of microbes commonly referred to as the bladder microbiota. 16S ribosomal RNA gene
sequencing provided DNA evidence of bacteria in transurethral catheterized urine specimens
that were deemed “negative” by standard urine culture in women with and without urinary tract
symptoms29. An enhanced urine culture method called EQUC (expanded quantitative urine
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culture) showed that these bacteria were alive34. This is not surprising because standard urine
culture methods preferentially grow Escherichia coli and fail to reproducibly grow many microbes
that were identified using 16S ribosomal gene sequencing15 44. In contrast, EQUC involves plating
larger amounts of urine onto various culture media and incubating samples in multiple conditions
for a longer length of time. As such, EQUC reproducibly cultures more diverse organisms than
standard urine culture, making it a more suitable culture technique to use when studying the
lower urinary tract microbiota34. Analyzing urine samples obtained by transurethral
catheterization by 16S ribosomal RNA sequencing and EQUC, our team and others have defined
the bladder microbiota and associations of microbes with specific lower urinary tract symptoms32
.

30 15 35 37 31 63 303

Because transurethral catheterization for urine collection is invasive, it has limitations as
a universal collection method for research of the microbiota of the lower urinary tract, especially
for longitudinal studies involving community populations. Although voided urine samples are
more practical, the typical “clean catch” method has been shown to contain high amounts of
microbes associated with the vagina, vulva, and surrounding skin411 243 412. The presence of these
contaminants can complicate the accurate depiction of lower urinary tract microbiota57.
The standard clean catch (SCC) method involves using a cleansing castile soap wipe,
urinating the initial urine stream into the toilet, and then collecting midstream urine into a sterile
cup243. Typically, there is no standard instruction for how much urine should be voided before
midstream collection. The lack of standardization of the standard clean catch procedure and the
varying physical characteristics of women may contribute to the contamination of these urine
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samples with the microbes residing in the urethra, the vagina, vulva and surrounding skin. Before
microbiome researchers can use voided urine, we need to develop or identify a “cleaner” catch
voided urine sample. Forte Medical has developed a device (Peezy) that discards ~10 mL of urine
prior to collection into a sterile container. Previous studies of Peezy’s efficacy have produced
conflicting results using standard urine culture techniques413

.
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In this study, we used EQUC to compare microbial abundance and diversity of voided
urines obtained by a standard urine collection method to the microbial abundance and diversity
of voided urines collected using the Peezy midstream device. We hypothesized that voided urines
obtained using Peezy have less “contamination” from the urethra, peri-urethra, vulva and vagina
than voided samples obtained by typical clean catch techniques.
Methods
This is a cross-sectional pilot cohort study of participants from 2 randomized trials with
Loyola IRB-approval. The first trial randomized 40 women into one of two arms of a voided urine
collection study (standard clean catch technique using a castile soap wipe versus a “modified
clean catch” approach that did not involve a castile soap wipe). Only the 20 women enrolled into
the standard clean catch method using a castile soap wipe were included in this analysis because
our “modified technique” demonstrated no superiority over the standard clean catch technique.
The second trial randomized 42 women to use the Peezy device with a castile soap wipe versus
using the Peezy device without the castile soap wipe.
Recruitment
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Adult women 18 or older who were employees or students of the Loyola University
Hospital System and/or Loyola University Health Sciences Campus were invited to participate in
these IRB approved trials. Women were included if they could speak fluent English, were
ambulatory, could view a video-based instruction for the collection method, and answered yes
to the query “do you feel your bladder is full enough to void.” Women were excluded if they had
a history of recurrent UTI (3 or more UTI in the last year or 2 in the last six months), pelvic organ
prolapse, urinary urgency incontinence or urinary stress incontinence. Other exclusion criteria
included current use of antibiotics, post-menopausal status, pregnancy, current menstruation or
the use of intermittent self-catheterization. Following a signed informed consent, participants
completed three forms: 1. Demographic information 2. the Pelvic Floor Distress Inventory-20414
and 3. the UTISA questionnaire307 in which the participant rates the severity and bother for seven
common UTI symptoms. All participants were enrolled by the first author, all samples were
collected at the Loyola University Outpatient Urogynecology clinic and the Clinical Research
Office, and all bacterial detection was performed by members of the Wolfe lab. Participants
received a $5 gift card.
Sample Collection
After watching a video detailing proper sample collection, each participant provided a
peri-urethral swab and voided urine specimen. For women in the standard clean catch cohort,
participants washed their hands with soap and water before collecting a peri-urethral sample
with the provided swab. Participants then used a castile soap wipe to cleanse the peri-urethral

368

Figure J.1. Peezy midstream urine collection device.
area by wiping from front to back before partially voiding into the toilet, then collecting
midstream urine in a sterile cup. For women in the two Peezy cohorts, participants washed their
hands with soap and water before collecting a peri-urethral sample with the provided swab. Half
of the participants, randomized to the castile soap wipe, then used the castile soap wipe to
cleanse the peri-urethral area by wiping from front to back before voiding into the device (Peezy
with wipe, PZW). The other half voided into the device without using a castile soap wipe (Peezy
without wipe, PZ). The Peezy device was held below the perineum and the participants urinated
into the device, which allows the initial stream (~10 milliliters of urine) to pass through into the
toilet (Figure J.1). This initial stream causes the expansion of a cellulose sponge that, when
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engaged, forces the midstream urine into a sterile urine collection tube through a one-way valve.
Once finished voiding, participants held the Peezy device over the toilet for 10 seconds to allow
excess urine to flow through the device. Participants then unscrewed the collection tube from
the device and placed the provided cap onto the tube.
Culture Method and Identification of Bacterial Isolates
Paired urine and peri-urethral samples were cultured using EQUC, which consists of
inoculation of 0.1mL urine onto diverse types of media (BAP, chocolate agar, colistin and nalidixic
acid (CNA) agar, CDC anaerobe 5% BAP) with incubation in diverse environments (5% CO2,
aerobic conditions, Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobic conditions) all at
35°C for 48 hours. The level of detection for EQUC is 10 CFU/mL, represented by 1 colony of
growth on any of the plates. EQUC is designed to isolate a broad array of Gram-negative and
Gram-positive bacteria, including anaerobes and fastidious bacteria that grow slowly. Each
morphologically distinct colony type was counted and isolated on a fresh plate of the same media
to prepare a pure culture that was used for identification with Matrix-Assisted Laser
Desorption/Ionization Time-of Flight (MALDI-TOF) mass spectroscopy.
Statistical Analysis
REDCap (Research Electronic Data Capture) was utilized for the implementation of the
random allocation sequence, which was only revealed upon participant enrollment just prior to
sample collection. At the conclusion of recruitment, bacterial compositions of voided urines and
peri-urethral swabs were analyzed using alpha diversity measures. Richness, or the number of
microbial species present, was calculated by comparing the number of observed species for each
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cohort and by each method of collection. Evenness, or the distribution of microbial species within
the sample, was calculated with Pielou’s Index. This index ranks samples from 0 to 1, with 1 being
completely even. A sample with a Pielou index score close to 1 contains all species present in
nearly equal abundance, while a lower index score indicates that certain species are more
abundant than others. Abundance, or the number of organisms, was calculated with Fisher’s
alpha diversity Index. Communities with higher Fisher’s Index values indicate multiple species are
present in low quantities. Combined interactions were calculated with the Shannon (richness and
evenness) and Simpson (richness and abundance) indices. Communities with a large number of
species that are present in similar amounts will have higher Shannon diversity values. A sample
with high Simpson diversity has similar numbers of individuals in each species present, regardless
of the number of species present. In all cases, higher index values describe more diverse samples.
Patient demographics and clinical characteristics were compared using Wilcoxon rank-sum tests
for continuous variables and chi-square or Fisher’s exact tests for nominal variables. Wilcoxon
signed rank tests were used to assess for statistical significance of within-group diversity
differences in colony forming units and diversity measures. Kruskal-Wallis tests on swab
measures were used to assess the statistical significance of differences in colony forming units
between groups. P-values < 0.05 were considered statistically significant.

Analyses were

performed using RStudio 1.1.423 (Boston, MA).
Results
The 62 female participants were predominantly Caucasian, had a mean age of 28.8 years
(range 22 -52) and a mean BMI of 25.7 kg/m2 (17.2-47.2 kg/m2). There were 20 participants in
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Table J.1. Participant Demographics, UTISA, and PFDI-20.

the standard clean catch cohort (SCC), 21 participants in the Peezy with periuretheral wipe cohort
(PZW) and 21 participants in the Peezy without periurethral wipe cohort (PZ). The cohorts did not
differ significantly in their demographics, PFDI-20, or UTISA symptoms scores (Table J.1). The
cohorts also represent healthy participants with no urinary tract symptoms and minimal pelvic
floor symptoms.
Microbiota Abundance
We investigated the abundance data by comparing the distribution of CFU/ml of voided
urines to the mean CFU/ml of the paired peri-urethral swabs (that were obtained prior to the
periurethral wipe). For both Peezy cohorts, the voided urines had significantly lower CFU/ml than
their paired peri-urethral swabs (Table J.2). In contrast, there was no difference in CFU/ml of
SCC-obtained urines and their paired peri-urethral swabs.
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Table J.2. Abundance Data Show the Peezy Device Reduces CFUs in Voided Urine Compared
with Internal Control.

PZW Versus PZ Microbiome Diversity
Microbiota of voided urines from both Peezy cohorts had significantly lower diversity
values than those of paired peri-urethral swabs in Pielou (evenness), Shannon (richness and
evenness), and Simpson (richness and abundance) indices (Figure J.2A-C, Supplemental Table
J.1). Voided urines from both Peezy cohorts did not differ significantly from paired peri-urethral
microbiota in species richness or abundance (Fisher’s Index).
SCC Microbiome Diversity
Microbiota from the paired SCC urine and peri-urethral swabs did not differ significantly
in diversity values for Pielou, Shannon, or Simpson indices. The only diversity measures in which
the microbiota from the paired SCC voided urine and peri-urethral swab significantly differed
were Fisher’s Index (Figure J.2D, Supplemental Table J.1) and species richness, with the
microbiota of the voided urine obtained by SCC having significantly greater relative abundance
and richness than the paired peri-urethral microbiota.
Discussion

373

Figure J.2. Comparison of diversity between Peezy and SCC cohorts. Diversity measures for
voided urines were compared to the paired periurethral swab. Median values are marked with
black lines. Significant differences are denoted with underlined P values
The aim of this study was to better understand the use of voided urine in microbiome
studies. Obtaining catheterized urine is a rate limiting step for many researchers who want to do
large community-based studies. Urine in the bladder has a low biomass and as urine from the
bladder traverses the urethra, the urethral meatus, peri-urethra and vulvovaginal skin, the
biomass increases. This has been previously demonstrated by the greater relative abundance of
voided urine compared to catheterized urine44

. Therefore, voided urine that has a higher
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relative abundance than its matched peri-urethral swabs (which were obtained prior to urination
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and the castile wipe) is suggestive of a higher post-bladder contribution to the voided urine. The
microbiota abundance data in this study demonstrates that standard clean catch urines produced
similar CFU/ml to paired peri-urethral specimens. In contrast, however, Peezy urines yielded
significantly lower CFU/ml than peri-urethral specimens. This contrast suggests that the Peezy
device, used with or without peri-urethral cleansing, is more capable of reducing post bladder
contributions to voided urines than the standard clean catch method.
One of the challenges of this study was how to measure “better” voided urine collection.
Previous studies have clearly demonstrated that voided and catheterized urine are distinct247.
Since each woman has her own bacterial community, we needed to compare voided urine
specimens to possible contamination from the urethra, peri-urethra, vulva and vagina. We used
diversity indices to compare the microbial communities between each participants voided urine
and peri-urethra. These indices are used to describe environmental and bacterial communities.
The periurethral vs. voided urine Shannon, Simpson and Pielou indices were significantly
different for Peezy but not for standard clean catch participants. This indicates that the periurethral and voided urine microbial communities were not distinct for standard clean catch but
were distinct for Peezy.
Bladder urine microbiota composition has been shown to have a lower biomass than the
peri-urethral skin and vagina. As a result, a voided urine obtained by a “cleaner” catch should
yield lower bacterial abundance which is measured by The Fischer alpha diversity index. The
Fischer diversity index was significantly higher for the clean catch voided urine compared to the
periurethral representing microbial contributions from the post bladder structures such as
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urethra, vulva and vagina. Significant differences in Fischer diversity indices were not seen for
the Peezy cohort. Likewise, the castile soap wipe does not appear to reduce peri-urethral
contribution to urine, therefore it may prove to be an unnecessary and possible confounding step
to voided urine collection.
Our study includes some important strengths. The first is the use of EQUC. While other
studies have examined the efficacy of Peezy, this is the first to utilize EQUC for sample analysis.
Standard urine culture method, utilized in previous studies, preferentially cultures Escherichia
coli, whereas EQUC has been shown to capture a wider range of bacterial species34 44. A sensitive
assay, such as EQUC, is necessary to assess a novel urine collection since the bladder and vaginal
microbiome have considerable overlap. In this study, the use of EQUC for analysis of the samples
enabled us to identify a broader and more accurate range of bacteria, thus providing a better
understanding of bacterial profiles both from the peri-urethra and LUT.
Another strength was our standardized protocol. Urine collection directions are given in
a variety of ways to patients; verbally, with written instructions, or sometimes no instruction at
all. In this study, the content and delivery of directions for each protocol was controlled through
the use of a pre-recorded video lasting approximately 2 minutes with both written and visual
instruction of the collection protocol. Participants were then given an opportunity to ask
clarifying questions before sample collection. The Peezy packaging contains visual and written
instructions. Because one possible source of vaginal and skin bacterial contribution to standard
urine collection may be inappropriate collection technique due to lack of standardized directions,
this study sought to minimize this confounding factor through consistent delivery of directions.
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Additionally, by utilizing written, visual, and verbal communication of directions, the diverse
learning needs of participants was addressed. The use of standardized directions does mean that
the results of this study may not be generalizable to studies where women are not given specific
directions on how to collect their voided urine sample. The Peezy device may provide an
additional level of standardization to the urine collection process by controlling the amount of
initial voided urine (~10ml) discarded prior to collection. Rather than the requirement to start
and stop one’s stream of urine, the device allows for one continuous void. This may be the
mechanism by which Peezy provides urine with lower bacterial abundance.
Finally, we used a peri-urethral swab as an internal control for vulvo-vaginal flora. Voided
urine not obtained by a clean catch has been shown to include microbiota that reside outside of
the LUT, most often due to vulvo-vaginal contribution, which cannot be easily distinguished from
bladder microbiota. To better ascertain the origin of bacterial species, we utilized paired periurethral swabs as a control for each individual. By understanding the bacterial profile of the periurethral area, we could then compare this sample to the voided urine sample. Through this
method we assessed the bacterial contribution of post-urethral bacteria to a given voided urine
sample. This allowed us to evaluate methods of collection for reduction in post-urethral
contribution. The Peezy device showed a significant reduction in post-urethral contribution.
We acknowledge that our study also had limitations. This study was limited by the number
of participants and the use of a “healthy” control population as clearly demonstrated by the low
UTISA and PFDI-20 subscales of the participants. Because this was a pilot study, future research
should focus on increasing the number and diversity of participants. Because the participants
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were young and relatively fit (avg. BMI: 24.7 kg/m2), they may have presented few issues with
urine collection which is not the case in older urogynecologic patients. The generalizability of
Peezy for future LUT microbiome research still needs to be assessed.
Our hope is that, as a research community, we can develop methods that allow us to
obtain voided urines with a little post-bladder contamination as possible. We recommend that
EQUC be utilized in future research studies due to its increased sensitivity and ability to capture
a broad range of bacteria. We found in this small study that the use of the PEEZY device suggests
a step towards a “cleaner catch”. We also found the peri-urethral wipe was not a necessary step.
Additional studies and methods will validate or refute our findings and build on the current
research of using voided urines to study the microbiome of the lower urinary tract.
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